Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:mercury coordination entity
go back to main search page
Accession:CHEBI:36561 term browser browse the term
Synonyms:related_synonym: mercury coordination compounds;   mercury coordination entities


show annotations for term's descendants           Sort by:
mercury diacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Tgfb1 transforming growth factor, beta 1 decreases activity ISO mercuric acetate results in decreased activity of TGFB1 protein CTD PMID:31652400 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
mercury dibromide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1bg alpha-1-B glycoprotein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of A1BG mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of A1BG mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:94,383,333...94,387,922
Ensembl chr 7:94,383,333...94,387,496 		JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ABCB6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ABCC4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCC4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ABCG2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCG2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abhd14a abhydrolase domain containing 14A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ABHD14A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD14A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697 		JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ABHD3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492 		JBrowse link
G Acp3 acid phosphatase 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP3 mRNA CTD PMID:27188386 NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Actg2 actin gamma 2, smooth muscle multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA CTD PMID:27188386 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn3 actinin alpha 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ACTN3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTN3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Adam28 ADAM metallopeptidase domain 28 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAM28 mRNA CTD PMID:27188386 NCBI chr15:50,184,286...50,250,605
Ensembl chr15:50,127,516...50,250,526 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ADAM9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAM9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ADAMTS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ADAMTS12 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS12 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:61,759,975...62,054,716
Ensembl chr 2:61,759,987...62,054,716 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADAMTS2 mRNA CTD PMID:27188386 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 decreases expression ISO mercuric bromide results in decreased expression of ADAMTS20 mRNA CTD PMID:26272509 NCBI chr 7:127,275,538...127,407,325
Ensembl chr 7:127,275,538...127,407,296 		JBrowse link
G Adcy2 adenylate cyclase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ADCY2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ADCYAP1R1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973 		JBrowse link
G Adgrg2 adhesion G protein-coupled receptor G2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ADGRG2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRG2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:38,106,067...38,231,286
Ensembl chr  X:38,106,067...38,231,331 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA
mercuric bromide results in increased expression of ADGRG6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023 		JBrowse link
G Adm adrenomedullin multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADM mRNA CTD PMID:27188386 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Afap1l2 actin filament associated protein 1-like 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of AFAP1L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AFAP1L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:265,969,368...266,065,951
Ensembl chr 1:265,969,368...266,065,943 		JBrowse link
G Afp alpha-fetoprotein multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AFP mRNA CTD PMID:27188386 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression ISO mercuric bromide results in increased expression of AGTR1 mRNA CTD PMID:27188386 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Ajap1 adherens junctions associated protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AJAP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AJAP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:169,190,477...169,302,938
Ensembl chr 5:169,190,477...169,304,515 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AKR1C1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AKR1C2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AKR1C3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALCAM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALDH1A3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALDH1L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALDH3B2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH3B2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:210,679,749...210,694,187
Ensembl chr 1:210,675,302...210,694,155 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALDH3B2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH3B2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:210,617,090...210,629,886
Ensembl chr 1:210,622,639...210,629,879 		JBrowse link
G Alkal2 ALK and LTK ligand 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALKAL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKAL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:53,223,204...53,232,794
Ensembl chr 6:53,223,341...53,233,011 		JBrowse link
G Alpk2 alpha-kinase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ALPK2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALPK2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985 		JBrowse link
G Ambp alpha-1-microglobulin/bikunin precursor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AMBP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMBP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:81,583,622...81,593,850 		JBrowse link
G Amer2 APC membrane recruitment protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AMER2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMER2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:38,701,509...38,711,817
Ensembl chr15:38,701,657...38,705,633 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of AMIGO2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMIGO2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Andpro androgen regulated protein multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CST4 mRNA CTD PMID:27188386 NCBI chr 3:157,171,739...157,178,262
Ensembl chr 3:157,171,740...157,178,104 		JBrowse link
G Ank1 ankyrin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANKRD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751 		JBrowse link
G Ankrd33b ankyrin repeat domain 33B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANKRD33B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD33B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANTXR1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANTXR1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Anxa1 annexin A1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANXA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa2 annexin A2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANXA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa3 annexin A3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANXA3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa4 annexin A4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ANXA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513 		JBrowse link
G Anxa9 annexin A9 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA9 mRNA CTD PMID:27188386 NCBI chr 2:185,562,174...185,572,560
Ensembl chr 2:185,562,174...185,572,560 		JBrowse link
G Aox1 aldehyde oxidase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of AOX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AOX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Apba2 amyloid beta precursor protein binding family A member 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of APBA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APBA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117 		JBrowse link
G Apcdd1 APC down-regulated 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of APCDD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APCDD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356 		JBrowse link
G Apoa1 apolipoprotein A1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of APOA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa2 apolipoprotein A2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of APOA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410 		JBrowse link
G Arap2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ARAP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ARHGAP18 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA CTD PMID:27188386 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arhgef25 Rho guanine nucleotide exchange factor 25 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ARHGEF25 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF25 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:64,891,260...64,898,382
Ensembl chr 7:64,890,879...64,898,697 		JBrowse link
G Arhgef9 Cdc42 guanine nucleotide exchange factor 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ARHGEF9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:63,929,168...64,087,267
Ensembl chr  X:63,929,176...64,087,104 		JBrowse link
G Arid5b AT-rich interaction domain 5B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ARID5B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,306,712...20,489,686 		JBrowse link
G Arl9 ARF like GTPase 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ARL9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:31,511,845...31,521,038
Ensembl chr14:31,511,330...31,520,988 		JBrowse link
G Arrb1 arrestin, beta 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ARRB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859 		JBrowse link
G Arrdc2 arrestin domain containing 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ARRDC2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARRDC2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158 		JBrowse link
G Arx aristaless related homeobox decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ARX mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARX mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:62,010,097...62,022,009
Ensembl chr  X:62,010,097...62,022,002 		JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ASCC3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCC3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ASF1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASF1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ASIC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASIC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ASNS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASNS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Asphd1 aspartate beta-hydroxylase domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ASPHD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPHD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:190,983,506...190,987,440
Ensembl chr 1:190,983,506...190,987,440 		JBrowse link
G Astn1 astrotactin 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ASTN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASTN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:73,070,754...73,388,902
Ensembl chr13:73,071,267...73,388,895 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA CTD PMID:27188386 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atl3 atlastin GTPase 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ATL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510 		JBrowse link
G Atp10d ATPase phospholipid transporting 10D (putative) increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ATP10D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP10D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:36,265,696...36,366,460
Ensembl chr14:36,265,696...36,366,460 		JBrowse link
G Atp6v1c1 ATPase H+ transporting V1 subunit C1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ATP6V1C1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V1C1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ATP8A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP8A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ATP8B1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP8B1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027 		JBrowse link
G B9d1 B9 domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of B9D1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:46,685,410...46,698,580
Ensembl chr10:46,686,133...46,695,428 		JBrowse link
G Bag2 BAG cochaperone 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BAG2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BAG3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BAMBI mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAMBI mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BBS9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BBS9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:29,288,846...29,713,889
Ensembl chr 8:29,289,997...29,713,880 		JBrowse link
G Bche butyrylcholinesterase decreases expression ISO mercuric bromide results in decreased expression of BCHE mRNA CTD PMID:26272509 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl11a BCL11 transcription factor A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BCL11A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2l11 Bcl2-like 11 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of BCL2L11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bco1 beta-carotene oxygenase 1 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCO1 mRNA
mercuric bromide results in decreased expression of BCO1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDNF mRNA CTD PMID:27188386 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bend4 BEN domain containing 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of BEND4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:41,106,206...41,142,572
Ensembl chr14:41,106,763...41,136,979 		JBrowse link
G Bend6 BEN domain containing 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BEND6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194 		JBrowse link
G Best4 bestrophin 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of BEST4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEST4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:135,858,774...135,865,624
Ensembl chr 5:135,860,018...135,863,707 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BHLHE40 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bmp4 bone morphogenetic protein 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BMP4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Bmp5 bone morphogenetic protein 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BMP5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp6 bone morphogenetic protein 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BMP6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261 		JBrowse link
G Bmp7 bone morphogenetic protein 7 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BMP7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bnc1 basonuclin zinc finger protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BNC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:145,326,881...145,352,534
Ensembl chr 1:145,326,892...145,353,510 		JBrowse link
G Bnipl BCL2 interacting protein like multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIPL mRNA CTD PMID:27188386 NCBI chr 2:185,507,591...185,519,415
Ensembl chr 2:185,507,593...185,517,582 		JBrowse link
G Boc BOC cell adhesion associated, oncogene regulated decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of BOC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:69,628,703...69,704,009
Ensembl chr11:69,628,660...69,704,004 		JBrowse link
G Bspry B-box and SPRY domain containing multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BSPRY mRNA CTD PMID:27188386 NCBI chr 5:80,942,974...80,965,157
Ensembl chr 5:80,942,979...80,988,154 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of BST2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BST2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of BTG2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BTG2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression ISO mercuric bromide results in increased expression of BTG3 mRNA CTD PMID:26272509 NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082 		JBrowse link
G C11h3orf70 similar to human chromosome 3 open reading frame 70 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of C3ORF70 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C3ORF70 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:92,850,327...92,900,608
Ensembl chr11:92,850,327...92,900,608 		JBrowse link
G C13h1orf226 similar to human chromosome 1 open reading frame 226 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1ORF226 mRNA
mercuric bromide results in decreased expression of C1ORF226 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:85,063,350...85,071,435
Ensembl chr13:85,063,350...85,353,741 		JBrowse link
G C1s complement C1s increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of C1S mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1S mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C3h11orf96 similar to human chromosome 11 open reading frame 96 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of C11ORF96 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C11ORF96 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:100,375,474...100,376,717
Ensembl chr 3:100,351,199...100,378,346 		JBrowse link
G C4h2orf68 similar to human chromosome 2 open reading frame 68 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of C2ORF68 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C2ORF68 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:105,960,543...105,966,509
Ensembl chr 4:105,960,751...105,966,508 		JBrowse link
G C5h1orf210 similar to human chromosome 1 open reading frame 210 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of C1ORF210 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:137,334,142...137,337,300
Ensembl chr 5:137,334,142...137,337,300 		JBrowse link
G C8h11orf52 similar to human chromosome 11 open reading frame 52 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C11ORF52 mRNA CTD PMID:27188386 NCBI chr 8:59,977,717...59,984,706
Ensembl chr 8:59,976,623...59,990,901 		JBrowse link
G C9h6orf141 similar to human chromosome 6 open reading frame 141 decreases expression ISO mercuric bromide results in decreased expression of C6ORF141 mRNA CTD PMID:26272509 NCBI chr 9:27,521,466...27,525,644
Ensembl chr 9:27,521,466...27,525,644 		JBrowse link
G Ca13 carbonic anhydrase 13 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA13 mRNA CTD PMID:27188386 NCBI chr 2:88,649,643...88,680,763
Ensembl chr 2:88,649,625...88,680,763 		JBrowse link
G Ca4 carbonic anhydrase 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916 		JBrowse link
G Cab39l calcium binding protein 39-like increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CAB39L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAB39L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742 		JBrowse link
G Cachd1 cache domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CACHD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CACHD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:120,527,224...120,752,685
Ensembl chr 5:120,526,770...120,772,877 		JBrowse link
G Cacnb2 calcium voltage-gated channel auxiliary subunit beta 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CACNB2 mRNA CTD PMID:27188386 NCBI chr17:82,473,097...82,818,564
Ensembl chr17:82,473,129...82,818,564 		JBrowse link
G Cadm2 cell adhesion molecule 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CADM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:17,994,856...18,971,895
Ensembl chr11:17,994,856...18,971,448 		JBrowse link
G Calb1 calbindin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CALB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CAMK2D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CAMK2N1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CARS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Casp3 caspase 3 decreases activity ISO mercuric bromide results in decreased activity of CASP3 protein CTD PMID:26272509 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp8 caspase 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CASP8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Cav1 caveolin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CAV1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav2 caveolin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CAV2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Cc2d1b coiled-coil and C2 domain containing 1B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CC2D1B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CC2D1B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:128,581,962...128,596,045
Ensembl chr 5:128,581,994...128,596,022 		JBrowse link
G Ccar2 cell cycle and apoptosis regulator 2 decreases expression ISO mercuric bromide results in decreased expression of CCAR2 mRNA CTD PMID:26272509 NCBI chr15:51,622,519...51,637,911
Ensembl chr15:51,622,464...51,637,774 		JBrowse link
G Ccbe1 collagen and calcium binding EGF domains 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCBE1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCBE1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:61,849,821...62,093,876
Ensembl chr18:61,853,149...62,094,075 		JBrowse link
G Ccdc102a coiled-coil domain containing 102A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCDC102A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC102A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:10,108,553...10,124,652
Ensembl chr19:10,109,364...10,124,652 		JBrowse link
G Ccdc136 coiled-coil domain containing 136 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCDC136 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC136 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975 		JBrowse link
G Ccdc177 coiled-coil domain containing 177 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCDC177 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC177 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:106,135,827...106,142,413
Ensembl chr 6:106,134,333...106,144,441 		JBrowse link
G Cckbr cholecystokinin B receptor decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCKBR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCKBR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CCN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCN2 mRNA CTD PMID:27188386 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccng2 cyclin G2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CCNG2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206 		JBrowse link
G Cd40 CD40 molecule decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CD40 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CD40 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd44 CD44 molecule multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA CTD PMID:27188386 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd82 Cd82 molecule decreases expression ISO mercuric bromide results in decreased expression of CD82 mRNA CTD PMID:26272509 NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744 		JBrowse link
G Cd9 CD9 molecule increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CD9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cdc14b cell division cycle 14B multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC14B mRNA CTD PMID:27188386 NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164 		JBrowse link
G Cdh1 cadherin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDH1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh10 cadherin 10 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDH10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:70,357,217...70,578,332 		JBrowse link
G Cdh13 cadherin 13 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDH13 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH13 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh3 cadherin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDH3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257 		JBrowse link
G Cdh6 cadherin 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDH6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:63,801,630...63,952,309
Ensembl chr 2:63,806,135...63,952,287 		JBrowse link
G Cdh7 cadherin 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CDH7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDH7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:27,186,223...27,336,076
Ensembl chr13:27,187,257...27,336,023 		JBrowse link
G Cdh9 cadherin 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CDH9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDH9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:67,954,708...68,094,371
Ensembl chr 2:67,955,166...68,094,365 		JBrowse link
G Cdk19 cyclin-dependent kinase 19 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CDK19 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:45,324,911...45,465,121
Ensembl chr20:45,324,862...45,465,121 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDK6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDK6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDKN1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDKN2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CDS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CEBPB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA CTD PMID:27188386 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CELF5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Cep85l centrosomal protein 85-like increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CEP85L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEP85L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:33,111,114...33,282,182
Ensembl chr20:33,115,438...33,282,238 		JBrowse link
G Cfap263 cilia and flagella associated protein 263 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CFAP263 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP263 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,503,066...9,522,957 		JBrowse link
G Cfap300 cilia and flagella associated protein 300 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CFAP300 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP300 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:13,465,016...13,483,679
Ensembl chr 8:13,464,984...13,483,839 		JBrowse link
G Cfap91 cilia and flagella associated protein 91 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CFAP91 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:75,919,129...75,962,786
Ensembl chr11:75,919,142...75,962,785 		JBrowse link
G Cfap96 cilia and flagella associated protein 96 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CFAP96 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP96 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:53,023,623...53,048,176
Ensembl chr16:53,023,878...53,048,965 		JBrowse link
G Cftr CF transmembrane conductance regulator increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CFTR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CFTR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHAC1 mRNA CTD PMID:27188386 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chka choline kinase alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CHKA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHKA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chmp4c charged multivesicular body protein 4C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CHMP4C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHMP4C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850 		JBrowse link
G Chodl chondrolectin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CHODL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHODL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:31,141,030...31,163,342
Ensembl chr11:31,141,021...31,163,334 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA CTD PMID:27188386 NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chrdl1 chordin-like 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CHRDL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:111,685,864...111,789,684
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Cimap1b ciliary microtubule associated protein 1B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CIMAP1B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIMAP1B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:122,323,860...122,326,921
Ensembl chr 7:122,323,860...122,326,876 		JBrowse link
G Cimap3 ciliary microtubule associated protein 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CIMAP3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CIMAP3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:196,164,103...196,181,466
Ensembl chr 2:196,163,275...196,181,604 		JBrowse link
G Cldn11 claudin 11 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CLDN11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539 		JBrowse link
G Cldn18 claudin 18 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN18 mRNA CTD PMID:27188386 NCBI chr 8:109,125,819...109,145,110
Ensembl chr 8:109,126,949...109,152,701 		JBrowse link
G Cldn4 claudin 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CLDN4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Cldn7 claudin 7 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CLDN7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Clec18a C-type lectin domain family 18, member A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CLEC18A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLEC18A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:55,947,625...55,964,505
Ensembl chr19:55,947,223...55,965,323 		JBrowse link
G Cln8 CLN8, transmembrane ER and ERGIC protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CLN8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLN8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:81,451,941...81,462,046
Ensembl chr16:81,451,944...81,461,832 		JBrowse link
G Cnfn cornifelin decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CNFN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNFN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556 		JBrowse link
G Cnksr2 connector enhancer of kinase suppressor of Ras 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CNKSR2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNKSR2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:40,722,843...40,971,730
Ensembl chr  X:40,722,996...40,965,604 		JBrowse link
G Cnot4 CCR4-NOT transcription complex, subunit 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CNOT4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:64,679,903...64,781,432
Ensembl chr 4:64,679,904...64,738,083 		JBrowse link
G Cntn2 contactin 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CNTN2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTN2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027 		JBrowse link
G Cntnap3 contactin associated protein family member 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CNTNAP3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTNAP3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:273,137...461,233
Ensembl chr17:273,137...461,233 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of COL11A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL11A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of COL12A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL12A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of COL1A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of COL1A2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL3A1 mRNA CTD PMID:27188386 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA CTD PMID:27188386 NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A1 mRNA CTD PMID:27188386 NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229 		JBrowse link
G Colgalt2 collagen beta(1-O)galactosyltransferase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of COLGALT2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:67,073,551...67,178,194
Ensembl chr13:67,073,551...67,178,194 		JBrowse link
G Cops8 COP9 signalosome subunit 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of COPS8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COPS8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:98,655,031...98,664,861
Ensembl chr 9:98,654,870...98,665,381 		JBrowse link
G Cpe carboxypeptidase E increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CPE mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CPEB2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPEB2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CPT1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpxm2 carboxypeptidase X (M14 family), member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CPXM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPXM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CREG1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREG1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CRIM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRIM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416 		JBrowse link
G Cryba4 crystallin, beta A4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CRYBA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CRYBA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:50,039,148...50,053,636
Ensembl chr12:50,047,049...50,053,634 		JBrowse link
G Csf2ra colony stimulating factor 2 receptor subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CSF2RA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSF2RA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:113,219...118,808
Ensembl chr14:113,225...118,117 		JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CSPG5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSPG5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907 		JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRP1 mRNA CTD PMID:27188386 NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139 		JBrowse link
G Ctdsp1 CTD small phosphatase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CTDSP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412 		JBrowse link
G Cth cystathionine gamma-lyase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CTH mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTH mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Cthrc1 collagen triple helix repeat containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CTHRC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTHRC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:72,007,372...72,017,654
Ensembl chr 7:72,007,372...72,017,654 		JBrowse link
G Ctnnd2 catenin delta 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CTNND2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNND2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409 		JBrowse link
G Cul3 cullin 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUL3 mRNA CTD PMID:27188386 NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CXCL14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of CXCR4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXCR4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CYB5A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CYP1A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP1A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CYP1B1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP1B1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyth3 cytohesin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of CYTH3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTH3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:15,953,781...16,076,584
Ensembl chr12:15,953,791...16,047,506 		JBrowse link
G Dab1 DAB adaptor protein 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DAB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584 		JBrowse link
G Dclk2 doublecortin-like kinase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DCLK2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:174,506,660...174,636,353
Ensembl chr 2:174,506,660...174,636,192 		JBrowse link
G Dcx doublecortin decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DCX mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCX mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDIT3 mRNA CTD PMID:27188386 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DDR2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288 		JBrowse link
G Dennd1b DENN domain containing 1B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DENND1B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND1B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:53,096,717...53,324,372
Ensembl chr13:53,092,261...53,324,369 		JBrowse link
G Dgki diacylglycerol kinase, iota decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DGKI mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DGKI mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:66,377,897...66,839,790
Ensembl chr 4:66,387,126...66,990,832 		JBrowse link
G Dhrs11 dehydrogenase/reductase 11 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DHRS11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHRS11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:70,195,637...70,205,735
Ensembl chr10:70,195,637...70,205,893 		JBrowse link
G Dhx15 DEAH-box helicase 15 decreases expression ISO mercuric bromide results in decreased expression of DHX15 mRNA CTD PMID:26272509 NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828 		JBrowse link
G Dipk1c divergent protein kinase domain 1C decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DIPK1C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIPK1C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:80,362,854...80,384,774
Ensembl chr18:80,362,982...80,386,551 		JBrowse link
G Dlc1 DLC1 Rho GTPase activating protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DLC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819 		JBrowse link
G Dll1 delta like canonical Notch ligand 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DLL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DLL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276 		JBrowse link
G Dlx3 distal-less homeobox 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DLX3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:80,561,335...80,566,730
Ensembl chr10:80,561,335...80,566,711 		JBrowse link
G Dlx5 distal-less homeobox 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DLX5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845 		JBrowse link
G Dlx6 distal-less homeobox 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DLX6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:35,951,005...35,956,354
Ensembl chr 4:35,951,005...35,956,354 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA CTD PMID:27188386 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajc6 DnaJ heat shock protein family (Hsp40) member C6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DNAJC6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJC6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:121,232,532...121,398,775
Ensembl chr 5:121,235,425...121,398,775 		JBrowse link
G Dock6 dedicator of cytokinesis 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DOCK6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:28,618,523...28,670,741
Ensembl chr 8:28,618,523...28,670,648 		JBrowse link
G Dock7 dedicator of cytokinesis 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DOCK7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:118,714,863...118,898,362
Ensembl chr 5:118,714,863...118,898,335 		JBrowse link
G Dock8 dedicator of cytokinesis 8 decreases expression ISO mercuric bromide results in decreased expression of DOCK8 mRNA CTD PMID:26272509 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833 		JBrowse link
G Dock9 dedicator of cytokinesis 9 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DOCK9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799 		JBrowse link
G Dqx1 DEAQ box RNA-dependent ATPase 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DQX1 mRNA CTD PMID:27188386 NCBI chr 4:117,121,216...117,130,315
Ensembl chr 4:117,121,452...117,130,307 		JBrowse link
G Drd4 dopamine receptor D4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DRD4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DRD4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458 		JBrowse link
G Dsc3 desmocollin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DSC3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSC3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,653,832...11,688,871 		JBrowse link
G Dsp desmoplakin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DSP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121 		JBrowse link
G Dstyk dual serine/threonine and tyrosine protein kinase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of DSTYK mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DSTYK mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:46,409,412...46,457,426
Ensembl chr13:46,409,412...46,457,424 		JBrowse link
G Dtna dystrobrevin, alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DTNA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DTNA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:14,862,801...15,218,993
Ensembl chr18:14,862,818...15,218,993 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP1 mRNA CTD PMID:27188386 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp10 dual specificity phosphatase 10 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP10 mRNA CTD PMID:27188386 NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304 		JBrowse link
G Dusp14 dual specificity phosphatase 14 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DUSP14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:69,433,949...69,463,863
Ensembl chr10:69,426,730...69,462,837 		JBrowse link
G Dusp2 dual specificity phosphatase 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA CTD PMID:27188386 NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of DUSP5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp8 dual specificity phosphatase 8 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA CTD PMID:27188386 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Eaf2 ELL associated factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EAF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EAF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993 		JBrowse link
G Ebf1 EBF transcription factor 1 decreases expression ISO mercuric bromide results in decreased expression of EBF1 mRNA CTD PMID:26272509 NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702 		JBrowse link
G Edn1 endothelin 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDN1 mRNA CTD PMID:27188386 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednrb endothelin receptor type B increases expression ISO mercuric bromide results in increased expression of EDNRB mRNA CTD PMID:26272509 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eef1akmt2 EEF1A lysine methyltransferase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EEF1AKMT2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EEF1AKMT2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:197,009,919...197,071,033
Ensembl chr 1:197,046,930...197,071,013 		JBrowse link
G Efhc2 EF-hand domain containing 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EFHC2 mRNA CTD PMID:27188386 NCBI chr  X:7,943,603...8,144,073
Ensembl chr  X:7,943,725...8,144,215 		JBrowse link
G Efna1 ephrin A1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EFNA1 mRNA CTD PMID:27188386 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efna2 ephrin A2 decreases expression ISO mercuric bromide results in decreased expression of EFNA2 mRNA CTD PMID:26272509 NCBI chr 7:10,167,091...10,177,719
Ensembl chr 7:10,167,091...10,177,719 		JBrowse link
G Egf epidermal growth factor multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGF mRNA
mercuric bromide results in increased expression of EGF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfl7 EGF-like-domain, multiple 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EGFL7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGFL7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:29,802,690...29,814,951 		JBrowse link
G Eid3 EP300 interacting inhibitor of differentiation 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EID3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EID3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:22,747,645...22,748,967
Ensembl chr 7:22,747,656...22,749,177 		JBrowse link
G Eif4e3 eukaryotic translation initiation factor 4E family member 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EIF4E3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF4E3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:133,709,802...133,858,398
Ensembl chr 4:133,625,768...133,885,647 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF3 mRNA CTD PMID:27188386 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Elf4 E74 like ETS transcription factor 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ELF4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:132,465,290...132,508,175
Ensembl chr  X:132,468,539...132,478,689 		JBrowse link
G Elf5 E74 like ETS transcription factor 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ELF5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:110,264,460...110,291,926
Ensembl chr 3:110,252,797...110,291,926 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ELK3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELK3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661 		JBrowse link
G Elmod1 ELMO domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ELMOD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELMOD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO mercuric bromide results in increased expression of EMP1 mRNA CTD PMID:26272509 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Ensa endosulfine alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ENSA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENSA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:185,874,500...185,881,838
Ensembl chr 2:185,874,500...185,881,838 		JBrowse link
G Eogt EGF domain specific O-linked N-acetylglucosamine transferase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EOGT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EOGT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:131,275,587...131,313,243
Ensembl chr 4:131,276,573...131,311,926 		JBrowse link
G Epas1 endothelial PAS domain protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPAS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPAS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA CTD PMID:27188386 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPB41L5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Epcam epithelial cell adhesion molecule increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPCAM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPCAM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epdr1 ependymin related 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPDR1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPDR1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250 		JBrowse link
G Epha2 Eph receptor A2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA CTD PMID:27188386 NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234 		JBrowse link
G Ephb1 Eph receptor B1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EPHB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759 		JBrowse link
G Ephb2 Eph receptor B2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of EPHB2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615 		JBrowse link
G Epn3 epsin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPN3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235 		JBrowse link
G Eps8l2 EPS8 signaling adaptor L2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPS8L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPS8L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:205,875,825...205,901,109
Ensembl chr 1:205,875,801...205,901,101 		JBrowse link
G Epsti1 epithelial stromal interaction 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of EPSTI1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPSTI1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380 		JBrowse link
G Erap1 endoplasmic reticulum aminopeptidase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ERAP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERAP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:5,666,337...5,705,256
Ensembl chr 2:5,666,436...5,740,056 		JBrowse link
G Erich1 glutamate-rich 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ERICH1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERICH1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:82,203,536...82,271,361
Ensembl chr16:82,203,610...82,272,989 		JBrowse link
G Erich5 glutamate-rich 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ERICH5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERICH5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:67,538,154...67,569,433
Ensembl chr 7:67,536,588...67,563,989 		JBrowse link
G Ero1b endoplasmic reticulum oxidoreductase 1 beta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERO1B mRNA CTD PMID:27188386 NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555 		JBrowse link
G Erp27 endoplasmic reticulum protein 27 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ERP27 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERP27 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression ISO mercuric bromide results in increased expression of ESRP1 mRNA CTD PMID:26272509 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrp2 epithelial splicing regulatory protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ESRP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:50,944,401...50,951,919
Ensembl chr19:50,944,401...50,951,568 		JBrowse link
G Etl4 enhancer trap locus 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KIAA1217 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA1217 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:87,749,486...88,213,158
Ensembl chr17:87,403,819...88,213,158 		JBrowse link
G Etnk1 ethanolamine kinase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ETNK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETNK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ETS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Evc2 EvC ciliary complex subunit 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA CTD PMID:27188386 NCBI chr14:77,591,581...77,679,286
Ensembl chr14:77,592,560...77,679,262 		JBrowse link
G F2rl2 coagulation factor II (thrombin) receptor-like 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of F2RL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of F3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F5 coagulation factor V increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of F5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247 		JBrowse link
G Fam110c family with sequence similarity 110, member C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FAM110C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM110C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117 		JBrowse link
G Fam124a family with sequence similarity 124 member A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FAM124A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM124A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:40,975,789...41,031,069
Ensembl chr15:40,975,877...41,029,628 		JBrowse link
G Fam13c family with sequence similarity 13, member C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FAM13C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM13C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:18,064,706...18,186,888
Ensembl chr20:18,064,706...18,286,674 		JBrowse link
G Fam149a family with sequence similarity 149, member A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FAM149A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM149A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072 		JBrowse link
G Fam169a family with sequence similarity 169, member A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FAM169A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM169A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:30,115,307...30,175,972
Ensembl chr 2:30,119,381...30,175,962 		JBrowse link
G Fam222a family with sequence similarity 222, member A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FAM222A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM222A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:47,647,221...47,693,703
Ensembl chr12:47,647,405...47,693,703 		JBrowse link
G Fam241a family with sequence similarity 241 member A multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM241A mRNA CTD PMID:27188386 NCBI chr 2:219,019,025...219,049,648
Ensembl chr 2:219,018,241...219,049,770 		JBrowse link
G Fam89a family with sequence similarity 89, member A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FAM89A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM89A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:69,607,391...69,620,019
Ensembl chr19:69,607,391...69,620,019 		JBrowse link
G Fas Fas cell surface death receptor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FAS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fblim1 filamin binding LIM protein 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLIM1 mRNA CTD PMID:27188386 NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853 		JBrowse link
G Fbxo9 f-box protein 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FBXO9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504 		JBrowse link
G Fech ferrochelatase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FECH mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FECH mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546 		JBrowse link
G Fez1 fasciculation and elongation protein zeta 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FEZ1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FEZ1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097 		JBrowse link
G Fezf2 Fez family zinc finger 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FEZF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FEZF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:15,199,045...15,207,982
Ensembl chr15:15,204,193...15,207,982 		JBrowse link
G Fgb fibrinogen beta chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FGB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA CTD PMID:27188386 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 decreases expression ISO mercuric bromide results in decreased expression of FGFR2 mRNA CTD PMID:26272509 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914 		JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FHOD3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508 		JBrowse link
G Fjx1 four-jointed box kinase 1 decreases expression ISO mercuric bromide results in decreased expression of FJX1 mRNA CTD PMID:26272509 NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FKBP5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fli1 Fli-1 proto-oncogene, ETS transcription factor multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLI1 mRNA CTD PMID:27188386 NCBI chr 8:39,089,526...39,209,511
Ensembl chr 8:39,089,533...39,208,557 		JBrowse link
G Flnb filamin B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FLNB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209 		JBrowse link
G Flnc filamin C increases expression ISO mercuric bromide results in increased expression of FLNC mRNA CTD PMID:26272509 NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FLT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Fn1 fibronectin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fndc4 fibronectin type III domain containing 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FNDC4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:30,797,102...30,800,782
Ensembl chr 6:30,796,871...30,800,769 		JBrowse link
G Fndc5 fibronectin type III domain containing 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FNDC5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FOSL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FOSL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406 		JBrowse link
G Foxc1 forkhead box C1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FOXC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,805,858...32,844,347 		JBrowse link
G Foxc2 forkhead box C2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA CTD PMID:27188386 NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977 		JBrowse link
G Foxl2 forkhead box L2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FOXL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:108,382,872...108,396,835 		JBrowse link
G Frem1 Fras1 related extracellular matrix 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FREM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FREM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:102,367,201...102,515,464
Ensembl chr 5:102,367,201...102,515,404 		JBrowse link
G Frmd3 FERM domain containing 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of FRMD3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325 		JBrowse link
G Frzb frizzled-related protein multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRZB mRNA CTD PMID:27188386 NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096 		JBrowse link
G Fth1 ferritin heavy chain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FTH1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FTH1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Ftl1 ferritin light chain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of FTL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FTL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Ftx FTX transcript, XIST regulator increases expression ISO mercuric bromide results in increased expression of FTX mRNA CTD PMID:26272509 NCBI chr  X:72,654,112...72,696,097 JBrowse link
G Fzd10 frizzled class receptor 10 decreases expression ISO mercuric bromide results in decreased expression of FZD10 mRNA CTD PMID:26272509 NCBI chr12:33,734,364...33,737,559
Ensembl chr12:33,734,364...33,741,646 		JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 increases expression ISO mercuric bromide results in increased expression of GABARAPL1 mRNA CTD PMID:26272509 NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578 		JBrowse link
G Gabra5 gamma-aminobutyric acid type A receptor subunit alpha 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GABRA5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GABRA5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:117,404,446...117,517,424
Ensembl chr 1:117,404,494...117,516,635 		JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GABRB2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171 		JBrowse link
G Gabrb3 gamma-aminobutyric acid type A receptor subunit beta 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GABRB3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GABRP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GADD45A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45B mRNA CTD PMID:27188386 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718 		JBrowse link
G Gal galanin and GMAP prepropeptide decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GAL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229 		JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GALNT10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:42,321,691...42,468,087
Ensembl chr10:42,322,161...42,468,087 		JBrowse link
G Galnt14 polypeptide N-acetylgalactosaminyltransferase 14 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GALNT14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:27,507,878...27,724,033
Ensembl chr 6:27,507,627...27,724,031 		JBrowse link
G Galnt3 polypeptide N-acetylgalactosaminyltransferase 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GALNT3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323 		JBrowse link
G Galp galanin-like peptide decreases expression ISO mercuric bromide results in decreased expression of GALP mRNA CTD PMID:26272509 NCBI chr 1:76,717,110...76,741,056
Ensembl chr 1:76,717,110...76,735,354 		JBrowse link
G Gas1 growth arrest-specific 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GAS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657 		JBrowse link
G Gas2l1 growth arrest-specific 2 like 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GAS2L1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAS2L1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:84,169,398...84,175,514
Ensembl chr14:84,169,398...84,175,514 		JBrowse link
G Gask1b golgi associated kinase 1B multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GASK1B mRNA CTD PMID:27188386 NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603 		JBrowse link
G Gata2 GATA binding protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GATA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gata3 GATA binding protein 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GATA3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670 		JBrowse link
G Gata6 GATA binding protein 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GATA6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GCLC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GCLM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gcnt1 glucosaminyl (N-acetyl) transferase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GCNT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741 		JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA CTD PMID:27188386 NCBI chr 3:172,529,523...172,549,128
Ensembl chr 3:172,509,564...172,549,125 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GDF15 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDF15 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GJB2 mRNA CTD PMID:27188386 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA CTD PMID:27188386 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glis3 GLIS family zinc finger 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GLIS3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLIS3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:235,389,567...235,809,416
Ensembl chr 1:235,392,651...235,809,221 		JBrowse link
G Glrx2 glutaredoxin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GLRX2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:58,032,199...58,055,061
Ensembl chr13:58,032,401...58,043,150 		JBrowse link
G Gls glutaminase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GLS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861 		JBrowse link
G Gna14 G protein subunit alpha 14 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GNA14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNA14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210 		JBrowse link
G Gnas GNAS complex locus increases expression ISO mercuric bromide results in increased expression of GNAS mRNA CTD PMID:26272509 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536 		JBrowse link
G Gne glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GNE mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNE mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251 		JBrowse link
G Gng11 G protein subunit gamma 11 increases expression ISO mercuric bromide results in increased expression of GNG11 mRNA CTD PMID:26272509 NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438 		JBrowse link
G Gng8 G protein subunit gamma 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GNG8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNG8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408 		JBrowse link
G Gpat3 glycerol-3-phosphate acyltransferase 3 multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPAT3 mRNA
mercuric bromide results in increased expression of GPAT3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:9,018,762...9,072,552 JBrowse link
G Gpm6a glycoprotein m6a increases expression ISO mercuric bromide results in increased expression of GPM6A mRNA CTD PMID:26272509 NCBI chr16:43,374,385...43,706,461
Ensembl chr16:43,374,385...43,706,705 		JBrowse link
G Gpm6b glycoprotein m6b decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GPM6B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPM6B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gpnmb glycoprotein nmb increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GPNMB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPNMB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpr153 G protein-coupled receptor 153 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GPR153 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR153 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:168,064,134...168,075,697
Ensembl chr 5:168,064,311...168,074,532 		JBrowse link
G Gpr27 G protein-coupled receptor 27 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GPR27 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR27 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:133,884,894...133,886,027
Ensembl chr 4:133,883,234...133,904,093 		JBrowse link
G Gpr37 G protein-coupled receptor 37 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GPR37 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR37 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:55,104,355...55,126,420
Ensembl chr 4:55,104,365...55,126,494 		JBrowse link
G Gpr39 G protein-coupled receptor 39 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GPR39 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR39 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:39,667,908...39,879,944
Ensembl chr13:39,667,909...39,880,902 		JBrowse link
G Gpr87 G protein-coupled receptor 87 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GPR87 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR87 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GPRC5A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPRC5A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625 		JBrowse link
G Gpx3 glutathione peroxidase 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPX3 mRNA CTD PMID:27188386 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gramd1c GRAM domain containing 1C decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GRAMD1C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:70,139,076...70,224,478
Ensembl chr11:70,139,184...70,224,478 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GREM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GREM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Grhl1 grainyhead-like transcription factor 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA CTD PMID:27188386 NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264 		JBrowse link
G Grhl2 grainyhead-like transcription factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GRHL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:70,280,360...70,415,277
Ensembl chr 7:70,285,310...70,415,274 		JBrowse link
G Grhl3 grainyhead-like transcription factor 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GRHL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:153,057,760...153,089,890
Ensembl chr 5:153,057,760...153,089,890 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GRIA3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:125,103,975...125,369,690
Ensembl chr  X:125,103,782...125,369,679 		JBrowse link
G Grin2a glutamate ionotropic receptor NMDA type subunit 2A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GRIN2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GSR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of GSTM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSTM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GSTP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Guca1a guanylate cyclase activator 1A multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCA1A mRNA
mercuric bromide results in decreased expression of GUCA1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:21,080,782...21,096,221
Ensembl chr 9:21,086,642...21,096,221 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of GULP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452 		JBrowse link
G Gxylt2 glucoside xylosyltransferase 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GXYLT2 mRNA CTD PMID:27188386 NCBI chr 4:134,903,595...135,006,066
Ensembl chr 4:134,903,859...134,987,956 		JBrowse link
G H2ac6 H2A clustered histone 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of H2AC6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2AC6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:47,403,701...47,404,167 JBrowse link
G H2bc14 H2B clustered histone 14 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2BC5 mRNA
mercuric bromide results in decreased expression of H2BC5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:47,488,627...47,489,008 JBrowse link
G H4f3 H1.3 linker histone, cluster member decreases expression ISO mercuric bromide results in decreased expression of H1-3 mRNA CTD PMID:26272509 NCBI chr17:41,979,562...41,980,341
Ensembl chr17:41,796,116...41,980,485 		JBrowse link
G Hacd1 3-hydroxyacyl-CoA dehydratase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HACD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592 		JBrowse link
G Hand1 heart and neural crest derivatives expressed 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAND1 mRNA CTD PMID:27188386 NCBI chr10:42,507,117...42,509,684
Ensembl chr10:42,507,122...42,509,684 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HAPLN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAPLN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Hdlbp high density lipoprotein binding protein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HDLBP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HDLBP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:101,395,491...101,465,446
Ensembl chr 9:101,397,305...101,465,379 		JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HERPUD1 mRNA CTD PMID:27188386 NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HES5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021 		JBrowse link
G Hexa hexosaminidase subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HEXA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEXA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:68,832,524...68,857,462
Ensembl chr 8:68,809,615...68,859,560 		JBrowse link
G Hgsnat heparan-alpha-glucosaminide N-acetyltransferase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HGSNAT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HGSNAT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:72,807,967...72,840,180
Ensembl chr16:72,807,849...72,840,176 		JBrowse link
G Hif3a hypoxia inducible factor 3 subunit alpha multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HIF3A mRNA CTD PMID:27188386 NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:86,850,554...86,877,838 		JBrowse link
G Hivep1 HIVEP zinc finger 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HIVEP1 mRNA CTD PMID:27188386 NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,790,855...22,917,196 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HMGCS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HMGCS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HMOX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMOX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnmt histamine N-methyltransferase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HNMT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HNMT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482 		JBrowse link
G Hnrnpr heterogeneous nuclear ribonucleoprotein R decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HNRNPR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HPGD mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HPGD mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hrh3 histamine receptor H3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HRH3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HRH3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:187,569,175...187,574,259 		JBrowse link
G Hrk harakiri, BCL2 interacting protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HRK mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HRK mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561 		JBrowse link
G Hs3st1 heparan sulfate-glucosamine 3-sulfotransferase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HS3ST1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848 		JBrowse link
G Hs3st3a1 heparan sulfate-glucosamine 3-sulfotransferase 3A1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HS3ST3A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST3A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,593,009...49,679,854 		JBrowse link
G Hs3st3b1 heparan sulfate-glucosamine 3-sulfotransferase 3B1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HS3ST3B1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST3B1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:49,060,693...49,093,185
Ensembl chr10:49,060,693...49,093,185 		JBrowse link
G Hsd17b8 hydroxysteroid (17-beta) dehydrogenase 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HSD17B8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,828,608...4,830,634 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HSPA4L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA4L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA CTD PMID:27188386 NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPH1 mRNA CTD PMID:27188386 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of HTATIP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HTATIP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815 		JBrowse link
G Htra1 HtrA serine peptidase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HTRA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HTRA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ID1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ID1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IDH3A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDH3A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223 		JBrowse link
G Ids iduronate 2-sulfatase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IDS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:154,070,781...154,093,681
Ensembl chr  X:154,070,781...154,091,444 		JBrowse link
G Ier3 immediate early response 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA CTD PMID:27188386 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFRD1 mRNA CTD PMID:27188386 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Ift57 intraflagellar transport 57 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of IFT57 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:64,528,349...64,593,545
Ensembl chr11:64,528,349...64,593,545 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of IGFBP3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGFBP3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO mercuric bromide results in decreased expression of IGFBP5 mRNA CTD PMID:26272509 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP6 mRNA CTD PMID:27188386 NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795 		JBrowse link
G Igfbp7 insulin-like growth factor binding protein 7 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IGFBP7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620 		JBrowse link
G Igsf21 immunoglobin superfamily, member 21 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of IGSF21 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGSF21 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:157,570,964...157,795,290
Ensembl chr 5:157,570,964...157,795,290 		JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IL13RA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL13RA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:120,213,670...120,294,777
Ensembl chr  X:120,214,075...120,274,461 		JBrowse link
G Il1rap interleukin 1 receptor accessory protein multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IL1RAP mRNA CTD PMID:27188386 NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342 		JBrowse link
G Il6 interleukin 6 increases expression ISO mercuric bromide results in increased expression of IL6 mRNA CTD PMID:26272509 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Il6r interleukin 6 receptor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IL6R mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL6R mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221 		JBrowse link
G Inf2 inverted formin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of INF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:137,470,286...137,497,039 		JBrowse link
G Inhbe inhibin subunit beta E increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of INHBE mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519 		JBrowse link
G Ino80d INO80 complex subunit D decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of INO80D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:71,940,941...72,007,879
Ensembl chr 9:71,951,031...72,040,232 		JBrowse link
G Inpp5d inositol polyphosphate-5-phosphatase D increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of INPP5D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589 		JBrowse link
G Insig1 insulin induced gene 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of INSIG1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INSIG1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Iqce IQ motif containing E decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of IQCE mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IQCE mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:19,057,060...19,096,626
Ensembl chr12:19,056,307...19,096,624 		JBrowse link
G Irs1 insulin receptor substrate 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of IRS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Isl1 ISL LIM homeobox 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ISL1 mRNA CTD PMID:27188386 NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442 		JBrowse link
G Isl2 ISL LIM homeobox 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ISL2 mRNA CTD PMID:27188386 NCBI chr 8:64,819,879...64,824,864
Ensembl chr 8:64,819,879...64,824,864 		JBrowse link
G Ist1 IST1 factor associated with ESCRT-III multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IST1 mRNA CTD PMID:27188386 NCBI chr19:54,558,353...54,580,551
Ensembl chr19:54,558,353...54,580,491 		JBrowse link
G Itga4 integrin subunit alpha 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ITGA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039 		JBrowse link
G Itga8 integrin subunit alpha 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITGA8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGA8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633 		JBrowse link
G Itgb6 integrin subunit beta 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITGB6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333 		JBrowse link
G Itih5 inter-alpha-trypsin inhibitor heavy chain 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITIH5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITIH5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496 		JBrowse link
G Itm2a integral membrane protein 2A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITM2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITM2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:76,559,183...76,565,144
Ensembl chr  X:76,559,181...76,565,437 		JBrowse link
G Itm2b integral membrane protein 2B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITM2B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITM2B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455 		JBrowse link
G Itpr2 inositol 1,4,5-trisphosphate receptor, type 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ITPR2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763 		JBrowse link
G Jam2 junctional adhesion molecule 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of JAM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JAM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jazf1 JAZF zinc finger 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of JAZF1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JAZF1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:83,210,054...83,513,790
Ensembl chr 4:83,210,058...83,513,644 		JBrowse link
G Jph4 junctophilin 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of JPH4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:32,549,536...32,558,859
Ensembl chr15:32,549,555...32,558,859 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JUN mRNA CTD PMID:27188386 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kat6a lysine acetyltransferase 6A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KAT6A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:75,787,411...75,868,584
Ensembl chr16:75,787,411...75,866,099 		JBrowse link
G Katnbl1 katanin regulatory subunit B1 like 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KATNBL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:119,638,068...119,680,179
Ensembl chr 3:119,638,107...119,680,173 		JBrowse link
G Kcnj12 potassium inwardly-rectifying channel, subfamily J, member 12 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KCNJ12 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNJ12 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:46,196,110...46,245,008
Ensembl chr10:46,195,428...46,260,169 		JBrowse link
G Kcnk1 potassium two pore domain channel subfamily K member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KCNK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:70,856,985...70,895,053
Ensembl chr19:70,856,985...70,895,051 		JBrowse link
G Kcnk10 potassium two pore domain channel subfamily K member 10 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KCNK10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNK10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:123,419,778...123,555,820
Ensembl chr 6:123,423,950...123,555,614 		JBrowse link
G Kcnq2 potassium voltage-gated channel subfamily Q member 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KCNQ2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNQ2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302 		JBrowse link
G Kctd1 potassium channel tetramerization domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KCTD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:6,396,947...6,591,026
Ensembl chr18:6,396,947...6,515,191 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KCTD12 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KEAP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Kif1a kinesin family member 1A multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA CTD PMID:27188386 NCBI chr 9:101,010,447...101,094,891
Ensembl chr 9:101,010,447...101,094,777 		JBrowse link
G Kitlg KIT ligand increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KITLG mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Klf11 KLF transcription factor 11 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KLF11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLF11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044 		JBrowse link
G Klf5 KLF transcription factor 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KLF5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262 		JBrowse link
G Klf6 KLF transcription factor 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KLF6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601 		JBrowse link
G Klf9 KLF transcription factor 9 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF9 mRNA CTD PMID:27188386 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Klhdc8a kelch domain containing 8A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KLHDC8A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:46,287,011...46,296,429
Ensembl chr13:46,288,344...46,296,429 		JBrowse link
G Klhl21 kelch-like family member 21 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA CTD PMID:27188386 NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276 		JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL4 mRNA CTD PMID:27188386 NCBI chr  X:83,626,047...83,916,328
Ensembl chr  X:83,819,076...83,916,328 		JBrowse link
G Klhl5 kelch-like family member 5 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL5 mRNA CTD PMID:27188386 NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894 		JBrowse link
G Klk8 kallikrein related-peptidase 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KLK8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195 		JBrowse link
G Kndc1 kinase non-catalytic C-lobe domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KNDC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNDC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:204,119,597...204,167,967
Ensembl chr 1:204,119,659...204,167,965 		JBrowse link
G Kras KRAS proto-oncogene, GTPase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of KRAS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320 		JBrowse link
G Krt18 keratin 18 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KRT18 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT18 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848 		JBrowse link
G Krt8 keratin 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of KRT8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Lacc1 laccase domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LACC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:58,799,477...58,816,840
Ensembl chr15:58,786,637...58,816,840 		JBrowse link
G Lactb lactamase, beta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA CTD PMID:27188386 NCBI chr 8:76,452,679...76,469,986
Ensembl chr 8:76,452,349...76,468,716 		JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LAMC2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMC2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LAMP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:122,038,734...122,087,745
Ensembl chr  X:121,922,187...122,087,675 		JBrowse link
G Layn layilin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LAYN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAYN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:60,261,325...60,280,797
Ensembl chr 8:60,263,456...60,281,418 		JBrowse link
G Lgals3 galectin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LGALS3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals8 galectin 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LGALS8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482 		JBrowse link
G Lhfpl4 LHFPL tetraspan subfamily member 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LHFPL4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHFPL4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:147,872,877...147,895,770
Ensembl chr 4:147,872,877...147,895,770 		JBrowse link
G Lhfpl6 LHFPL tetraspan subfamily member 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LHFPL6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LHFPL6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:139,276,810...139,474,740
Ensembl chr 2:139,276,789...139,474,737 		JBrowse link
G Lhx2 LIM homeobox 2 decreases expression ISO mercuric bromide results in decreased expression of LHX2 mRNA CTD PMID:26272509 NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:42,535,744...42,553,645 		JBrowse link
G Lhx4 LIM homeobox 4 increases expression ISO mercuric bromide results in increased expression of LHX4 mRNA CTD PMID:26272509 NCBI chr13:70,423,768...70,477,337
Ensembl chr13:70,427,399...70,467,505 		JBrowse link
G Lhx8 LIM homeobox 8 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LHX8 mRNA CTD PMID:27188386 NCBI chr 2:245,904,712...245,929,376
Ensembl chr 2:245,904,712...245,929,376 		JBrowse link
G Lifr LIF receptor subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LIFR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIFR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364 		JBrowse link
G Lim2 lens intrinsic membrane protein 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIM2 mRNA CTD PMID:27188386 NCBI chr 1:102,974,188...102,980,358
Ensembl chr 1:102,974,188...102,980,358 		JBrowse link
G Limch1 LIM and calponin homology domains 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA CTD PMID:27188386 NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837 		JBrowse link
G Lix1 limb and CNS expressed 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LIX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:66,802,044...66,859,040
Ensembl chr 1:66,802,272...66,860,627 		JBrowse link
G Lman1 lectin, mannose-binding, 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LMAN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMAN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:61,778,971...61,800,960
Ensembl chr18:61,772,917...61,800,820 		JBrowse link
G Lmna lamin A/C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LMNA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMNA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072 		JBrowse link
G Lmo1 LIM domain only 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LMO1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:172,567,156...172,603,282
Ensembl chr 1:172,567,156...172,603,157 		JBrowse link
G Lmo3 LIM domain only 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LMO3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:172,965,944...173,028,980
Ensembl chr 4:172,965,951...173,025,156 		JBrowse link
G Lmo7 LIM domain 7 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LMO7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:84,981,689...85,184,554
Ensembl chr15:84,981,735...85,184,551 		JBrowse link
G Lnx1 ligand of numb-protein X 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LNX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LNX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:33,868,517...33,971,217
Ensembl chr14:33,868,571...33,971,217 		JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LPAR3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:237,785,371...237,854,199
Ensembl chr 2:237,787,766...237,854,197 		JBrowse link
G Lpar6 lysophosphatidic acid receptor 6 increases expression ISO mercuric bromide results in increased expression of LPAR6 mRNA CTD PMID:26272509 NCBI chr15:54,826,110...54,827,919
Ensembl chr15:54,823,717...54,978,783 		JBrowse link
G Lrp10 LDL receptor related protein 10 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LRP10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:31,891,358...31,897,530
Ensembl chr15:31,891,362...31,897,528 		JBrowse link
G Lrrc34 leucine rich repeat containing 34 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LRRC34 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC34 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:114,680,787...114,702,961
Ensembl chr 2:114,680,094...114,702,961 		JBrowse link
G Lrrc3b leucine rich repeat containing 3B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LRRC3B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC3B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:12,404,309...12,481,618
Ensembl chr15:12,336,369...12,481,866 		JBrowse link
G Lrrn4 leucine rich repeat neuronal 4 increases expression ISO mercuric bromide results in increased expression of LRRN4 mRNA CTD PMID:26272509 NCBI chr 3:140,592,303...140,603,986
Ensembl chr 3:140,592,076...140,605,574 		JBrowse link
G Lsamp limbic system-associated membrane protein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of LSAMP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LSAMP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:72,053,285...74,223,019
Ensembl chr11:72,053,285...72,702,134 		JBrowse link
G Ly6k lymphocyte antigen 6 family member K increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LY6K mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY6K mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:108,572,732...108,575,450
Ensembl chr 7:108,572,732...108,575,450 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of LYVE1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYVE1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Lzts1 leucine zipper tumor suppressor 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LZTS1 mRNA CTD PMID:27188386 NCBI chr16:25,309,502...25,364,942
Ensembl chr16:25,309,507...25,364,940 		JBrowse link
G Mab21l2 mab-21 like 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MAB21L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAB21L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:174,244,538...174,247,620
Ensembl chr 2:174,238,828...174,252,064 		JBrowse link
G Macc1 MET transcriptional regulator MACC1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MACC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MACC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:146,495,544...146,574,254
Ensembl chr 6:146,495,861...146,574,260 		JBrowse link
G Macroh2a1 macroH2A.1 histone decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MACROH2A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,484,246...8,547,257 		JBrowse link
G Mafb MAF bZIP transcription factor B multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFB mRNA CTD PMID:27188386 NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975 		JBrowse link
G Maff MAF bZIP transcription factor F multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147 		JBrowse link
G Mafg MAF bZIP transcription factor G increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAFG mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFG mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:106,401,633...106,410,159 JBrowse link
G Mal2 mal, T-cell differentiation protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:87,790,239...87,850,403 		JBrowse link
G Man1a1 mannosidase, alpha, class 1A, member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAN1A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAN1A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:33,745,158...33,928,584
Ensembl chr20:33,745,165...33,928,584 		JBrowse link
G Man1c1 mannosidase, alpha, class 1C, member 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MAN1C1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAN1C1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138 		JBrowse link
G Map1a microtubule-associated protein 1A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAP1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:128,716,940...128,740,159 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MAP2K6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k14 mitogen-activated protein kinase kinase kinase 14 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K14 mRNA CTD PMID:27188386 NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,665,417...88,715,592 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA CTD PMID:27188386 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898 		JBrowse link
G Map4 microtubule-associated protein 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAP4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:118,804,022...118,942,805 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 increases expression ISO mercuric bromide results in increased expression of MAP4K4 mRNA CTD PMID:26272509 NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353 		JBrowse link
G Map6 microtubule-associated protein 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP6 mRNA CTD PMID:27188386 NCBI chr 1:162,980,339...163,046,548
Ensembl chr 1:162,980,181...163,046,548 		JBrowse link
G Map7 microtubule-associated protein 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MAP7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:16,730,000...16,857,173
Ensembl chr 1:16,730,075...16,857,170 		JBrowse link
G Mapk10 mitogen activated protein kinase 10 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MAPK10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100 		JBrowse link
G Marveld3 MARVEL domain containing 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MARVELD3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARVELD3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:54,818,180...54,832,871
Ensembl chr19:54,818,180...54,832,871 		JBrowse link
G Mast4 microtubule associated serine/threonine kinase family member 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MAST4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAST4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:35,627,190...36,219,090
Ensembl chr 2:35,627,190...36,218,832 		JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MBD2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:66,449,196...66,516,112
Ensembl chr18:66,449,358...66,516,111 		JBrowse link
G Mbnl3 muscleblind-like splicing regulator 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MBNL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:135,526,256...135,621,499
Ensembl chr  X:135,532,494...135,621,976 		JBrowse link
G Mboat1 membrane bound O-acyltransferase domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MBOAT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBOAT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:34,540,032...34,653,705
Ensembl chr17:34,540,041...34,653,698 		JBrowse link
G Mcc MCC regulator of WNT signaling pathway increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MCC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:37,042,350...37,517,114
Ensembl chr18:37,049,253...37,517,076 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MCM7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771 		JBrowse link
G Mcoln3 mucolipin TRP cation channel 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MCOLN3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCOLN3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:237,596,544...237,705,770
Ensembl chr 2:237,626,302...237,705,769 		JBrowse link
G Mctp1 multiple C2 and transmembrane domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MCTP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:7,798,968...8,493,596
Ensembl chr 2:7,803,382...8,493,596 		JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MDM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Me1 malic enzyme 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ME1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ME1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Megf10 multiple EGF-like domains 10 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MEGF10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEGF10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:52,803,292...52,953,431
Ensembl chr18:52,847,781...52,950,675 		JBrowse link
G Meiob meiosis specific with OB-fold decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MEIOB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEIOB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:14,336,869...14,369,566
Ensembl chr10:14,338,288...14,369,565 		JBrowse link
G Meltf melanotransferrin decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MELTF mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MELTF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:82,389,420...82,411,270
Ensembl chr11:82,389,420...82,411,270 		JBrowse link
G Meox1 mesenchyme homeobox 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MEOX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEOX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:87,318,668...87,338,169
Ensembl chr10:87,318,695...87,337,976 		JBrowse link
G Mfap3l microfibril associated protein 3 like decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MFAP3L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MFAP3L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709 		JBrowse link
G Mfap5 microfibril associated protein 5 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MFAP5 mRNA CTD PMID:27188386 NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448 		JBrowse link
G Mfng MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MFNG mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MFNG mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:112,161,071...112,209,129 		JBrowse link
G Mgarp mitochondria-localized glutamic acid-rich protein multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGARP mRNA CTD PMID:27188386 NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481 		JBrowse link
G Mif4gd MIF4G domain containing decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MIF4GD mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIF4GD mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:101,346,120...101,350,584
Ensembl chr10:101,346,123...101,350,169 		JBrowse link
G Mitf melanocyte inducing transcription factor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MITF mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MITF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790 		JBrowse link
G Mmab metabolism of cobalamin associated B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MMAB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:47,819,757...47,833,127
Ensembl chr12:47,819,724...47,833,118 		JBrowse link
G Mmp14 matrix metallopeptidase 14 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MMP14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MMP14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp16 matrix metallopeptidase 16 decreases expression ISO mercuric bromide results in decreased expression of MMP16 mRNA CTD PMID:26272509 NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252 		JBrowse link
G Mnx1 motor neuron and pancreas homeobox 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MNX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MNX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:6,541,645...6,546,604
Ensembl chr 4:6,541,645...6,546,604 		JBrowse link
G Mpzl2 myelin protein zero-like 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MPZL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPZL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:54,243,556...54,256,074 		JBrowse link
G Mrgprf MAS related GPR family member F multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRGPRF mRNA CTD PMID:27188386 NCBI chr 1:209,893,384...209,902,852
Ensembl chr 1:209,892,450...209,903,614 		JBrowse link
G Mrpl4 mitochondrial ribosomal protein L4 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL4 mRNA CTD PMID:27188386 NCBI chr 8:27,815,771...27,821,786
Ensembl chr 8:27,815,740...27,821,780 		JBrowse link
G Msrb3 methionine sulfoxide reductase B3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MSRB3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MSRB3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:57,968,124...58,311,116 		JBrowse link
G Msx1 msh homeobox 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MSX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:77,185,802...77,189,735
Ensembl chr14:77,185,802...77,189,735 		JBrowse link
G Msx2 msh homeobox 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MSX2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945 		JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1E mRNA
mercuric bromide results in increased expression of MT1E mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MT2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mt2-ps1 metallothionein 2, pseudogene 1 multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA
mercuric bromide results in increased expression of MT1HL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:3,163,749...3,164,121 JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MTSS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTSS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303 		JBrowse link
G Muc15 mucin 15, cell surface associated increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MUC15 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUC15 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:117,749,161...117,761,466
Ensembl chr 3:117,749,324...117,762,101 		JBrowse link
G Mycl MYCL proto-oncogene, bHLH transcription factor decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MYCL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYCL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:140,559,843...140,566,704
Ensembl chr 5:140,560,152...140,566,699 		JBrowse link
G Myct1 myc target 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCT1 mRNA CTD PMID:27188386 NCBI chr 1:44,423,478...44,434,751
Ensembl chr 1:44,423,544...44,436,992 		JBrowse link
G Mylk myosin light chain kinase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of MYLK mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myo10 myosin X increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MYO10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:77,831,532...78,036,137
Ensembl chr 2:77,831,532...78,036,137 		JBrowse link
G Myo1d myosin ID increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MYO1D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:65,986,900...66,263,538
Ensembl chr10:65,975,122...66,263,958 		JBrowse link
G Myof myoferlin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of MYOF mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768 		JBrowse link
G N4bp2l2 NEDD4 binding protein 2-like 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of N4BP2L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of N4BP2L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:4,972,967...5,038,027
Ensembl chr12:4,972,990...5,033,405 		JBrowse link
G Nabp1 nucleic acid binding protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NABP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NABP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052 		JBrowse link
G Nat1 N-acetyltransferase 1 increases expression ISO mercuric bromide results in increased expression of NAT1 mRNA CTD PMID:26272509 NCBI chr16:26,984,882...27,005,194
Ensembl chr16:26,982,625...26,986,527 		JBrowse link
G Nav1 neuron navigator 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NAV1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004 		JBrowse link
G Ncald neurocalcin delta decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NCALD mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:70,417,683...70,849,763
Ensembl chr 7:70,419,433...70,849,482 		JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NCAM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971 		JBrowse link
G Ncan neurocan decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NCAN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:19,335,907...19,362,371
Ensembl chr16:19,335,907...19,362,371 		JBrowse link
G Ncoa7 nuclear receptor coactivator 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NCOA7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCOA7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:28,674,614...28,835,891
Ensembl chr 1:28,675,426...28,835,886 		JBrowse link
G Ndfip2 Nedd4 family interacting protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NDFIP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDFIP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:88,394,548...88,500,881
Ensembl chr15:88,395,032...88,503,600 		JBrowse link
G Ndp norrin cystine knot growth factor NDP decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NDP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NDP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:8,379,569...8,404,019
Ensembl chr  X:8,379,569...8,406,802 		JBrowse link
G Ndst4 N-deacetylase and N-sulfotransferase 4 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA CTD PMID:27188386 NCBI chr 2:216,461,542...216,794,035
Ensembl chr 2:216,461,543...216,794,035 		JBrowse link
G Ndufb1 NADH:ubiquinone oxidoreductase subunit B1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NDUFB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NDUFB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:126,880,537...126,888,935
Ensembl chr 6:126,880,537...126,888,864 		JBrowse link
G Nectin4 nectin cell adhesion molecule 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NECTIN4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NECTIN4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:86,335,027...86,354,152
Ensembl chr13:86,335,831...86,353,967 		JBrowse link
G Nefh neurofilament heavy chain decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NEFH mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEFH mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417 		JBrowse link
G Nefl neurofilament light chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NEFL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515 		JBrowse link
G Nefm neurofilament medium chain increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NEFM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163 		JBrowse link
G Neil2 nei-like DNA glycosylase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NEIL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEIL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:41,620,650...41,631,551
Ensembl chr15:41,621,352...41,630,834 		JBrowse link
G Nexmif neurite extension and migration factor decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NEXMIF mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEXMIF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:73,153,786...73,284,943
Ensembl chr  X:73,153,786...73,178,639 		JBrowse link
G Nf1 neurofibromin 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NF1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NF1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946 		JBrowse link
G Nfasc neurofascin decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NFASC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFASC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:46,549,369...46,735,989
Ensembl chr13:46,549,369...46,736,139 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NFE2L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfib nuclear factor I/B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NFIB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:101,805,168...102,019,945 		JBrowse link
G Nhlh2 nescient helix loop helix 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NHLH2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NHLH2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:192,132,848...192,138,186
Ensembl chr 2:192,132,686...192,138,186 		JBrowse link
G Nhs NHS actin remodeling regulator decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NHS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:36,185,067...36,524,711
Ensembl chr  X:36,438,178...36,524,708 		JBrowse link
G Niban1 niban apoptosis regulator 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NIBAN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIBAN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724 		JBrowse link
G Nipal2 NIPA-like domain containing 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NIPAL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIPAL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:67,659,628...67,771,105
Ensembl chr 7:67,659,628...67,769,959 		JBrowse link
G Nkain3 Sodium/potassium transporting ATPase interacting 3 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN3 mRNA
mercuric bromide results in decreased expression of NKAIN3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:38,410,576...39,106,910
Ensembl chr 5:38,386,841...39,106,385 		JBrowse link
G Nln neurolysin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NLN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NLN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:36,867,436...36,966,749
Ensembl chr 2:36,853,551...36,966,680 		JBrowse link
G Nlrx1 NLR family member X1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NLRX1 mRNA CTD PMID:27188386 NCBI chr 8:53,486,866...53,503,498
Ensembl chr 8:53,486,867...53,503,523 		JBrowse link
G Nme8 NME/NM23 family member 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NME8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:49,932,861...50,000,610
Ensembl chr17:49,932,860...50,000,608 		JBrowse link
G Nmrk1 nicotinamide riboside kinase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NMRK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NMRK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:225,475,975...225,503,414
Ensembl chr 1:225,475,830...225,503,602 		JBrowse link
G Noct nocturnin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NOCT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:137,422,074...137,442,282 		JBrowse link
G Nog noggin multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of A1BG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCC4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD14A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTN3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADAMTS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AFAP1L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AFDN-DT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AOX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APBA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APCDD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF25 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARRDC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARX mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASIC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASPHD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASTN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP2B1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP8A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B9D1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCO1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEST4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BOC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BST2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C11ORF96 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C1ORF226 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C2ORF68 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C3ORF70 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CACHD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CACNB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCBE1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC102A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC136 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC177 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCKBR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CD40 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDH7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDH9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDK19 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP263 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP300 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP91 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFAP96 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIMAP1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLEC18A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNFN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNKSR2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTN2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTNAP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTNAP3P2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COLGALT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COPS8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CRYBA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSPG5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNND2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUTALP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXCR4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCLK2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DCX mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DGKI mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DHRS11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DICER1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIPK1C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DLL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DRD4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DSTYK mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EEF1AKMT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EFHC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGFL7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EID3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF4E3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EPHB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERAP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERICH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ERO1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EVC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM124A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM149A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM222A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FEZ1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FEZF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGF9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FKBP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FNDC5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRZB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GABRA5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAS2L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLIS3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNAS-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNE mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNG8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPM6B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR153 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR27 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRAMD1C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIA3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRIN2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSTM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GUCA1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2AC6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2BC21 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2BC5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HCG11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HDLBP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HGSNAT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HIF3A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HIVEP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DMA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DMB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DOA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HMGCS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST3A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST3B1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HTRA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGFBP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGSF21 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IL1RAP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INO80D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INSIG1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPW mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IQCE mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IST1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JAM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JAZF1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPH4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNJ12 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNK10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNQ2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLF11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHDC8A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNDC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHFPL4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00648 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC01138 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMAN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC34 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRRC3B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LSAMP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAB21L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAN1C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEGF10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEIOB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MELTF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MFAP3L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MFNG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGARP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIF4GD mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIR124-2HG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIR210HG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MSRB3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTSS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYCL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYLK mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAV1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCALD mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCAN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NCOA7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NDP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NDUFB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEFH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEIL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEXMIF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NF1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFASC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NHS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NLRX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NOS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPHP4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPRL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPTX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRXN3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NSL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OLFM3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSBPL6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAMR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAPLN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAX6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAXIP1-DT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PEX13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PEX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGM5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIERCE2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIK3R5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIP4K2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PKNOX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXNC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU4F1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPFIA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R16A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R17 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRIMA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PROK2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRORSD1P mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRSS23 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTGS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTP4A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYGM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB33A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAI2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBFOX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of REEP6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of REPS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RET mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFLNB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFX4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RMST mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF125 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF130 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF32-DT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ROBO3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRAS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSKR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSPH9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSPO2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUNDC3B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SALL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMD13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMHD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEC24B-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOW mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEZ6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHC3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISA6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISAL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKIDA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC18A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC1A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A21-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A53 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A15 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMKR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAP91 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOBP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX2-OT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SQLE mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SRCIN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GAL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SULF1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNGR3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYT9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAPT1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCEAL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TEKT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TINCR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM132D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM132E mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM150C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM163 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM231 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMTC4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFRSF19 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TOB1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPBG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRAPPC6A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRMT1L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPC4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSFM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPOAP1-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTLL6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TWIST2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TYSND1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2QL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE3D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ULK2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPK1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VASH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VCAM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VWF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WASF3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNT5B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of XPNPEP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB24 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZIC5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF207 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF287 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF385B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF385D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF436-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF493 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF503-AS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF521 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF529 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF674-AS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF717 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAM28 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAM9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS12 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRG6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AFP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AJAP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1C3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH3B2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKAL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALPK2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMBP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMER2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMIGO2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD33B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANTXR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2P2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2P3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APOA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID5B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCC3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASNS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP10D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V1C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP8B1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAMBI mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BBS9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL11A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BDNF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE40 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BSPRY mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BTG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C11ORF52 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF210 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1S mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAB39L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CC2D1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCN2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD44 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC14B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDK6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPD mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEP85L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CFTR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHAC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHKA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHMP4C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHODL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CIMAP3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN18 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLN8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL11A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL12A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL3A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPE mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPEB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPXM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREG1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRIM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSF2RA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CST1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CST4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTHRC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSV mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP1A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP1B1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYTH3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDIT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJC6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOCK9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DQX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSC3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DTNA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUBR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EAF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EDN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EFNA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELK3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELMOD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ENSA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EOGT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPAS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPCAM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPDR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPS8L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPSTI1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERICH5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERP27 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ERVMER61-1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ESRP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETNK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F2RL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM110C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM13C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM162B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM169A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM241A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM89A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLIM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FECH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLI1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLNB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOSL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FREM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FTH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FTL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GADD45B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GASK1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GATA6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCNA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDF15 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GJB2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLRX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNA14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPAT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPNMB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR37 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR39 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR87 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPRC5A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GREM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GSTP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GXYLT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAND1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HAPLN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HERC5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HERPUD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEXA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMOX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HNMT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HPGD mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HRH3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HRK mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA4L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPB8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HTATIP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ID1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDH3A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IDS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IER3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFI16 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IFRD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL13RA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL6R mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ISL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ISL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGA8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITGB6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITIH5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITM2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITM2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ITPR2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JUN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCNK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KEAP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA1217 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT18 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAYN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LHFPL6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LHX8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIFR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIMCH1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC-PINT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01088 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01128 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMNA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LNX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY6K mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LYVE1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LZTS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MACC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAN1A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARVELD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAST4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBOAT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCOLN3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MCTP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ME1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEOX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MFAP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIR22HG mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MITF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MMP14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MNX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPZL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRGPRF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MSX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1E mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1F mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1G mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1H mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1X mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MUC15 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of N4BP2L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NABP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDFIP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEAT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NECTIN4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFIB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NHLH2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIBAN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIPAL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NLN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NMRK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPNT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPPB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPY mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR3C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5E mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NXPE3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFML1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ONECUT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSBPL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAPPA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PATJ mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE3A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDLIM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDPN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PERP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PI15 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PITX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKD1L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLCE1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLOD2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLSCR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PMAIP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1H mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDM5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKX mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRNP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROSER2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRRG1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRSS12 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRSS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRSS8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTGER4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PVT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PWWP2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXDC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGRF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASSF6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM47 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RELN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPK4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RND3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF144B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF217 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNFT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPRM mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS27L mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAMD4A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAT1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SBF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCIN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCN2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCNN1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SELENOP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINE1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINI1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SESN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SESN2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGPP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH2D4A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SHTN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC10A4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC22A15 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC38A6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC3A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC40A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLIT2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLIT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMOC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMPDL3A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SNAI2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOST mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPAG1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPANXC mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPSB4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTLC3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SQSTM1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRXN1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SST mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST8SIA4 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STAM2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STK17A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STX3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STYK1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1A1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1A2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNJ2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNPR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAFA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TC2N mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENT5C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX19 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFE3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TGFB1I1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THBS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THSD7A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THUMPD3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TJP2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TKT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TM4SF18 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM144 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM154 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM30B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM37 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM63A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMPRSS13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMT1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMTC3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFAIP6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10D mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF21 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFSF9 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNIK mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TOX mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPD52L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRBC1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIB3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM38 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTR mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UNKL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP28 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP43 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VAMP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VAMP8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VEGFA mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VGLL1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VGLL3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VHRT mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WWTR1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XAGE2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZDHHC13 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFP36 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF750 mRNA CTD PMID:27188386 NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103 		JBrowse link
G Nol3 nucleolar protein 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOL3 mRNA CTD PMID:27188386 NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722 		JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NOS2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NOS2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nphp4 nephrocystin 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NPHP4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPHP4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:168,270,522...168,356,393
Ensembl chr 5:168,271,073...168,358,242 		JBrowse link
G Npnt nephronectin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NPNT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPNT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:224,065,191...224,133,567
Ensembl chr 2:224,065,191...224,133,435 		JBrowse link
G Nppb natriuretic peptide B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NPPB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPPB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310 		JBrowse link
G Nprl3 NPR3-like, GATOR1 complex subunit decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NPRL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPRL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:15,859,739...15,900,261
Ensembl chr10:15,859,789...15,902,332 		JBrowse link
G Nptx1 neuronal pentraxin 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NPTX1 mRNA CTD PMID:27188386 NCBI chr10:105,309,578...105,318,829
Ensembl chr10:105,309,578...105,318,863 		JBrowse link
G Npy neuropeptide Y multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPY mRNA CTD PMID:27188386 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Npy2r neuropeptide Y receptor Y2 decreases expression ISO mercuric bromide results in decreased expression of NPY2R mRNA CTD PMID:26272509 NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:170,200,027...170,210,448 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NQO1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NR2F1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F2 mRNA CTD PMID:27188386 NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:133,420,227...133,431,975 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NR3C1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR3C1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nrip3 nuclear receptor interacting protein 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NRIP3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:173,224,532...173,249,829
Ensembl chr 1:173,224,532...173,251,769 		JBrowse link
G Nrk Nik related kinase multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRK mRNA CTD PMID:27188386 NCBI chr  X:107,159,154...107,256,417
Ensembl chr  X:107,159,233...107,256,417 		JBrowse link
G Nrp1 neuropilin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NRP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702 		JBrowse link
G Nrxn3 neurexin 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NRXN3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRXN3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:113,443,524...115,002,540 		JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of NSL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NSL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117 		JBrowse link
G Nt5e 5' nucleotidase, ecto multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5E mRNA CTD PMID:27188386 NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645 		JBrowse link
G Ntn4 netrin 4 decreases expression ISO mercuric bromide results in decreased expression of NTN4 mRNA CTD PMID:26272509 NCBI chr 7:30,073,637...30,187,407
Ensembl chr 7:30,073,333...30,188,309 		JBrowse link
G Nts neurotensin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NTS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Nxpe3 neurexophilin and PC-esterase domain family, member 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of NXPE3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NXPE3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:58,195,951...58,246,739
Ensembl chr11:58,195,976...58,248,644 		JBrowse link
G Olfm3 olfactomedin 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OLFM3 mRNA CTD PMID:27188386 NCBI chr 2:205,417,962...205,640,479
Ensembl chr 2:205,598,959...205,640,479 		JBrowse link
G Olfml1 olfactomedin-like 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of OLFML1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLFML1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762 		JBrowse link
G Onecut2 one cut homeobox 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ONECUT2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ONECUT2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:60,101,967...60,161,095
Ensembl chr18:60,102,126...60,107,668 		JBrowse link
G Oplah 5-oxoprolinase (ATP-hydrolysing) multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA CTD PMID:27188386 NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979 		JBrowse link
G Osbpl3 oxysterol binding protein-like 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of OSBPL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSBPL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:80,677,383...80,854,169
Ensembl chr 4:80,677,390...80,854,169 		JBrowse link
G Osbpl6 oxysterol binding protein-like 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of OSBPL6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSBPL6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:81,751,020...81,948,186
Ensembl chr 3:81,750,982...81,946,615 		JBrowse link
G Ovol1 ovo like transcriptional repressor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of OVOL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:212,284,601...212,296,106
Ensembl chr 1:212,284,605...212,296,106 		JBrowse link
G Ovol2 ovo-like zinc finger 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of OVOL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:152,130,767...152,160,487
Ensembl chr 3:152,130,767...152,160,487 		JBrowse link
G Pak6 p21 (RAC1) activated kinase 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA CTD PMID:27188386 NCBI chr 3:126,092,576...126,128,320
Ensembl chr 3:126,093,013...126,128,318 		JBrowse link
G Palld palladin, cytoskeletal associated protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PALLD mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALLD mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232 		JBrowse link
G Pamr1 peptidase domain containing associated with muscle regeneration 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PAMR1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAMR1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:109,340,411...109,443,595
Ensembl chr 3:109,341,476...109,443,585 		JBrowse link
G Papln papilin, proteoglycan-like sulfated glycoprotein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PAPLN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAPLN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:109,129,268...109,163,300
Ensembl chr 6:109,129,261...109,161,483 		JBrowse link
G Pappa pappalysin 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAPPA mRNA CTD PMID:27188386 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361 		JBrowse link
G Patj PATJ, crumbs cell polarity complex component increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PATJ mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PATJ mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301 		JBrowse link
G Pawr pro-apoptotic WT1 regulator increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PAWR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492 		JBrowse link
G Pax6 paired box 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PAX6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAX6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763 		JBrowse link
G Pax7 paired box 7 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX7 mRNA CTD PMID:27188386 NCBI chr 5:157,279,623...157,381,188
Ensembl chr 5:157,279,623...157,381,121 		JBrowse link
G Pcdh10 protocadherin 10 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PCDH10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:130,553,432...130,619,591
Ensembl chr 2:130,553,425...130,613,407 		JBrowse link
G Pcdh17 protocadherin 17 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PCDH17 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdh18 protocadherin 18 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PCDH18 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:135,982,929...135,996,917
Ensembl chr 2:135,983,144...135,996,826 		JBrowse link
G Pcdh20 protocadherin 20 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PCDH20 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:70,834,042...70,840,298
Ensembl chr15:70,834,042...70,840,298 		JBrowse link
G Pcdh8 protocadherin 8 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH8 mRNA CTD PMID:27188386 NCBI chr15:61,607,521...61,612,090
Ensembl chr15:61,607,521...61,612,097 		JBrowse link
G Pcdh9 protocadherin 9 increases expression ISO mercuric bromide results in increased expression of PCDH9 mRNA CTD PMID:26272509 NCBI chr15:75,748,472...76,646,644
NCBI chr15:76,078,024...76,127,778
Ensembl chr15:75,749,278...76,645,302 		JBrowse link
G Pcsk1 proprotein convertase subtilisin/kexin type 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PCSK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:6,130,045...6,176,974
Ensembl chr 2:6,129,592...6,176,974 		JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PCSK9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCSK9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507 		JBrowse link
G Pde10a phosphodiesterase 10A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PDE10A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:54,313,343...54,765,668
Ensembl chr 1:54,317,732...54,764,051 		JBrowse link
G Pde3a phosphodiesterase 3A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDE3A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE3A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270 		JBrowse link
G Pde4b phosphodiesterase 4B increases expression ISO mercuric bromide results in increased expression of PDE4B mRNA CTD PMID:26272509 NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267 		JBrowse link
G Pde4d phosphodiesterase 4D increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDE4D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569 		JBrowse link
G Pdgfb platelet derived growth factor subunit B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDGFB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pdgfc platelet derived growth factor C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDGFC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:168,613,409...168,791,575
Ensembl chr 2:168,614,353...168,791,573 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PDK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pdlim1 PDZ and LIM domain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDLIM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDLIM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379 		JBrowse link
G Pdpn podoplanin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PDPN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDPN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:160,884,993...160,925,637 		JBrowse link
G Pelo pelota mRNA surveillance and ribosome rescue factor multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA CTD PMID:27188386 NCBI chr 2:48,530,902...48,532,670
Ensembl chr 2:48,530,907...48,532,761 		JBrowse link
G Perp p53 apoptosis effector related to PMP22 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PERP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PERP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687 		JBrowse link
G Pex13 peroxisomal biogenesis factor 13 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PEX13 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PEX13 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:101,804,673...101,822,367
Ensembl chr14:101,804,673...101,822,367 		JBrowse link
G Pex2 peroxisomal biogenesis factor 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PEX2 mRNA CTD PMID:27188386 NCBI chr 2:97,957,479...97,973,767
Ensembl chr 2:97,948,443...97,981,092 		JBrowse link
G Pfkp phosphofructokinase, platelet increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PFKP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PFKP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752 		JBrowse link
G Pgcka1 PDCD10 and GCKIII kinases associated 1 increases expression ISO mercuric bromide results in increased expression of PGCKA1 mRNA CTD PMID:26272509 NCBI chr14:44,740,965...44,832,180
Ensembl chr14:44,740,972...44,831,613 		JBrowse link
G Pgm5 phosphoglucomutase 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PGM5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PGM5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:231,752,052...231,939,812
Ensembl chr 1:231,752,052...231,939,812 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PHLDA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PHLDA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920 		JBrowse link
G Pi15 peptidase inhibitor 15 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PI15 mRNA CTD PMID:27188386 NCBI chr 5:6,178,427...6,206,548
Ensembl chr 5:6,174,963...6,247,841 		JBrowse link
G Pierce2 piercer of microtubule wall 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PIERCE2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIERCE2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:82,596,034...82,600,500
Ensembl chr 8:82,591,000...82,600,852 		JBrowse link
G Pik3r5 phosphoinositide-3-kinase, regulatory subunit 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PIK3R5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIK3R5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539 		JBrowse link
G Pip4k2a phosphatidylinositol-5-phosphate 4-kinase type 2 alpha decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PIP4K2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIP4K2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:86,405,080...86,576,597
Ensembl chr17:86,405,081...86,576,430 		JBrowse link
G Pir pirin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PIR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:33,740,428...33,851,049
Ensembl chr  X:33,740,429...33,851,049 		JBrowse link
G Pitx2 paired-like homeodomain 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PITX2 mRNA CTD PMID:27188386 NCBI chr 2:220,391,417...220,411,588
Ensembl chr 2:220,391,888...220,411,591 		JBrowse link
G Pkd1l2 polycystin 1 like 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PKD1L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKD1L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:61,958,351...62,045,324
Ensembl chr19:61,958,415...62,044,358 		JBrowse link
G Pknox2 PBX/knotted 1 homeobox 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PKNOX2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PKNOX2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:44,789,467...44,979,754 		JBrowse link
G Pkp2 plakophilin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PKP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:98,165,974...98,231,916
Ensembl chr11:98,165,974...98,231,916 		JBrowse link
G Pla2g4a phospholipase A2 group 4A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLA2G4A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G4A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Plce1 phospholipase C, epsilon 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLCE1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLCE1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:245,657,080...245,963,828 		JBrowse link
G Plekha2 pleckstrin homology domain containing A2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLEKHA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:73,641,338...73,704,068
Ensembl chr16:73,641,344...73,703,087 		JBrowse link
G Plk2 polo-like kinase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLK2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLK2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLOD2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLOD2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022 		JBrowse link
G Plscr1 phospholipid scramblase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PLSCR1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLSCR1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:101,662,512...101,684,474
Ensembl chr 8:101,664,056...101,684,614 		JBrowse link
G Plxnc1 plexin C1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PLXNC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXNC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PMAIP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PMAIP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Polh DNA polymerase eta increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of POLH mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:22,275,929...22,310,576
Ensembl chr 9:22,275,946...22,310,577 		JBrowse link
G Postn periostin multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA CTD PMID:27188386 NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300 		JBrowse link
G Pou3f1 POU class 3 homeobox 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of POU3F1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:142,195,090...142,198,070
Ensembl chr 5:142,194,066...142,202,704 		JBrowse link
G Pou3f2 POU class 3 homeobox 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of POU3F2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU3F2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:40,874,631...40,880,539
Ensembl chr 5:40,874,601...40,881,010 		JBrowse link
G Pou4f1 POU class 4 homeobox 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of POU4F1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POU4F1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:87,668,328...87,674,643
Ensembl chr15:87,668,328...87,674,643 		JBrowse link
G Ppfia4 PTPRF interacting protein alpha 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPFIA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPFIA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279 		JBrowse link
G Ppic peptidylprolyl isomerase C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PPIC mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPIC mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:49,040,690...49,053,296
Ensembl chr18:49,040,692...49,053,466 		JBrowse link
G Ppil2 peptidylprolyl isomerase like 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPIL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPIL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:97,401,944...97,424,581
Ensembl chr11:97,401,963...97,430,769 		JBrowse link
G Ppl periplakin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PPL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658 		JBrowse link
G Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PPM1D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256 		JBrowse link
G Ppm1h protein phosphatase, Mg2+/Mn2+ dependent, 1H increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PPM1H mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1H mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:60,224,087...60,484,947
Ensembl chr 7:60,223,745...60,488,140 		JBrowse link
G Ppp1r16a protein phosphatase 1, regulatory subunit 16A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPP1R16A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R16A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:110,272,307...110,295,452
Ensembl chr 7:110,272,282...110,295,450 		JBrowse link
G Ppp1r17 protein phosphatase 1, regulatory subunit 17 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPP1R17 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R17 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:86,544,024...86,560,839
Ensembl chr 4:86,544,121...86,560,835 		JBrowse link
G Ppp1r1a protein phosphatase 1, regulatory (inhibitor) subunit 1A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPP1R1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:136,533,031...136,540,687
Ensembl chr 7:136,523,604...136,540,683 		JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PPP2R2B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R2B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:34,904,686...35,357,299
Ensembl chr18:34,904,686...35,356,977 		JBrowse link
G Prdm1 PR/SET domain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRDM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088 		JBrowse link
G Prdm5 PR/SET domain 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRDM5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDM5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:96,405,492...96,567,647
Ensembl chr 4:96,405,493...96,567,647 		JBrowse link
G Prdx1 peroxiredoxin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRDX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRDX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504 		JBrowse link
G Prima1 proline rich membrane anchor 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PRIMA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRIMA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:128,094,686...128,155,592
Ensembl chr 6:128,103,175...128,154,865 		JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRKACA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494 		JBrowse link
G Prkcb protein kinase C, beta decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PRKCB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKCB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Prkch protein kinase C, eta increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRKCH mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477 		JBrowse link
G Prkx protein kinase cAMP-dependent X-linked catalytic subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRKX mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKX mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:45,701,747...45,745,210
Ensembl chr  X:45,701,747...45,745,066 		JBrowse link
G Prnp prion protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRNP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRNP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436 		JBrowse link
G Prok2 prokineticin 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PROK2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PROK2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:133,903,210...133,918,126
Ensembl chr 4:133,903,210...133,917,933 		JBrowse link
G Prorsd1 prolyl-tRNA synthetase associated domain containing 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRORSD1P mRNA CTD PMID:27188386 NCBI chr14:107,458,910...107,461,179
Ensembl chr14:107,458,857...107,461,205 		JBrowse link
G Proser2 proline and serine rich 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROSER2 mRNA CTD PMID:27188386 NCBI chr17:77,061,371...77,096,788
Ensembl chr17:77,077,727...77,095,194 		JBrowse link
G Prrg1 proline rich and Gla domain 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRRG1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRRG1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:46,381,329...46,493,677
Ensembl chr  X:46,383,967...46,493,700 		JBrowse link
G Prss12 serine protease 12 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRSS12 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRSS12 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:214,308,695...214,368,679
Ensembl chr 2:214,308,774...214,369,941 		JBrowse link
G Prss23 serine protease 23 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PRSS23 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRSS23 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871 		JBrowse link
G Prss8 serine protease 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PRSS8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRSS8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:191,966,701...191,971,271
Ensembl chr 1:191,966,701...191,971,193 		JBrowse link
G Prune2 prune homolog 2 with BCH domain decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PRUNE2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:223,779,617...224,130,058
Ensembl chr 1:223,969,102...224,051,592 		JBrowse link
G Psmb8 proteasome 20S subunit beta 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PSMB8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,654,068...4,657,031 		JBrowse link
G Ptger4 prostaglandin E receptor 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PTGER4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTGER4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PTGS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTGS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptp4a3 protein tyrosine phosphatase 4A3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PTP4A3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTP4A3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:107,518,220...107,549,949
Ensembl chr 7:107,541,047...107,549,949 		JBrowse link
G Ptx3 pentraxin 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTX3 mRNA CTD PMID:27188386 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Pvt1 Pvt1 oncogene increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PVT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PVT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:95,545,916...95,769,306 JBrowse link
G Pwwp2b PWWP domain containing 2B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PWWP2B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PWWP2B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:203,470,172...203,489,575
Ensembl chr 1:203,470,928...203,489,549 		JBrowse link
G Pxdc1 PX domain containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of PXDC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXDC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:30,481,336...30,510,330
Ensembl chr17:30,481,373...30,510,331 		JBrowse link
G Pygm glycogen phosphorylase, muscle associated decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of PYGM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYGM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:213,119,791...213,134,612 		JBrowse link
G Rab17 RAB17, member RAS oncogene family increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RAB17 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:99,001,045...99,014,032 		JBrowse link
G Rab20 RAB20, member RAS oncogene family increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RAB20 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:84,721,427...84,745,610
Ensembl chr16:84,721,427...84,745,610 		JBrowse link
G Rab33a RAB33A, member RAS oncogene family decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RAB33A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB33A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:132,572,133...132,584,255
Ensembl chr  X:132,572,148...132,584,254 		JBrowse link
G Rai2 retinoic acid induced 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAI2 mRNA CTD PMID:27188386 NCBI chr  X:36,580,406...36,642,943
Ensembl chr  X:36,573,917...36,643,240 		JBrowse link
G Rarb retinoic acid receptor, beta increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RARB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RARB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040 		JBrowse link
G Rasef RAS and EF hand domain containing multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA CTD PMID:27188386 NCBI chr 5:92,595,148...92,665,526
Ensembl chr 5:92,595,148...92,666,117 		JBrowse link
G Rasgrf2 RAS protein-specific guanine nucleotide-releasing factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RASGRF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGRF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:24,848,699...25,096,773
Ensembl chr 2:24,848,699...25,147,558 		JBrowse link
G Rassf6 Ras association domain family member 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RASSF6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASSF6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:17,717,505...17,757,507
Ensembl chr14:17,717,567...17,760,378 		JBrowse link
G Rbfox3 RNA binding fox-1 homolog 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RBFOX3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBFOX3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945 		JBrowse link
G Rbm20 RNA binding motif protein 20 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RBM20 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM20 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:262,671,311...262,912,551
Ensembl chr 1:262,688,978...262,891,364 		JBrowse link
G Rbm47 RNA binding motif protein 47 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RBM47 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM47 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163 		JBrowse link
G Rbms3 RNA binding motif, single stranded interacting protein 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RBMS3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBMS3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:125,183,311...125,970,239
Ensembl chr 8:125,183,315...126,503,586 		JBrowse link
G Rbp7 retinol binding protein 7 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RBP7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBP7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:165,169,700...165,177,427
Ensembl chr 5:165,172,785...165,177,399 		JBrowse link
G Reep6 receptor accessory protein 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of REEP6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of REEP6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:10,024,601...10,031,507
Ensembl chr 7:10,024,602...10,031,740 		JBrowse link
G Reln reelin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RELN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RELN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162 		JBrowse link
G Reps2 RALBP1 associated Eps domain containing 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of REPS2 mRNA CTD PMID:27188386 NCBI chr  X:35,681,260...35,954,103
Ensembl chr  X:35,681,263...35,954,103 		JBrowse link
G Ret ret proto-oncogene decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RET mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RET mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556 		JBrowse link
G Retreg1 reticulophagy regulator 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RETREG1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RETREG1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:78,066,031...78,225,356 		JBrowse link
G Rev3l REV3 like, DNA directed polymerase zeta catalytic subunit increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of REV3L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:44,686,482...44,844,668
Ensembl chr20:44,686,940...44,844,668 		JBrowse link
G Rflnb refilin B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RFLNB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFLNB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:61,391,947...61,398,224
Ensembl chr10:61,390,659...61,398,224 		JBrowse link
G Rfx2 regulatory factor X2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RFX2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFX2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:1,691,762...1,759,159
Ensembl chr 9:1,690,612...1,758,529 		JBrowse link
G Rfx4 regulatory factor X4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RFX4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFX4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:20,740,760...20,903,355
Ensembl chr 7:20,741,079...20,902,851 		JBrowse link
G Rgma repulsive guidance molecule BMP co-receptor a decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RGMA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:136,538,782...136,582,763
Ensembl chr 1:136,538,759...136,582,763 		JBrowse link
G Rgmb repulsive guidance molecule BMP co-receptor b multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGMB mRNA CTD PMID:27188386 NCBI chr 1:65,439,748...65,465,149
Ensembl chr 1:65,441,410...65,465,098 		JBrowse link
G Rgs5 regulator of G-protein signaling 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RGS5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:84,381,077...84,417,875
Ensembl chr13:84,380,910...84,421,352 		JBrowse link
G Rgs7 regulator of G-protein signaling 7 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RGS7 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS7 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:89,511,492...89,941,082
Ensembl chr13:89,511,150...89,940,987 		JBrowse link
G Rhob ras homolog family member B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RHOB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rhobtb3 Rho-related BTB domain containing 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RHOBTB3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:7,095,253...7,150,906 		JBrowse link
G Ripk4 receptor-interacting serine-threonine kinase 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RIPK4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPK4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:50,591,926...50,614,169
Ensembl chr11:50,591,936...50,614,169 		JBrowse link
G Ripor2 RHO family interacting cell polarization regulator 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RIPOR2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337 		JBrowse link
G Ripply3 ripply transcriptional repressor 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY3 mRNA CTD PMID:27188386 NCBI chr11:47,118,147...47,126,244
Ensembl chr11:47,118,147...47,131,954 		JBrowse link
G Rnd3 Rho family GTPase 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RND3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RND3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536 		JBrowse link
G Rnf125 ring finger protein 125 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RNF125 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF125 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:12,528,995...12,550,646
Ensembl chr18:12,528,838...12,554,430 		JBrowse link
G Rnf130 ring finger protein 130 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RNF130 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF130 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:34,843,920...34,957,130
Ensembl chr10:34,843,915...34,960,408 		JBrowse link
G Rnf144b ring finger protein 144B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RNF144B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF144B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:17,637,564...17,786,685
Ensembl chr17:17,639,079...17,769,037 		JBrowse link
G Rnf217 ring finger protein 217 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RNF217 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF217 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:27,835,741...27,927,805
Ensembl chr 1:27,835,148...27,928,044 		JBrowse link
G Rnft1 ring finger protein, transmembrane 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RNFT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNFT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:71,807,403...71,821,132
Ensembl chr10:71,807,456...71,821,141 		JBrowse link
G Robo3 roundabout guidance receptor 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ROBO3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ROBO3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:45,322,323...45,340,466
Ensembl chr 8:45,323,344...45,340,222 		JBrowse link
G Rprm reprimo, TP53 dependent G2 arrest mediator homolog increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RPRM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPRM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:58,948,618...58,950,035
Ensembl chr 3:58,799,866...58,950,542 		JBrowse link
G Rps27l ribosomal protein S27-like increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of RPS27L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS27L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130
Ensembl chr 8:33,713,661...33,714,130 		JBrowse link
G Rras RAS related decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RRAS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRAS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:104,637,061...104,640,841
Ensembl chr 1:104,634,951...104,640,841 		JBrowse link
G Rskr ribosomal protein S6 kinase related decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RSKR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSKR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:63,683,387...63,690,032
Ensembl chr10:63,683,479...63,687,889 		JBrowse link
G Rsph9 radial spoke head component 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RSPH9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSPH9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:22,337,681...22,350,515
Ensembl chr 9:22,337,668...22,351,448 		JBrowse link
G Rspo2 R-spondin 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RSPO2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RSPO2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:75,987,217...76,123,984
Ensembl chr 7:75,987,817...76,123,654 		JBrowse link
G RT1-DMa RT1 class II, locus DMa multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DMA mRNA CTD PMID:27188386 NCBI chr20:4,708,932...4,712,335
Ensembl chr20:4,708,933...4,712,335 		JBrowse link
G RT1-DMb RT1 class II, locus DMb decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HLA-DMB mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DMB mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246 		JBrowse link
G RT1-DOa RT1 class II, locus DOa decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of HLA-DOA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HLA-DOA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,755,499...4,758,478 		JBrowse link
G Rundc3b RUN domain containing 3B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of RUNDC3B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUNDC3B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:26,417,501...26,554,404
Ensembl chr 4:26,417,437...26,554,403 		JBrowse link
G Runx1t1 RUNX1 partner transcriptional co-repressor 1 increases expression ISO mercuric bromide results in increased expression of RUNX1T1 mRNA CTD PMID:26272509 NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:31,984,855...32,132,855 		JBrowse link
G Runx2 RUNX family transcription factor 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUNX2 mRNA CTD PMID:27188386 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027 		JBrowse link
G S100a10 S100 calcium binding protein A10 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of S100A10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103 		JBrowse link
G S100a11 S100 calcium binding protein A11 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of S100A11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541 		JBrowse link
G S100a14 S100 calcium binding protein A14 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of S100A14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of S100A14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:178,306,025...178,307,999 		JBrowse link
G Sall3 spalt-like transcription factor 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SALL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SALL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:76,680,997...76,700,905
Ensembl chr18:76,681,005...76,700,905 		JBrowse link
G Samd13 sterile alpha motif domain containing 13 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SAMD13 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMD13 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:238,194,962...238,200,790
Ensembl chr 2:238,194,965...238,233,496 		JBrowse link
G Samd4a sterile alpha motif domain containing 4A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SAMD4A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAMD4A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:22,616,200...22,831,872
Ensembl chr15:22,614,287...22,831,872 		JBrowse link
G Samhd1 SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SAMHD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SAMHD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:166,179,742...166,214,448
Ensembl chr 3:166,181,588...166,214,410 		JBrowse link
G Sar1b secretion associated, Ras related GTPase 1B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SAR1B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,519,384...36,555,005 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SAT1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAT1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:44,008,089...44,011,376
Ensembl chr  X:44,006,781...44,011,374 		JBrowse link
G Satb2 SATB homeobox 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SATB2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:65,842,351...66,028,569
Ensembl chr 9:65,844,570...66,021,238 		JBrowse link
G Sbf2 SET binding factor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SBF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SBF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:173,787,638...174,154,589
Ensembl chr 1:173,788,187...174,154,522 		JBrowse link
G Scin scinderin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SCIN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCIN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:62,836,641...62,915,287
Ensembl chr 6:62,836,641...62,915,287 		JBrowse link
G Scn2a sodium voltage-gated channel alpha subunit 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SCN2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCN2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:70,710,862...70,845,569
Ensembl chr 3:70,710,954...70,845,279 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SCNN1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCNN1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405 		JBrowse link
G Scube2 signal peptide, CUB domain and EGF like domain containing 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SCUBE2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:173,264,862...173,341,323
Ensembl chr 1:173,264,865...173,334,372 		JBrowse link
G Selenom selenoprotein M decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SELENOM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:82,619,453...82,622,056
Ensembl chr14:82,619,436...82,622,054 		JBrowse link
G Selenop selenoprotein P increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SELENOP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SELENOP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Selenow selenoprotein W decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SELENOW mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENOW mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703 		JBrowse link
G Sema3c semaphorin 3C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SEMA3C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740 		JBrowse link
G Sema3e semaphorin 3E increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SEMA3E mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:21,252,686...21,510,449
Ensembl chr 4:21,210,734...21,510,374 		JBrowse link
G Sema6a semaphorin 6A increases expression ISO mercuric bromide results in increased expression of SEMA6A mRNA CTD PMID:26272509 NCBI chr18:42,237,227...42,358,540
Ensembl chr18:42,237,228...42,358,540 		JBrowse link
G Serpinb1a serpin family B member 1A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SERPINB1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166 		JBrowse link
G Serpinb9 serpin family B member 9 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SERPINB9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINB9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:31,628,887...31,652,003
Ensembl chr17:31,629,392...31,651,974 		JBrowse link
G Serpine1 serpin family E member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SERPINE1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINE1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Serpini1 serpin family I member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SERPINI1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SERPINI1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:162,645,209...162,731,737
Ensembl chr 2:162,645,350...162,731,740 		JBrowse link
G Sesn1 sestrin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SESN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SESN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010 		JBrowse link
G Sesn2 sestrin 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SESN2 mRNA CTD PMID:27188386 NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255 		JBrowse link
G Sez6 seizure related 6 homolog decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SEZ6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEZ6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:63,317,065...63,366,733
Ensembl chr10:63,316,953...63,366,723 		JBrowse link
G Sfn stratifin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SFN mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995 		JBrowse link
G Sfrp1 secreted frizzled-related protein 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SFRP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFRP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736 		JBrowse link
G Sfxn5 sideroflexin 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SFXN5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:119,307,692...119,427,531
Ensembl chr 4:119,308,386...119,427,259 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SGK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Sgk3 serum/glucocorticoid regulated kinase family, member 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SGK3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGK3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:14,128,628...14,255,099
Ensembl chr 5:14,126,257...14,198,331 		JBrowse link
G Sgpp2 sphingosine-1-phosphate phosphatase 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SGPP2 mRNA CTD PMID:27188386 NCBI chr 9:87,211,155...87,331,787
Ensembl chr 9:87,211,717...87,333,132 		JBrowse link
G Sh2d4a SH2 domain containing 4A multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH2D4A mRNA CTD PMID:27188386 NCBI chr16:26,106,721...26,176,069
Ensembl chr16:26,106,730...26,175,974 		JBrowse link
G Shc3 SHC adaptor protein 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHC3 mRNA CTD PMID:27188386 NCBI chr17:13,803,980...13,924,433
Ensembl chr17:13,803,781...13,924,433 		JBrowse link
G Shisa6 shisa family member 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SHISA6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISA6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:51,396,806...51,691,156
Ensembl chr10:51,396,806...51,691,156 		JBrowse link
G Shisal1 shisa like 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SHISAL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISAL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:117,388,210...117,491,539 JBrowse link
G Shtn1 shootin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SHTN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SHTN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:268,108,095...268,211,947
Ensembl chr 1:268,108,097...268,211,947 		JBrowse link
G Sipa1l2 signal-induced proliferation-associated 1 like 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SIPA1L2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773 		JBrowse link
G Six1 SIX homeobox 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SIX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:97,482,617...97,487,853 		JBrowse link
G Six3 SIX homeobox 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX3 mRNA CTD PMID:27188386 NCBI chr 6:14,791,937...14,796,365
Ensembl chr 6:14,789,354...14,804,175 		JBrowse link
G Six5 SIX homeobox 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SIX5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:87,868,859...87,873,929
Ensembl chr 1:87,869,405...87,873,929 		JBrowse link
G Six6 SIX homeobox 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX6 mRNA CTD PMID:27188386 NCBI chr 6:97,357,883...97,375,415
Ensembl chr 6:97,370,435...97,375,415 		JBrowse link
G Skida1 SKI/DACH domain containing 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SKIDA1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKIDA1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:85,706,693...85,717,499
Ensembl chr17:85,707,366...85,716,576 		JBrowse link
G Slc10a4 solute carrier family 10, member 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC10A4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC10A4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:35,552,170...35,557,884
Ensembl chr14:35,552,170...35,557,884 		JBrowse link
G Slc16a3 solute carrier family 16 member 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC16A3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903 		JBrowse link
G Slc18a2 solute carrier family 18 member A2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC18A2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC18A2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231 		JBrowse link
G Slc1a2 solute carrier family 1 member 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC1A2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC1A2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249 		JBrowse link
G Slc1a4 solute carrier family 1 member 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC1A4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC1A4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:98,718,646...98,761,672
Ensembl chr14:98,730,450...98,761,790 		JBrowse link
G Slc22a15 solute carrier family 22, member 15 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC22A15 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC22A15 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:191,987,409...192,049,859
Ensembl chr 2:191,987,409...192,047,362 		JBrowse link
G Slc25a53 solute carrier family 25, member 53 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC25A53 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A53 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:105,099,191...105,111,936
Ensembl chr  X:105,099,112...105,113,009 		JBrowse link
G Slc27a2 solute carrier family 27 member 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A2 mRNA CTD PMID:27188386 NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC2A3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC30A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc35g2 solute carrier family 35, member G2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC35G2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:109,964,589...109,992,347
Ensembl chr 8:109,964,378...109,992,412 		JBrowse link
G Slc38a6 solute carrier family 38, member 6 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC38A6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC38A6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:97,723,526...97,814,394
Ensembl chr 6:97,723,471...97,785,791 		JBrowse link
G Slc39a8 solute carrier family 39 member 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC39A8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC39A8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:226,845,686...226,992,668
Ensembl chr 2:226,929,644...226,992,667 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC3A2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC3A2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064 		JBrowse link
G Slc40a1 solute carrier family 40 member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC40A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC40A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460 		JBrowse link
G Slc44a3 solute carrier family 44, member 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC44A3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:212,234,425...212,312,886
Ensembl chr 2:212,236,853...212,312,982 		JBrowse link
G Slc6a15 solute carrier family 6 member 15 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC6A15 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A15 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:40,439,607...40,493,788
Ensembl chr 7:40,439,658...40,493,786 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SLC6A8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:156,536,017...156,545,321
Ensembl chr  X:156,536,017...156,545,321 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC7A11 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc7a2 solute carrier family 7 member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC7A2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLC7A5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412 		JBrowse link
G Slc7a7 solute carrier family 7 member 7 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A7 mRNA CTD PMID:27188386 NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683 		JBrowse link
G Slco4c1 solute carrier organic anion transporter family, member 4C1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 NCBI chr 9:104,624,802...104,676,462
Ensembl chr 9:104,624,802...104,676,462 		JBrowse link
G Slfn4 schlafen family member 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLFN12 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:68,492,135...68,515,674
Ensembl chr10:68,508,916...68,513,991 		JBrowse link
G Slit2 slit guidance ligand 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLIT2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLIT2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146 		JBrowse link
G Slit3 slit guidance ligand 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SLIT3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLIT3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704 		JBrowse link
G Slitrk1 SLIT and NTRK-like family, member 1 decreases expression ISO mercuric bromide results in decreased expression of SLITRK1 mRNA CTD PMID:26272509 NCBI chr15:92,137,703...92,141,741
Ensembl chr15:92,135,994...92,142,105 		JBrowse link
G Smarca2 SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SMARCA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:233,617,277...233,784,908
Ensembl chr 1:233,617,366...233,784,869 		JBrowse link
G Smkr1-ps1 small lysine-rich protein 1, pseudogene 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SMKR1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMKR1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:59,562,818...59,576,401
Ensembl chr 4:59,569,149...59,576,661 		JBrowse link
G Smoc1 SPARC related modular calcium binding 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SMOC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMOC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956 		JBrowse link
G Smoc2 SPARC related modular calcium binding 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SMOC2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMOC2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:63,935,627...64,064,952
Ensembl chr 1:63,935,647...64,064,955 		JBrowse link
G Smpdl3a sphingomyelin phosphodiesterase, acid-like 3A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SMPDL3A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMPDL3A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:37,679,004...37,701,979
Ensembl chr20:37,678,964...37,704,260 		JBrowse link
G Snai2 snail family transcriptional repressor 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SNAI2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SNAI2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349 		JBrowse link
G Snap91 synaptosome associated protein 91 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SNAP91 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAP91 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:96,618,039...96,732,763
Ensembl chr 8:96,618,041...96,732,507 		JBrowse link
G Snca synuclein alpha decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SNCA mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCA mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315 		JBrowse link
G Sncaip synuclein, alpha interacting protein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SNCAIP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:48,402,164...48,542,246
Ensembl chr18:48,404,531...48,574,002 		JBrowse link
G Sobp sine oculis binding protein homolog decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SOBP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOBP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:48,064,445...48,243,607
Ensembl chr20:48,064,445...48,243,607 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SOCS2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOCS2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423 		JBrowse link
G Sorcs1 sortilin-related VPS10 domain containing receptor 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SORCS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:259,022,007...259,535,731
Ensembl chr 1:259,021,631...259,535,685 		JBrowse link
G Sost sclerostin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SOST mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOST mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:87,412,722...87,415,766
Ensembl chr10:87,411,721...87,415,766 		JBrowse link
G Sox1 SRY-box transcription factor 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SOX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:83,837,689...83,841,703
Ensembl chr16:83,802,160...83,841,775 		JBrowse link
G Sox2 SRY-box transcription factor 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SOX2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350 		JBrowse link
G Sox6 SRY-box transcription factor 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SOX6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:179,157,678...179,769,243
Ensembl chr 1:179,163,566...179,711,727 		JBrowse link
G Sp5 Sp5 transcription factor multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SP5 mRNA CTD PMID:27188386 NCBI chr 3:75,682,677...75,685,479
Ensembl chr 3:75,682,677...75,685,479 		JBrowse link
G Spag1 sperm associated antigen 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SPAG1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPAG1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:69,246,301...69,306,483
Ensembl chr 7:69,246,582...69,306,482 		JBrowse link
G Spag4 sperm associated antigen 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SPAG4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:165,040,682...165,047,963
Ensembl chr 3:165,041,134...165,045,519 		JBrowse link
G Spag6 sperm associated antigen 6 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA
mercuric bromide results in decreased expression of SPAG6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:86,258,418...86,309,922
Ensembl chr17:86,262,000...86,309,909 		JBrowse link
G Spon1 spondin 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SPON1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:177,363,197...177,662,676 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SPP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spry4 sprouty RTK signaling antagonist 4 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA CTD PMID:27188386 NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,687,039...30,704,173 		JBrowse link
G Spsb4 splA/ryanodine receptor domain and SOCS box containing 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SPSB4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPSB4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:106,416,039...106,489,271
Ensembl chr 8:106,416,040...106,489,271 		JBrowse link
G Sptlc3 serine palmitoyltransferase, long chain base subunit 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SPTLC3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPTLC3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:147,301,570...147,431,696
Ensembl chr 3:147,301,801...147,434,044 		JBrowse link
G Sqle squalene epoxidase decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SQLE mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SQLE mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050 		JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SQSTM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SQSTM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Srcin1 SRC kinase signaling inhibitor 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SRCIN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SRCIN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,991,033...83,067,419 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SRXN1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRXN1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Sst somatostatin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SST mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SST mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823 		JBrowse link
G St14 ST14 transmembrane serine protease matriptase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ST14 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST14 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652 		JBrowse link
G St6gal2 ST6 beta-galactoside alpha-2,6-sialyltransferase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ST6GAL2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GAL2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:9,508,928...9,606,900
Ensembl chr 9:9,509,548...9,594,007 		JBrowse link
G St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ST8SIA4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ST8SIA4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:103,437,479...103,532,008 		JBrowse link
G Stam2 signal transducing adaptor molecule 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STAM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STAM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:57,597,557...57,643,915
Ensembl chr 3:57,597,559...57,643,915 		JBrowse link
G Stc2 stanniocalcin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STC2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STC2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447 		JBrowse link
G Steap1 STEAP family member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STEAP1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:29,231,809...29,242,317
Ensembl chr 4:29,231,753...29,242,317 		JBrowse link
G Stk32a serine/threonine kinase 32A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of STK32A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:35,509,791...35,620,421
Ensembl chr18:35,509,982...35,628,985 		JBrowse link
G Stox1 storkhead box 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of STOX1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOX1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:31,140,993...31,209,126
Ensembl chr20:31,140,993...31,208,877 		JBrowse link
G Sts steroid sulfatase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STS mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STS mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:46,102,524...46,110,868
Ensembl chr  X:46,102,548...46,111,104 		JBrowse link
G Stt3b STT3 oligosaccharyltransferase complex catalytic subunit B decreases expression ISO mercuric bromide results in decreased expression of STT3B mRNA CTD PMID:26272509 NCBI chr 8:123,806,836...123,872,179
Ensembl chr 8:123,795,983...123,872,180 		JBrowse link
G Stx3 syntaxin 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STX3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STX3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:217,909,169...218,110,466 		JBrowse link
G Styk1 serine/threonine/tyrosine kinase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of STYK1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STYK1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:166,779,030...166,829,310
Ensembl chr 4:166,779,040...166,827,738 		JBrowse link
G Sulf1 sulfatase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SULF1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SULF1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643 		JBrowse link
G Sulf2 sulfatase 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SULF2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SULT1A1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1A1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Sv2c synaptic vesicle glycoprotein 2c decreases expression ISO mercuric bromide results in decreased expression of SV2C mRNA CTD PMID:26272509 NCBI chr 2:28,967,631...29,163,168
Ensembl chr 2:28,964,582...29,163,168 		JBrowse link
G Sybu syntabulin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SYBU mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYBU mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:77,731,662...77,833,413
Ensembl chr 7:77,731,605...77,833,686 		JBrowse link
G Syne1 spectrin repeat containing nuclear envelope protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SYNE1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:43,895,994...44,388,721 		JBrowse link
G Syngr3 synaptogyrin 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SYNGR3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNGR3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:14,215,088...14,219,844
Ensembl chr10:14,215,088...14,220,179 		JBrowse link
G Synj2 synaptojanin 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SYNJ2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNJ2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:48,923,737...49,038,650 		JBrowse link
G Synpr synaptoporin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of SYNPR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNPR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:14,003,861...14,330,808
Ensembl chr15:14,004,715...14,330,848 		JBrowse link
G Syt9 synaptotagmin 9 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of SYT9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYT9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:170,687,666...170,868,146
Ensembl chr 1:170,687,606...170,881,375 		JBrowse link
G Tac1 tachykinin, precursor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TAC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546 		JBrowse link
G Tacc1 transforming, acidic coiled-coil containing protein 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TACC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:73,515,016...73,598,395
Ensembl chr16:73,514,889...73,598,394 		JBrowse link
G Tacstd2 tumor-associated calcium signal transducer 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TACSTD2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACSTD2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:98,037,620...98,039,320
Ensembl chr 4:98,033,251...98,039,323 		JBrowse link
G Tafa2 TAFA chemokine like family member 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TAFA2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAFA2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:60,827,985...61,303,873
Ensembl chr 7:60,891,958...61,303,869 		JBrowse link
G Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TANC1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:64,508,037...64,741,826
Ensembl chr 3:64,508,085...64,741,825 		JBrowse link
G Tc2n tandem C2 domains, nuclear multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TC2N mRNA CTD PMID:27188386 NCBI chr 6:126,526,006...126,622,163
Ensembl chr 6:126,526,009...126,614,215 		JBrowse link
G Tdrp testis development related protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TDRP mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:82,326,837...82,354,861
Ensembl chr16:82,314,220...82,354,861 		JBrowse link
G Tekt2 tektin 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TEKT2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TEKT2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:143,904,185...143,907,724
Ensembl chr 5:143,904,187...143,907,724 		JBrowse link
G Tent5c terminal nucleotidyltransferase 5C increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TENT5C mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENT5C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:190,541,668...190,563,902
Ensembl chr 2:190,540,650...190,565,995 		JBrowse link
G Tes testin LIM domain protein increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TES mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:46,331,257...46,369,780 		JBrowse link
G Tex19.2 testis expressed gene 19.2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX19 mRNA CTD PMID:27188386 NCBI chr10:106,878,083...106,880,671
Ensembl chr10:106,878,085...106,880,671 		JBrowse link
G Tfap2a transcription factor AP-2 alpha increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TFAP2A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:24,230,064...24,253,219
Ensembl chr17:24,229,910...24,253,219 		JBrowse link
G Tfap2b transcription factor AP-2 beta multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA CTD PMID:27188386 NCBI chr 9:29,282,703...29,312,568
Ensembl chr 9:29,282,825...29,312,568 		JBrowse link
G Tfap2c transcription factor AP-2 gamma multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 NCBI chr 3:181,733,524...181,742,412
Ensembl chr 3:181,733,419...181,741,404 		JBrowse link
G Tfe3 transcription factor binding to IGHM enhancer 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TFE3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFE3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:17,401,466...17,414,829
Ensembl chr  X:17,401,466...17,414,685 		JBrowse link
G Tfpi tissue factor pathway inhibitor increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TFPI mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742 		JBrowse link
G Tfpi2 tissue factor pathway inhibitor 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:32,936,854...32,941,426 		JBrowse link
G Tgfb1i1 transforming growth factor beta 1 induced transcript 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:192,258,598...192,265,903 		JBrowse link
G Thada THADA, armadillo repeat containing decreases expression ISO mercuric bromide results in decreased expression of THADA mRNA CTD PMID:26272509 NCBI chr 6:15,936,593...16,240,523
Ensembl chr 6:15,936,632...16,239,749 		JBrowse link
G Thbs1 thrombospondin 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of THBS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THBS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thsd7a thrombospondin type 1 domain containing 7A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of THSD7A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THSD7A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:41,426,275...41,865,723 		JBrowse link
G Thumpd3 THUMP domain containing 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of THUMPD3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of THUMPD3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:147,741,288...147,764,254
Ensembl chr 4:147,741,309...147,765,579 		JBrowse link
G Tincr TINCR ubiquitin domain containing decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TINCR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TINCR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:1,476,770...1,477,039
NCBI chr 9:1,474,238...1,476,470
Ensembl chr 9:1,476,147...1,477,238 		JBrowse link
G Tjp2 tight junction protein 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TJP2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TJP2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750 		JBrowse link
G Tkt transketolase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TKT mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TKT mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431 		JBrowse link
G Tmem132d transmembrane protein 132D decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMEM132D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM132D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:33,905,971...34,553,267
Ensembl chr12:33,906,644...34,551,317 		JBrowse link
G Tmem132e transmembrane protein 132E decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMEM132E mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM132E mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:67,828,475...67,884,398
Ensembl chr10:67,828,475...67,884,398 		JBrowse link
G Tmem144 transmembrane protein 144 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM144 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM144 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:167,258,788...167,291,701
Ensembl chr 2:167,258,789...167,290,902 		JBrowse link
G Tmem150c transmembrane protein 150C multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM150C mRNA CTD PMID:27188386 NCBI chr14:9,759,028...9,829,588
Ensembl chr14:9,752,716...9,829,588 		JBrowse link
G Tmem154 transmembrane protein 154 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM154 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM154 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:172,313,290...172,352,939
Ensembl chr 2:172,313,240...172,361,723 		JBrowse link
G Tmem163 transmembrane protein 163 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMEM163 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM163 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:41,520,595...41,693,938
Ensembl chr13:41,520,359...41,693,938 		JBrowse link
G Tmem218 transmembrane protein 218 decreases expression ISO mercuric bromide results in decreased expression of TMEM218 mRNA CTD PMID:26272509 NCBI chr 8:45,113,368...45,128,739
Ensembl chr 8:45,113,427...45,129,152 		JBrowse link
G Tmem231 transmembrane protein 231 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMEM231 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM231 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr19:56,792,329...56,813,515
Ensembl chr19:56,792,329...56,820,094 		JBrowse link
G Tmem30b transmembrane protein 30B increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM30B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM30B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:97,987,130...97,991,170 		JBrowse link
G Tmem37 transmembrane protein 37 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM37 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM37 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:33,737,096...33,743,602
Ensembl chr13:33,736,308...33,743,747 		JBrowse link
G Tmem40 transmembrane protein 40 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM40 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM40 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:150,464,123...150,491,895
Ensembl chr 4:150,464,128...150,492,183 		JBrowse link
G Tmem63a transmembrane protein 63a increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMEM63A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM63A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:95,194,323...95,227,944
Ensembl chr13:95,195,234...95,228,302 		JBrowse link
G Tmem74 transmembrane protein 74 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMEM74 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM74 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:76,814,000...76,822,633
Ensembl chr 7:76,813,212...76,822,925 		JBrowse link
G Tmod2 tropomodulin 2 increases expression ISO mercuric bromide results in increased expression of TMOD2 mRNA CTD PMID:26272509 NCBI chr 8:85,197,222...85,250,627
Ensembl chr 8:85,196,226...85,246,371 		JBrowse link
G Tmprss13 transmembrane serine protease 13 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMPRSS13 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMPRSS13 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:54,522,069...54,550,673
Ensembl chr 8:54,522,443...54,550,670 		JBrowse link
G Tmt1a thiol methyltransferase 1A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMT1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMT1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:133,330,447...133,338,959 		JBrowse link
G Tmtc3 transmembrane O-mannosyltransferase targeting cadherins 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TMTC3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMTC3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:37,151,456...37,196,550
Ensembl chr 7:37,151,456...37,196,540 		JBrowse link
G Tmtc4 transmembrane O-mannosyltransferase targeting cadherins 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TMTC4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMTC4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:106,406,795...106,463,226
Ensembl chr15:106,407,597...106,463,210 		JBrowse link
G Tnfaip6 TNF alpha induced protein 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFAIP6 mRNA CTD PMID:27188386 NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796 		JBrowse link
G Tnfrsf10b TNF receptor superfamily member 10b increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TNFRSF10A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082 		JBrowse link
G Tnfrsf19 TNF receptor superfamily member 19 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TNFRSF19 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFRSF19 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:39,268,305...39,334,566
Ensembl chr15:39,268,305...39,356,438 		JBrowse link
G Tnfrsf21 TNF receptor superfamily member 21 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF21 mRNA CTD PMID:27188386 NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:25,376,400...25,451,323 		JBrowse link
G Tnfrsf22 tumor necrosis factor receptor superfamily, member 22 multiple interactions
increases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFRSF10C mRNA
mercuric bromide results in increased expression of TNFRSF10C mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:208,258,836...208,289,832 		JBrowse link
G Tnfsf9 TNF superfamily member 9 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TNFSF9 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFSF9 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:2,031,011...2,033,345
Ensembl chr 9:2,030,953...2,033,339 		JBrowse link
G Tnik TRAF2 and NCK interacting kinase increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TNIK mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNIK mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:113,112,937...113,511,341
Ensembl chr 2:113,112,938...113,511,339 		JBrowse link
G Tox thymocyte selection-associated high mobility group box increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TOX mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TOX mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:24,672,487...24,968,754
Ensembl chr 5:24,672,487...24,968,754 		JBrowse link
G Tpbg trophoblast glycoprotein decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TPBG mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPBG mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:95,673,993...95,677,364
Ensembl chr 8:95,629,267...95,678,394 		JBrowse link
G Tpd52l1 TPD52 like 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TPD52L1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPD52L1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158 		JBrowse link
G Trappc6a trafficking protein particle complex subunit 6A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TRAPPC6A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRAPPC6A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:88,286,533...88,293,493
Ensembl chr 1:88,286,362...88,293,493 		JBrowse link
G Trib3 tribbles pseudokinase 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIB3 mRNA CTD PMID:27188386 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802 		JBrowse link
G Trim2 tripartite motif-containing 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TRIM2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRIM2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:171,798,660...171,913,468 		JBrowse link
G Trim38 tripartite motif containing 38 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TRIM38 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM38 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:41,774,419...41,787,709 JBrowse link
G Trmt1l tRNA methyltransferase 1-like decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TRMT1L mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRMT1L mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr13:66,060,186...66,093,247
Ensembl chr13:66,060,162...66,093,643 		JBrowse link
G Trpc4 transient receptor potential cation channel, subfamily C, member 4 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TRPC4 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPC4 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:140,457,841...140,629,556
Ensembl chr 2:140,458,296...140,626,969 		JBrowse link
G Trps1 transcriptional repressor GATA binding 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TRPS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:83,806,121...84,032,609
Ensembl chr 7:83,811,497...84,031,786 		JBrowse link
G Tsc2 TSC complex subunit 2 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSC2 mRNA CTD PMID:27188386 NCBI chr10:14,125,679...14,160,317
Ensembl chr10:14,125,680...14,160,600 		JBrowse link
G Tsfm Ts translation elongation factor, mitochondrial decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TSFM mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSFM mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:64,714,330...64,750,106
Ensembl chr 7:64,714,036...64,750,171 		JBrowse link
G Ttc39c tetratricopeptide repeat domain 39C multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA CTD PMID:27188386 NCBI chr18:4,043,364...4,162,660
Ensembl chr18:4,080,391...4,165,315 		JBrowse link
G Ttll6 tubulin tyrosine ligase like 6 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TTLL6 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTLL6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:81,579,110...81,623,917
Ensembl chr10:81,579,178...81,623,919 		JBrowse link
G Ttr transthyretin increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TTR mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTR mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969 		JBrowse link
G Tuba1a tubulin, alpha 1A decreases expression ISO mercuric bromide results in decreased expression of TUBA1A mRNA CTD PMID:27015953 NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Twist1 twist family bHLH transcription factor 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TWIST1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TWIST1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965 		JBrowse link
G Twist2 twist family bHLH transcription factor 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TWIST2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TWIST2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:99,822,242...99,866,722
Ensembl chr 9:99,818,962...99,920,270 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of TXNRD1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Tysnd1 trypsin like peroxisomal matrix peptidase 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of TYSND1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TYSND1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:30,180,878...30,188,239
Ensembl chr20:30,181,090...30,188,236 		JBrowse link
G Ube2ql1 ubiquitin conjugating enzyme E2 QL1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of UBE2QL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2QL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:35,377,264...35,417,624 JBrowse link
G Ube3d ubiquitin protein ligase E3D decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of UBE3D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE3D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:96,125,609...96,293,122
Ensembl chr 8:95,882,167...96,293,078 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of UCHL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417 		JBrowse link
G Ulk2 unc-51 like autophagy activating kinase 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ULK2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ULK2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:46,951,038...47,029,844
Ensembl chr10:46,951,038...47,029,844 		JBrowse link
G Unkl unk like zinc finger increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of UNKL mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UNKL mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:14,710,627...14,756,725
Ensembl chr10:14,710,563...14,756,724 		JBrowse link
G Upk1a uroplakin 1A decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of UPK1A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPK1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:94,987,108...94,997,787 		JBrowse link
G Usp28 ubiquitin specific peptidase 28 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of USP28 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP28 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:58,222,258...58,282,711
Ensembl chr 8:58,222,220...58,282,750 		JBrowse link
G Usp43 ubiquitin specific peptidase 43 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of USP43 mRNA CTD PMID:27188386 NCBI chr10:53,047,368...53,110,099
Ensembl chr10:53,048,158...53,110,180 		JBrowse link
G Vamp7 vesicle-associated membrane protein 7 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VAMP7 mRNA CTD PMID:27188386 NCBI chr12:21,842,206...21,958,556
Ensembl chr12:21,842,228...21,958,552 		JBrowse link
G Vamp8 vesicle-associated membrane protein 8 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of VAMP8 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VAMP8 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073 		JBrowse link
G Vash1 vasohibin 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of VASH1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VASH1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 6:112,060,086...112,076,689
Ensembl chr 6:112,060,086...112,076,689 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of VCAM1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VCAM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VEGFA mRNA CTD PMID:27188386 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vgll1 vestigial-like family member 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of VGLL1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VGLL1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr  X:140,016,938...140,036,348 JBrowse link
G Vgll3 vestigial-like family member 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of VGLL3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VGLL3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr11:17,089,484...17,136,501
Ensembl chr11:17,089,597...17,138,937 		JBrowse link
G Vps13c vacuolar protein sorting 13 homolog C increases expression ISO mercuric bromide results in increased expression of VPS13C mRNA CTD PMID:26272509 NCBI chr 8:77,359,499...77,533,009
Ensembl chr 8:77,359,504...77,531,871 		JBrowse link
G Vwf von Willebrand factor decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of VWF mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VWF mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
G Wasf3 WASP family member 3 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of WASF3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WASF3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr12:13,675,642...13,774,648
Ensembl chr12:13,675,645...13,774,559 		JBrowse link
G Wfdc2 WAP four-disulfide core domain 2 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of WFDC2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161 		JBrowse link
G Wfdc21 WAP four-disulfide core domain 21 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC21P mRNA CTD PMID:27188386 NCBI chr10:69,125,336...69,131,205
Ensembl chr10:69,125,320...69,131,201 		JBrowse link
G Wnt5a Wnt family member 5A increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of WNT5A mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860 		JBrowse link
G Wnt5b Wnt family member 5B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of WNT5B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNT5B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:154,281,852...154,406,081
Ensembl chr 4:154,281,852...154,405,681 		JBrowse link
G Wnt6 Wnt family member 6 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA CTD PMID:27188386 NCBI chr 9:83,778,552...83,792,186
Ensembl chr 9:83,778,552...83,792,186 		JBrowse link
G Wwtr1 WW domain containing transcription regulator 1 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WWTR1 mRNA CTD PMID:27188386 NCBI chr 2:143,801,181...143,916,941
Ensembl chr 2:143,801,181...143,991,950 		JBrowse link
G Xpnpep3 X-prolyl aminopeptidase 3 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of XPNPEP3 mRNA CTD PMID:27188386 NCBI chr 7:114,806,398...114,858,934
Ensembl chr 7:114,806,357...114,855,125 		JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of YARS1 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377 		JBrowse link
G Zbtb10 zinc finger and BTB domain containing 10 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZBTB10 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB10 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:94,382,670...94,417,308
Ensembl chr 2:94,386,400...94,417,308 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZBTB16 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB16 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507 		JBrowse link
G Zbtb24 zinc finger and BTB domain containing 24 multiple interactions ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB24 mRNA CTD PMID:27188386 NCBI chr20:46,525,982...46,546,363
Ensembl chr20:46,525,637...46,546,363 		JBrowse link
G Zdhhc13 zinc finger DHHC-type palmitoyltransferase 13 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ZDHHC13 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZDHHC13 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:107,623,599...107,662,178
Ensembl chr 1:107,623,599...107,662,178 		JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZEB2 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB2 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323 		JBrowse link
G Zfp207 zinc finger protein 207 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZNF207 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF207 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:65,883,630...65,895,895
Ensembl chr10:65,883,599...65,895,895 		JBrowse link
G Zfp287 zinc finger protein 287 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZNF287 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF287 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:47,896,517...47,914,860
Ensembl chr10:47,896,517...47,914,950 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ZFP36 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFP36 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
G Zfp385b zinc finger protein 385B decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZNF385B mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF385B mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 3:82,762,387...83,140,856
Ensembl chr 3:82,762,387...83,084,615 		JBrowse link
G Zfp385d zinc finger protein 385D decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZNF385D mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF385D mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:7,473,431...7,854,364
Ensembl chr15:7,473,435...8,504,582 		JBrowse link
G Zfp39 zinc finger protein 39 multiple interactions
decreases expression 		ISO [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF717 mRNA
mercuric bromide results in decreased expression of ZNF717 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:44,156,031...44,179,332
Ensembl chr10:44,154,243...44,179,332 		JBrowse link
G Zfp521 zinc finger protein 521 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZNF521 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF521 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr18:5,050,297...5,343,188
Ensembl chr18:5,056,236...5,343,054 		JBrowse link
G Zic5 Zic family member 5 decreases expression
multiple interactions 		ISO mercuric bromide results in decreased expression of ZIC5 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZIC5 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr15:105,964,932...105,973,669
Ensembl chr15:105,964,932...105,973,669 		JBrowse link
G Zmat3 zinc finger, matrin type 3 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ZMAT3 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294 		JBrowse link
G Znf750 zinc finger protein 750 increases expression
multiple interactions 		ISO mercuric bromide results in increased expression of ZNF750 mRNA
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF750 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:107,270,926...107,279,904
Ensembl chr10:107,270,763...107,279,300 		JBrowse link
mercury dichloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1bg alpha-1-B glycoprotein increases expression ISO Mercuric Chloride results in increased expression of A1BG mRNA CTD PMID:11267658 NCBI chr 7:94,383,333...94,387,922
Ensembl chr 7:94,383,333...94,387,496 		JBrowse link
G A2m alpha-2-macroglobulin increases expression ISO Mercuric Chloride results in increased expression of A2M mRNA CTD PMID:27188386 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression EXP
ISO 		Mercuric Chloride results in increased expression of ABCB1B mRNA CTD PMID:28536007 PMID:31175882 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression
decreases response to substance
multiple interactions 		ISO
EXP 		Mercuric Chloride results in increased expression of ABCC1 mRNA
Mercuric Chloride results in increased expression of ABCC1 protein
ABCC1 protein results in decreased susceptibility to Mercuric Chloride
Mercuric Chloride results in increased expression of and affects the localization of ABCC1 protein; SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of and affects the localization of ABCC1 protein]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Mercuric Chloride] 		CTD PMID:10685512 PMID:15585369 PMID:21783896 PMID:30031051 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 decreases response to substance
increases expression
affects expression
multiple interactions
affects response to substance 		ISO
EXP 		ABCC2 protein results in decreased susceptibility to Mercuric Chloride
Mercuric Chloride results in increased expression of ABCC2 mRNA
Mercuric Chloride affects the expression of ABCC2 mRNA
ABCC2 gene mutant form promotes the reaction [Mercuric Chloride results in increased expression of GCLM mRNA]
ABCC2 gene mutant form affects the susceptibility to Mercuric Chloride
ABCC2 protein affects the reaction [Succimer binds to and results in increased secretion of [Mercuric Chloride binds to Cysteine]]; ABCC2 protein affects the reaction [Unithiol binds to and results in increased secretion of [Mercuric Chloride binds to Cysteine]]; ABCC2 protein binds to and results in increased secretion of [Succimer binds to [Mercuric Chloride binds to Cysteine]]; ABCC2 protein binds to and results in increased secretion of [Unithiol binds to [Mercuric Chloride binds to Cysteine]] 		CTD PMID:18511429 PMID:21783896 PMID:24039982 PMID:25145654 PMID:27720909 More... NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 increases expression ISO
EXP 		Mercuric Chloride results in increased expression of ABCC4 mRNA CTD PMID:27720909 PMID:28536007 PMID:31175882 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression
affects export
increases response to substance 		ISO
EXP 		Mercuric Chloride results in increased expression of ABCG2 mRNA
ABCG2 protein affects the export of Mercuric Chloride
ABCG2 gene mutant form results in increased susceptibility to Mercuric Chloride 		CTD PMID:24118919 PMID:25868844 PMID:31175882 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 increases expression ISO Mercuric Chloride results in increased expression of ABCG8 mRNA CTD PMID:31175882 NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730 		JBrowse link
G Abhd17c abhydrolase domain containing 17C, depalmitoylase decreases expression EXP Mercuric Chloride results in decreased expression of ABHD17C mRNA CTD PMID:16507785 NCBI chr 1:147,493,755...147,534,715
Ensembl chr 1:147,493,753...147,534,715 		JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity 		EXP [lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased activity of ACHE protein; [zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased activity of ACHE protein]; cupric chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ACHE protein] CTD PMID:24799335 PMID:36646412 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 decreases expression ISO Mercuric Chloride results in decreased expression of ACOT1 protein CTD PMID:37172713 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 decreases expression ISO Mercuric Chloride results in decreased expression of ACSS3 protein CTD PMID:37172713 NCBI chr 7:44,127,725...44,336,707
Ensembl chr 7:44,127,122...44,336,684 		JBrowse link
G Actb actin, beta increases expression
decreases expression 		ISO Mercuric Chloride results in increased expression of ACTB mRNA
Mercuric Chloride results in decreased expression of ACTB protein 		CTD PMID:20452446 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actn2 actinin alpha 2 increases expression EXP Mercuric Chloride results in increased expression of ACTN2 mRNA CTD PMID:16507785 NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression EXP Mercuric Chloride results in increased expression of ADAMTS1 mRNA CTD PMID:16507785 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I increases expression EXP Mercuric Chloride results in increased expression of ADCYAP1R1 mRNA CTD PMID:32599119 NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression EXP Mercuric Chloride results in increased expression of ADIPOQ mRNA CTD PMID:30807803 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adm adrenomedullin increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of ADM mRNA; Mercuric Chloride results in increased expression of ADM protein
Fingolimod Hydrochloride promotes the reaction [Mercuric Chloride results in increased expression of ADM mRNA]; Fingolimod Hydrochloride promotes the reaction [Mercuric Chloride results in increased expression of ADM protein]; Mycophenolic Acid inhibits the reaction [Mercuric Chloride results in increased expression of ADM protein] 		CTD PMID:15063164 PMID:15680492 PMID:16507785 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression EXP Mercuric Chloride results in decreased expression of ADORA1 protein CTD PMID:10677590 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Adtrp androgen-dependent TFPI-regulating protein decreases expression EXP Mercuric Chloride results in decreased expression of ADTRP mRNA CTD PMID:16507785 NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622 		JBrowse link
G Aff3 ALF transcription elongation factor 3 decreases expression EXP Mercuric Chloride results in decreased expression of AFF3 mRNA CTD PMID:32599119 NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000 		JBrowse link
G Aff4 ALF transcription elongation factor 4 decreases expression ISO Mercuric Chloride results in decreased expression of AFF4 mRNA CTD PMID:27188386 NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580 		JBrowse link
G Afg1l AFG1 like ATPase decreases expression EXP Mercuric Chloride results in decreased expression of AFG1L mRNA CTD PMID:16507785 NCBI chr20:47,380,582...47,550,307
Ensembl chr20:47,380,583...47,550,126 		JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression 		EXP carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of AGER mRNA] CTD PMID:39105374 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression EXP Mercuric Chloride results in increased expression of AGO2 mRNA CTD PMID:16507785 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Agrn agrin multiple interactions ISO Mercuric Chloride inhibits the reaction [AGRN protein results in increased phosphorylation of CHRNB1 protein] CTD PMID:15045580 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agt angiotensinogen increases expression EXP Mercuric Chloride results in increased expression of AGT protein; Mercuric Chloride results in increased expression of AGT protein modified form CTD PMID:18093879 PMID:22822941 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression EXP Mercuric Chloride results in increased expression of AGTR1A mRNA CTD PMID:28987480 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agxt alanine--glyoxylate aminotransferase decreases expression ISO Mercuric Chloride results in decreased expression of AGXT mRNA CTD PMID:37172713 NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745 		JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 decreases expression ISO Mercuric Chloride results in decreased expression of AHNAK2 mRNA CTD PMID:27188386 NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546 		JBrowse link
G Akap17a A-kinase anchoring protein 17A increases expression EXP Mercuric Chloride results in increased expression of AKAP17A mRNA CTD PMID:16507785 NCBI chr12:21,424,202...21,428,308
Ensembl chr12:21,424,202...21,428,247 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression ISO Mercuric Chloride results in increased expression of AKR1C1 mRNA CTD PMID:38568856 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression ISO Mercuric Chloride results in increased expression of AKR1C2 mRNA CTD PMID:38568856 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression ISO Mercuric Chloride results in increased expression of AKR1C3 mRNA CTD PMID:38568856 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions EXP [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation 		ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Mercuric Chloride results in increased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of AKT1 protein] CTD PMID:16731823 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Alad aminolevulinate dehydratase multiple interactions
increases activity
decreases activity
decreases expression 		ISO
EXP 		[Mercuric Chloride co-treated with diphenyldiselenide] results in decreased activity of ALAD protein; [zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]] which affects the abundance of Mercury; Cadmium Chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; diphenyldiselenide inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; Mercuric Chloride promotes the reaction [Sodium Selenite results in decreased activity of ALAD protein]; Sodium Selenite promotes the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]
lycopene inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of ALAD protein]
Mercuric Chloride results in decreased expression of ALAD protein 		CTD PMID:12595158 PMID:14615064 PMID:14630126 PMID:17516994 PMID:21259295 More... NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041 		JBrowse link
G Alb albumin affects binding
multiple interactions
increases expression
decreases expression 		ISO
EXP 		Mercuric Chloride binds to ALB protein
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein
Mercuric Chloride results in increased expression of ALB protein
Mercuric Chloride results in decreased expression of ALB protein
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with nickel chloride co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]] 		CTD PMID:17489621 PMID:17657459 PMID:21549428 PMID:24485406 PMID:37172713 More... NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 increases expression EXP Mercuric Chloride results in increased expression of ALDH18A1 mRNA CTD PMID:16507785 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression ISO Mercuric Chloride results in increased expression of ALDH3A1 mRNA CTD PMID:38568856 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Mercuric Chloride results in decreased expression of ALDH6A1 mRNA CTD PMID:27188386 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743 		JBrowse link
G Alkbh5 alkB homolog 5, RNA demethylase increases expression EXP Mercuric Chloride results in increased expression of ALKBH5 mRNA CTD PMID:16507785 NCBI chr10:45,844,411...45,865,853
Ensembl chr10:45,843,656...45,869,658 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of ALPL protein CTD PMID:39414706 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression
multiple interactions 		EXP
ISO 		Mercuric Chloride results in decreased expression of AMACR mRNA
[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMACR mRNA 		CTD PMID:16507785 PMID:27188386 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Amer2 APC membrane recruitment protein 2 decreases expression EXP Mercuric Chloride results in decreased expression of AMER2 mRNA CTD PMID:16507785 NCBI chr15:38,701,509...38,711,817
Ensembl chr15:38,701,657...38,705,633 		JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 decreases expression ISO Mercuric Chloride results in decreased expression of ANAPC5 mRNA CTD PMID:27188386 NCBI chr12:39,409,519...39,442,518
Ensembl chr12:39,385,399...39,442,762 		JBrowse link
G Angpt1 angiopoietin 1 decreases expression EXP Mercuric Chloride results in decreased expression of ANGPT1 mRNA CTD PMID:16507785 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Ankrd10 ankyrin repeat domain 10 decreases expression ISO Mercuric Chloride results in decreased expression of ANKRD10 mRNA CTD PMID:27188386 NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846 		JBrowse link
G Ankrd66 ankyrin repeat domain 66 increases expression EXP Mercuric Chloride results in increased expression of ANKRD66 mRNA CTD PMID:32599119 NCBI chr 9:24,918,206...24,938,481
Ensembl chr 9:24,912,521...24,938,488 		JBrowse link
G Anxa5 annexin A5 multiple interactions ISO ANXA5 protein inhibits the reaction [Mercuric Chloride results in increased activity of F3 protein] CTD PMID:17726162 NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of APAF1 mRNA
carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of APAF1 mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of APAF1 mRNA] 		CTD PMID:39096083 PMID:39105374 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apob apolipoprotein B increases expression ISO Mercuric Chloride results in increased expression of APOB mRNA CTD PMID:37172713 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G App amyloid beta precursor protein multiple interactions
increases secretion 		ISO Melatonin inhibits the reaction [Mercuric Chloride results in increased secretion of APP protein modified form] CTD PMID:10617124 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aqp1 aquaporin 1 affects activity
multiple interactions
decreases activity 		ISO
EXP 		Mercuric Chloride affects the activity of AQP1 protein
Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water]
Mercuric Chloride results in decreased activity of AQP1 protein 		CTD PMID:7528928 PMID:8457558 PMID:10559675 PMID:11468359 PMID:19539607 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp11 aquaporin 11 multiple interactions ISO Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water] CTD PMID:21251984 NCBI chr 1:161,457,752...161,467,918
Ensembl chr 1:161,457,754...161,467,945 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) decreases activity
decreases expression
multiple interactions 		ISO
EXP 		Mercuric Chloride results in decreased activity of AQP3 protein
Mercuric Chloride results in decreased expression of AQP3 mRNA; Mercuric Chloride results in decreased expression of AQP3 protein
Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]
Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]] 		CTD PMID:9124401 PMID:9374739 PMID:19513079 PMID:22687538 PMID:25766885 More... NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp4 aquaporin 4 decreases expression EXP Mercuric Chloride results in decreased expression of AQP4 mRNA; Mercuric Chloride results in decreased expression of AQP4 protein CTD PMID:25854323 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp7 aquaporin 7 decreases activity
decreases expression
multiple interactions 		ISO
EXP 		Mercuric Chloride results in decreased activity of AQP7 protein
Mercuric Chloride results in decreased expression of AQP7 protein
Mercaptoethanol inhibits the reaction [Mercuric Chloride results in decreased activity of AQP7 protein] 		CTD PMID:10777495 PMID:25854323 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp8 aquaporin 8 decreases activity
multiple interactions 		ISO Mercuric Chloride results in decreased activity of AQP8 protein
Mercuric Chloride inhibits the reaction [AQP8 protein results in increased transport of Water] 		CTD PMID:19840149 NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242 		JBrowse link
G Aqp9 aquaporin 9 multiple interactions
decreases activity 		EXP
ISO 		Mercuric Chloride inhibits the reaction [AQP9 protein results in increased transport of Water]
Mercuric Chloride results in decreased activity of AQP9 protein 		CTD PMID:9514918 PMID:9733774 PMID:10205677 PMID:22114114 NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240 		JBrowse link
G Arb2a ARB2 cotranscriptional regulator A decreases expression ISO Mercuric Chloride results in decreased expression of ARB2A mRNA CTD PMID:27188386 NCBI chr 2:9,289,694...9,753,991
Ensembl chr 2:9,289,699...9,753,989 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein increases expression EXP Mercuric Chloride results in increased expression of ARC mRNA CTD PMID:16507785 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Arf5 ARF GTPase 5 increases expression EXP Mercuric Chloride results in increased expression of ARF5 mRNA CTD PMID:16507785 NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835 		JBrowse link
G Arfgef3 ARFGEF family member 3 decreases expression ISO Mercuric Chloride results in decreased expression of ARFGEF3 mRNA CTD PMID:27188386 NCBI chr 1:15,058,574...15,223,742
Ensembl chr 1:15,058,579...15,223,742 		JBrowse link
G Arg2 arginase 2 decreases response to substance
multiple interactions 		ISO
EXP 		ARG2 protein results in decreased susceptibility to Mercuric Chloride
Mercuric Chloride results in decreased expression of and results in decreased activity of ARG2 protein 		CTD PMID:17874066 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression EXP Mercuric Chloride results in increased expression of ARL5B mRNA CTD PMID:16507785 NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression EXP Mercuric Chloride results in increased expression of ASNS mRNA CTD PMID:16507785 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspa aspartoacylase decreases expression EXP Mercuric Chloride results in decreased expression of ASPA mRNA CTD PMID:16507785 NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769 		JBrowse link
G Atf3 activating transcription factor 3 increases expression EXP Mercuric Chloride results in increased expression of ATF3 mRNA; Mercuric Chloride results in increased expression of ATF3 protein CTD PMID:16507785 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of ATF4 mRNA
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF4 mRNA] 		CTD PMID:39096083 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of ATF6 mRNA
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA] 		CTD PMID:39096083 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atp11b ATPase phospholipid transporting 11B (putative) decreases expression ISO Mercuric Chloride results in decreased expression of ATP11B mRNA CTD PMID:27188386 NCBI chr 2:120,513,535...120,619,249
Ensembl chr 2:120,513,552...120,619,249 		JBrowse link
G Atp13a5 ATPase 13A5 decreases expression ISO Mercuric Chloride results in decreased expression of ATP13A5 mRNA CTD PMID:27188386 NCBI chr11:84,881,196...85,020,597
Ensembl chr11:84,881,230...85,020,593 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 decreases expression EXP Mercuric Chloride results in decreased expression of ATP1A1 protein CTD PMID:16189294 PMID:21723307 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO B2M protein affects the reaction [Mercuric Chloride results in increased expression of IFNG mRNA]; B2M protein affects the reaction [Mercuric Chloride results in increased expression of IL4 mRNA] CTD PMID:21793797 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3gat1 beta-1,3-glucuronyltransferase 1 decreases expression EXP Mercuric Chloride results in decreased expression of B3GAT1 mRNA CTD PMID:16507785 NCBI chr 8:33,362,791...33,390,446
Ensembl chr 8:33,363,048...33,390,443 		JBrowse link
G Bace2 beta-secretase 2 affects expression ISO Mercuric Chloride affects the expression of BACE2 mRNA CTD PMID:24118919 NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008 		JBrowse link
G Bag2 BAG cochaperone 2 increases expression EXP Mercuric Chloride results in increased expression of BAG2 mRNA CTD PMID:16507785 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression EXP Mercuric Chloride results in increased expression of BAG3 mRNA CTD PMID:16507785 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression EXP Mercuric Chloride results in increased expression of BAMBI mRNA CTD PMID:16507785 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
increases activity 		ISO
EXP 		GSK3B protein promotes the reaction [Mercuric Chloride results in increased activity of BAX protein]
Mercuric Chloride results in increased expression of BAX protein
Mercuric Chloride results in increased expression of BAX mRNA; Mercuric Chloride results in increased expression of BAX protein
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of BAX mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of BAX mRNA] 		CTD PMID:22785175 PMID:25600690 PMID:32134168 PMID:37172713 PMID:39096083 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bche butyrylcholinesterase decreases activity ISO Mercuric Chloride results in decreased activity of BCHE protein CTD PMID:17355286 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions
increases expression 		ISO
EXP 		Mercuric Chloride results in decreased expression of BCL2 mRNA; Mercuric Chloride results in decreased expression of BCL2 protein
Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein]; carvacrol inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 mRNA]
Mercuric Chloride results in increased expression of BCL2 mRNA
Mercuric Chloride results in increased expression of BCL2 protein 		CTD PMID:8872981 PMID:11068922 PMID:23202902 PMID:24751971 PMID:25600690 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 increases expression EXP Mercuric Chloride results in increased expression of BCL2L1 mRNA CTD PMID:8872981 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions ISO [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of BDNF mRNA CTD PMID:21084432 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression 		EXP carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of BECN1 mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of BECN1 protein]
Mercuric Chloride results in increased expression of BECN1 mRNA; Mercuric Chloride results in increased expression of BECN1 protein 		CTD PMID:39096083 PMID:39105374 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of BHMT mRNA CTD PMID:21084432 NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715 		JBrowse link
G Bicdl1 BICD family like cargo adaptor 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICDL1 mRNA CTD PMID:27188386 NCBI chr12:46,537,525...46,626,876
Ensembl chr12:46,538,396...46,628,866 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 decreases expression ISO Mercuric Chloride results in decreased expression of BMPR2 mRNA CTD PMID:27188386 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Mercuric Chloride results in increased expression of BTG2 mRNA CTD PMID:16507785 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression EXP Mercuric Chloride results in increased expression of BTG3 mRNA CTD PMID:16507785 NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082 		JBrowse link
G C13h1orf53 similar to human chromosome 1 open reading frame 53 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF53 mRNA CTD PMID:27188386 NCBI chr13:52,965,244...52,970,432
Ensembl chr13:52,965,244...52,970,607 		JBrowse link
G C19h1orf198 similar to human chromosome 1 open reading frame 198 decreases expression EXP Mercuric Chloride results in decreased expression of C19H1ORF198 mRNA CTD PMID:16507785 NCBI chr19:69,501,453...69,526,826
Ensembl chr19:69,501,453...69,526,826 		JBrowse link
G C3 complement C3 decreases expression ISO Mercuric Chloride results in decreased expression of C3 mRNA CTD PMID:22136142 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G Ca14 carbonic anhydrase 14 decreases expression EXP Mercuric Chloride results in decreased expression of CAR14 mRNA CTD PMID:16507785 NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863 		JBrowse link
G Cacybp calcyclin binding protein increases expression EXP Mercuric Chloride results in increased expression of CACYBP mRNA CTD PMID:16507785 NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression EXP Mercuric Chloride results in increased expression of CARS1 mRNA CTD PMID:16507785 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO CASP1 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]; CASP1 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA] CTD PMID:28453771 NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
decreases activity
increases activity
increases cleavage
decreases expression 		ISO
EXP 		Mercuric Chloride inhibits the reaction [FAS affects the activity of CASP3 protein]
Mercuric Chloride results in increased expression of CASP3 protein
Mercuric Chloride results in increased expression of CASP3 mRNA; Mercuric Chloride results in increased expression of CASP3 protein
Mercuric Chloride results in decreased activity of CASP3 protein
Mercuric Chloride results in increased activity of CASP3 protein
Mercuric Chloride results in increased cleavage of CASP3 protein
Mercuric Chloride results in decreased expression of CASP3 mRNA
Mercuric Chloride results in increased expression of CASP3 mRNA; Mercuric Chloride results in increased expression of CASP3 protein; Mercuric Chloride results in increased expression of CASP3 protein modified form
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of CASP3 protein; [zinc chloride co-treated with lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of CASP3 protein; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 mRNA]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 mRNA]; Mercuric Chloride inhibits the reaction [Gliotoxin results in increased activity of CASP3 protein]; Mercuric Chloride inhibits the reaction [S-nitro-N-acetylpenicillamine inhibits the reaction [Doxorubicin results in increased activity of and results in increased cleavage of CASP3 protein]]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein]
4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein modified form]; [Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP3 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP3 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein]; GSK3B protein promotes the reaction [Mercuric Chloride results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [Mercuric Chloride results in increased activity of CASP3 protein] 		CTD PMID:12504520 PMID:12505371 PMID:15050407 PMID:15150681 PMID:15585371 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp6 caspase 6 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP6 protein CTD PMID:39414706 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases expression 		ISO [Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein]
Mercuric Chloride results in increased expression of CASP7 mRNA 		CTD PMID:22909951 PMID:23202902 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 multiple interactions
increases activity 		ISO [Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased activity of CASP8 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP8 protein
Mercuric Chloride results in increased activity of CASP8 protein 		CTD PMID:16421179 PMID:39414706 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression 		EXP carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of CASP9 mRNA] CTD PMID:39105374 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases activity
decreases expression
affects activity
decreases activity
multiple interactions
increases expression 		EXP
ISO 		Mercuric Chloride results in increased activity of CAT protein
Mercuric Chloride results in decreased expression of CAT protein
Mercuric Chloride affects the activity of CAT protein
Mercuric Chloride results in decreased activity of CAT protein
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased activity of CAT protein; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; allyl sulfide inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Berberine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; carvacrol inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Lycopene inhibits the reaction [Mercuric Chloride results in increased activity of CAT protein]; Plant Extracts inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]]; Sodium Selenite inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased activity of CAT protein]; Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; syringic acid inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]
mangiferin inhibits the reaction [Mercuric Chloride results in decreased expression of CAT protein]
[Mercuric Chloride co-treated with diphenyldiselenide] results in decreased activity of CAT protein
Mercuric Chloride results in increased expression of CAT protein 		CTD PMID:15977196 PMID:17516994 PMID:19427169 PMID:20629087 PMID:20820944 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cbl Cbl proto-oncogene multiple interactions
decreases expression 		ISO Mercuric Chloride promotes the reaction [HCK protein results in increased phosphorylation of CBL protein]
Mercuric Chloride results in decreased expression of CBL mRNA 		CTD PMID:10092522 PMID:27188386 NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067 		JBrowse link
G Cc2d2b coiled-coil and C2 domain containing 2B decreases expression ISO Mercuric Chloride results in decreased expression of CC2D2B mRNA CTD PMID:27188386 NCBI chr 1:249,509,371...249,608,894
Ensembl chr 1:249,511,389...249,606,142 		JBrowse link
G Ccdc186 coiled-coil domain containing 186 increases expression EXP Mercuric Chloride results in increased expression of CCDC186 mRNA CTD PMID:16507785 NCBI chr 1:265,840,429...265,878,082
Ensembl chr 1:265,843,039...265,877,131 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 decreases expression
increases expression 		ISO Mercuric Chloride results in decreased expression of CCL11 protein
Mercuric Chloride results in increased expression of CCL11 protein 		CTD PMID:21984480 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases response to substance
multiple interactions
increases expression 		EXP
ISO 		CCL2 protein results in increased susceptibility to Mercuric Chloride
Mercuric Chloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
Mercuric Chloride results in increased expression of CCL2 mRNA; Mercuric Chloride results in increased expression of CCL2 protein 		CTD PMID:12834626 PMID:36416909 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression EXP Mercuric Chloride results in increased expression of CCL20 mRNA CTD PMID:16507785 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression
multiple interactions 		ISO Mercuric Chloride results in increased expression of CCL3 protein
Mercuric Chloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] 		CTD PMID:21984480 PMID:36416909 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
increases response to substance 		EXP Mercuric Chloride results in increased expression of CCL5 mRNA; Mercuric Chloride results in increased expression of CCL5 protein
CCL5 protein results in increased susceptibility to Mercuric Chloride 		CTD PMID:12834626 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Mercuric Chloride results in increased expression of CCN1 mRNA CTD PMID:38568856 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression
increases expression 		EXP
ISO 		Mercuric Chloride results in decreased expression of CCN2 mRNA
Mercuric Chloride results in increased expression of CCN2 mRNA 		CTD PMID:16507785 PMID:38568856 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccnb2 cyclin B2 decreases expression EXP Mercuric Chloride results in decreased expression of CCNB2 mRNA CTD PMID:16507785 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnh cyclin H increases expression ISO Mercuric Chloride results in increased expression of CCNH protein CTD PMID:37172713 NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860 		JBrowse link
G Ccnt1 cyclin T1 decreases expression ISO Mercuric Chloride results in decreased expression of CCNT1 mRNA CTD PMID:27188386 NCBI chr 7:131,566,176...131,596,988
Ensembl chr 7:131,566,176...131,596,938 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 increases expression
increases response to substance 		EXP Mercuric Chloride results in increased expression of CCR1 mRNA; Mercuric Chloride results in increased expression of CCR1 protein
CCR1 protein results in increased susceptibility to Mercuric Chloride 		CTD PMID:12834626 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Ccr2 C-C motif chemokine receptor 2 increases expression
increases response to substance 		EXP Mercuric Chloride results in increased expression of CCR2 mRNA; Mercuric Chloride results in increased expression of CCR2 protein
CCR2 protein results in increased susceptibility to Mercuric Chloride 		CTD PMID:12834626 NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059 		JBrowse link
G Ccr5 C-C motif chemokine receptor 5 increases expression
increases response to substance 		EXP Mercuric Chloride results in increased expression of CCR5 mRNA; Mercuric Chloride results in increased expression of CCR5 protein
CCR5 protein results in increased susceptibility to Mercuric Chloride 		CTD PMID:12834626 NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594 		JBrowse link
G Cd22 CD22 molecule multiple interactions ISO Mercuric Chloride inhibits the reaction [CD22 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Mercuric Chloride inhibits the reaction [CD22 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Mercuric Chloride promotes the reaction [CD22 protein results in increased phosphorylation of SYK protein] CTD PMID:17656488 NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730 		JBrowse link
G Cd28 Cd28 molecule affects response to substance
multiple interactions 		ISO CD28 protein affects the susceptibility to Mercuric Chloride
CD28 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein] 		CTD PMID:19077085 NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) multiple interactions
affects response to substance 		ISO [Mercuric Chloride co-treated with CD55] results in increased expression of IFNG mRNA; [Mercuric Chloride co-treated with CD55] results in increased expression of IL10 mRNA; CD55 affects the reaction [Mercuric Chloride results in increased expression of IL10 mRNA]; CD55 affects the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]
CD55 protein affects the susceptibility to Mercuric Chloride 		CTD PMID:20408894 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd86 CD86 molecule increases expression ISO Mercuric Chloride results in increased expression of CD86 protein CTD PMID:20417223 PMID:20457211 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cdc42 cell division cycle 42 decreases expression EXP Mercuric Chloride results in decreased expression of CDC42 protein CTD PMID:22223485 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdca2 cell division cycle associated 2 decreases expression ISO Mercuric Chloride results in decreased expression of CDCA2 mRNA CTD PMID:27188386 NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639 		JBrowse link
G Cdh2 cadherin 2 decreases expression EXP Mercuric Chloride results in decreased expression of CDH2 mRNA CTD PMID:21126564 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh5 cadherin 5 multiple interactions ISO Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein] CTD PMID:31404653 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression EXP Mercuric Chloride results in decreased expression of CDK1 mRNA CTD PMID:16507785 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk14 cyclin-dependent kinase 14 increases expression
decreases expression 		ISO Mercuric Chloride results in increased expression of CDK14 mRNA
Mercuric Chloride results in decreased expression of CDK14 mRNA 		CTD PMID:27188386 NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651 		JBrowse link
G Cdk20 cyclin-dependent kinase 20 increases expression EXP Mercuric Chloride results in increased expression of CDK20 mRNA CTD PMID:16507785 NCBI chr17:706,863...717,828
Ensembl chr17:706,865...713,567 		JBrowse link
G Cdkl1 cyclin dependent kinase like 1 decreases expression EXP Mercuric Chloride results in decreased expression of CDKL1 mRNA CTD PMID:16507785 NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP Mercuric Chloride results in increased expression of CDKN1A mRNA CTD PMID:16507785 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression EXP Mercuric Chloride results in increased expression of CDKN2B mRNA CTD PMID:16507785 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions
decreases expression 		ISO Mercuric Chloride results in decreased expression of and results in decreased activity of CEBPA protein
Mercuric Chloride results in decreased expression of CEBPA mRNA 		CTD PMID:11267658 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
increases stability 		ISO Mercuric Chloride results in increased expression of and results in increased activity of CEBPB protein
Mercuric Chloride results in increased stability of CEBPB mRNA 		CTD PMID:11267658 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression EXP Mercuric Chloride results in increased expression of CEBPD mRNA CTD PMID:16507785 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf2 CUGBP, Elav-like family member 2 decreases expression ISO Mercuric Chloride results in decreased expression of CELF2 mRNA CTD PMID:27188386 NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362 		JBrowse link
G Cep128 centrosomal protein 128 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEP128 mRNA CTD PMID:27188386 NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:115,681,712...116,057,167 		JBrowse link
G Cep68 centrosomal protein 68 increases expression ISO Mercuric Chloride results in increased expression of CEP68 mRNA CTD PMID:27188386 NCBI chr14:98,649,993...98,671,892
Ensembl chr14:98,649,993...98,671,868 		JBrowse link
G Cfb complement factor B increases expression ISO Mercuric Chloride results in increased expression of CFB mRNA CTD PMID:22136142 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cfd complement factor D decreases expression ISO Mercuric Chloride results in decreased expression of CFD mRNA CTD PMID:22136142 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression EXP Mercuric Chloride results in increased expression of CHAC1 mRNA CTD PMID:16507785 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chd3 chromodomain helicase DNA binding protein 3 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHD3 mRNA CTD PMID:27188386 NCBI chr10:54,562,437...54,588,842
Ensembl chr10:54,562,437...54,588,810 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 increases expression EXP Mercuric Chloride results in increased expression of CHD7 mRNA CTD PMID:16507785 NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734 		JBrowse link
G Chka choline kinase alpha increases expression
affects expression 		EXP
ISO 		Mercuric Chloride results in increased expression of CHKA mRNA
Mercuric Chloride affects the expression of CHKA mRNA 		CTD PMID:16507785 PMID:24118919 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chkb choline kinase beta increases expression ISO Mercuric Chloride results in increased expression of CHKB mRNA CTD PMID:24118919 NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 increases expression EXP Mercuric Chloride results in increased expression of CHORDC1 mRNA CTD PMID:16507785 NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chrna3 cholinergic receptor nicotinic alpha 3 subunit multiple interactions EXP [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA3 protein binds to CHRNB4 protein] CTD PMID:12130716 NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412 		JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions EXP [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein] CTD PMID:12130716 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105 		JBrowse link
G Chrnb1 cholinergic receptor nicotinic beta 1 subunit multiple interactions ISO Mercuric Chloride inhibits the reaction [AGRN protein results in increased phosphorylation of CHRNB1 protein] CTD PMID:15045580 NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein] CTD PMID:12130716 NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326 		JBrowse link
G Chrnb4 cholinergic receptor nicotinic beta 4 subunit multiple interactions EXP [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA3 protein binds to CHRNB4 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein] CTD PMID:12130716 NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions ISO Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] CTD PMID:10820281 NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273 		JBrowse link
G Cibar1 CBY1 interacting BAR domain containing 1 decreases expression ISO Mercuric Chloride results in decreased expression of CIBAR1 mRNA CTD PMID:27188386 NCBI chr 5:30,411,325...30,429,770
Ensembl chr 5:30,410,511...30,429,893 		JBrowse link
G Cimip2a ciliary microtubule inner protein 2A increases expression EXP Mercuric Chloride results in increased expression of CIMIP2A mRNA CTD PMID:32599119 NCBI chr 3:28,429,413...28,437,210
Ensembl chr 3:28,431,410...28,436,125 		JBrowse link
G Clic4 chloride intracellular channel 4 decreases activity ISO Mercuric Chloride results in decreased activity of CLIC4 protein CTD PMID:10968996 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118 		JBrowse link
G Clip3 CAP-GLY domain containing linker protein 3 increases expression EXP Mercuric Chloride results in increased expression of CLIP3 mRNA CTD PMID:32599119 NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642 		JBrowse link
G Clu clusterin increases expression EXP Mercuric Chloride results in increased expression of CLU mRNA CTD PMID:16507785 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Clvs2 clavesin 2 decreases expression ISO Mercuric Chloride results in decreased expression of CLVS2 mRNA CTD PMID:27188386 NCBI chr 1:25,553,981...25,661,806
Ensembl chr 1:25,554,375...25,580,830 		JBrowse link
G Cntf ciliary neurotrophic factor multiple interactions
decreases activity 		ISO Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Ascorbic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Ascorbic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]; Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]; Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]; Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]; Thioctic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]]; Thioctic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]]; Thioctic Acid inhibits the reaction [Mercuric Chloride results in decreased activity of CNTF protein] CTD PMID:16896058 PMID:19635391 NCBI chr 1:219,312,512...219,314,535
Ensembl chr 1:219,312,512...219,314,488 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression EXP Mercuric Chloride results in increased expression of COL1A1 mRNA CTD PMID:16507785 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain decreases expression EXP Mercuric Chloride results in decreased expression of COL4A4 mRNA CTD PMID:16507785 NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577 		JBrowse link
G Crat carnitine O-acetyltransferase decreases activity EXP Mercuric Chloride results in decreased activity of CRAT protein CTD PMID:8075222 NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099 		JBrowse link
G Crem cAMP responsive element modulator increases expression EXP Mercuric Chloride results in increased expression of CREM mRNA CTD PMID:16507785 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crocc ciliary rootlet coiled-coil, rootletin decreases expression EXP Mercuric Chloride results in decreased expression of CROCC mRNA CTD PMID:16507785 NCBI chr 5:158,603,979...158,646,728
Ensembl chr 5:158,603,556...158,640,238 		JBrowse link
G Crtap cartilage associated protein decreases expression EXP Mercuric Chloride results in decreased expression of CRTAP mRNA CTD PMID:16507785 NCBI chr 8:122,926,117...122,945,843
Ensembl chr 8:122,926,117...122,945,843 		JBrowse link
G Csf2 colony stimulating factor 2 increases expression ISO Mercuric Chloride results in increased expression of CSF2 protein CTD PMID:21984480 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csf3 colony stimulating factor 3 increases expression ISO Mercuric Chloride results in increased expression of CSF3 protein CTD PMID:21984480 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 increases expression EXP Mercuric Chloride results in increased expression of CSMD1 mRNA CTD PMID:32599119 NCBI chr16:78,920,549...80,520,710
Ensembl chr16:78,921,002...80,519,944 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression EXP Mercuric Chloride results in increased expression of CSRNP1 mRNA CTD PMID:16507785 NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 increases expression EXP Mercuric Chloride results in increased expression of CSRP3 mRNA CTD PMID:16507785 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cth cystathionine gamma-lyase decreases activity
multiple interactions 		EXP Mercuric Chloride results in decreased activity of CTH protein
[Mercuric Chloride co-treated with Cysteine] results in decreased activity of CTH protein 		CTD PMID:22093698 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctsb cathepsin B increases activity ISO Mercuric Chloride results in increased activity of CTSB protein CTD PMID:25237059 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsc cathepsin C decreases expression EXP Mercuric Chloride results in decreased expression of CTSC mRNA CTD PMID:16507785 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Cwc27 CWC27 spliceosome associated cyclophilin decreases expression EXP Mercuric Chloride results in decreased expression of CWC27 mRNA CTD PMID:16507785 NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases response to substance
increases expression 		EXP CXCL10 protein results in increased susceptibility to Mercuric Chloride
Mercuric Chloride results in increased expression of CXCL10 mRNA 		CTD PMID:12834626 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression EXP Mercuric Chloride results in increased expression of CXCL2 mRNA CTD PMID:16507785 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 increases expression EXP Mercuric Chloride results in increased expression of CXCR3 mRNA; Mercuric Chloride results in increased expression of CXCR3 protein CTD PMID:12834626 NCBI chr  X:70,884,293...70,886,944
Ensembl chr  X:70,883,958...70,886,871 		JBrowse link
G Cyba cytochrome b-245 alpha chain multiple interactions
increases expression 		EXP Peptides inhibits the reaction [Mercuric Chloride results in increased expression of CYBA mRNA] CTD PMID:28987480 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases activity
decreases stability 		ISO Hemin inhibits the reaction [Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; HMOX1 mRNA affects the reaction [Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; Mercuric Chloride inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Mercuric Chloride promotes the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; tin mesoporphyrin inhibits the reaction [Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]
Mercuric Chloride results in increased expression of CYP1A1 mRNA
Mercuric Chloride results in decreased activity of CYP1A1 protein
Mercuric Chloride results in decreased stability of CYP1A1 protein 		CTD PMID:11162773 PMID:11408366 PMID:17889500 PMID:20837117 PMID:21435368 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
decreases expression 		ISO Mercuric Chloride results in decreased activity of CYP1A2 protein
Mercuric Chloride results in decreased expression of CYP1A2 protein 		CTD PMID:11162773 PMID:37172713 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO Mercuric Chloride results in increased expression of CYP1B1 mRNA CTD PMID:21435368 PMID:24472606 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO Mercuric Chloride results in increased expression of CYP2B10 mRNA CTD PMID:24472606 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 increases expression ISO Mercuric Chloride results in increased expression of CYP2C29 mRNA CTD PMID:24472606 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases expression
increases expression 		EXP
ISO 		Mercuric Chloride results in decreased expression of CYP2E1 mRNA
Mercuric Chloride results in increased expression of CYP2E1 protein 		CTD PMID:22792809 PMID:37172713 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression ISO Mercuric Chloride results in increased expression of CYP3A5 mRNA CTD PMID:37172713 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp4f18 cytochrome P450, family 4, subfamily f, polypeptide 18 increases expression ISO Mercuric Chloride results in increased expression of CYP4F18 mRNA CTD PMID:24472606 NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958 		JBrowse link
G Cyp4f6 cytochrome P450, family 4, subfamily f, polypeptide 6 increases expression ISO Mercuric Chloride results in increased expression of CYP4F16 mRNA CTD PMID:24472606 NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor increases expression EXP Mercuric Chloride results in increased expression of DBP mRNA CTD PMID:16507785 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DBT mRNA CTD PMID:27188386 NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525 		JBrowse link
G Dcaf12l2 DDB1 and CUL4 associated factor 12-like 2 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF12L2 mRNA CTD PMID:27188386 NCBI chr  X:128,167,040...128,169,829
Ensembl chr  X:128,167,040...128,169,829 		JBrowse link
G Dcaf8 DDB1 and CUL4 associated factor 8 decreases expression EXP Mercuric Chloride results in decreased expression of DCAF8 mRNA CTD PMID:16507785 NCBI chr13:87,141,940...87,199,859
Ensembl chr13:87,142,525...87,202,099 		JBrowse link
G Dcn decorin increases expression EXP Mercuric Chloride results in increased expression of DCN mRNA; Mercuric Chloride results in increased expression of DCN protein CTD PMID:16005714 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions 		EXP
ISO 		Mercuric Chloride results in increased expression of DDIT3 mRNA
syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of DDIT3 mRNA]
4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of DDIT3 protein] 		CTD PMID:30807803 PMID:32879258 PMID:39096083 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Dgkg diacylglycerol kinase, gamma decreases expression EXP Mercuric Chloride results in decreased expression of DGKG mRNA CTD PMID:16507785 NCBI chr11:91,888,957...92,083,715
Ensembl chr11:91,888,782...92,082,105 		JBrowse link
G Dglucy D-glutamate cyclase decreases expression EXP Mercuric Chloride results in decreased expression of DGLUCY mRNA CTD PMID:16507785 NCBI chr 6:125,785,075...125,860,496
Ensembl chr 6:125,785,087...125,860,496 		JBrowse link
G Dixdc1 DIX domain containing 1 decreases expression ISO Mercuric Chloride results in decreased expression of DIXDC1 mRNA CTD PMID:27188386 NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 increases expression EXP Mercuric Chloride results in increased expression of DNAJB4 mRNA CTD PMID:16507785 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression EXP Mercuric Chloride results in increased expression of DNAJB9 mRNA CTD PMID:16507785 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344 		JBrowse link
G Dock10 dedicator of cytokinesis 10 increases expression EXP Mercuric Chloride results in increased expression of DOCK10 mRNA CTD PMID:32599119 NCBI chr 9:89,291,936...89,549,871
Ensembl chr 9:89,291,800...89,549,973 		JBrowse link
G Dock11 dedicator of cytokinesis 11 decreases expression ISO Mercuric Chloride results in decreased expression of DOCK11 mRNA CTD PMID:27188386 NCBI chr  X:119,997,523...120,180,643
Ensembl chr  X:119,997,552...120,180,634 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression EXP Mercuric Chloride results in increased expression of DUSP5 mRNA CTD PMID:16507785 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp7 dual specificity phosphatase 7 decreases expression EXP Mercuric Chloride results in decreased expression of DUSP7 mRNA CTD PMID:16507785 NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:115,887,892...115,895,126 		JBrowse link
G Dusp8 dual specificity phosphatase 8 increases expression EXP Mercuric Chloride results in increased expression of DUSP8 mRNA CTD PMID:16507785 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Ebf2 EBF transcription factor 2 decreases expression EXP Mercuric Chloride results in decreased expression of EBF2 mRNA CTD PMID:32599119 NCBI chr15:45,610,949...45,809,828
Ensembl chr15:45,610,949...45,809,822 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression 		EXP candesartan cilexetil inhibits the reaction [Mercuric Chloride results in increased expression of EDN1 mRNA]; pimagedine inhibits the reaction [Mercuric Chloride results in increased expression of EDN1 mRNA]
Mercuric Chloride results in increased expression of EDN1 mRNA; Mercuric Chloride results in increased expression of EDN1 protein 		CTD PMID:9788586 PMID:9853001 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma multiple interactions ISO Mercuric Chloride results in increased expression of and results in increased secretion of EEF1G protein CTD PMID:24980261 NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479 		JBrowse link
G Egf epidermal growth factor decreases expression EXP Mercuric Chloride results in decreased expression of EGF mRNA CTD PMID:8538927 PMID:10901180 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfr epidermal growth factor receptor increases expression EXP
ISO 		Mercuric Chloride results in increased expression of EGFR mRNA CTD PMID:10901180 PMID:37172713 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 increases expression EXP Mercuric Chloride results in increased expression of EGR1 mRNA CTD PMID:16507785 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Ehbp1 EH domain binding protein 1 decreases expression ISO Mercuric Chloride results in decreased expression of EHBP1 mRNA CTD PMID:27188386 NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579 		JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP Mercuric Chloride results in decreased expression of EHD1 mRNA CTD PMID:16507785 NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase decreases expression EXP Mercuric Chloride results in decreased expression of EHHADH mRNA CTD PMID:16507785 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions ISO 2-Aminopurine inhibits the reaction [[IFNB1 results in increased expression of EIF2AK2 protein] which results in decreased susceptibility to Mercuric Chloride]; [IFNB1 results in increased expression of EIF2AK2 protein] which results in decreased susceptibility to Mercuric Chloride CTD PMID:16324719 NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases expression 		EXP syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of EIF2AK3 mRNA] CTD PMID:39096083 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases expression 		EXP syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of EIF2S1 mRNA] CTD PMID:39096083 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 decreases response to substance
increases expression 		ISO ELOVL3 protein results in decreased susceptibility to Mercuric Chloride
Mercuric Chloride results in increased expression of ELOVL3 mRNA 		CTD PMID:24118919 NCBI chr 1:254,938,731...254,942,559
Ensembl chr 1:254,938,731...254,942,559 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases response to substance
affects expression 		ISO ELOVL6 protein results in increased susceptibility to Mercuric Chloride
Mercuric Chloride affects the expression of ELOVL6 mRNA 		CTD PMID:24118919 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Eno1 enolase 1 multiple interactions ISO Mercuric Chloride results in increased expression of and results in increased secretion of ENO1 protein CTD PMID:26259607 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression EXP Mercuric Chloride results in increased expression of ENTPD5 mRNA CTD PMID:16507785 NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 decreases expression EXP Mercuric Chloride results in decreased expression of EPB41L3 mRNA CTD PMID:16507785 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression EXP Mercuric Chloride results in increased expression of EPHX1 mRNA CTD PMID:32599119 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions ISO [Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid; [Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid; Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein CTD PMID:24472606 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Epo erythropoietin multiple interactions ISO Mercuric Chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA]; Mercuric Chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO protein]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO protein] CTD PMID:11090055 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression
increases activity
multiple interactions
affects response to substance 		ISO Mercuric Chloride results in decreased expression of ESR1 mRNA; Mercuric Chloride results in decreased expression of ESR1 protein
Mercuric Chloride results in increased activity of ESR1 protein
Mercuric Chloride inhibits the reaction [Estradiol binds to ESR1 protein]
ESR1 protein affects the susceptibility to Mercuric Chloride 		CTD PMID:12746304 PMID:17716812 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Etv2 ETS variant transcription factor 2 multiple interactions ISO Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] CTD PMID:31404653 NCBI chr 1:95,017,980...95,021,582
Ensembl chr 1:95,017,687...95,021,457 		JBrowse link
G Etv4 ETS variant transcription factor 4 increases expression EXP Mercuric Chloride results in increased expression of ETV4 mRNA CTD PMID:16507785 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318 		JBrowse link
G Evi5 ecotropic viral integration site 5 decreases expression ISO Mercuric Chloride results in decreased expression of EVI5 mRNA CTD PMID:27188386 NCBI chr14:2,020,524...2,166,593
Ensembl chr14:2,020,581...2,166,593 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases activity 		ISO ANXA5 protein inhibits the reaction [Mercuric Chloride results in increased activity of F3 protein] CTD PMID:17726162 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G Fabp6 fatty acid binding protein 6 increases expression ISO Mercuric Chloride results in increased expression of FABP6 mRNA CTD PMID:31175882 NCBI chr10:28,565,054...28,569,727
Ensembl chr10:28,565,054...28,573,058 		JBrowse link
G Fadd Fas associated via death domain increases expression
multiple interactions 		ISO Mercuric Chloride results in increased expression of FADD protein
[Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of FADD protein 		CTD PMID:16421179 NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976 		JBrowse link
G Fads1 fatty acid desaturase 1 decreases expression EXP Mercuric Chloride results in decreased expression of FADS1 mRNA CTD PMID:16507785 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615 		JBrowse link
G Fam135a family with sequence similarity 135, member A decreases expression ISO Mercuric Chloride results in decreased expression of FAM135A mRNA CTD PMID:27188386 NCBI chr 9:33,916,449...33,997,140
Ensembl chr 9:33,916,449...33,997,051 		JBrowse link
G Fam169a family with sequence similarity 169, member A decreases expression ISO Mercuric Chloride results in decreased expression of FAM169A mRNA CTD PMID:27188386 NCBI chr 2:30,115,307...30,175,972
Ensembl chr 2:30,119,381...30,175,962 		JBrowse link
G Fam219a family with sequence similarity 219, member A increases expression EXP Mercuric Chloride results in increased expression of FAM219A mRNA CTD PMID:16507785 NCBI chr 5:61,475,185...61,525,749
Ensembl chr 5:61,475,185...61,525,749 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions
increases expression 		ISO Mercuric Chloride inhibits the reaction [FAS affects the activity of CASP3 protein]
Mercuric Chloride results in increased expression of FAS protein
[Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of FAS protein 		CTD PMID:15585371 PMID:16421179 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fbl fibrillarin affects localization
decreases activity
increases cleavage
multiple interactions 		ISO Mercuric Chloride affects the localization of FBL protein
Mercuric Chloride results in decreased activity of FBL protein
Mercuric Chloride results in increased cleavage of FBL protein
CD28 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IFNG protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL4 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL6 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein] 		CTD PMID:10925315 PMID:10942594 PMID:12388758 PMID:19077085 NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506 		JBrowse link
G Fcer2 Fc epsilon receptor II affects expression
increases expression 		EXP Mercuric Chloride affects the expression of FCER2 protein
[Mercuric Chloride results in increased expression of IL4 protein] which results in increased expression of FCER2 protein 		CTD PMID:7657819 NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374 		JBrowse link
G Fcgr1a Fc gamma receptor 1A multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of FCGR1 mRNA; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of FCGR1 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of FCGR1 mRNA] CTD PMID:28453771 NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858 		JBrowse link
G Fcgr2a Fc gamma receptor 2A affects response to substance
affects binding 		ISO FCGR3 protein affects the susceptibility to Mercuric Chloride
Mercuric Chloride binds to FCGR3 protein 		CTD PMID:10666595 PMID:18314309 NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394 		JBrowse link
G Fcgr2b Fc gamma receptor 2B affects response to substance ISO FCGR2B protein affects the susceptibility to Mercuric Chloride CTD PMID:18314309 NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517 		JBrowse link
G Fkbp1a FKBP prolyl isomerase 1A increases expression EXP Mercuric Chloride results in increased expression of FKBP1A mRNA CTD PMID:16507785 NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233 		JBrowse link
G Fn1 fibronectin 1 affects folding
increases expression
affects binding 		EXP Mercuric Chloride affects the folding of FN1 protein
Mercuric Chloride results in increased expression of FN1 protein
Mercuric Chloride binds to FN1 protein 		CTD PMID:10469268 PMID:11768240 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fn3k fructosamine 3 kinase increases expression EXP Mercuric Chloride results in increased expression of FN3K mRNA CTD PMID:16507785 NCBI chr10:107,198,566...107,214,176
Ensembl chr10:107,198,892...107,214,175 		JBrowse link
G Fnbp4 formin binding protein 4 decreases expression ISO Mercuric Chloride results in decreased expression of FNBP4 mRNA CTD PMID:27188386 NCBI chr 3:97,188,852...97,218,916
Ensembl chr 3:97,188,884...97,219,435 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		EXP
ISO 		Mercuric Chloride promotes the reaction [HSPA5 protein binds to FOS enhancer]
Mercuric Chloride results in increased expression of FOS mRNA 		CTD PMID:10362023 PMID:15111246 PMID:16507785 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression EXP Mercuric Chloride results in increased expression of FOSL1 mRNA CTD PMID:16507785 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Fsd1l fibronectin type III and SPRY domain containing 1-like increases expression EXP Mercuric Chloride results in increased expression of FSD1L mRNA CTD PMID:32599119 NCBI chr 5:73,052,565...73,130,292
Ensembl chr 5:73,054,274...73,130,292 		JBrowse link
G Ftl1 ferritin light chain 1 increases expression ISO Mercuric Chloride results in increased expression of FTL mRNA CTD PMID:38568856 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 decreases expression ISO Mercuric Chloride results in decreased expression of G3BP1 mRNA CTD PMID:27188386 NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression
multiple interactions
increases activity
decreases activity 		EXP Mercuric Chloride results in decreased expression of G6PC1 mRNA
zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of G6PC1 protein]
Mercuric Chloride results in decreased activity of G6PC1 protein 		CTD PMID:16507785 PMID:22413763 PMID:22416658 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases activity EXP Mercuric Chloride results in increased activity of G6PD protein CTD PMID:15977196 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 increases expression EXP Mercuric Chloride results in increased expression of GABBR2 mRNA CTD PMID:32599119 NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695 		JBrowse link
G Gabrb3 gamma-aminobutyric acid type A receptor subunit beta 3 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB3 mRNA CTD PMID:27188386 NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP Mercuric Chloride results in increased expression of GADD45A mRNA CTD PMID:16507785 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Galnt11 polypeptide N-acetylgalactosaminyltransferase 11 decreases expression EXP Mercuric Chloride results in decreased expression of GALNT11 mRNA CTD PMID:16507785 NCBI chr 4:10,571,464...10,604,974
Ensembl chr 4:10,571,464...10,604,974 		JBrowse link
G Gar1 GAR1 ribonucleoprotein increases expression EXP Mercuric Chloride results in increased expression of GAR1 mRNA CTD PMID:16507785 NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749 		JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein]; Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] CTD PMID:31404653 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gatm glycine amidinotransferase decreases expression EXP Mercuric Chloride results in decreased expression of GATM mRNA CTD PMID:16507785 NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions
decreases response to substance 		ISO
EXP 		Mercuric Chloride results in increased expression of GCLC mRNA
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC mRNA; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC protein; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC mRNA]; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC protein]
[Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of GCLC protein
GCLC protein results in decreased susceptibility to Mercuric Chloride 		CTD PMID:24118919 PMID:27837179 PMID:30359721 PMID:38568856 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions
increases expression 		ISO ABCC2 gene mutant form promotes the reaction [Mercuric Chloride results in increased expression of GCLM mRNA]
[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA 		CTD PMID:24039982 PMID:27188386 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression EXP Mercuric Chloride results in increased expression of GDF15 mRNA CTD PMID:16507785 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gemin4 gem (nuclear organelle) associated protein 4 increases expression EXP Mercuric Chloride results in increased expression of GEMIN4 mRNA CTD PMID:16507785 NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions
increases expression 		EXP Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]] CTD PMID:24485406 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression ISO Mercuric Chloride results in increased expression of GJA1 mRNA; Mercuric Chloride results in increased expression of GJA1 protein CTD PMID:18409822 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gjb1 gap junction protein, beta 1 increases expression
decreases expression 		ISO
EXP 		Mercuric Chloride results in increased expression of GJB1 mRNA; Mercuric Chloride results in increased expression of GJB1 protein
Mercuric Chloride results in decreased expression of GJB1 mRNA 		CTD PMID:16507785 PMID:18409822 NCBI chr  X:70,541,845...70,549,776
Ensembl chr  X:70,541,862...70,549,843 		JBrowse link
G Gjb2 gap junction protein, beta 2 increases expression ISO Mercuric Chloride results in increased expression of GJB2 mRNA; Mercuric Chloride results in increased expression of GJB2 protein CTD PMID:18409822 NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877 		JBrowse link
G Gldc glycine decarboxylase decreases expression EXP Mercuric Chloride results in decreased expression of GLDC mRNA CTD PMID:16507785 NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604 		JBrowse link
G Glrx glutaredoxin affects metabolic processing ISO Mercuric Chloride affects the metabolism of GLRX protein CTD PMID:18321861 NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of GOT1 protein CTD PMID:39414706 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gpat3 glycerol-3-phosphate acyltransferase 3 increases expression EXP Mercuric Chloride results in increased expression of GPAT3 mRNA CTD PMID:16507785 NCBI chr14:9,018,762...9,072,552 JBrowse link
G Gpnmb glycoprotein nmb increases expression EXP Mercuric Chloride results in increased expression of GPNMB mRNA CTD PMID:16507785 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases activity
increases expression
decreases activity 		EXP
ISO 		Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Selenium inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]]
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of GPT protein
Mercuric Chloride results in increased expression of GPT protein
Mercuric Chloride results in decreased activity of GPT protein 		CTD PMID:24485406 PMID:24751971 PMID:24954677 PMID:26215012 PMID:33476711 More... NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases expression 		EXP Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of GPX1 mRNA] CTD PMID:24751971 PMID:33460233 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gramd1b GRAM domain containing 1B increases expression EXP Mercuric Chloride results in increased expression of GRAMD1B mRNA CTD PMID:16507785 NCBI chr 8:49,551,642...49,790,965
Ensembl chr 8:49,556,332...49,791,052 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO GSK3B protein promotes the reaction [Mercuric Chloride results in increased activity of BAX protein]; GSK3B protein promotes the reaction [Mercuric Chloride results in increased cleavage of CASP3 protein] CTD PMID:22785175 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases activity 		ISO
EXP 		naringin inhibits the reaction [Mercuric Chloride results in decreased activity of GSR protein]
Berberine inhibits the reaction [Mercuric Chloride results in decreased activity of GSR protein]; Plant Extracts inhibits the reaction [Mercuric Chloride results in decreased activity of GSR protein] 		CTD PMID:23650045 PMID:24751971 PMID:25600690 PMID:26215012 PMID:33460233 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression
multiple interactions 		ISO Mercuric Chloride results in increased expression of GSTA1 mRNA; Mercuric Chloride results in increased expression of GSTA1 protein
Tetradecanoylphorbol Acetate promotes the reaction [Mercuric Chloride results in increased expression of GSTA1 mRNA] 		CTD PMID:7568053 PMID:9434069 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression
multiple interactions 		ISO Mercuric Chloride results in increased expression of GSTM1 protein
[Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of GSTM1 protein 		CTD PMID:9434069 PMID:30359721 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 affects response to substance
multiple interactions
increases expression 		ISO
EXP 		GSTP1 protein SNP affects the susceptibility to Mercuric Chloride
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GSTP1 mRNA; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GSTP1 protein
Mercuric Chloride results in increased expression of GSTP1 mRNA
Mercuric Chloride inhibits the reaction [GSTP1 protein SNP binds to and results in increased glutathionylation of Dinitrochlorobenzene] 		CTD PMID:22401947 PMID:29298499 PMID:32599119 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Hacd2 3-hydroxyacyl-CoA dehydratase 2 decreases expression ISO Mercuric Chloride results in decreased expression of HACD2 mRNA CTD PMID:27188386 NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP
ISO 		Mercuric Chloride results in increased expression of HAVCR1 mRNA; Mercuric Chloride results in increased expression of HAVCR1 protein CTD PMID:18441258 PMID:21126564 PMID:25145654 PMID:27720909 PMID:28536007 More... NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression EXP Mercuric Chloride results in increased expression of HBEGF mRNA; Mercuric Chloride results in increased expression of HBEGF protein CTD PMID:7635938 PMID:10901180 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hck HCK proto-oncogene, Src family tyrosine kinase multiple interactions
increases activity 		ISO Mercuric Chloride promotes the reaction [HCK protein results in increased phosphorylation of CBL protein]
Mercuric Chloride results in increased activity of HCK protein 		CTD PMID:10092522 PMID:14551197 NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 decreases expression ISO Mercuric Chloride results in decreased expression of HECTD1 mRNA CTD PMID:27188386 NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408 		JBrowse link
G Hgf hepatocyte growth factor increases activity
increases expression 		EXP Mercuric Chloride results in increased activity of HGF protein
Mercuric Chloride results in increased expression of HGF mRNA 		CTD PMID:8342615 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases activity
multiple interactions 		ISO Mercuric Chloride results in increased activity of HIF1A protein
Mercuric Chloride inhibits the reaction [cobaltous chloride results in increased activity of HIF1A protein]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein] 		CTD PMID:11090055 PMID:19502547 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hk2 hexokinase 2 increases expression EXP Mercuric Chloride results in increased expression of HK2 mRNA CTD PMID:16507785 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275 		JBrowse link
G Hmbs hydroxymethylbilane synthase decreases activity EXP Mercury dichloride decreases activity of purified Hmbs protein RGD PMID:6732900 RGD:25394584 NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase increases expression EXP Mercuric Chloride results in increased expression of HMGCR mRNA CTD PMID:16507785 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor increases expression EXP Mercuric Chloride results in increased expression of HMMR mRNA CTD PMID:16507785 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
affects expression 		ISO
EXP 		[Mercuric Chloride co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 mRNA; HMOX1 mRNA affects the reaction [Mercuric Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; Mercuric Chloride promotes the reaction [HSF1 protein binds to HMOX1 promoter]
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased expression of HMOX1 protein; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of HMOX1 mRNA; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of HMOX1 protein; [zinc chloride co-treated with Sodium Selenite] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased expression of HMOX1 protein]; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of HMOX1 mRNA]; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of HMOX1 protein]; Sodium Selenite inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in decreased expression of HMOX1 protein]
Mercuric Chloride results in increased expression of HMOX1 mRNA
HMOX1 enhancer affects the reaction [Mercuric Chloride results in increased expression of HMOX1 mRNA]
Mercuric Chloride results in increased expression of HMOX1 mRNA; Mercuric Chloride results in increased expression of HMOX1 protein
Mercuric Chloride affects the expression of HMOX1 mRNA 		CTD PMID:7538129 PMID:8612205 PMID:8872981 PMID:9544699 PMID:9863766 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions EXP Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer] CTD PMID:15111246 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP Mercuric Chloride results in decreased expression of HSD11B2 protein CTD PMID:16189294 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression EXP Mercuric Chloride results in decreased expression of HSD17B2 mRNA CTD PMID:16507785 NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Hsd17b3 hydroxysteroid (17-beta) dehydrogenase 3 multiple interactions
decreases expression 		EXP alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD17B3 mRNA] CTD PMID:32134168 NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283 		JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions
decreases expression 		EXP alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD3B2 mRNA] CTD PMID:32134168 NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569 		JBrowse link
G Hsf1 heat shock transcription factor 1 multiple interactions
increases activity 		ISO Mercuric Chloride promotes the reaction [HSF1 protein binds to HMOX1 promoter]; Mercuric Chloride promotes the reaction [HSF1 protein binds to HSPA1A promoter]
Mercuric Chloride results in increased activity of HSF1 protein 		CTD PMID:17244614 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 increases expression EXP Mercuric Chloride results in increased expression of HSP90B1 protein CTD PMID:10696793 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa12a heat shock protein family A (Hsp70) member 12A decreases expression EXP Mercuric Chloride results in decreased expression of HSPA12A mRNA CTD PMID:16507785 NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions
increases expression 		ISO
EXP 		[Mercuric Chloride results in increased abundance of Reactive Oxygen Species] which results in increased expression of HSPA1A mRNA; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of HSPA1A mRNA]; Mercuric Chloride promotes the reaction [HSF1 protein binds to HSPA1A promoter]; Selenomethionine inhibits the reaction [Mercuric Chloride results in increased expression of HSPA1A mRNA] CTD PMID:16324719 PMID:16507785 PMID:17244614 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression EXP Mercuric Chloride results in increased expression of HSPA1B mRNA CTD PMID:16507785 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression EXP Mercuric Chloride results in increased expression of HSPA4L mRNA CTD PMID:16507785 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
affects expression 		EXP
ISO 		Cycloheximide inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein]; Dactinomycin inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 mRNA]; Mercuric Chloride promotes the reaction [HSPA5 protein binds to FOS enhancer]; Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer]; Mercuric Chloride results in increased expression of and results in increased activity of HSPA5 protein
4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein]
Mercuric Chloride results in increased expression of HSPA5 mRNA; Mercuric Chloride results in increased expression of HSPA5 protein
Mercuric Chloride affects the expression of HSPA5 mRNA 		CTD PMID:15111246 PMID:17915553 PMID:30807803 PMID:32879258 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa6l-ps1 heat shock protein family A (Hsp70) member 6 like, pseudogene 1 increases expression ISO Mercuric Chloride results in increased expression of HSPA6 mRNA CTD PMID:15287566 NCBI chr13:85,805,911...85,807,052 JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions ISO Mercuric Chloride results in increased expression of and results in increased secretion of HSPA8 protein CTD PMID:26259607 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 multiple interactions
increases expression 		EXP [Mercuric Chloride co-treated with bimoclomol] affects the localization of HSPA9 protein; Melatonin affects the reaction [Mercuric Chloride results in increased expression of HSPA9 protein] CTD PMID:15375764 PMID:16801527 PMID:16891066 PMID:21616119 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 decreases response to substance EXP HSPB1 protein results in decreased susceptibility to Mercuric Chloride CTD PMID:8917706 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression EXP Mercuric Chloride results in increased expression of HSPB8 mRNA CTD PMID:16507785 NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937 		JBrowse link
G Iars1 isoleucyl-tRNA synthetase 1 increases expression EXP Mercuric Chloride results in increased expression of IARS1 mRNA CTD PMID:16507785 NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652 		JBrowse link
G Icam1 intercellular adhesion molecule 1 increases expression ISO
EXP 		Mercuric Chloride results in increased expression of ICAM1 mRNA; Mercuric Chloride results in increased expression of ICAM1 protein CTD PMID:11884233 PMID:22822941 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Ier2 immediate early response 2 increases expression EXP Mercuric Chloride results in increased expression of IER2 mRNA CTD PMID:16507785 NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708 		JBrowse link
G Ifi44 interferon-induced protein 44 multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IFI44 mRNA CTD PMID:28453771 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO 2-Aminopurine inhibits the reaction [[IFNB1 results in increased expression of EIF2AK2 protein] which results in decreased susceptibility to Mercuric Chloride]; [IFNB1 results in increased expression of EIF2AK2 protein] which results in decreased susceptibility to Mercuric Chloride CTD PMID:16324719 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Ifng interferon gamma multiple interactions
increases expression
increases secretion
decreases expression
affects response to substance
decreases activity 		ISO
EXP 		[Mercuric Chloride co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Mercuric Chloride inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]; Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]
[Mercuric Chloride co-treated with CD55] results in increased expression of IFNG mRNA; [Mercuric Chloride co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG protein; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IFNG protein; [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of IFNG protein; B2M protein affects the reaction [Mercuric Chloride results in increased expression of IFNG mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of FCGR1 mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF8 mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA]; IFNG protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IFNG mRNA]; N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [Mercuric Chloride results in increased expression of IFNG mRNA]
Mercuric Chloride results in increased expression of IFNG mRNA; Mercuric Chloride results in increased expression of IFNG protein
Mercuric Chloride results in increased secretion of IFNG protein
Mercuric Chloride results in decreased expression of IFNG protein
IFNG protein affects the susceptibility to Mercuric Chloride
Mercuric Chloride results in decreased activity of IFNG protein 		CTD PMID:7657819 PMID:8898950 PMID:9376071 PMID:10447925 PMID:15588918 More... NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 increases expression EXP Mercuric Chloride results in increased expression of IFRD1 mRNA CTD PMID:16507785 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression EXP Mercuric Chloride results in decreased expression of IGF1 mRNA CTD PMID:7540432 PMID:8538927 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression EXP Mercuric Chloride results in increased expression of IGFBP1 mRNA CTD PMID:7540432 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Ighg1 immunoglobulin heavy constant gamma 1 increases expression ISO Mercuric Chloride results in increased expression of IGHG1 protein CTD PMID:17015760
G Il10 interleukin 10 multiple interactions
decreases expression
increases expression
increases secretion 		ISO
EXP 		Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]
Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL10 protein]
Mercuric Chloride results in increased expression of IL10 mRNA
[Mercuric Chloride co-treated with CD55] results in increased expression of IL10 mRNA; CD55 affects the reaction [Mercuric Chloride results in increased expression of IL10 mRNA]
Mercuric Chloride results in increased expression of IL10 mRNA; Mercuric Chloride results in increased expression of IL10 protein
Mercuric Chloride results in increased secretion of IL10 protein 		CTD PMID:8898950 PMID:12490134 PMID:20049214 PMID:20408894 PMID:21984480 More... NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO Mercuric Chloride results in increased expression of [IL12A protein binds to IL12B protein] CTD PMID:21984480 NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997 		JBrowse link
G Il12b interleukin 12B decreases expression
multiple interactions 		ISO Mercuric Chloride results in decreased expression of IL12B protein
Mercuric Chloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
Mercuric Chloride results in increased expression of [IL12A protein binds to IL12B protein] 		CTD PMID:21984480 PMID:36416909 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
G Il12rb2 interleukin 12 receptor subunit beta 2 decreases expression
increases expression 		EXP Mercuric Chloride results in decreased expression of IL12RB2 mRNA
Mercuric Chloride results in increased expression of IL12RB2 mRNA 		CTD PMID:10447925 PMID:10651948 NCBI chr 4:97,756,089...97,844,937
Ensembl chr 4:97,756,089...97,844,937 		JBrowse link
G Il13 interleukin 13 decreases expression ISO Mercuric Chloride results in decreased expression of IL13 protein CTD PMID:21984480 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il17a interleukin 17A increases expression ISO Mercuric Chloride results in increased expression of IL-17A protein CTD PMID:21984480 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Mercuric Chloride results in increased expression of IL1A protein CTD PMID:21984480 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
affects secretion
affects expression
decreases expression
increases expression 		EXP
ISO 		carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of IL1B mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of IL1B mRNA]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of IL1B protein]; Tretinoin inhibits the reaction [Mercuric Chloride results in increased expression of IL1B mRNA]
Mercuric Chloride affects the secretion of IL1B protein; Mercuric Chloride analog affects the secretion of IL1B protein
Mercuric Chloride analog affects the expression of IL1B mRNA
Mercuric Chloride results in decreased expression of IL1B mRNA
Mercuric Chloride results in increased expression of IL1B mRNA; Mercuric Chloride results in increased expression of IL1B protein
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL1B mRNA; [Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of IL1B mRNA; N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [Mercuric Chloride results in increased expression of IL1B mRNA]
Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Mercuric Chloride inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
Mercuric Chloride results in decreased expression of IL1B protein 		CTD PMID:9138684 PMID:16507785 PMID:17250768 PMID:20049214 PMID:21051542 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions ISO Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1RN protein] CTD PMID:20049214 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 decreases expression
decreases secretion
decreases activity
multiple interactions
increases expression 		ISO
EXP 		Mercuric Chloride results in decreased expression of IL2 protein
Mercuric Chloride results in decreased secretion of IL2 protein
Mercuric Chloride results in decreased activity of IL2 protein
Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of IL2 protein]; Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]; Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]
Mercuric Chloride results in increased expression of IL2 mRNA
Mercuric Chloride results in increased expression of IL2 protein 		CTD PMID:8898950 PMID:9376071 PMID:16428073 PMID:21984480 PMID:22910795 More... NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il20 interleukin 20 increases expression EXP Mercuric Chloride results in increased expression of IL20 mRNA; Mercuric Chloride results in increased expression of IL20 protein CTD PMID:18496552 NCBI chr13:44,933,249...44,936,893
Ensembl chr13:44,933,249...44,936,893 		JBrowse link
G Il20ra interleukin 20 receptor subunit alpha increases expression EXP Mercuric Chloride results in increased expression of IL20RA mRNA CTD PMID:18496552 NCBI chr 1:16,243,683...16,313,229
Ensembl chr 1:16,243,801...16,313,221 		JBrowse link
G Il20rb interleukin 20 receptor subunit beta increases expression EXP Mercuric Chloride results in increased expression of IL20RB mRNA CTD PMID:18496552 NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363 		JBrowse link
G Il22ra1 interleukin 22 receptor subunit alpha 1 increases expression EXP Mercuric Chloride results in increased expression of IL22RA1 mRNA CTD PMID:18496552 NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:153,245,002...153,271,683 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha increases expression ISO Mercuric Chloride results in increased expression of IL2RA protein CTD PMID:7867075 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il4 interleukin 4 multiple interactions
increases response to substance
increases expression
decreases expression
affects response to substance
increases secretion
increases activity 		ISO
EXP 		Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased secretion of IL4 protein]
IL4 protein results in increased susceptibility to Mercuric Chloride
Mercuric Chloride results in increased expression of IL4 mRNA; Mercuric Chloride results in increased expression of IL4 protein
Mercuric Chloride results in decreased expression of IL4 mRNA
[Mercuric Chloride results in increased expression of IL4 protein] which results in increased expression of FCER2 protein; Mercuric Chloride results in increased expression of IL4; Mercuric Chloride results in increased expression of IL4 mRNA; Mercuric Chloride results in increased expression of IL4 protein
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA; B2M protein affects the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; CASP1 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]; CD55 affects the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]; IL4 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]
IL4 protein affects the susceptibility to Mercuric Chloride
Mercuric Chloride results in increased secretion of IL4 protein
Mercuric Chloride results in increased activity of IL4 promoter
Deferoxamine inhibits the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; Levamisole inhibits the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; Pyruvic Acid inhibits the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; S-ethyl glutathione inhibits the reaction [Mercuric Chloride results in increased expression of IL4 mRNA]; S-ethyl glutathione inhibits the reaction [Mercuric Chloride results in increased expression of IL4 protein] 		CTD PMID:7589090 PMID:7657819 PMID:7664789 PMID:7867075 PMID:7871386 More... NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 increases expression ISO Mercuric Chloride results in increased expression of IL5 protein CTD PMID:21984480 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 decreases activity
increases expression
multiple interactions
decreases expression
increases secretion
affects response to substance 		ISO
EXP 		Mercuric Chloride results in decreased activity of IL6 protein
Mercuric Chloride results in increased expression of IL6 protein
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of IL6 protein; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 protein]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 mRNA]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL6 protein]; Sodium Selenite promotes the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of IL6 protein]; zinc chloride inhibits the reaction [Sodium Selenite promotes the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of IL6 protein]]
Mercuric Chloride results in increased secretion of IL6 protein
Mercuric Chloride results in increased expression of IL6 mRNA; Mercuric Chloride results in increased expression of IL6 protein
IL6 protein affects the susceptibility to Mercuric Chloride
Mercuric Chloride promotes the reaction [TAC1 protein results in increased secretion of IL6 protein]
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL6 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of IL6 protein; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of FCGR1 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IFNG mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IL4 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF8 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA]; IL6 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; Mercuric Chloride promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 mRNA] 		CTD PMID:8898950 PMID:12175822 PMID:16428073 PMID:19077085 PMID:19635391 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 decreases expression
decreases secretion
multiple interactions 		EXP
ISO 		Mercuric Chloride results in decreased expression of INS1 protein
Mercuric Chloride results in decreased secretion of INS1 protein
[Mercuric Chloride results in increased abundance of Mercury] inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased secretion of INS1 protein] 		CTD PMID:20006636 PMID:30807803 PMID:33038468 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Insyn1 inhibitory synaptic factor 1 decreases expression EXP Mercuric Chloride results in decreased expression of INSYN1 mRNA CTD PMID:16507785 NCBI chr 8:67,799,989...67,810,685
Ensembl chr 8:67,799,304...67,814,536 		JBrowse link
G Ipo5 importin 5 increases expression EXP Mercuric Chloride results in increased expression of IPO5 mRNA CTD PMID:16507785 NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985 		JBrowse link
G Ipp intracisternal A particle-promoted polypeptide decreases expression EXP Mercuric Chloride results in decreased expression of IPP mRNA CTD PMID:16507785 NCBI chr 5:135,199,198...135,237,912
Ensembl chr 5:135,180,109...135,238,000 		JBrowse link
G Irf1 interferon regulatory factor 1 multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF1 mRNA] CTD PMID:28453771 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 decreases expression ISO Mercuric Chloride results in decreased expression of IRF2BP2 mRNA CTD PMID:27188386 NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368 		JBrowse link
G Irf8 interferon regulatory factor 8 multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF8 mRNA; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF8 mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of IRF8 mRNA] CTD PMID:28453771 NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062 		JBrowse link
G Irs2 insulin receptor substrate 2 increases expression EXP Mercuric Chloride results in increased expression of IRS2 mRNA CTD PMID:16507785 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Itga4 integrin subunit alpha 4 increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of ITGA4 protein
Tretinoin inhibits the reaction [Mercuric Chloride results in increased expression of ITGA4 mRNA] 		CTD PMID:17250768 NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039 		JBrowse link
G Itprid2 ITPR interacting domain containing 2 decreases expression ISO Mercuric Chloride results in decreased expression of ITPRID2 mRNA CTD PMID:27188386 NCBI chr 3:84,943,572...84,980,993
Ensembl chr 3:84,939,808...84,980,899 		JBrowse link
G Itsn2 intersectin 2 decreases expression ISO Mercuric Chloride results in decreased expression of ITSN2 mRNA CTD PMID:27188386 NCBI chr 6:33,336,086...33,446,818
Ensembl chr 6:33,336,441...33,446,818 		JBrowse link
G Jag1 jagged canonical Notch ligand 1 increases expression EXP Mercuric Chloride results in increased expression of JAG1 mRNA CTD PMID:16507785 NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872 		JBrowse link
G Jak1 Janus kinase 1 decreases phosphorylation ISO Mercuric Chloride results in decreased phosphorylation of JAK1 protein CTD PMID:16896058 PMID:19635391 NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758 		JBrowse link
G Jak2 Janus kinase 2 decreases phosphorylation
multiple interactions 		ISO
EXP 		Mercuric Chloride results in decreased phosphorylation of JAK2 protein
carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of JAK2 mRNA] 		CTD PMID:16896058 PMID:19635391 PMID:39105374 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jmjd1c jumonji domain containing 1C decreases expression ISO Mercuric Chloride results in decreased expression of JMJD1C mRNA CTD PMID:27188386 NCBI chr20:21,330,990...21,508,580
Ensembl chr20:21,330,990...21,461,916 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases phosphorylation
increases expression 		ISO
EXP 		Mercuric Chloride results in increased phosphorylation of JUN protein
Mercuric Chloride results in increased expression of JUN mRNA 		CTD PMID:10861847 PMID:16507785 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression EXP Mercuric Chloride results in increased expression of JUNB mRNA CTD PMID:16507785 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Kat6a lysine acetyltransferase 6A decreases expression ISO Mercuric Chloride results in decreased expression of KAT6A mRNA CTD PMID:27188386 NCBI chr16:75,787,411...75,868,584
Ensembl chr16:75,787,411...75,866,099 		JBrowse link
G Kcmf1 potassium channel modulatory factor 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA CTD PMID:27188386 NCBI chr 4:106,447,974...106,508,359
Ensembl chr 4:106,447,981...106,508,359 		JBrowse link
G Kcnab1 potassium voltage-gated channel subfamily A regulatory beta subunit 1 decreases expression EXP Mercuric Chloride results in decreased expression of KCNAB1 mRNA CTD PMID:16507785 NCBI chr 2:151,446,975...151,913,636
Ensembl chr 2:151,446,947...151,913,636 		JBrowse link
G Kcne1 potassium voltage-gated channel subfamily E regulatory subunit 1 increases expression EXP Mercuric Chloride results in increased expression of KCNE1 mRNA CTD PMID:16507785 NCBI chr11:45,066,875...45,080,024
Ensembl chr11:45,064,162...45,081,247 		JBrowse link
G Kcnj12 potassium inwardly-rectifying channel, subfamily J, member 12 decreases expression EXP Mercuric Chloride results in decreased expression of KCNJ12 mRNA CTD PMID:16507785 NCBI chr10:46,196,110...46,245,008
Ensembl chr10:46,195,428...46,260,169 		JBrowse link
G Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 decreases expression EXP Mercuric Chloride results in decreased expression of KCNJ15 mRNA CTD PMID:16507785 NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457 		JBrowse link
G Kcnk3 potassium two pore domain channel subfamily K member 3 decreases expression
multiple interactions 		EXP Mercuric Chloride results in decreased expression of KCNK3 mRNA
Mercuric Chloride results in increased expression of and affects the localization of KCNK3 protein 		CTD PMID:19533102 NCBI chr 6:31,483,129...31,519,061
Ensembl chr 6:31,483,140...31,519,061 		JBrowse link
G Kctd4 potassium channel tetramerization domain containing 4 increases expression EXP Mercuric Chloride results in increased expression of KCTD4 mRNA CTD PMID:16507785 NCBI chr15:57,675,024...57,686,816
Ensembl chr15:57,673,741...57,687,798 		JBrowse link
G Kdm6b lysine demethylase 6B increases expression EXP Mercuric Chloride results in increased expression of KDM6B mRNA CTD PMID:16507785 NCBI chr10:54,619,520...54,641,014
Ensembl chr10:54,619,544...54,629,610 		JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDSR mRNA CTD PMID:27188386 NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897 		JBrowse link
G Khnyn KH and NYN domain containing increases expression ISO Mercuric Chloride results in increased expression of KHNYN protein CTD PMID:37172713 NCBI chr15:33,335,290...33,349,553
Ensembl chr15:33,335,274...33,349,552 		JBrowse link
G Kif3a kinesin family member 3a decreases expression ISO Mercuric Chloride results in decreased expression of KIF3A mRNA CTD PMID:27188386 NCBI chr10:38,226,388...38,263,062
Ensembl chr10:38,226,741...38,260,516 		JBrowse link
G Kifc1 kinesin family member C1 decreases expression EXP Mercuric Chloride results in decreased expression of KIFC1 mRNA CTD PMID:16507785 NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988 		JBrowse link
G Klf6 KLF transcription factor 6 increases expression EXP Mercuric Chloride results in increased expression of KLF6 mRNA CTD PMID:16507785 NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601 		JBrowse link
G Klhl28 kelch-like family member 28 decreases expression ISO Mercuric Chloride results in decreased expression of KLHL28 mRNA CTD PMID:27188386 NCBI chr 6:88,723,624...88,755,072
Ensembl chr 6:88,727,205...88,752,457 		JBrowse link
G Klk4 kallikrein-related peptidase 4 increases expression ISO Mercuric Chloride results in increased expression of KLK4 mRNA CTD PMID:27188386 NCBI chr 1:103,480,731...103,485,963
Ensembl chr 1:103,480,731...103,485,963 		JBrowse link
G Klrd1 killer cell lectin like receptor D1 increases expression ISO Mercuric Chloride results in increased expression of KLRD1 mRNA CTD PMID:27188386 NCBI chr 4:164,730,833...164,742,539
Ensembl chr 4:164,730,856...164,742,538 		JBrowse link
G Kpna4 karyopherin subunit alpha 4 increases expression EXP Mercuric Chloride results in increased expression of KPNA4 mRNA CTD PMID:16507785 NCBI chr 2:155,635,679...155,691,056
Ensembl chr 2:155,634,247...155,691,053 		JBrowse link
G Krt79 keratin 79 decreases expression EXP Mercuric Chloride results in decreased expression of KRT79 mRNA CTD PMID:32599119 NCBI chr 7:134,935,395...134,946,447
Ensembl chr 7:134,935,396...134,947,286 		JBrowse link
G Krtap1-1 keratin associated protein 1-1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRTAP1-5 mRNA CTD PMID:27188386 NCBI chr10:85,041,910...85,042,476
Ensembl chr10:85,041,910...85,042,476 		JBrowse link
G Kyat1 kynurenine aminotransferase 1 multiple interactions
increases expression 		ISO
EXP 		KYAT1 protein results in increased amination of [Mercuric Chloride co-treated with Cysteine]
Mercuric Chloride results in increased expression of KYAT1 protein
[Mercuric Chloride co-treated with Cysteine] results in decreased activity of KYAT1 protein 		CTD PMID:9765069 PMID:22093698 NCBI chr 3:33,857,407...33,891,153
Ensembl chr 3:33,857,743...33,890,642 		JBrowse link
G Kynu kynureninase decreases expression EXP Mercuric Chloride results in decreased expression of KYNU mRNA CTD PMID:16507785 NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014 		JBrowse link
G L2hgdh L-2-hydroxyglutarate dehydrogenase multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L2HGDH mRNA CTD PMID:27188386 NCBI chr 6:93,900,427...93,941,534
Ensembl chr 6:93,900,427...93,941,534 		JBrowse link
G L3hypdh trans-L-3-hydroxyproline dehydratase decreases expression EXP Mercuric Chloride results in decreased expression of L3HYPDH mRNA CTD PMID:16507785 NCBI chr 6:96,372,243...96,383,039 JBrowse link
G Lama3 laminin subunit alpha 3 decreases expression EXP Mercuric Chloride results in decreased expression of LAMA3 mRNA CTD PMID:16507785 NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449 		JBrowse link
G Larp4 La ribonucleoprotein 4 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LARP4 mRNA CTD PMID:27188386 NCBI chr 7:132,983,276...133,031,514
Ensembl chr 7:132,980,385...133,029,633 		JBrowse link
G Lcn2 lipocalin 2 increases expression
decreases secretion 		EXP
ISO 		Mercuric Chloride results in increased expression of LCN2 mRNA
Mercuric Chloride results in decreased secretion of LCN2 protein 		CTD PMID:16507785 PMID:25145654 PMID:27720909 PMID:27888128 PMID:28536007 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Lep leptin decreases expression
increases expression
decreases secretion 		ISO
EXP 		Mercuric Chloride results in decreased expression of LEP mRNA
Mercuric Chloride results in increased expression of LEP mRNA
Mercuric Chloride results in decreased secretion of LEP protein 		CTD PMID:22019852 PMID:30807803 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression EXP Mercuric Chloride results in decreased expression of LHB protein CTD PMID:25368988 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Litaf lipopolysaccharide-induced TNF factor increases expression EXP Mercuric Chloride results in increased expression of LITAF mRNA CTD PMID:16507785 NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930 		JBrowse link
G Lmnb1 lamin B1 increases activity ISO Mercuric Chloride results in increased activity of LMNB1 protein CTD PMID:12504520 NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283 		JBrowse link
G Lonrf3 LON peptidase N-terminal domain and ring finger 3 increases expression EXP Mercuric Chloride results in increased expression of LONRF3 mRNA CTD PMID:16507785 NCBI chr  X:120,430,975...120,469,648
Ensembl chr  X:120,430,996...120,464,572 		JBrowse link
G Lpgat1 lysophosphatidylglycerol acyltransferase 1 decreases expression ISO Mercuric Chloride results in decreased expression of LPGAT1 mRNA CTD PMID:27188386 NCBI chr13:105,825,630...105,896,366
Ensembl chr13:105,820,468...105,896,364 		JBrowse link
G Lrp6 LDL receptor related protein 6 decreases expression ISO Mercuric Chloride results in decreased expression of LRP6 mRNA CTD PMID:27188386 NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716 		JBrowse link
G Lrp8 LDL receptor related protein 8 increases expression EXP Mercuric Chloride results in increased expression of LRP8 mRNA CTD PMID:16507785 NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207 		JBrowse link
G Lrrc61 leucine rich repeat containing 61 increases expression ISO Mercuric Chloride results in increased expression of LRRC61 mRNA CTD PMID:27188386 NCBI chr 4:78,834,783...78,854,810
Ensembl chr 4:78,833,857...78,868,931 		JBrowse link
G Lst1 leukocyte specific transcript 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LST1 mRNA CTD PMID:27188386 NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669 		JBrowse link
G Ly96 lymphocyte antigen 96 increases expression EXP Mercuric Chloride results in increased expression of LY96 mRNA CTD PMID:16507785 NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816 		JBrowse link
G Map1lc3a microtubule-associated protein 1 light chain 3 alpha multiple interactions
increases expression 		EXP carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of MAP1LC3A mRNA] CTD PMID:39105374 NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression 		EXP carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of MAP1LC3B mRNA] CTD PMID:39105374 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 decreases expression ISO Mercuric Chloride results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k3 mitogen activated protein kinase kinase kinase 3 decreases expression ISO Mercuric Chloride results in decreased expression of MAP3K3 mRNA CTD PMID:27188386 NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,519,888...91,588,651 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 increases activity ISO Mercuric Chloride results in increased activity of MAP3K5 protein CTD PMID:16337887 NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation 		ISO
EXP 		[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to Mercuric Chloride; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK1 protein]; Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]
Mercuric Chloride analog results in increased phosphorylation of MAPK1 protein; Mercuric Chloride results in increased phosphorylation of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Mercuric Chloride analog results in increased phosphorylation of MAPK1 protein]; Mercuric Chloride inhibits the reaction [CD22 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] 		CTD PMID:10861847 PMID:17656488 PMID:19327394 PMID:20951154 PMID:22910795 More... NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 increases phosphorylation ISO Mercuric Chloride results in increased phosphorylation of MAPK14 protein CTD PMID:15585369 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation 		ISO
EXP 		[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to Mercuric Chloride; Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPK3 protein]; Mercuric Chloride inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]
Mercuric Chloride analog results in increased phosphorylation of MAPK3 protein; Mercuric Chloride results in increased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Mercuric Chloride analog results in increased phosphorylation of MAPK3 protein]; Mercuric Chloride inhibits the reaction [CD22 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] 		CTD PMID:10861847 PMID:17656488 PMID:19327394 PMID:20951154 PMID:22910795 More... NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk4 mitogen-activated protein kinase 4 decreases expression EXP Mercuric Chloride results in decreased expression of MAPK4 mRNA CTD PMID:16507785 NCBI chr18:69,788,058...69,937,524
Ensembl chr18:69,788,060...69,837,037 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases phosphorylation ISO Mercuric Chloride results in increased phosphorylation of MAPK8 protein CTD PMID:10861847 PMID:12883084 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases phosphorylation ISO Mercuric Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:10861847 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mapt microtubule-associated protein tau multiple interactions
increases phosphorylation 		ISO Melatonin inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPT protein]; Mercuric Chloride binds to and affects the folding of MAPT protein; Mercuric Chloride promotes the reaction [Heparin promotes the reaction [MAPT protein binds to MAPT protein]] CTD PMID:10617124 PMID:20665688 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Mbd4 methyl-CpG binding domain 4 DNA glycosylase multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD4 mRNA CTD PMID:27188386 NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:150,565,655...150,577,578 		JBrowse link
G Mbl1 mannose binding lectin 1 decreases expression EXP Mercuric Chloride results in decreased expression of MBL1 mRNA CTD PMID:32599119 NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,060,703...17,069,271 		JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member decreases expression ISO Mercuric Chloride results in decreased expression of MCL1 mRNA CTD PMID:23202902 NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782 		JBrowse link
G Mdm2 MDM2 proto-oncogene decreases expression ISO Mercuric Chloride results in decreased expression of MDM2 mRNA CTD PMID:23202902 NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Me1 malic enzyme 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ME1 mRNA CTD PMID:27188386 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Mef2d myocyte enhancer factor 2D increases expression EXP Mercuric Chloride results in increased expression of MEF2D mRNA CTD PMID:16507785 NCBI chr 2:175,904,332...175,933,451
Ensembl chr 2:175,903,959...175,930,760 		JBrowse link
G Miga1 mitoguardin 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIGA1 mRNA CTD PMID:27188386 NCBI chr 2:243,884,071...243,939,059
Ensembl chr 2:243,886,617...243,937,086 		JBrowse link
G Mmp1 matrix metallopeptidase 1 decreases expression EXP Mercuric Chloride results in decreased expression of MMP1 mRNA CTD PMID:11817102 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp9 matrix metallopeptidase 9 decreases expression EXP Mercuric Chloride results in decreased expression of MMP9 mRNA CTD PMID:32599119 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mob1a MOB kinase activator 1A decreases expression ISO Mercuric Chloride results in decreased expression of MOB1A mRNA CTD PMID:27188386 NCBI chr 4:117,389,278...117,406,255
Ensembl chr 4:117,389,186...117,406,250 		JBrowse link
G Mobp myelin-associated oligodendrocyte basic protein increases expression ISO Mercuric Chloride results in increased expression of MOBP mRNA CTD PMID:27188386 NCBI chr 8:128,747,117...128,777,238
Ensembl chr 8:128,747,232...128,777,936 		JBrowse link
G Mpst mercaptopyruvate sulfurtransferase decreases expression EXP Mercuric Chloride results in decreased expression of MPST mRNA CTD PMID:16507785 NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650 		JBrowse link
G Mrs2 magnesium transporter MRS2 decreases expression ISO Mercuric Chloride results in decreased expression of MRS2 mRNA CTD PMID:27188386 NCBI chr17:40,491,963...40,515,116
Ensembl chr17:40,491,963...40,511,232 		JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of MSR1 mRNA CTD PMID:28453771 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Mt1a metallothionein 1A increases expression
decreases expression
multiple interactions
affects binding
affects expression 		EXP
ISO 		Mercuric Chloride results in increased expression of MT1 mRNA; Mercuric Chloride results in increased expression of MT1 protein; Mercuric Chloride results in increased expression of MT1A mRNA
Mercuric Chloride results in decreased expression of MT1 mRNA
[MT1 gene mutant form co-treated with MT2 gene mutant form co-treated with Mercuric Chloride] results in decreased abundance of Dopamine; [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased susceptibility to Mercuric Chloride
[Zinc binds to MT1 protein] which binds to Mercuric Chloride
Mercuric Chloride affects the expression of MT1A mRNA
Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT1A mRNA]; Vitamin E promotes the reaction [Mercuric Chloride results in increased expression of MT1A mRNA] 		CTD PMID:10991963 PMID:12815612 PMID:15606775 PMID:16507785 PMID:18226494 More... NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 multiple interactions
increases expression
affects expression 		ISO
EXP 		Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA]
Mercuric Chloride results in increased expression of MT2 mRNA
[MT1 gene mutant form co-treated with MT2 gene mutant form co-treated with Mercuric Chloride] results in decreased abundance of Dopamine; [MT1 gene mutant form co-treated with MT2 gene mutant form] results in increased susceptibility to Mercuric Chloride
Mercuric Chloride affects the expression of MT2A mRNA
Mercuric Chloride results in increased expression of MT2A mRNA
Curcumin affects the reaction [Mercuric Chloride results in increased expression of MT2A mRNA] 		CTD PMID:9138684 PMID:10362023 PMID:10991963 PMID:18226494 PMID:20229497 More... NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mt3 metallothionein 3 increases expression ISO Mercuric Chloride results in increased expression of MT3 mRNA CTD PMID:21628964 NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080 		JBrowse link
G Mta2 metastasis associated 1 family, member 2 decreases expression ISO Mercuric Chloride results in decreased expression of MTA2 mRNA CTD PMID:27188386 NCBI chr 1:215,267,286...215,276,008
Ensembl chr 1:215,267,046...215,276,062 		JBrowse link
G Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like increases expression EXP Mercuric Chloride results in increased expression of MTHFD1L mRNA CTD PMID:16507785 NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression EXP Mercuric Chloride results in increased expression of MTHFD2 mRNA CTD PMID:16507785 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtpap mitochondrial poly(A) polymerase increases expression ISO Mercuric Chloride results in increased expression of MTPAP mRNA CTD PMID:27188386 NCBI chr17:58,015,979...58,036,735
Ensembl chr17:58,015,979...58,036,954 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression EXP Mercuric Chloride results in increased expression of MYC mRNA CTD PMID:16507785 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Myh10 myosin heavy chain 10 increases expression ISO Mercuric Chloride results in increased expression of MYH10 protein CTD PMID:37172713 NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036 		JBrowse link
G Mylk3 myosin light chain kinase 3 decreases expression EXP Mercuric Chloride results in decreased expression of MYLK3 mRNA CTD PMID:32599119 NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827 		JBrowse link
G Myo5a myosin VA decreases expression ISO Mercuric Chloride results in decreased expression of MYO5A mRNA CTD PMID:27188386 NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265 		JBrowse link
G Naa16 N(alpha)-acetyltransferase 16, NatA auxiliary subunit decreases expression ISO Mercuric Chloride results in decreased expression of NAA16 mRNA CTD PMID:27188386 NCBI chr15:61,120,704...61,179,979
Ensembl chr15:61,120,704...61,180,146 		JBrowse link
G Naalad2 N-acetylated alpha-linked acidic dipeptidase 2 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA CTD PMID:27188386 NCBI chr 8:23,682,499...23,756,066
Ensembl chr 8:23,683,395...23,756,060 		JBrowse link
G Ncbp1 nuclear cap binding protein subunit 1 decreases expression EXP Mercuric Chloride results in decreased expression of NCBP1 mRNA CTD PMID:16507785 NCBI chr 5:65,211,632...65,244,532
Ensembl chr 5:65,211,358...65,244,665 		JBrowse link
G Ndnf neuron-derived neurotrophic factor increases expression EXP Mercuric Chloride results in increased expression of NDNF mRNA CTD PMID:32599119 NCBI chr 4:96,274,147...96,311,624
Ensembl chr 4:96,274,147...96,311,624 		JBrowse link
G Ndrg3 NDRG family member 3 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDRG3 mRNA CTD PMID:27188386 NCBI chr 3:166,007,556...166,070,981
Ensembl chr 3:165,890,091...166,049,887 		JBrowse link
G Nefm neurofilament medium chain increases expression EXP Mercuric Chloride results in increased expression of NEFM mRNA CTD PMID:16507785 NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163 		JBrowse link
G Neurl2 neuralized E3 ubiquitin protein ligase 2 decreases expression EXP Mercuric Chloride results in decreased expression of NEURL2 mRNA CTD PMID:16507785 NCBI chr 3:173,985,996...173,988,717
Ensembl chr 3:173,986,857...173,989,043 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
decreases expression
affects localization
increases expression
affects response to substance 		ISO
EXP 		[Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein; Acetylcysteine inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]]; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein]; Mercuric Chloride affects the localization of and results in increased stability of NFE2L2 protein; Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]; NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased activity of NQO1 protein]; NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased expression of NQO1 mRNA]; sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]]; sodium selenide inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein]; Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein]
Mercuric Chloride results in decreased expression of NFE2L2 protein
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of NFE2L2 mRNA; [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of NFE2L2 protein; [Sodium Selenite co-treated with zinc chloride] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of NFE2L2 protein]; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of NFE2L2 mRNA]; Curcumin promotes the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of NFE2L2 protein]
Mercuric Chloride results in decreased expression of NFE2L2 mRNA
[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Mercuric Chloride 		CTD PMID:17959236 PMID:19303893 PMID:21843634 PMID:23202902 PMID:24816296 More... NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfia nuclear factor I/A decreases expression EXP Mercuric Chloride results in decreased expression of NFIA mRNA CTD PMID:16507785 NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions
increases expression 		ISO
EXP 		Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased activity of [RELA protein binds to NFKB1 protein]]; Mercuric Chloride inhibits the reaction [TNF results in increased activity of [RELA protein binds to NFKB1 protein]]
Mercuric Chloride results in increased expression of NFKB1 mRNA
carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of NFKB1 mRNA]; Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased activity of [RELA protein binds to NFKB1 protein]]; Mercuric Chloride inhibits the reaction [TNF results in increased activity of [RELA protein binds to NFKB1 protein]]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of NFKB1 mRNA] 		CTD PMID:12426138 PMID:39096083 PMID:39105374 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkbia NFKB inhibitor alpha decreases expression
multiple interactions 		EXP Mercuric Chloride results in decreased expression of NFKBIA mRNA
carvacrol inhibits the reaction [Mercuric Chloride results in decreased expression of NFKBIA mRNA] 		CTD PMID:39105374 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nipsnap1 nipsnap homolog 1 decreases expression ISO Mercuric Chloride results in decreased expression of NIPSNAP1 mRNA CTD PMID:27188386 NCBI chr14:83,957,714...83,981,579
Ensembl chr14:83,957,702...83,981,576 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases expression 		ISO
EXP 		N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [Mercuric Chloride results in increased expression of NLRP3 mRNA]
carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of NLRP3 mRNA] 		CTD PMID:25237059 PMID:39105374 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 decreases expression EXP Mercuric Chloride results in decreased expression of NME4 mRNA CTD PMID:16507785 NCBI chr10:15,619,106...15,622,961
Ensembl chr10:15,619,106...15,623,098 		JBrowse link
G Nog noggin multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AMACR mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICDL1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHD3 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRTAP1-5 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LST1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPATA6L mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPSG1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C1ORF53 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEP128 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DBT mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF12L2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GABRB3 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLM mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDSR mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L2HGDH mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LARP4 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD4 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ME1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIGA1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDRG3 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIR mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF32 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN5 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLA2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VIRMA mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XIAP mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF814 mRNA CTD PMID:27188386 NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103 		JBrowse link
G Nop58 NOP58 ribonucleoprotein increases expression EXP Mercuric Chloride results in increased expression of NOP58 mRNA CTD PMID:16507785 NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909 		JBrowse link
G Nos1 nitric oxide synthase 1 decreases expression
decreases phosphorylation 		EXP Mercuric Chloride results in decreased expression of NOS1 mRNA; Mercuric Chloride results in decreased expression of NOS1 protein
Mercuric Chloride results in decreased phosphorylation of NOS1 protein 		CTD PMID:12460744 PMID:21554244 NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
affects expression
increases expression 		ISO
EXP 		[Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NOS2 mRNA]; Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NOS2 protein]; Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]
Mercuric Chloride analog affects the expression of NOS2 mRNA
candesartan cilexetil inhibits the reaction [Mercuric Chloride results in increased expression of NOS2 mRNA]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of NOS2 mRNA]; Melatonin affects the reaction [Mercuric Chloride results in increased expression of NOS2 protein]; pimagedine inhibits the reaction [Mercuric Chloride results in increased expression of NOS2 mRNA]; pimagedine inhibits the reaction [Mercuric Chloride results in increased expression of NOS2 protein]
Mercuric Chloride results in increased expression of NOS2 mRNA; Mercuric Chloride results in increased expression of NOS2 protein 		CTD PMID:9810145 PMID:9853001 PMID:12175822 PMID:16801527 PMID:18441258 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nos3 nitric oxide synthase 3 decreases expression EXP Mercuric Chloride results in decreased expression of NOS3 mRNA; Mercuric Chloride results in decreased expression of NOS3 protein CTD PMID:9788586 PMID:9853001 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions
decreases expression
increases expression 		EXP celecoxib inhibits the reaction [Mercuric Chloride results in increased expression of NOX1 mRNA]; rofecoxib inhibits the reaction [Mercuric Chloride results in increased expression of NOX1 mRNA]; SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of NOX1 mRNA]; U 0126 inhibits the reaction [Mercuric Chloride results in increased expression of NOX1 mRNA]
Mercuric Chloride results in decreased expression of NOX1 protein 		CTD PMID:21232032 PMID:23415682 PMID:28987480 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nox4 NADPH oxidase 4 increases expression
multiple interactions 		EXP
ISO 		Mercuric Chloride results in increased expression of NOX4 mRNA
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of NOX4 protein
Peptides inhibits the reaction [Mercuric Chloride results in increased expression of NOX4 mRNA] 		CTD PMID:21232032 PMID:28987480 PMID:30359721 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Nphs1 NPHS1 adhesion molecule, nephrin multiple interactions
decreases expression 		EXP Mercuric Chloride promotes the reaction [Puromycin Aminonucleoside results in decreased expression of NPHS1 protein]; Puromycin Aminonucleoside promotes the reaction [Mercuric Chloride results in decreased expression of NPHS1 mRNA] CTD PMID:11012881 NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521 		JBrowse link
G Nploc4 NPL4 homolog, ubiquitin recognition factor increases expression EXP Mercuric Chloride results in increased expression of NPL4 mRNA CTD PMID:16507785 NCBI chr10:106,152,756...106,208,306
Ensembl chr10:106,153,173...106,208,264 		JBrowse link
G Nppa natriuretic peptide A increases expression ISO Mercuric Chloride results in increased expression of NPPA mRNA CTD PMID:24472606 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nppb natriuretic peptide B increases expression ISO Mercuric Chloride results in increased expression of NPPB mRNA CTD PMID:24472606 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 increases expression EXP Mercuric Chloride results in increased expression of NPY1R mRNA CTD PMID:16507785 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression
increases expression
increases activity 		ISO [Dimercaprol co-treated with Mercuric Chloride] results in increased activity of NQO1 protein
Mercuric Chloride results in decreased expression of NQO1 protein
Mercuric Chloride results in increased expression of NQO1 mRNA
Mercuric Chloride results in decreased expression of NQO1 mRNA; Mercuric Chloride results in decreased expression of NQO1 protein
[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NQO1 mRNA; Mercuric Chloride promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; Mercuric Chloride promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Mercuric Chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]; Mercuric Chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Mercuric Chloride results in increased expression of and results in increased activity of NQO1 protein; NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased activity of NQO1 protein]; NFE2L2 mRNA affects the reaction [Mercuric Chloride results in increased expression of NQO1 mRNA] 		CTD PMID:18838692 PMID:21843634 PMID:23202902 PMID:26272509 PMID:27188386 More... NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 increases expression EXP Mercuric Chloride results in increased expression of NR1D2 mRNA CTD PMID:16507785 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 decreases expression EXP Mercuric Chloride results in decreased expression of NR1I2 mRNA CTD PMID:16507785 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions EXP Dithiothreitol inhibits the reaction [Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein]]; Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein] CTD PMID:15250541 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nt5e 5' nucleotidase, ecto decreases activity EXP Mercuric Chloride results in decreased activity of NT5E protein CTD PMID:22416658 NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645 		JBrowse link
G Ntf3 neurotrophin 3 decreases expression EXP Mercuric Chloride results in decreased expression of NTF3 mRNA CTD PMID:16507785 NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:160,600,770...160,676,349 		JBrowse link
G Nudt16l1 nudix hydrolase 16 like 1 decreases expression EXP Mercuric Chloride results in decreased expression of NUDT16L1 mRNA CTD PMID:16507785 NCBI chr10:11,142,626...11,144,542
Ensembl chr10:11,142,627...11,144,764 		JBrowse link
G Odf2 outer dense fiber of sperm tails 2 increases expression EXP Mercuric Chloride results in increased expression of ODF2 mRNA CTD PMID:32599119 NCBI chr 3:33,557,738...33,605,076
Ensembl chr 3:33,558,832...33,605,076 		JBrowse link
G Olfml1 olfactomedin-like 1 decreases expression EXP Mercuric Chloride results in decreased expression of OLFML1 mRNA CTD PMID:16507785 NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762 		JBrowse link
G Ormdl1 ORMDL sphingolipid biosynthesis regulator 1 decreases expression ISO Mercuric Chloride results in decreased expression of ORMDL1 mRNA CTD PMID:27188386 NCBI chr 9:55,735,081...55,745,287
Ensembl chr 9:55,735,097...55,745,340 		JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 increases expression EXP Mercuric Chloride results in increased expression of OSGIN1 mRNA CTD PMID:16507785 NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162 		JBrowse link
G Osr1 odd-skipped related transcription factor 1 increases expression EXP Mercuric Chloride results in increased expression of OSR1 mRNA CTD PMID:16507785 NCBI chr 6:38,088,688...38,100,010
Ensembl chr 6:38,093,011...38,100,021 		JBrowse link
G P2rx2 purinergic receptor P2X 2 multiple interactions EXP Mercuric Chloride promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] CTD PMID:16190872 NCBI chr12:51,999,107...52,002,627
Ensembl chr12:51,999,372...52,002,627 		JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 increases expression EXP Mercuric Chloride results in increased expression of P4HA1 mRNA CTD PMID:16507785 NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404 		JBrowse link
G Parg poly (ADP-ribose) glycohydrolase decreases expression ISO Mercuric Chloride results in decreased expression of PARG mRNA CTD PMID:24118919 NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage
multiple interactions 		ISO Mercuric Chloride results in increased cleavage of PARP1 protein
[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of PARP1 protein] 		CTD PMID:11068922 PMID:12504520 PMID:12505371 PMID:22909951 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Patj PATJ, crumbs cell polarity complex component decreases expression ISO Mercuric Chloride results in decreased expression of PATJ mRNA CTD PMID:27188386 NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:118,177,565...118,480,301 		JBrowse link
G Pcnp PEST proteolytic signal containing nuclear protein decreases expression ISO Mercuric Chloride results in decreased expression of PCNP mRNA CTD PMID:27188386 NCBI chr11:58,061,885...58,076,436
Ensembl chr11:58,061,570...58,076,436 		JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 increases expression ISO Mercuric Chloride results in increased expression of PCSK6 mRNA CTD PMID:27188386 NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128 		JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 decreases expression EXP Mercuric Chloride results in decreased expression of PCSK9 mRNA CTD PMID:32599119 NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507 		JBrowse link
G Pdk2 pyruvate dehydrogenase kinase 2 decreases expression EXP Mercuric Chloride results in decreased expression of PDK2 mRNA CTD PMID:16507785 NCBI chr10:80,469,388...80,483,988
Ensembl chr10:80,469,389...80,484,355 		JBrowse link
G Pdzd2 PDZ domain containing 2 decreases expression EXP Mercuric Chloride results in decreased expression of PDZD2 mRNA CTD PMID:16507785 NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478 		JBrowse link
G Pdzd7 PDZ domain containing 7 decreases expression ISO Mercuric Chloride results in decreased expression of PDZD7 mRNA CTD PMID:27188386 NCBI chr 1:253,837,454...253,856,919
Ensembl chr 1:253,837,459...253,855,999 		JBrowse link
G Pdzd8 PDZ domain containing 8 increases expression EXP Mercuric Chloride results in increased expression of PDZD8 mRNA CTD PMID:16507785 NCBI chr 1:268,435,304...268,492,923
Ensembl chr 1:268,435,304...268,492,913 		JBrowse link
G Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 increases expression EXP Mercuric Chloride results in increased expression of PFKFB3 mRNA CTD PMID:16507785 NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052 		JBrowse link
G Pgr progesterone receptor multiple interactions
increases expression 		ISO Estradiol promotes the reaction [Mercuric Chloride results in increased expression of PGR mRNA]; Estradiol promotes the reaction [Mercuric Chloride results in increased expression of PGR protein]; fulvestrant inhibits the reaction [Mercuric Chloride results in increased expression of PGR mRNA]; fulvestrant inhibits the reaction [Mercuric Chloride results in increased expression of PGR protein]; Mercuric Chloride promotes the reaction [Estradiol results in increased expression of PGR mRNA]; Mercuric Chloride promotes the reaction [Estradiol results in increased expression of PGR protein]
Mercuric Chloride results in increased expression of PGR mRNA; Mercuric Chloride results in increased expression of PGR protein 		CTD PMID:12746304 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pias2 protein inhibitor of activated STAT, 2 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA CTD PMID:27188386 NCBI chr18:72,883,008...72,989,486
Ensembl chr18:72,882,890...73,006,662 		JBrowse link
G Pip4p2 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 increases expression EXP Mercuric Chloride results in increased expression of PIP4P2 mRNA CTD PMID:16507785 NCBI chr 5:33,057,046...33,104,448
Ensembl chr 5:33,056,684...33,104,451 		JBrowse link
G Pir pirin increases expression
multiple interactions 		ISO Mercuric Chloride results in increased expression of PIR mRNA
[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIR mRNA 		CTD PMID:27188386 NCBI chr  X:33,740,428...33,851,049
Ensembl chr  X:33,740,429...33,851,049 		JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions ISO Mercuric Chloride results in increased expression of and results in increased secretion of PKM protein CTD PMID:24980261 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Plekha5 pleckstrin homology domain containing A5 decreases expression ISO Mercuric Chloride results in decreased expression of PLEKHA5 mRNA CTD PMID:27188386 NCBI chr 4:175,065,011...175,234,672
Ensembl chr 4:175,065,183...175,234,672 		JBrowse link
G Plk2 polo-like kinase 2 increases expression EXP Mercuric Chloride results in increased expression of PLK2 mRNA CTD PMID:16507785 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Pln phospholamban decreases phosphorylation
increases expression 		EXP Mercuric Chloride results in decreased phosphorylation of PLN protein
Mercuric Chloride results in increased expression of PLN protein 		CTD PMID:21723307 NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241 		JBrowse link
G Pm20d2 peptidase M20 domain containing 2 decreases expression EXP Mercuric Chloride results in decreased expression of PM20D2 mRNA CTD PMID:16507785 NCBI chr 5:52,362,384...52,382,647
Ensembl chr 5:52,362,392...52,382,532 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO Mercuric Chloride results in increased expression of PMAIP1 mRNA CTD PMID:20713136 NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pnkd PNKD metallo-beta-lactamase domain containing decreases expression EXP Mercuric Chloride results in decreased expression of PNKD mRNA CTD PMID:16507785 NCBI chr 9:83,317,757...83,386,263
Ensembl chr 9:83,317,738...83,386,262 		JBrowse link
G Ppan peter pan homolog increases expression EXP Mercuric Chloride results in increased expression of PPAN mRNA CTD PMID:16507785 NCBI chr 8:27,700,147...27,704,127
Ensembl chr 8:27,700,152...27,704,128 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression
increases expression 		ISO
EXP 		Mercuric Chloride results in decreased expression of PPARA mRNA
Mercuric Chloride results in increased expression of PPARA mRNA 		CTD PMID:22019852 PMID:30807803 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma decreases expression
increases expression 		ISO
EXP 		Mercuric Chloride results in decreased expression of PPARG mRNA; Mercuric Chloride results in decreased expression of PPARG protein
Mercuric Chloride results in increased expression of PPARG mRNA 		CTD PMID:12883084 PMID:22019852 PMID:30807803 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression EXP Mercuric Chloride results in increased expression of PPP1R15A mRNA CTD PMID:16507785 NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774 		JBrowse link
G Pprc1 PPARG related coactivator 1 increases expression EXP Mercuric Chloride results in increased expression of PPRC1 mRNA CTD PMID:16507785 NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 increases expression EXP Mercuric Chloride results in increased expression of PRKAA1 mRNA CTD PMID:16507785 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450 		JBrowse link
G Prkaa2 protein kinase AMP-activated catalytic subunit alpha 2 decreases expression ISO Mercuric Chloride results in decreased expression of PRKAA2 mRNA CTD PMID:22019852 NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324 		JBrowse link
G Prkrip1 PRKR interacting protein 1 decreases expression ISO Mercuric Chloride results in decreased expression of PRKRIP1 mRNA CTD PMID:27188386 NCBI chr12:26,107,422...26,128,404
Ensembl chr12:26,107,398...26,130,026 		JBrowse link
G Prph peripherin increases expression EXP Mercuric Chloride results in increased expression of PRPH mRNA CTD PMID:16507785 NCBI chr 7:132,096,888...132,101,070
Ensembl chr 7:132,097,285...132,101,068 		JBrowse link
G Pten phosphatase and tensin homolog decreases expression ISO Mercuric Chloride results in decreased expression of PTEN mRNA CTD PMID:27188386 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptges3 prostaglandin E synthase 3 increases expression EXP Mercuric Chloride results in increased expression of PTGES3 mRNA CTD PMID:16507785 NCBI chr 7:1,075,230...1,092,363
Ensembl chr 7:1,075,227...1,092,695 		JBrowse link
G Ptgr1 prostaglandin reductase 1 increases expression ISO Mercuric Chloride results in increased expression of PTGR1 mRNA CTD PMID:38568856 NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		EXP acetovanillone inhibits the reaction [Mercuric Chloride results in increased expression of PTGS2 mRNA]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of PTGS2 mRNA]; SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of PTGS2 mRNA]; tempol inhibits the reaction [Mercuric Chloride results in increased expression of PTGS2 mRNA]; U 0126 inhibits the reaction [Mercuric Chloride results in increased expression of PTGS2 mRNA]
Mercuric Chloride results in increased expression of PTGS2 mRNA; Mercuric Chloride results in increased expression of PTGS2 protein 		CTD PMID:20228412 PMID:23415682 PMID:28987480 PMID:39105374 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Pth1r parathyroid hormone 1 receptor decreases expression EXP Mercuric Chloride results in decreased expression of PTH1R mRNA CTD PMID:16507785 NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:119,575,868...119,598,108 		JBrowse link
G Pthlh parathyroid hormone-like hormone increases expression EXP Mercuric Chloride results in increased expression of PTHLH mRNA CTD PMID:16507785 NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:181,919,400...181,930,454 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression EXP Mercuric Chloride results in increased expression of PTP4A1 mRNA CTD PMID:16507785 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptpn12 protein tyrosine phosphatase, non-receptor type 12 decreases expression ISO Mercuric Chloride results in decreased expression of PTPN12 mRNA CTD PMID:27188386 NCBI chr 4:14,913,071...14,985,084
Ensembl chr 4:14,913,218...14,985,284 		JBrowse link
G Pvr PVR cell adhesion molecule increases expression EXP Mercuric Chloride results in increased expression of PVR mRNA CTD PMID:16507785 NCBI chr 1:88,689,235...88,704,641
Ensembl chr 1:88,688,981...88,704,630 		JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 decreases expression EXP Mercuric Chloride results in decreased expression of RAB11FIP3 mRNA CTD PMID:16507785 NCBI chr10:15,507,151...15,591,173
Ensembl chr10:15,507,151...15,591,173 		JBrowse link
G Rab2a RAB2A, member RAS oncogene family decreases expression ISO Mercuric Chloride results in decreased expression of RAB2A mRNA CTD PMID:27188386 NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488 		JBrowse link
G Rac1 Rac family small GTPase 1 decreases expression EXP Mercuric Chloride results in decreased expression of RAC1 protein CTD PMID:22223485 NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109 		JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression EXP Mercuric Chloride results in decreased expression of RANBP1 mRNA CTD PMID:16507785 NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145 		JBrowse link
G Rapgef1 Rap guanine nucleotide exchange factor 1 increases phosphorylation ISO Mercuric Chloride results in increased phosphorylation of RAPGEF1 protein CTD PMID:14551197 NCBI chr 3:33,296,211...33,414,119
Ensembl chr 3:33,296,230...33,414,119 		JBrowse link
G Rbak RB-associated KRAB zinc finger decreases expression ISO Mercuric Chloride results in decreased expression of RBAK mRNA CTD PMID:27188386 NCBI chr12:16,488,895...16,502,523
Ensembl chr12:16,488,950...16,502,733 		JBrowse link
G Rbm15 RNA binding motif protein 15 increases expression EXP Mercuric Chloride results in increased expression of RBM15 mRNA CTD PMID:16507785 NCBI chr 2:197,634,174...197,642,697
Ensembl chr 2:197,583,002...197,643,037 		JBrowse link
G Rbm39 RNA binding motif protein 39 decreases expression ISO Mercuric Chloride results in decreased expression of RBM39 mRNA CTD PMID:27188386 NCBI chr 3:165,123,087...165,156,453
Ensembl chr 3:165,123,095...165,149,397 		JBrowse link
G Rc3h2 ring finger and CCCH-type domains 2 increases expression EXP Mercuric Chloride results in increased expression of RC3H2 mRNA CTD PMID:32599119 NCBI chr 3:41,531,319...41,596,496
Ensembl chr 3:41,531,617...41,589,715 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO
EXP 		Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of RELA protein]
Mercuric Chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased activity of [RELA protein binds to NFKB1 protein]]; Mercuric Chloride inhibits the reaction [TNF results in increased activity of [RELA protein binds to NFKB1 protein]] 		CTD PMID:12175822 PMID:12426138 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rfx4 regulatory factor X4 decreases expression EXP Mercuric Chloride results in decreased expression of RFX4 mRNA CTD PMID:32599119 NCBI chr 7:20,740,760...20,903,355
Ensembl chr 7:20,741,079...20,902,851 		JBrowse link
G Rhoa ras homolog family member A decreases response to substance EXP RHOA protein results in decreased susceptibility to Mercuric Chloride CTD PMID:22223485 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Riok3 RIO kinase 3 increases expression EXP Mercuric Chloride results in increased expression of RIOK3 mRNA CTD PMID:16507785 NCBI chr18:3,602,535...3,628,108
Ensembl chr18:3,602,535...3,628,108 		JBrowse link
G Rnd3 Rho family GTPase 3 increases expression EXP Mercuric Chloride results in increased expression of RND3 mRNA CTD PMID:16507785 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536 		JBrowse link
G Rnf32 ring finger protein 32 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF32 mRNA CTD PMID:27188386 NCBI chr 4:6,822,700...6,884,411
Ensembl chr 4:6,824,970...6,883,976 		JBrowse link
G Rpgr retinitis pigmentosa GTPase regulator affects response to substance ISO RPGR gene SNP affects the susceptibility to Mercuric Chloride CTD PMID:25622337 NCBI chr  X:15,238,961...15,299,004
Ensembl chr  X:15,239,159...15,298,999 		JBrowse link
G Rrp12 ribosomal RNA processing 12 increases expression EXP Mercuric Chloride results in increased expression of RRP12 mRNA CTD PMID:16507785 NCBI chr 1:250,621,707...250,655,318
Ensembl chr 1:250,621,707...250,655,318 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 multiple interactions ISO [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of RSAD2 mRNA CTD PMID:28453771 NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320 		JBrowse link
G RT1-Ba RT1 class II, locus Ba increases expression EXP Mercuric Chloride results in increased expression of RT1-BA protein CTD PMID:9536116 NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653 		JBrowse link
G RT1-Da RT1 class II, locus Da increases expression EXP Mercuric Chloride results in increased expression of RT1-DA protein CTD PMID:9536116 NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,513,908...4,520,383 		JBrowse link
G Rxrg retinoid X receptor gamma decreases expression EXP Mercuric Chloride results in decreased expression of RXRG mRNA CTD PMID:16507785 NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095 		JBrowse link
G Ryr2 ryanodine receptor 2 decreases expression EXP Mercuric Chloride results in decreased expression of RYR2 mRNA CTD PMID:32599119 NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705 		JBrowse link
G S100a8 S100 calcium binding protein A8 decreases expression ISO Mercuric Chloride results in decreased expression of S100A8 mRNA CTD PMID:38568856 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221 		JBrowse link
G S100a9 S100 calcium binding protein A9 increases expression
decreases expression 		EXP
ISO 		Mercuric Chloride results in increased expression of S100A9 mRNA
Mercuric Chloride results in decreased expression of S100A9 mRNA 		CTD PMID:16507785 PMID:38568856 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870 		JBrowse link
G Sars1 seryl-tRNA synthetase 1 increases expression EXP Mercuric Chloride results in increased expression of SARS1 mRNA CTD PMID:16507785 NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha increases expression EXP Mercuric Chloride results in increased expression of SCNN1A protein CTD PMID:16189294 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405 		JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta affects expression EXP Mercuric Chloride affects the expression of SCNN1B protein CTD PMID:16189294 NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049 		JBrowse link
G Scnn1g sodium channel epithelial 1 subunit gamma affects expression EXP Mercuric Chloride affects the expression of SCNN1G protein CTD PMID:16189294 NCBI chr 1:185,736,225...185,770,099
Ensembl chr 1:185,736,191...185,770,097 		JBrowse link
G Sdcbp syndecan binding protein increases expression EXP Mercuric Chloride results in increased expression of SDCBP mRNA CTD PMID:16507785 NCBI chr 5:24,245,279...24,314,712
Ensembl chr 5:24,245,033...24,326,197 		JBrowse link
G Sel1l SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO Mercuric Chloride results in decreased expression of SEL1L mRNA CTD PMID:27188386 NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:116,466,163...116,510,578 		JBrowse link
G Selenow selenoprotein W decreases expression ISO Mercuric Chloride results in decreased expression of SELENOW mRNA CTD PMID:27188386 PMID:38568856 NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703 		JBrowse link
G Serpine1 serpin family E member 1 increases expression
multiple interactions 		EXP
ISO 		Mercuric Chloride results in increased expression of SERPINE1 mRNA; Mercuric Chloride results in increased expression of SERPINE1 protein
Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of SERPINE1 protein] 		CTD PMID:11817102 PMID:14620542 PMID:38568856 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sesn1 sestrin 1 decreases expression EXP Mercuric Chloride results in decreased expression of SESN1 mRNA CTD PMID:16507785 NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010 		JBrowse link
G Setx senataxin decreases expression ISO Mercuric Chloride results in decreased expression of SETX mRNA CTD PMID:27188386 NCBI chr 3:32,825,771...32,878,740
Ensembl chr 3:32,828,412...32,878,740 		JBrowse link
G Sfxn5 sideroflexin 5 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN5 mRNA CTD PMID:27188386 NCBI chr 4:119,307,692...119,427,531
Ensembl chr 4:119,308,386...119,427,259 		JBrowse link
G Sh3pxd2b SH3 and PX domains 2B decreases expression EXP Mercuric Chloride results in decreased expression of SH3PXD2B mRNA CTD PMID:16507785 NCBI chr10:17,422,906...17,538,977
Ensembl chr10:17,422,947...17,512,854 		JBrowse link
G Sik1 salt-inducible kinase 1 increases expression EXP Mercuric Chloride results in increased expression of SIK1 mRNA CTD PMID:16507785 NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,105...9,958,698 		JBrowse link
G Simc1 SUMO-interacting motifs containing 1 increases expression EXP Mercuric Chloride results in increased expression of SIMC1 mRNA CTD PMID:16507785 NCBI chr17:10,066,855...10,112,010
Ensembl chr17:10,066,855...10,120,237 		JBrowse link
G Sla2 Src-like-adaptor 2 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLA2 mRNA CTD PMID:27188386 NCBI chr 3:165,821,164...165,848,087
Ensembl chr 3:165,828,657...165,847,062 		JBrowse link
G Slc12a1 solute carrier family 12 member 1 decreases expression EXP Mercuric Chloride results in decreased expression of SLC12A1 protein CTD PMID:16189294 NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340 		JBrowse link
G Slc12a3 solute carrier family 12 member 3 decreases expression EXP Mercuric Chloride results in decreased expression of SLC12A3 protein CTD PMID:16189294 NCBI chr19:10,636,594...10,690,008
Ensembl chr19:10,636,596...10,675,050 		JBrowse link
G Slc13a2 solute carrier family 13 member 2 increases secretion EXP Mercuric Chloride results in increased secretion of SLC13A2 protein CTD PMID:20407758 NCBI chr10:63,789,874...63,817,441
Ensembl chr10:63,789,876...63,817,184 		JBrowse link
G Slc15a1 solute carrier family 15 member 1 decreases expression ISO Mercuric Chloride results in decreased expression of SLC15A1 mRNA CTD PMID:31175882 NCBI chr15:104,944,461...104,991,316
Ensembl chr15:104,944,463...104,989,369 		JBrowse link
G Slc16a6 solute carrier family 16, member 6 decreases expression EXP Mercuric Chloride results in decreased expression of SLC16A6 mRNA CTD PMID:16507785 NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,923,888...94,947,965 		JBrowse link
G Slc19a3 solute carrier family 19 member 3 decreases expression EXP Mercuric Chloride results in decreased expression of SLC19A3 mRNA CTD PMID:16507785 NCBI chr 9:91,723,799...91,747,499
Ensembl chr 9:91,724,718...91,754,991 		JBrowse link
G Slc20a1 solute carrier family 20 member 1 increases expression EXP Mercuric Chloride results in increased expression of SLC20A1 mRNA CTD PMID:16507785 NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions
decreases expression
decreases activity 		ISO
EXP 		[Mercuric Chloride results in decreased activity of SLC22A2 protein] which results in decreased uptake of Tetraethylammonium
Mercuric Chloride results in decreased expression of SLC22A2 mRNA 		CTD PMID:17287197 PMID:28536007 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a25 solute carrier family 22, member 25 decreases expression
increases secretion 		EXP Mercuric Chloride results in decreased expression of SLC22A9 mRNA; Mercuric Chloride results in decreased expression of SLC22A9 protein
Mercuric Chloride results in increased secretion of SLC22A9 protein 		CTD PMID:20407758 NCBI chr 1:214,767,837...214,956,535
Ensembl chr 1:214,767,837...214,862,340 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 increases expression EXP Mercuric Chloride results in increased expression of SLC22A3 mRNA CTD PMID:28536007 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slc22a5 solute carrier family 22 member 5 decreases expression
decreases transport
multiple interactions 		EXP Mercuric Chloride results in decreased expression of SLC22A5 mRNA
Mercuric Chloride results in decreased transport of SLC22A5 protein
Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein]; Cysteine inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein]; Dithioerythritol inhibits the reaction [Mercuric Chloride results in decreased transport of SLC22A5 protein] 		CTD PMID:16507785 PMID:22900493 NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases expression
increases expression 		EXP
ISO 		Mercuric Chloride results in decreased expression of SLC22A6 mRNA
Mercuric Chloride results in increased expression of SLC22A6 protein 		CTD PMID:16507785 PMID:26788513 PMID:28536007 PMID:30031051 NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions
increases expression
decreases expression 		EXP
ISO 		Mercuric Chloride results in decreased expression of and affects the localization of SLC22A8 protein
Mercuric Chloride results in increased expression of SLC22A8 protein
Mercuric Chloride results in decreased expression of SLC22A8 mRNA 		CTD PMID:19533102 PMID:26788513 PMID:27720909 PMID:30031051 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588 		JBrowse link
G Slc24a3 solute carrier family 24 member 3 decreases expression EXP Mercuric Chloride results in decreased expression of SLC24A3 mRNA CTD PMID:32599119 NCBI chr 3:153,005,418...153,504,497
Ensembl chr 3:153,004,987...153,504,497 		JBrowse link
G Slc25a1 solute carrier family 25 member 1 decreases expression EXP Mercuric Chloride results in decreased expression of SLC25A1 mRNA CTD PMID:16507785 NCBI chr11:96,560,054...96,563,071
Ensembl chr11:96,560,041...96,565,052 		JBrowse link
G Slc25a20 solute carrier family 25 member 20 multiple interactions
decreases activity 		ISO Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of SLC25A20 protein]; Dithioerythritol inhibits the reaction [Mercuric Chloride results in decreased activity of SLC25A20 protein]; Glutathione inhibits the reaction [Mercuric Chloride results in decreased activity of SLC25A20 protein] CTD PMID:25849418 NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027 		JBrowse link
G Slc25a25 solute carrier family 25 member 25 increases expression EXP Mercuric Chloride results in increased expression of SLC25A25 mRNA CTD PMID:16507785 NCBI chr 3:36,106,448...36,139,812
Ensembl chr 3:36,106,449...36,140,011 		JBrowse link
G Slc25a33 solute carrier family 25 member 33 increases expression EXP Mercuric Chloride results in increased expression of SLC25A33 mRNA CTD PMID:16507785 NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:165,478,072...165,502,973 		JBrowse link
G Slc25a36 solute carrier family 25 member 36 decreases expression ISO Mercuric Chloride results in decreased expression of SLC25A36 mRNA CTD PMID:27188386 NCBI chr 8:106,539,355...106,573,240 JBrowse link
G Slc28a1 solute carrier family 28 member 1 decreases expression EXP Mercuric Chloride results in decreased expression of SLC28A1 mRNA CTD PMID:16507785 NCBI chr 1:144,490,453...144,532,025
Ensembl chr 1:144,490,623...144,531,544 		JBrowse link
G Slc29a1 solute carrier family 29 member 1 increases expression ISO Mercuric Chloride results in increased expression of SLC29A1 mRNA CTD PMID:31175882 NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620 		JBrowse link
G Slc29a3 solute carrier family 29 member 3 decreases expression EXP Mercuric Chloride results in decreased expression of SLC29A3 mRNA CTD PMID:16507785 NCBI chr20:29,191,086...29,228,299
Ensembl chr20:29,191,127...29,228,299 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions EXP Mercuric Chloride inhibits the reaction [Cytochalasin B binds to SLC2A2 protein]; Mercuric Chloride inhibits the reaction [SLC2A2 protein results in increased uptake of 3-O-Methylglucose] CTD PMID:10825458 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 increases expression EXP Mercuric Chloride results in increased expression of SLC2A3 mRNA CTD PMID:32599119 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 decreases expression ISO Mercuric Chloride results in decreased expression of SLC2A4 protein CTD PMID:12883084 NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 increases expression EXP Mercuric Chloride results in increased expression of SLC30A1 mRNA CTD PMID:16507785 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc30a5 solute carrier family 30 member 5 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA CTD PMID:27188386 NCBI chr 2:33,679,800...33,710,025
Ensembl chr 2:33,679,800...33,712,596 		JBrowse link
G Slc37a4 solute carrier family 37 member 4 decreases expression EXP Mercuric Chloride results in decreased expression of SLC37A4 mRNA CTD PMID:16507785 NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:53,620,141...53,626,110 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 multiple interactions ISO Mercaptoethanol promotes the reaction [Mercuric Chloride inhibits the reaction [SLC3A2 protein results in increased uptake of Amino Acids, Peptides, and Proteins]]; Mercuric Chloride inhibits the reaction [SLC3A2 protein results in increased uptake of Amino Acids, Peptides, and Proteins] CTD PMID:9761775 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064 		JBrowse link
G Slc40a1 solute carrier family 40 member 1 increases expression EXP Mercuric Chloride results in increased expression of SLC40A1 mRNA CTD PMID:16507785 NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460 		JBrowse link
G Slc47a2 solute carrier family 47 member 2 increases expression ISO Mercuric Chloride results in increased expression of SLC47A2 mRNA CTD PMID:27720909 NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425 		JBrowse link
G Slc51b SLC51 subunit beta decreases expression ISO Mercuric Chloride results in decreased expression of SLC51B mRNA CTD PMID:31175882 NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109 		JBrowse link
G Slc6a4 solute carrier family 6 member 4 decreases expression EXP Mercuric Chloride results in decreased expression of SLC6A4 mRNA CTD PMID:16507785 NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056 		JBrowse link
G Slc6a9 solute carrier family 6 member 9 increases expression EXP Mercuric Chloride results in increased expression of SLC6A9 mRNA CTD PMID:16507785 NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO Mercuric Chloride results in increased expression of SLC7A11 mRNA CTD PMID:38568856 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression EXP Mercuric Chloride results in increased expression of SLC7A5 mRNA CTD PMID:16507785 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412 		JBrowse link
G Slc7a7 solute carrier family 7 member 7 decreases expression EXP Mercuric Chloride results in decreased expression of SLC7A7 mRNA CTD PMID:16507785 NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683 		JBrowse link
G Slc7a9 solute carrier family 7 member 9 decreases expression EXP Mercuric Chloride results in decreased expression of SLC7A9 mRNA CTD PMID:16507785 NCBI chr 1:97,246,253...97,269,546
Ensembl chr 1:97,247,547...97,269,543 		JBrowse link
G Slc9a3 solute carrier family 9 member A3 decreases expression
multiple interactions 		EXP Mercuric Chloride results in decreased expression of SLC9A3 protein
Mercuric Chloride results in decreased activity of and results in increased phosphorylation of SLC9A3 protein 		CTD PMID:16189294 PMID:33476711 NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002 		JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 decreases expression EXP Mercuric Chloride results in decreased expression of SLCO1A1 mRNA CTD PMID:28536007 NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992 		JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 decreases expression EXP Mercuric Chloride results in decreased expression of SLCO1A2 mRNA CTD PMID:28536007 NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816 		JBrowse link
G Slco4c1 solute carrier organic anion transporter family, member 4C1 decreases expression ISO
EXP 		Mercuric Chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:27720909 PMID:28536007 NCBI chr 9:104,624,802...104,676,462
Ensembl chr 9:104,624,802...104,676,462 		JBrowse link
G Smtnl2 smoothelin-like 2 decreases expression EXP Mercuric Chloride results in decreased expression of SMTNL2 mRNA CTD PMID:16507785 NCBI chr10:57,506,873...57,528,050
Ensembl chr10:57,506,873...57,528,050 		JBrowse link
G Sncaip synuclein, alpha interacting protein increases expression EXP Mercuric Chloride results in increased expression of SNCAIP mRNA CTD PMID:32599119 NCBI chr18:48,402,164...48,542,246
Ensembl chr18:48,404,531...48,574,002 		JBrowse link
G Sod1 superoxide dismutase 1 increases expression
increases activity 		EXP Mercuric Chloride results in increased expression of SOD1 protein
Mercuric Chloride results in increased activity of SOD1 protein 		CTD PMID:15977196 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 increases activity
decreases expression
multiple interactions
increases expression 		EXP
ISO 		Mercuric Chloride results in increased activity of SOD2 protein
Mercuric Chloride results in decreased expression of SOD2 mRNA
Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of SOD2 mRNA]
Mercuric Chloride results in increased expression of SOD2 protein
Mercuric Chloride results in increased expression of SOD2 mRNA; Mercuric Chloride results in increased expression of SOD2 protein
Dexamethasone inhibits the reaction [Mercuric Chloride results in increased expression of SOD2 protein]; Mercuric Chloride results in decreased activity of and results in increased reduction of SOD2 protein; Mercuric Chloride results in increased expression of and results in increased activity of SOD2 protein 		CTD PMID:9374288 PMID:12111001 PMID:15977196 PMID:21232032 PMID:23415682 More... NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sod3 superoxide dismutase 3 increases expression EXP Mercuric Chloride results in increased expression of SOD3 protein CTD PMID:18599595 PMID:23415682 NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125 		JBrowse link
G Sp1 Sp1 transcription factor increases expression EXP Mercuric Chloride results in increased expression of SP1 mRNA CTD PMID:16507785 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Spata6l spermatogenesis associated 6-like multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPATA6L mRNA CTD PMID:27188386 NCBI chr 1:236,042,960...236,096,530
Ensembl chr 1:236,033,147...236,096,730 		JBrowse link
G Spn sialophorin multiple interactions ISO Mercuric Chloride inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein] CTD PMID:31404653 NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:191,178,096...191,187,852 		JBrowse link
G Spock1 sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 decreases expression EXP Mercuric Chloride results in decreased expression of SPOCK1 mRNA CTD PMID:16507785 NCBI chr17:6,746,892...7,227,034
Ensembl chr17:6,747,646...7,230,282 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions
increases expression 		ISO
EXP 		[Trichloroethylene co-treated with Mercuric Chloride] results in increased expression of SPP1 protein
[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPP1 mRNA
Mercuric Chloride results in increased expression of SPP1 mRNA
Mercuric Chloride results in increased expression of SPP1 mRNA; Mercuric Chloride results in increased expression of SPP1 protein 		CTD PMID:11274264 PMID:21084432 PMID:26272509 PMID:27188386 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 increases expression EXP Mercuric Chloride results in increased expression of SPSB1 mRNA CTD PMID:16507785 NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:165,642,851...165,654,225 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 increases expression EXP Mercuric Chloride results in increased expression of SPTBN1 mRNA CTD PMID:16507785 NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase increases expression ISO Mercuric Chloride results in increased expression of SRC mRNA CTD PMID:37172713 NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462 		JBrowse link
G Srebf2 sterol regulatory element binding transcription factor 2 decreases expression ISO Mercuric Chloride results in decreased expression of SREBF2 mRNA CTD PMID:27188386 NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression EXP Mercuric Chloride results in increased expression of SRXN1 mRNA CTD PMID:16507785 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions 		EXP Mercuric Chloride results in decreased expression of STAR mRNA
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of STAR mRNA] 		CTD PMID:32134168 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Ascorbic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]]; Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]; Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]; Mercuric Chloride inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]; Thioctic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]] CTD PMID:16896058 PMID:19635391 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
increases expression
increases phosphorylation 		ISO
EXP 		Acetylcysteine inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Ascorbic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Glutathione inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]]; Mercuric Chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]; Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]; Thioctic Acid inhibits the reaction [Mercuric Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]]
Mercuric Chloride results in increased expression of STAT3 mRNA
Mercuric Chloride analog results in increased phosphorylation of STAT3 protein; Mercuric Chloride results in increased phosphorylation of STAT3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Mercuric Chloride results in increased phosphorylation of STAT3 protein] 		CTD PMID:16896058 PMID:19635391 PMID:29981841 PMID:37172713 PMID:39105374 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stat6 signal transducer and activator of transcription 6 increases phosphorylation EXP Mercuric Chloride results in increased phosphorylation of STAT6 protein CTD PMID:19604304 NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795 		JBrowse link
G Stbd1 starch binding domain 1 increases expression EXP Mercuric Chloride results in increased expression of STBD1 mRNA CTD PMID:16507785 NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,754,644...15,761,659 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 increases expression EXP Mercuric Chloride results in increased expression of STIP1 mRNA CTD PMID:16507785 NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:213,638,641...213,657,654 		JBrowse link
G Stra6 signaling receptor and transporter of retinol STRA6 decreases expression EXP Mercuric Chloride results in decreased expression of STRA6 mRNA CTD PMID:32599119 NCBI chr 8:67,444,757...67,464,719
Ensembl chr 8:67,444,742...67,464,720 		JBrowse link
G Suox sulfite oxidase decreases expression EXP Mercuric Chloride results in decreased expression of SUOX mRNA CTD PMID:16507785 NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,687,666...1,690,235 		JBrowse link
G Supt16h SPT16 homolog, facilitates chromatin remodeling subunit decreases expression ISO Mercuric Chloride results in decreased expression of SUPT16H mRNA CTD PMID:27188386 NCBI chr15:27,341,196...27,378,314
Ensembl chr15:27,341,196...27,378,314 		JBrowse link
G Susd2 sushi domain containing 2 decreases expression ISO Mercuric Chloride results in decreased expression of SUSD2 mRNA CTD PMID:38568856 NCBI chr20:13,016,960...13,024,264
Ensembl chr20:13,016,907...13,024,264 		JBrowse link
G Syk spleen associated tyrosine kinase multiple interactions ISO Mercuric Chloride promotes the reaction [CD22 protein results in increased phosphorylation of SYK protein] CTD PMID:17656488 NCBI chr17:12,756,493...12,830,927
Ensembl chr17:12,756,493...12,813,278 		JBrowse link
G Syne4 spectrin repeat containing nuclear envelope family member 4 increases expression EXP Mercuric Chloride results in increased expression of SYNE4 mRNA CTD PMID:32599119 NCBI chr 1:94,696,866...94,701,230
Ensembl chr 1:94,696,609...94,701,230 		JBrowse link
G Syt8 synaptotagmin 8 increases expression ISO Mercuric Chloride results in increased expression of SYT8 mRNA CTD PMID:27188386 NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:207,017,461...207,023,076 		JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions ISO Mercuric Chloride promotes the reaction [TAC1 protein results in increased secretion of IL6 protein] CTD PMID:20222982 NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546 		JBrowse link
G Tardbp TAR DNA binding protein increases expression EXP Mercuric Chloride results in increased expression of TARDBP mRNA CTD PMID:16507785 NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204 		JBrowse link
G Tars1 threonyl-tRNA synthetase 1 increases expression EXP Mercuric Chloride results in increased expression of TARS1 mRNA CTD PMID:16507785 NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802 		JBrowse link
G Tf transferrin increases expression EXP Mercuric Chloride results in increased expression of TF protein CTD PMID:21549428 NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400 		JBrowse link
G Tfrc transferrin receptor increases expression ISO Mercuric Chloride results in increased expression of TFRC protein CTD PMID:9693280 NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318 		JBrowse link
G Tgfa transforming growth factor alpha increases expression EXP Mercuric Chloride results in increased expression of TGFA mRNA; Mercuric Chloride results in increased expression of TGFA protein CTD PMID:10901180 NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
decreases activity
increases expression 		EXP
ISO 		Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of TGFB1 protein]
Mercuric Chloride results in decreased activity of TGFB1 protein
Mercuric Chloride results in increased expression of TGFB1 mRNA; Mercuric Chloride results in increased expression of TGFB1 protein 		CTD PMID:10469268 PMID:14620542 PMID:31652400 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 increases expression EXP Mercuric Chloride results in increased expression of TGIF1 mRNA CTD PMID:16507785 NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:118,194,444...118,204,442 		JBrowse link
G Thbs1 thrombospondin 1 increases expression EXP Mercuric Chloride results in increased expression of THBS1 mRNA; Mercuric Chloride results in increased expression of THBS1 protein CTD PMID:16005714 NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402 		JBrowse link
G Thbs4 thrombospondin 4 decreases expression EXP Mercuric Chloride results in decreased expression of THBS4 mRNA CTD PMID:16507785 NCBI chr 2:25,718,219...25,760,345
Ensembl chr 2:25,718,219...25,761,369 		JBrowse link
G Thy1 Thy-1 cell surface antigen multiple interactions ISO Mercuric Chloride promotes the reaction [THY1 protein binds to THY1 protein] CTD PMID:7698341 NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression EXP Mercuric Chloride results in increased expression of TIMP1 mRNA CTD PMID:11817102 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Timp4 TIMP metallopeptidase inhibitor 4 decreases expression EXP Mercuric Chloride results in decreased expression of TIMP4 mRNA CTD PMID:16507785 NCBI chr 4:149,978,667...149,985,350
Ensembl chr 4:149,978,685...149,985,452 		JBrowse link
G Tmem106b transmembrane protein 106B decreases expression ISO Mercuric Chloride results in decreased expression of TMEM106B mRNA CTD PMID:27188386 NCBI chr 4:42,294,074...42,313,426
Ensembl chr 4:42,294,101...42,313,407 		JBrowse link
G Tmem86a transmembrane protein 86A decreases expression EXP Mercuric Chloride results in decreased expression of TMEM86A mRNA CTD PMID:16507785 NCBI chr 1:106,732,168...106,736,518
Ensembl chr 1:106,661,042...106,736,516 		JBrowse link
G Tmtc3 transmembrane O-mannosyltransferase targeting cadherins 3 decreases expression ISO Mercuric Chloride results in decreased expression of TMTC3 mRNA CTD PMID:27188386 NCBI chr 7:37,151,456...37,196,550
Ensembl chr 7:37,151,456...37,196,540 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
affects expression
affects secretion
decreases expression
increases secretion 		ISO
EXP 		Mercuric Chloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Mercuric Chloride inhibits the reaction [TNF results in increased activity of [RELA protein binds to NFKB1 protein]]; Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
Mercuric Chloride results in increased expression of TNF protein
Mercuric Chloride affects the expression of TNF mRNA
Mercuric Chloride affects the secretion of TNF protein; Mercuric Chloride analog affects the secretion of TNF protein
Mercuric Chloride results in decreased expression of TNF protein
[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of TNF protein; Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; CASP1 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA]; IFNG gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA]; IL6 gene mutant form inhibits the reaction [[Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of TNF mRNA]; Mercuric Chloride promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF mRNA]; N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Silymarin inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]
Mercuric Chloride results in increased expression of TNF mRNA; Mercuric Chloride results in increased expression of TNF protein
Mercuric Chloride results in decreased expression of TNF mRNA
[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein; [Sodium Selenite co-treated with zinc chloride] affects the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein]; Berberine inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein]; carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Mercuric Chloride inhibits the reaction [TNF results in increased activity of [RELA protein binds to NFKB1 protein]]; Mycophenolic Acid inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Mycophenolic Acid inhibits the reaction [Mercuric Chloride results in increased secretion of TNF protein]; Pentoxifylline inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of TNF protein]; Sodium Selenite affects the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein]; syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; Tretinoin inhibits the reaction [Mercuric Chloride results in increased expression of TNF mRNA]; zinc chloride inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of TNF protein] 		CTD PMID:7589090 PMID:8560497 PMID:11912253 PMID:12175822 PMID:12426138 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf12a TNF receptor superfamily member 12A increases expression EXP Mercuric Chloride results in increased expression of TNFRSF12A mRNA CTD PMID:16507785 NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704 		JBrowse link
G Tnfrsf4 TNF receptor superfamily member 4 increases expression
multiple interactions 		EXP Mercuric Chloride results in increased expression of TNFRSF4 protein
Mercuric Chloride promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF4 protein]; Staurosporine promotes the reaction [Mercuric Chloride results in increased expression of TNFRSF4 protein] 		CTD PMID:9766631 NCBI chr 5:171,889,134...171,891,824
Ensembl chr 5:171,889,117...171,892,616 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions 		ISO
EXP 		Mercuric Chloride results in increased expression of TRP53 mRNA
carvacrol inhibits the reaction [Mercuric Chloride results in increased expression of TP53 mRNA] 		CTD PMID:23202902 PMID:39105374 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tp53bp1 tumor protein p53 binding protein 1 decreases expression ISO Mercuric Chloride results in decreased expression of TP53BP1 mRNA CTD PMID:27188386 NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747 		JBrowse link
G Tpsg1 tryptase gamma 1 multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPSG1 mRNA CTD PMID:27188386 NCBI chr10:14,889,838...14,895,605
Ensembl chr10:14,890,734...14,894,786 		JBrowse link
G Trdmt1 tRNA aspartic acid methyltransferase 1 decreases expression ISO Mercuric Chloride results in decreased expression of TRDMT1 mRNA CTD PMID:27188386 NCBI chr17:81,510,740...81,554,036
Ensembl chr17:81,521,200...81,577,639 		JBrowse link
G Trib1 tribbles pseudokinase 1 decreases expression EXP Mercuric Chloride results in decreased expression of TRIB1 mRNA CTD PMID:16507785 NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480 		JBrowse link
G Trim5 tripartite motif-containing 5 decreases expression ISO Mercuric Chloride results in decreased expression of TRIM5 mRNA CTD PMID:27188386 NCBI chr 1:168,132,277...168,149,263
Ensembl chr 1:168,132,308...168,141,657 		JBrowse link
G Trpc4 transient receptor potential cation channel, subfamily C, member 4 increases activity
multiple interactions 		ISO Mercuric Chloride results in increased activity of TRPC4 protein
2-aminoethoxydiphenyl borate inhibits the reaction [Mercuric Chloride results in increased activity of TRPC4 protein] 		CTD PMID:21984481 NCBI chr 2:140,457,841...140,629,556
Ensembl chr 2:140,458,296...140,626,969 		JBrowse link
G Trpc5 transient receptor potential cation channel, subfamily C, member 5 multiple interactions
affects response to substance
increases activity 		ISO 2-aminoethoxydiphenyl borate inhibits the reaction [Mercuric Chloride results in increased activity of TRPC5 protein]; Dithiothreitol inhibits the reaction [Mercuric Chloride results in increased activity of TRPC5 protein]
TRPC5 mRNA affects the susceptibility to Mercuric Chloride 		CTD PMID:21984481 NCBI chr  X:112,742,828...113,027,638
Ensembl chr  X:112,742,828...113,027,638 		JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions ISO Mercuric Chloride inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein] CTD PMID:22750002 NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression EXP Mercuric Chloride results in increased expression of TSC22D3 mRNA CTD PMID:16507785 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Tsx testis specific X-linked gene decreases expression EXP Mercuric Chloride results in decreased expression of TSX mRNA CTD PMID:16507785 NCBI chr  X:72,493,147...72,503,653
Ensembl chr  X:72,489,226...72,503,653 		JBrowse link
G Tulp4 TUB like protein 4 decreases expression ISO Mercuric Chloride results in decreased expression of TULP4 mRNA CTD PMID:27188386 NCBI chr 1:49,082,492...49,218,262
Ensembl chr 1:49,087,886...49,218,250 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions
increases oxidation
decreases expression 		ISO Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]; Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of TXN protein]; Mercuric Chloride results in decreased activity of and affects the metabolism of TXN protein; sodium selenide inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]
Mercuric Chloride results in increased oxidation of TXN protein 		CTD PMID:16337887 PMID:17959236 PMID:18321861 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307 		JBrowse link
G Txn2 thioredoxin 2 increases oxidation ISO Mercuric Chloride results in increased oxidation of TXN2 protein CTD PMID:16337887 NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022 		JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions
increases expression
decreases activity 		ISO
EXP 		Mercuric Chloride promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 mRNA]; Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 protein]
Mercuric Chloride results in increased expression of TXNRD1 mRNA; Mercuric Chloride results in increased expression of TXNRD1 protein
[Sodium Selenite co-treated with NADP] inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Dimercaprol inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; dimethyl mercaptosuccinate inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Thioctic Acid inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]; Unithiol inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein] 		CTD PMID:16507785 PMID:17959236 PMID:18321861 PMID:20810785 PMID:24816296 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Txnrd2 thioredoxin reductase 2 decreases activity EXP
ISO 		Mercuric Chloride results in decreased activity of TXNRD2 protein CTD PMID:17157198 PMID:24816296 NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475 		JBrowse link
G U2surp U2 snRNP-associated SURP domain containing decreases expression ISO Mercuric Chloride results in decreased expression of U2SURP mRNA CTD PMID:27188386 NCBI chr 8:104,898,580...104,963,642
Ensembl chr 8:104,898,425...104,955,422 		JBrowse link
G Uba6 ubiquitin-like modifier activating enzyme 6 decreases expression ISO Mercuric Chloride results in decreased expression of UBA6 mRNA CTD PMID:27188386 NCBI chr14:22,238,832...22,302,650
Ensembl chr14:22,211,601...22,302,650 		JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B increases expression EXP Mercuric Chloride results in increased expression of UBE2B mRNA CTD PMID:16507785 NCBI chr10:36,749,365...36,764,335
Ensembl chr10:36,749,369...36,765,587 		JBrowse link
G Ube2z ubiquitin-conjugating enzyme E2Z decreases expression ISO Mercuric Chloride results in decreased expression of UBE2Z mRNA CTD PMID:27188386 NCBI chr10:81,494,522...81,513,641
Ensembl chr10:81,494,523...81,513,641 		JBrowse link
G Ubqln1 ubiquilin 1 increases expression EXP Mercuric Chloride results in increased expression of UBQLN1 mRNA CTD PMID:16507785 NCBI chr17:6,438,456...6,482,498
Ensembl chr17:6,444,124...6,482,499 		JBrowse link
G Ubr4 ubiquitin protein ligase E3 component n-recognin 4 increases expression EXP Mercuric Chloride results in increased expression of UBR4 mRNA CTD PMID:16507785 NCBI chr 5:156,919,029...157,027,127
Ensembl chr 5:156,919,085...157,027,127 		JBrowse link
G Ucp1 uncoupling protein 1 decreases expression EXP Mercuric Chloride results in decreased expression of UCP1 mRNA CTD PMID:32599119 NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420 		JBrowse link
G Ugdh UDP-glucose 6-dehydrogenase increases expression EXP Mercuric Chloride results in increased expression of UGDH mRNA CTD PMID:16507785 NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629 		JBrowse link
G Uggt1 UDP-glucose glycoprotein glucosyltransferase 1 increases expression EXP Mercuric Chloride results in increased expression of UGGT1 mRNA CTD PMID:16507785 NCBI chr 9:45,851,127...45,964,454
Ensembl chr 9:45,854,985...45,964,455 		JBrowse link
G Ugt2b35 UDP glucuronosyltransferase 2 family, polypeptide B35 increases expression EXP Mercuric Chloride results in increased expression of UGT2B35 mRNA CTD PMID:32599119 NCBI chr14:21,208,389...21,245,893
Ensembl chr14:21,208,430...21,246,694 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases expression EXP Mercuric Chloride results in increased expression of UGT2B7 mRNA CTD PMID:16507785 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451 		JBrowse link
G Uhmk1 U2AF homology motif kinase 1 decreases expression ISO Mercuric Chloride results in decreased expression of UHMK1 mRNA CTD PMID:27188386 NCBI chr13:84,929,418...84,949,194
Ensembl chr13:84,922,829...84,949,061 		JBrowse link
G Upp1 uridine phosphorylase 1 increases expression EXP Mercuric Chloride results in increased expression of UPP1 mRNA CTD PMID:16507785 NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034 		JBrowse link
G Usp2 ubiquitin specific peptidase 2 increases expression EXP Mercuric Chloride results in increased expression of USP2 mRNA CTD PMID:16507785 NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794 		JBrowse link
G Usp36 ubiquitin specific peptidase 36 increases expression EXP Mercuric Chloride results in increased expression of USP36 mRNA CTD PMID:16507785 NCBI chr10:103,995,970...104,027,492
Ensembl chr10:103,995,970...104,023,450 		JBrowse link
G Uspl1 ubiquitin specific peptidase like 1 increases expression EXP Mercuric Chloride results in increased expression of USPL1 mRNA CTD PMID:16507785 NCBI chr12:10,859,764...10,886,761
Ensembl chr12:10,859,764...10,886,744 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases expression 		EXP Tretinoin inhibits the reaction [Mercuric Chloride results in increased expression of VCAM1 protein] CTD PMID:17250768 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Virma vir like m6A methyltransferase associated multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VIRMA mRNA CTD PMID:27188386 NCBI chr 5:29,758,529...29,822,030
Ensembl chr 5:29,758,147...29,822,156 		JBrowse link
G Vsnl1 visinin-like 1 decreases expression EXP Mercuric Chloride results in decreased expression of VSNL1 mRNA CTD PMID:16507785 NCBI chr 6:39,757,721...39,878,556
Ensembl chr 6:39,757,722...39,878,556 		JBrowse link
G Wdr43 WD repeat domain 43 increases expression EXP Mercuric Chloride results in increased expression of WDR43 mRNA CTD PMID:16507785 NCBI chr 6:29,565,610...29,604,954
Ensembl chr 6:29,565,610...29,604,954 		JBrowse link
G Wdr59 WD repeat domain 59 decreases expression ISO Mercuric Chloride results in decreased expression of WDR59 mRNA CTD PMID:27188386 NCBI chr19:56,321,529...56,393,195
Ensembl chr19:56,325,438...56,393,132 		JBrowse link
G Wsb1 WD repeat and SOCS box-containing 1 decreases expression ISO Mercuric Chloride results in decreased expression of WSB1 mRNA CTD PMID:27188386 NCBI chr10:64,700,752...64,717,038
Ensembl chr10:64,700,762...64,716,832 		JBrowse link
G Xiap X-linked inhibitor of apoptosis multiple interactions ISO [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of XIAP mRNA CTD PMID:27188386 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:125,737,971...125,803,978 		JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 increases expression EXP Mercuric Chloride results in increased expression of YARS1 mRNA CTD PMID:16507785 NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377 		JBrowse link
G Ylpm1 YLP motif containing 1 decreases expression ISO Mercuric Chloride results in decreased expression of YLPM1 mRNA CTD PMID:27188386 NCBI chr 6:110,373,371...110,449,578
Ensembl chr 6:110,373,686...110,449,578 		JBrowse link
G Ywhag tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma increases expression EXP Mercuric Chloride results in increased expression of YWHAG mRNA CTD PMID:16507785 NCBI chr12:26,381,106...26,409,466
Ensembl chr12:26,380,816...26,409,465 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 increases expression EXP Mercuric Chloride results in increased expression of ZBTB16 mRNA CTD PMID:16507785 NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507 		JBrowse link
G Zeb1 zinc finger E-box binding homeobox 1 increases expression EXP Mercuric Chloride results in increased expression of ZEB1 mRNA CTD PMID:16507785 NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745 		JBrowse link
G Zfp354a zinc finger protein 354A decreases expression EXP Mercuric Chloride results in decreased expression of ZNF354A mRNA CTD PMID:16507785 NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,897,228...35,909,510 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression EXP Mercuric Chloride results in increased expression of ZFP36 mRNA CTD PMID:16507785 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
G Zfp394 zinc finger protein 394 increases expression EXP Mercuric Chloride results in increased expression of ZNF394 mRNA CTD PMID:16507785 NCBI chr12:14,522,820...14,530,998 JBrowse link
G Zfp523 zinc finger protein 523 increases expression EXP Mercuric Chloride results in increased expression of ZFP523 mRNA CTD PMID:32599119 NCBI chr20:6,234,951...6,268,258
Ensembl chr20:6,236,522...6,268,257 		JBrowse link
G Zmym5 zinc finger MYM-type containing 5 decreases expression ISO Mercuric Chloride results in decreased expression of ZMYM5 mRNA CTD PMID:27188386 NCBI chr15:35,036,226...35,056,842
Ensembl chr15:35,038,015...35,056,707 		JBrowse link
G Zwint ZW10 interacting kinetochore protein increases expression EXP Mercuric Chloride results in increased expression of ZWINT mRNA CTD PMID:16507785 NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203 		JBrowse link
methylmercury chloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 9330159F19Rikl RIKEN cDNA 9330159F19 gene like increases expression ISO methylmercuric chloride results in increased expression of KIAA0408 mRNA CTD PMID:23179753 NCBI chr 1:30,444,202...30,469,195
Ensembl chr 1:30,444,208...30,453,155 		JBrowse link
G A2m alpha-2-macroglobulin increases expression
multiple interactions 		EXP methylmercuric chloride results in increased expression of A2M mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of A2M mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of A2M mRNA 		CTD PMID:30744511 PMID:31378766 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Aagab alpha- and gamma-adaptin binding protein decreases expression ISO methylmercuric chloride results in decreased expression of AAGAB mRNA CTD PMID:28001369 NCBI chr 8:72,978,719...73,017,275
Ensembl chr 8:72,978,741...73,017,278 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression ISO methylmercuric chloride results in decreased expression of ABCA1 mRNA CTD PMID:28001369 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abca5 ATP binding cassette subfamily A member 5 decreases expression ISO methylmercuric chloride results in decreased expression of ABCA5 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr10:95,739,610...95,808,633
Ensembl chr10:95,739,610...95,808,424 		JBrowse link
G Abca8a ATP-binding cassette, subfamily A (ABC1), member 8a multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of ABCA8A mRNA CTD PMID:30744511 NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873 		JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 increases expression ISO methylmercuric chloride results in increased expression of ABCB6 mRNA CTD PMID:28001369 NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of ABCC2 mRNA
methylmercuric chloride results in increased expression of ABCC2 mRNA; methylmercuric chloride results in increased expression of ABCC2 protein 		CTD PMID:27720909 PMID:28536007 PMID:38692911 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of ABCC4 mRNA
methylmercuric chloride results in increased expression of ABCC4 mRNA 		CTD PMID:27720909 PMID:28001369 PMID:28536007 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 decreases expression ISO methylmercuric chloride results in decreased expression of ABCC6 mRNA CTD PMID:28001369 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 decreases response to substance
increases expression
decreases expression 		ISO
EXP 		ABCG2 protein results in decreased susceptibility to methylmercuric chloride
methylmercuric chloride results in increased expression of ABCG2 mRNA
methylmercuric chloride results in decreased expression of ABCG2 mRNA 		CTD PMID:24118919 PMID:28536007 PMID:31175882 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ABCG5 mRNA CTD PMID:30744511 NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376 		JBrowse link
G Abhd10 abhydrolase domain containing 10, depalmitoylase decreases expression ISO methylmercuric chloride results in decreased expression of ABHD10 mRNA CTD PMID:28001369 NCBI chr11:68,543,860...68,556,059
Ensembl chr11:68,543,606...68,557,640 		JBrowse link
G Abhd13 abhydrolase domain containing 13 decreases expression ISO methylmercuric chloride results in decreased expression of ABHD13 mRNA CTD PMID:28001369 NCBI chr16:86,203,851...86,218,843
Ensembl chr16:86,201,794...86,290,906 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase increases expression ISO methylmercuric chloride results in increased expression of ABHD5 mRNA CTD PMID:28001369 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase decreases expression ISO methylmercuric chloride results in decreased expression of ABHD6 mRNA CTD PMID:28001369 NCBI chr15:19,289,967...19,337,500
Ensembl chr15:19,289,969...19,337,193 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase increases expression ISO methylmercuric chloride results in increased expression of ABL1 mRNA CTD PMID:20061341 NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846 		JBrowse link
G Abr ABR activator of RhoGEF and GTPase affects expression EXP methylmercuric chloride affects the expression of ABR mRNA CTD PMID:20864626 NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467 		JBrowse link
G Abraxas1 abraxas 1, BRCA1 A complex subunit decreases expression ISO methylmercuric chloride results in decreased expression of ABRAXAS1 mRNA CTD PMID:28001369 NCBI chr14:9,100,650...9,115,012
Ensembl chr14:9,100,671...9,115,011 		JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 increases expression ISO methylmercuric chloride results in increased expression of ABTB2 mRNA CTD PMID:28001369 NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
increases phosphorylation 		ISO [Cadmium Chloride co-treated with methylmercuric chloride] results in decreased expression of ACACA mRNA
methylmercuric chloride results in increased phosphorylation of ACACA protein 		CTD PMID:27814245 PMID:33301842 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta decreases expression ISO methylmercuric chloride results in decreased expression of ACACB mRNA CTD PMID:28001369 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain decreases expression ISO methylmercuric chloride results in decreased expression of ACADSB mRNA CTD PMID:28001369 NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561 		JBrowse link
G Acbd3 acyl-CoA binding domain containing 3 increases expression ISO methylmercuric chloride results in increased expression of ACBD3 mRNA CTD PMID:28001369 NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355 		JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 increases expression ISO methylmercuric chloride results in increased expression of ACBD5 mRNA CTD PMID:28001369 NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286 		JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity 		EXP sodium bisulfide inhibits the reaction [methylmercuric chloride results in decreased activity of ACHE protein] CTD PMID:28027877 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acot13 acyl-CoA thioesterase 13 decreases expression ISO methylmercuric chloride results in decreased expression of ACOT13 mRNA CTD PMID:27188386 NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression ISO methylmercuric chloride results in increased expression of ACOX1 mRNA CTD PMID:28001369 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox3 acyl-CoA oxidase 3, pristanoyl decreases expression ISO methylmercuric chloride results in decreased expression of ACOX3 mRNA CTD PMID:28001369 NCBI chr14:79,358,604...79,405,160
Ensembl chr14:79,302,042...79,400,881 		JBrowse link
G Acoxl acyl-CoA oxidase-like increases expression ISO methylmercuric chloride results in increased expression of ACOXL mRNA CTD PMID:28001369 NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291 		JBrowse link
G Acrbp acrosin binding protein decreases expression ISO methylmercuric chloride results in decreased expression of ACRBP mRNA CTD PMID:28001369 NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:159,537,391...159,550,454 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 increases expression ISO methylmercuric chloride results in increased expression of ACSL1 mRNA CTD PMID:28001369 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 decreases expression ISO methylmercuric chloride results in decreased expression of ACSL4 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 increases expression ISO methylmercuric chloride results in increased expression of ACSL5 mRNA CTD PMID:28001369 NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of ACSM3 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ACSM3 mRNA 		CTD PMID:28001369 PMID:30744511 NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437 		JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 decreases expression ISO methylmercuric chloride results in decreased expression of ACSS3 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 7:44,127,725...44,336,707
Ensembl chr 7:44,127,122...44,336,684 		JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ACTA2 mRNA
methylmercuric chloride results in decreased expression of ACTA2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTA2 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:34089799 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta increases expression ISO methylmercuric chloride results in increased expression of ACTB mRNA CTD PMID:26272509 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actc1 actin, alpha, cardiac muscle 1 decreases expression
multiple interactions
increases expression 		ISO methylmercuric chloride results in decreased expression of ACTC1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTC1 mRNA
methylmercuric chloride results in increased expression of ACTC1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:34089799 NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827 		JBrowse link
G Actg2 actin gamma 2, smooth muscle decreases expression ISO methylmercuric chloride results in decreased expression of ACTG2 mRNA CTD PMID:34089799 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn1 actinin, alpha 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ACTN1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTN1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Actn3 actinin alpha 3 decreases expression ISO methylmercuric chloride results in decreased expression of ACTN3 mRNA CTD PMID:28001369 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Actr3 actin related protein 3 decreases expression ISO methylmercuric chloride results in decreased expression of ACTR3 mRNA CTD PMID:28001369 NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711 		JBrowse link
G Actr8 actin related protein 8 decreases expression ISO methylmercuric chloride results in decreased expression of ACTR8 mRNA CTD PMID:28001369 NCBI chr16:5,170,649...5,192,883
Ensembl chr16:5,167,237...5,186,180 		JBrowse link
G Actrt3 actin-related protein T3 decreases expression ISO methylmercuric chloride results in decreased expression of ACTRT3 mRNA CTD PMID:28001369 NCBI chr 2:114,727,534...114,729,561
Ensembl chr 2:114,727,534...114,729,563 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 decreases expression ISO methylmercuric chloride results in decreased expression of ADAM10 mRNA CTD PMID:28001369 NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600 		JBrowse link
G Adam1a ADAM metallopeptidase domain 1a decreases expression ISO methylmercuric chloride results in decreased expression of ADAM1A mRNA CTD PMID:28001369 NCBI chr12:40,674,460...40,680,988
Ensembl chr12:40,676,918...40,684,619 		JBrowse link
G Adam22 ADAM metallopeptidase domain 22 decreases expression ISO methylmercuric chloride results in decreased expression of ADAM22 mRNA CTD PMID:28001369 NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 increases expression ISO methylmercuric chloride results in increased expression of ADAM9 mRNA CTD PMID:28001369 NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ADAMTS1 mRNA
methylmercuric chloride results in decreased expression of ADAMTS1 mRNA 		CTD PMID:28001369 PMID:34089799 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts17 ADAM metallopeptidase with thrombospondin type 1 motif, 17 decreases expression ISO methylmercuric chloride results in decreased expression of ADAMTS17 mRNA CTD PMID:28001369 NCBI chr 1:129,856,062...130,178,430
Ensembl chr 1:129,856,074...130,176,844 		JBrowse link
G Adamts18 ADAM metallopeptidase with thrombospondin type 1 motif, 18 decreases expression ISO methylmercuric chloride results in decreased expression of ADAMTS18 mRNA CTD PMID:28001369 NCBI chr19:58,596,095...58,749,239
Ensembl chr19:58,597,761...58,749,138 		JBrowse link
G Adamts19 ADAM metallopeptidase with thrombospondin type 1 motif, 19 decreases expression
multiple interactions
increases expression 		ISO methylmercuric chloride results in decreased expression of ADAMTS19 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS19 mRNA
methylmercuric chloride results in increased expression of ADAMTS19 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr18:54,545,357...54,729,184
Ensembl chr18:54,545,357...54,729,181 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 decreases expression ISO methylmercuric chloride results in decreased expression of ADAMTS2 mRNA CTD PMID:28001369 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 decreases expression ISO methylmercuric chloride results in decreased expression of ADAMTS20 mRNA CTD PMID:28001369 NCBI chr 7:127,275,538...127,407,325
Ensembl chr 7:127,275,538...127,407,296 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 increases expression EXP methylmercuric chloride results in increased expression of ADAMTS4 mRNA CTD PMID:31378766 NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514 		JBrowse link
G Adarb1 adenosine deaminase, RNA-specific, B1 decreases expression EXP methylmercuric chloride results in decreased expression of ADARB1 mRNA CTD PMID:20864626 NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415 		JBrowse link
G Adat2 adenosine deaminase, tRNA-specific 2 decreases expression ISO methylmercuric chloride results in decreased expression of ADAT2 mRNA CTD PMID:28001369 NCBI chr 1:9,774,680...9,795,376
Ensembl chr 1:9,774,680...9,795,376 		JBrowse link
G Adcy1 adenylate cyclase 1 decreases expression ISO methylmercuric chloride results in decreased expression of ADCY1 mRNA CTD PMID:28001369 NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases expression ISO methylmercuric chloride results in decreased expression of ADCY7 mRNA CTD PMID:23179753 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I decreases expression ISO methylmercuric chloride results in decreased expression of ADCYAP1R1 mRNA CTD PMID:28001369 NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973 		JBrowse link
G Adgrg5 adhesion G protein-coupled receptor G5 increases expression ISO methylmercuric chloride results in increased expression of ADGRG5 mRNA CTD PMID:19465457 PMID:28001369 NCBI chr19:10,080,800...10,104,659
Ensembl chr19:10,085,388...10,103,220 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 decreases expression ISO methylmercuric chloride results in decreased expression of ADGRG6 mRNA CTD PMID:23179753 NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023 		JBrowse link
G Adgrl3 adhesion G protein-coupled receptor L3 decreases expression ISO methylmercuric chloride results in decreased expression of ADGRL3 mRNA CTD PMID:28001369 NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,722,194...27,280,418 		JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 increases expression ISO methylmercuric chloride results in increased expression of ADGRL4 mRNA CTD PMID:28001369 NCBI chr 2:243,014,927...243,117,226
Ensembl chr 2:243,014,796...243,117,222 		JBrowse link
G Adgrv1 adhesion G protein-coupled receptor V1 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ADGRV1 mRNA
methylmercuric chloride results in decreased expression of ADGRV1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRV1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:13,067,150...13,647,372 		JBrowse link
G Adm adrenomedullin decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of ADM mRNA
methylmercuric chloride results in increased expression of ADM mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression ISO methylmercuric chloride results in decreased expression of ADORA1 mRNA CTD PMID:28001369 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Adrm1 ADRM1 26S proteasome ubiquitin receptor increases expression ISO methylmercuric chloride results in increased expression of ADRM1 mRNA CTD PMID:28001369 NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483 		JBrowse link
G Afap1l2 actin filament associated protein 1-like 2 decreases expression ISO methylmercuric chloride results in decreased expression of AFAP1L2 mRNA CTD PMID:23179753 NCBI chr 1:265,969,368...266,065,951
Ensembl chr 1:265,969,368...266,065,943 		JBrowse link
G Aff1 ALF transcription elongation factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of AFF1 mRNA CTD PMID:28001369 NCBI chr14:6,165,864...6,328,848
Ensembl chr14:6,169,562...6,328,879 		JBrowse link
G Aff4 ALF transcription elongation factor 4 increases expression ISO methylmercuric chloride results in increased expression of AFF4 mRNA CTD PMID:28001369 NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580 		JBrowse link
G Afp alpha-fetoprotein decreases expression ISO methylmercuric chloride results in decreased expression of AFP mRNA CTD PMID:23179753 PMID:27188386 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Aftph aftiphilin decreases expression ISO methylmercuric chloride results in decreased expression of AFTPH mRNA CTD PMID:28001369 NCBI chr14:99,072,761...99,127,006
Ensembl chr14:99,072,761...99,126,727 		JBrowse link
G Aga aspartylglucosaminidase decreases expression ISO methylmercuric chloride results in decreased expression of AGA mRNA CTD PMID:28001369 NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551 		JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of AGAP1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGAP1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 9:97,487,382...97,922,870
Ensembl chr 9:97,487,406...97,922,870 		JBrowse link
G Agbl1 AGBL carboxypeptidase 1 decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of AGBL1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGBL1 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:139,453,667...140,360,473
Ensembl chr 1:139,453,867...140,360,629 		JBrowse link
G Agbl2 AGBL carboxypeptidase 2 decreases expression ISO methylmercuric chloride results in decreased expression of AGBL2 mRNA CTD PMID:28001369 NCBI chr 3:97,220,654...97,255,905
Ensembl chr 3:97,220,781...97,255,904 		JBrowse link
G Agbl3 AGBL carboxypeptidase 3 decreases expression ISO methylmercuric chloride results in decreased expression of AGBL3 mRNA CTD PMID:28001369 NCBI chr 4:64,416,139...64,498,987
Ensembl chr 4:64,421,397...64,498,985 		JBrowse link
G Agbl5 AGBL carboxypeptidase 5 decreases expression ISO methylmercuric chloride results in decreased expression of AGBL5 mRNA CTD PMID:28001369 NCBI chr 6:31,192,281...31,213,494
Ensembl chr 6:31,191,635...31,210,676 		JBrowse link
G Ager advanced glycosylation end product-specific receptor decreases expression EXP methylmercuric chloride results in decreased expression of AGER protein CTD PMID:28821999 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 increases expression ISO methylmercuric chloride results in increased expression of AGFG1 mRNA CTD PMID:26272509 NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910 		JBrowse link
G Agl amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase decreases expression ISO methylmercuric chloride results in decreased expression of AGL mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724 		JBrowse link
G Agmat agmatinase increases expression ISO methylmercuric chloride results in increased expression of AGMAT mRNA CTD PMID:28001369 NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299 		JBrowse link
G Ago1 argonaute RISC component 1 decreases expression ISO methylmercuric chloride results in decreased expression of AGO1 mRNA CTD PMID:28001369 NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of AGO2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGO2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Ago4 argonaute RISC component 4 decreases expression ISO methylmercuric chloride results in decreased expression of AGO4 mRNA CTD PMID:28001369 NCBI chr 5:144,064,949...144,110,422
Ensembl chr 5:144,064,949...144,110,402 		JBrowse link
G Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 decreases expression ISO methylmercuric chloride results in decreased expression of AGPAT4 mRNA CTD PMID:28001369 NCBI chr 1:51,075,081...51,181,548
Ensembl chr 1:51,075,081...51,180,976 		JBrowse link
G Agps alkylglycerone phosphate synthase decreases expression ISO methylmercuric chloride results in decreased expression of AGPS mRNA CTD PMID:28001369 NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277 		JBrowse link
G Agrn agrin affects expression EXP methylmercuric chloride affects the expression of AGRN mRNA CTD PMID:20864626 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agrp agouti related neuropeptide increases expression ISO methylmercuric chloride results in increased expression of AGRP mRNA CTD PMID:29850906 NCBI chr19:50,357,899...50,396,758
Ensembl chr19:50,357,905...50,358,698 		JBrowse link
G Agtpbp1 ATP/GTP binding carboxypeptidase 1 decreases expression ISO methylmercuric chloride results in decreased expression of AGTPBP1 mRNA CTD PMID:28001369 NCBI chr17:5,092,108...5,244,414
Ensembl chr17:5,126,146...5,244,420 		JBrowse link
G Ahcy adenosylhomocysteinase decreases expression ISO methylmercuric chloride results in decreased expression of AHCY mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 increases expression ISO methylmercuric chloride results in increased expression of AHCYL2 mRNA CTD PMID:28001369 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahsa2 activator of HSP90 ATPase homolog 2 decreases expression ISO methylmercuric chloride results in decreased expression of AHSA2P mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr14:101,677,447...101,688,706
Ensembl chr14:101,677,447...101,686,923 		JBrowse link
G Aif1 allograft inflammatory factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of AIF1 protein CTD PMID:33338554 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 multiple interactions
increases expression 		EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [methylmercuric chloride results in increased expression of AIFM1 protein] CTD PMID:35678294 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Aifm3 AIF family member 3 decreases expression ISO methylmercuric chloride results in decreased expression of AIFM3 mRNA CTD PMID:28001369 NCBI chr11:97,009,100...97,030,601
Ensembl chr11:97,008,426...97,023,334 		JBrowse link
G Ajuba ajuba LIM protein decreases expression ISO methylmercuric chloride results in decreased expression of AJUBA mRNA CTD PMID:28001369 NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042 		JBrowse link
G Ak2 adenylate kinase 2 decreases expression ISO methylmercuric chloride results in decreased expression of AK2 mRNA CTD PMID:28001369 NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610 		JBrowse link
G Ak4 adenylate kinase 4 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of AK4 mRNA
methylmercuric chloride results in increased expression of AK4 mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401 		JBrowse link
G Ak5 adenylate kinase 5 decreases expression ISO methylmercuric chloride results in decreased expression of AK5 mRNA CTD PMID:28001369 NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366 		JBrowse link
G Ak9 adenylate kinase 9 decreases expression ISO methylmercuric chloride results in decreased expression of AK9 mRNA CTD PMID:28001369 NCBI chr20:46,307,100...46,523,537
Ensembl chr20:46,307,119...46,523,536 		JBrowse link
G Akap12 A-kinase anchoring protein 12 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of AKAP12 mRNA
methylmercuric chloride results in increased expression of AKAP12 mRNA 		CTD PMID:28001369 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akap13 A-kinase anchoring protein 13 increases expression ISO methylmercuric chloride results in increased expression of AKAP13 mRNA CTD PMID:26272509 NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401 		JBrowse link
G Akap5 A-kinase anchoring protein 5 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of AKAP5 mRNA CTD PMID:30744511 NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620 		JBrowse link
G Akap7 A-kinase anchoring protein 7 decreases expression ISO methylmercuric chloride results in decreased expression of AKAP7 mRNA CTD PMID:28001369 NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090 		JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO methylmercuric chloride results in decreased expression of AKAP9 mRNA CTD PMID:28001369 NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338 		JBrowse link
G Aknad1 AKNA domain containing 1 increases expression ISO methylmercuric chloride results in increased expression of AKNAD1 mRNA CTD PMID:28001369 NCBI chr 2:199,076,864...199,120,402
Ensembl chr 2:199,081,596...199,120,375 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of AKR1C1 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of AKR1C1 mRNA 		CTD PMID:28001369 PMID:30744511 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c12 aldo-keto reductase family 1, member C12 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of AKR1C12 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of AKR1C12 mRNA CTD PMID:30744511 NCBI chr17:70,955,288...70,971,412
Ensembl chr17:70,955,294...70,971,431 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of AKR1C2 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of AKR1C2 mRNA 		CTD PMID:28001369 PMID:30744511 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression ISO methylmercuric chloride results in increased expression of AKR1C18 mRNA
methylmercuric chloride results in increased expression of AKR1C3 mRNA 		CTD PMID:20061341 PMID:28001369 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr1c3l1 aldo-keto reductase family 1 member C3-like 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of AKR1C3L1 mRNA CTD PMID:30744511 NCBI chr17:70,745,496...70,791,411
Ensembl chr17:70,745,496...70,791,322 		JBrowse link
G Akr1c8 aldo-keto reductase family 1 member C8 increases expression EXP methylmercuric chloride results in increased expression of AKR1C8 mRNA CTD PMID:31378766 NCBI chr17:71,091,398...71,117,985
Ensembl chr17:71,083,080...71,117,957 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 decreases expression ISO methylmercuric chloride results in decreased expression of AKR1D1 mRNA CTD PMID:23179753 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of AKR7A3 mRNA CTD PMID:30744511 NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
decreases phosphorylation
multiple interactions 		EXP
ISO 		methylmercuric chloride results in increased phosphorylation of AKT1 protein
methylmercuric chloride results in decreased phosphorylation of AKT1 protein
AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of ATF4 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of ERN1 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of PARP1 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2S1 protein]; GHRL protein promotes the reaction [methylmercuric chloride results in decreased phosphorylation of AKT1 protein] 		CTD PMID:28736149 PMID:31330229 PMID:33301842 PMID:33338554 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt3 AKT serine/threonine kinase 3 decreases expression
increases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of AKT3 mRNA
methylmercuric chloride results in increased expression of AKT3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKT3 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020 		JBrowse link
G Aktip AKT interacting protein decreases expression ISO methylmercuric chloride results in decreased expression of AKTIP mRNA CTD PMID:20061341 PMID:28001369 NCBI chr19:32,039,507...32,059,634
Ensembl chr19:32,039,466...32,067,178 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ALAS1 mRNA CTD PMID:30744511 NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642 		JBrowse link
G Alb albumin multiple interactions ISO methylmercuric chloride binds to and affects the folding of ALB protein CTD PMID:17489621 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule affects expression
decreases expression
increases expression 		ISO methylmercuric chloride affects the expression of ALCAM mRNA
methylmercuric chloride results in decreased expression of ALCAM mRNA
methylmercuric chloride results in increased expression of ALCAM mRNA 		CTD PMID:21613230 PMID:23179753 PMID:28001369 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions
decreases expression 		EXP
ISO 		[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ALDH1A1 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ALDH1A1 mRNA
methylmercuric chloride results in decreased expression of ALDH1A1 mRNA 		CTD PMID:30744511 PMID:34089799 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 increases expression ISO methylmercuric chloride results in increased expression of ALDH1A2 mRNA CTD PMID:28001369 NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883 		JBrowse link
G Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ALDH1A7 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ALDH1A7 mRNA CTD PMID:30744511 NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ALDH1B1 mRNA CTD PMID:30744511 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases expression ISO methylmercuric chloride results in increased expression of ALDH1L2 mRNA CTD PMID:28001369 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 decreases expression ISO methylmercuric chloride results in decreased expression of ALDH5A1 mRNA CTD PMID:28001369 NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,558,347...40,586,714 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 decreases expression ISO methylmercuric chloride results in decreased expression of ALDH7A1 mRNA CTD PMID:28001369 NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467 		JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 increases expression EXP methylmercuric chloride results in increased expression of ALDH9A1 mRNA CTD PMID:20864626 NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481 		JBrowse link
G Alg9 ALG9, alpha-1,2-mannosyltransferase decreases expression ISO methylmercuric chloride results in decreased expression of ALG9 mRNA CTD PMID:28001369 NCBI chr 8:60,013,429...60,085,159
Ensembl chr 8:60,009,618...60,085,054 		JBrowse link
G Alkal2 ALK and LTK ligand 2 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of ALKAL2 mRNA CTD PMID:23179753 PMID:28001369 PMID:31378766 NCBI chr 6:53,223,204...53,232,794
Ensembl chr 6:53,223,341...53,233,011 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein decreases expression ISO methylmercuric chloride results in decreased expression of ALMS1 mRNA CTD PMID:28001369 NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase decreases expression ISO methylmercuric chloride results in decreased expression of ALOX5 mRNA CTD PMID:28001369 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alpk2 alpha-kinase 2 increases expression ISO methylmercuric chloride results in increased expression of ALPK2 mRNA CTD PMID:28001369 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO methylmercuric chloride results in decreased expression of AMACR mRNA CTD PMID:28001369 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Amdhd1 amidohydrolase domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of AMDHD1 mRNA CTD PMID:28001369 NCBI chr 7:29,930,966...29,946,199
Ensembl chr 7:29,929,965...29,959,683 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO methylmercuric chloride results in decreased expression of AMIGO2 mRNA CTD PMID:23179753 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Amotl2 angiomotin like 2 increases expression ISO methylmercuric chloride results in increased expression of AMOTL2 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030 		JBrowse link
G Amph amphiphysin decreases expression ISO methylmercuric chloride results in decreased expression of AMPH mRNA CTD PMID:28001369 NCBI chr17:50,435,018...50,678,583
Ensembl chr17:50,435,018...50,678,501 		JBrowse link
G Amy1 amylase alpha 1 decreases expression ISO methylmercuric chloride results in decreased expression of AMY2B mRNA CTD PMID:28001369 NCBI chr 2:204,071,101...204,085,910
Ensembl chr 2:204,071,098...204,086,239 		JBrowse link
G Anapc1 anaphase promoting complex subunit 1 decreases expression ISO methylmercuric chloride results in decreased expression of ANAPC1 mRNA CTD PMID:28001369 NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464 		JBrowse link
G Anapc10 anaphase promoting complex subunit 10 decreases expression ISO methylmercuric chloride results in decreased expression of ANAPC10 mRNA CTD PMID:27188386 PMID:28001369 NCBI chr19:45,057,278...45,109,882
Ensembl chr19:45,029,546...45,109,882 		JBrowse link
G Anapc4 anaphase promoting complex subunit 4 decreases expression ISO methylmercuric chloride results in decreased expression of ANAPC4 mRNA CTD PMID:28001369 NCBI chr14:62,338,798...62,370,572
Ensembl chr14:62,338,798...62,370,572 		JBrowse link
G Angpt1 angiopoietin 1 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of ANGPT1 mRNA
methylmercuric chloride results in increased expression of ANGPT1 mRNA 		CTD PMID:28001369 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Angpt2 angiopoietin 2 increases expression ISO methylmercuric chloride results in increased expression of ANGPT2 mRNA CTD PMID:28001369 NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO methylmercuric chloride results in increased expression of ANGPTL4 mRNA CTD PMID:28001369 NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Ank2 ankyrin 2 decreases expression ISO methylmercuric chloride results in decreased expression of ANK2 mRNA CTD PMID:28001369 NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259 		JBrowse link
G Ank3 ankyrin 3 decreases expression ISO methylmercuric chloride results in decreased expression of ANK3 mRNA CTD PMID:28001369 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankef1 ankyrin repeat and EF-hand domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of ANKEF1 mRNA CTD PMID:28001369 NCBI chr 3:144,300,500...144,335,759
Ensembl chr 3:144,300,529...144,335,753 		JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 increases expression ISO methylmercuric chloride results in increased expression of ANKHD1 mRNA CTD PMID:28001369 NCBI chr18:28,436,296...28,534,954
Ensembl chr18:28,436,394...28,534,954 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD1 mRNA CTD PMID:34089799 NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751 		JBrowse link
G Ankrd10 ankyrin repeat domain 10 increases expression ISO methylmercuric chloride results in increased expression of ANKRD10 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ANKRD11 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD11 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD12 mRNA CTD PMID:28001369 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd13c ankyrin repeat domain 13C decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD13C mRNA CTD PMID:28001369 NCBI chr 2:249,679,752...249,729,272
Ensembl chr 2:249,681,872...249,729,272 		JBrowse link
G Ankrd26 ankyrin repeat domain containing 26 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD26 mRNA CTD PMID:28001369 NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256 		JBrowse link
G Ankrd28 ankyrin repeat domain 28 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ANKRD28 mRNA
methylmercuric chloride results in decreased expression of ANKRD28 mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593 		JBrowse link
G Ankrd33b ankyrin repeat domain 33B increases expression ISO methylmercuric chloride results in increased expression of ANKRD33B mRNA CTD PMID:28001369 NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936 		JBrowse link
G Ankrd37 ankyrin repeat domain 37 decreases expression EXP
ISO 		methylmercuric chloride results in decreased expression of ANKRD37 mRNA CTD PMID:20864626 PMID:23179753 PMID:27188386 NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD44 mRNA CTD PMID:28001369 NCBI chr 9:63,621,193...63,921,999
Ensembl chr 9:63,555,869...63,921,940 		JBrowse link
G Ankrd50 ankyrin repeat domain containing 50 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD50 mRNA CTD PMID:28001369 NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340 		JBrowse link
G Ankrd52 ankyrin repeat domain 52 increases expression ISO methylmercuric chloride results in increased expression of ANKRD52 mRNA CTD PMID:28001369 NCBI chr 7:1,390,730...1,410,139
Ensembl chr 7:1,391,325...1,407,410 		JBrowse link
G Ankrd6 ankyrin repeat domain 6 decreases expression ISO methylmercuric chloride results in decreased expression of ANKRD6 mRNA CTD PMID:28001369 NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:51,999,221...52,139,594 		JBrowse link
G Ano5 anoctamin 5 decreases expression ISO methylmercuric chloride results in decreased expression of ANO5 mRNA CTD PMID:28001369 NCBI chr 1:110,222,411...110,323,505
Ensembl chr 1:110,222,446...110,323,501 		JBrowse link
G Anp32e acidic nuclear phosphoprotein 32 family member E increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ANP32E mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANP32E mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986 		JBrowse link
G Anpep alanyl aminopeptidase, membrane increases expression ISO methylmercuric chloride results in increased expression of ANPEP mRNA CTD PMID:28001369 NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ANTXR1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANTXR1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Anxa1 annexin A1 increases expression ISO methylmercuric chloride results in increased expression of ANXA1 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa11 annexin A11 decreases expression ISO methylmercuric chloride results in decreased expression of ANXA11 mRNA CTD PMID:23179753 NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839 		JBrowse link
G Anxa2 annexin A2 increases expression ISO methylmercuric chloride results in increased expression of ANXA2 mRNA CTD PMID:28001369 NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa3 annexin A3 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of ANXA3 mRNA
methylmercuric chloride results in increased expression of ANXA3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa4 annexin A4 decreases expression ISO methylmercuric chloride results in decreased expression of ANXA4 mRNA CTD PMID:23179753 NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513 		JBrowse link
G Anxa6 annexin A6 decreases expression ISO methylmercuric chloride results in decreased expression of ANXA6 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359 		JBrowse link
G Aopep aminopeptidase O decreases expression ISO methylmercuric chloride results in decreased expression of AOPEP mRNA CTD PMID:28001369 NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104 		JBrowse link
G Aox1 aldehyde oxidase 1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of AOX1 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of AOX1 mRNA
methylmercuric chloride results in increased expression of AOX1 mRNA 		CTD PMID:28001369 PMID:29581082 PMID:30744511 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap1g2 adaptor related protein complex 1 subunit gamma 2 decreases expression ISO methylmercuric chloride results in decreased expression of AP1G2 mRNA CTD PMID:28001369 NCBI chr15:32,541,528...32,549,392
Ensembl chr15:32,541,528...32,549,280 		JBrowse link
G Ap2b1 adaptor related protein complex 2 subunit beta 1 increases expression ISO methylmercuric chloride results in increased expression of AP2B1 mRNA CTD PMID:28001369 NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539 		JBrowse link
G Ap3d1 adaptor related protein complex 3 subunit delta 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of AP3D1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP3D1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342 		JBrowse link
G Ap4s1 adaptor related protein complex 4 subunit sigma 1 decreases expression ISO methylmercuric chloride results in decreased expression of AP4S1 mRNA CTD PMID:28001369 NCBI chr 6:74,863,742...74,916,907
Ensembl chr 6:74,868,558...74,912,406 		JBrowse link
G Ap5m1 adaptor related protein complex 5 subunit mu 1 decreases expression ISO methylmercuric chloride results in decreased expression of AP5M1 mRNA CTD PMID:28001369 NCBI chr15:24,835,122...24,864,854
Ensembl chr15:24,835,100...24,862,606 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression ISO methylmercuric chloride results in increased expression of APAF1 mRNA CTD PMID:28001369 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apba2 amyloid beta precursor protein binding family A member 2 decreases expression ISO methylmercuric chloride results in decreased expression of APBA2 mRNA CTD PMID:28001369 NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117 		JBrowse link
G Apbb2 amyloid beta precursor protein binding family B member 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of APBB2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression ISO methylmercuric chloride results in decreased expression of APC mRNA CTD PMID:28001369 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apcdd1 APC down-regulated 1 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of APCDD1 mRNA
methylmercuric chloride results in decreased expression of APCDD1 mRNA 		CTD PMID:26272509 PMID:28001369 NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356 		JBrowse link
G Apcs amyloid P component, serum increases expression ISO methylmercuric chloride results in increased expression of APCS protein CTD PMID:24055825 NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824 		JBrowse link
G Apela apelin receptor early endogenous ligand decreases expression ISO methylmercuric chloride results in decreased expression of APELA mRNA CTD PMID:28001369 NCBI chr16:29,460,855...29,469,962
Ensembl chr16:29,460,812...29,469,955 		JBrowse link
G Apln apelin increases expression ISO methylmercuric chloride results in increased expression of APLN mRNA CTD PMID:28001369 NCBI chr  X:132,058,739...132,091,518
Ensembl chr  X:132,081,759...132,091,246 		JBrowse link
G Aplp1 amyloid beta precursor like protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of APLP1 mRNA CTD PMID:28001369 NCBI chr 1:94,824,330...94,834,705
Ensembl chr 1:94,824,072...94,834,610 		JBrowse link
G Apoa1 apolipoprotein A1 decreases expression ISO methylmercuric chloride results in decreased expression of APOA1 mRNA CTD PMID:23179753 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa2 apolipoprotein A2 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of APOA2 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of APOA2 mRNA 		CTD PMID:23179753 PMID:27188386 PMID:30744511 NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410 		JBrowse link
G Apob apolipoprotein B decreases expression ISO methylmercuric chloride results in decreased expression of APOB mRNA CTD PMID:23179753 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Apoc1 apolipoprotein C1 decreases expression ISO methylmercuric chloride results in decreased expression of APOC1 mRNA CTD PMID:23179753 NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155 		JBrowse link
G Apoc3 apolipoprotein C3 decreases expression ISO methylmercuric chloride results in decreased expression of APOC3 mRNA CTD PMID:23179753 NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679 		JBrowse link
G Apoc4 apolipoprotein C4 increases expression ISO methylmercuric chloride results in increased expression of APOC4 mRNA CTD PMID:28001369 NCBI chr 1:88,463,713...88,467,909
Ensembl chr 1:88,463,713...88,468,044 		JBrowse link
G Apoe apolipoprotein E decreases expression ISO methylmercuric chloride results in decreased expression of APOE mRNA CTD PMID:23179753 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apold1 apolipoprotein L domain containing 1 increases expression ISO methylmercuric chloride results in increased expression of APOLD1 mRNA CTD PMID:28001369 NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176 		JBrowse link
G Apom apolipoprotein M decreases expression ISO methylmercuric chloride results in decreased expression of APOM mRNA CTD PMID:28001369 NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218 		JBrowse link
G Apool apolipoprotein O-like decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of APOOL mRNA
methylmercuric chloride results in increased expression of APOOL mRNA 		CTD PMID:28001369 NCBI chr  X:81,569,960...81,635,906
Ensembl chr  X:81,570,053...81,640,036 		JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO methylmercuric chloride results in decreased expression of AQP1 mRNA CTD PMID:23179753 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) decreases expression ISO
EXP 		methylmercuric chloride results in decreased expression of AQP3 mRNA
methylmercuric chloride results in decreased expression of AQP3 mRNA; methylmercuric chloride results in decreased expression of AQP3 protein 		CTD PMID:23179753 PMID:25854323 PMID:28001369 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp4 aquaporin 4 decreases expression ISO
EXP 		methylmercuric chloride results in decreased expression of AQP4 mRNA
methylmercuric chloride results in decreased expression of AQP4 mRNA; methylmercuric chloride results in decreased expression of AQP4 protein 		CTD PMID:23179753 PMID:25854323 PMID:28001369 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp7 aquaporin 7 decreases expression EXP methylmercuric chloride results in decreased expression of AQP7 protein CTD PMID:25854323 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein increases expression ISO methylmercuric chloride results in increased expression of ARC mRNA CTD PMID:19465457 PMID:28001369 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Areg amphiregulin increases expression ISO methylmercuric chloride results in increased expression of AREG mRNA CTD PMID:28001369 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arf4 ARF GTPase 4 increases expression ISO methylmercuric chloride results in increased expression of ARF4 mRNA CTD PMID:28001369 NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011 		JBrowse link
G Arg2 arginase 2 increases expression ISO methylmercuric chloride results in increased expression of ARG2 mRNA CTD PMID:20061341 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arglu1 arginine and glutamate rich 1 decreases expression ISO methylmercuric chloride results in decreased expression of ARGLU1 mRNA CTD PMID:28001369 NCBI chr16:87,455,097...87,479,148
Ensembl chr16:87,455,113...87,479,148 		JBrowse link
G Arhgap11a Rho GTPase activating protein 11A decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP11A mRNA CTD PMID:28001369 NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468 		JBrowse link
G Arhgap15 Rho GTPase activating protein 15 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP15 mRNA CTD PMID:28001369 NCBI chr 3:48,382,945...49,002,213
Ensembl chr 3:48,382,904...49,011,378 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP18 mRNA CTD PMID:28001369 NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670 		JBrowse link
G Arhgap21 Rho GTPase activating protein 21 increases expression ISO methylmercuric chloride results in increased expression of ARHGAP21 mRNA CTD PMID:28001369 NCBI chr17:88,256,961...88,380,478
Ensembl chr17:88,256,961...88,380,797 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 increases expression ISO methylmercuric chloride results in increased expression of ARHGAP23 mRNA CTD PMID:28001369 NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,890,853...82,993,228 		JBrowse link
G Arhgap24 Rho GTPase activating protein 24 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP24 mRNA CTD PMID:28001369 NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950 		JBrowse link
G Arhgap26 Rho GTPase activating protein 26 increases expression ISO methylmercuric chloride results in increased expression of ARHGAP26 mRNA CTD PMID:28001369 NCBI chr18:30,702,602...31,489,047
Ensembl chr18:31,089,787...31,489,047 		JBrowse link
G Arhgap28 Rho GTPase activating protein 28 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP28 mRNA CTD PMID:28001369 NCBI chr 9:115,277,849...115,444,789
Ensembl chr 9:115,279,734...115,445,008 		JBrowse link
G Arhgap29 Rho GTPase activating protein 29 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP29 mRNA CTD PMID:23179753 NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729 		JBrowse link
G Arhgap32 Rho GTPase activating protein 32 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP32 mRNA CTD PMID:28001369 NCBI chr 8:38,679,368...38,939,960
Ensembl chr 8:38,684,484...38,939,960 		JBrowse link
G Arhgap36 Rho GTPase activating protein 36 increases expression ISO methylmercuric chloride results in increased expression of ARHGAP36 mRNA CTD PMID:28001369 NCBI chr  X:133,635,996...133,664,995
Ensembl chr  X:133,635,973...133,664,888 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGAP5 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression ISO methylmercuric chloride results in increased expression of ARHGDIB mRNA CTD PMID:28001369 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arhgef19 Rho guanine nucleotide exchange factor 19 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ARHGEF19 mRNA CTD PMID:30744511 NCBI chr 5:158,818,840...158,837,196
Ensembl chr 5:158,818,932...158,837,196 		JBrowse link
G Arhgef26 Rho guanine nucleotide exchange factor 26 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF26 mRNA CTD PMID:28001369 NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538 		JBrowse link
G Arhgef3 Rho guanine nucleotide exchange factor 3 increases expression ISO methylmercuric chloride results in increased expression of ARHGEF3 mRNA CTD PMID:28001369 NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819 		JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor 39 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF39 mRNA CTD PMID:28001369 NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870 		JBrowse link
G Arhgef4 Rho guanine nucleotide exchange factor 4 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF4 mRNA CTD PMID:28001369 NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:44,357,736...44,501,550 		JBrowse link
G Arhgef6 Rac/Cdc42 guanine nucleotide exchange factor 6 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF6 mRNA CTD PMID:28001369 NCBI chr  X:140,182,734...140,302,812
Ensembl chr  X:140,182,734...140,344,458 		JBrowse link
G Arhgef7 Rho guanine nucleotide exchange factor 7 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF7 mRNA CTD PMID:28001369 NCBI chr16:84,373,123...84,484,759
Ensembl chr16:84,373,123...84,484,597 		JBrowse link
G Arhgef9 Cdc42 guanine nucleotide exchange factor 9 decreases expression ISO methylmercuric chloride results in decreased expression of ARHGEF9 mRNA CTD PMID:28001369 NCBI chr  X:63,929,168...64,087,267
Ensembl chr  X:63,929,176...64,087,104 		JBrowse link
G Arid1a AT-rich interaction domain 1A increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ARID1A mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386 		JBrowse link
G Arid1b AT-rich interaction domain 1B decreases expression ISO methylmercuric chloride results in decreased expression of ARID1B mRNA CTD PMID:28001369 NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793 		JBrowse link
G Arid2 AT-rich interaction domain 2 decreases expression ISO methylmercuric chloride results in decreased expression of ARID2 mRNA CTD PMID:26272509 NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187 		JBrowse link
G Arid3a AT-rich interaction domain 3A increases expression ISO methylmercuric chloride results in increased expression of ARID3A mRNA CTD PMID:23179753 NCBI chr 7:10,403,161...10,431,551
Ensembl chr 7:10,405,631...10,427,926 		JBrowse link
G Arid5a AT-rich interaction domain 5A increases expression EXP methylmercuric chloride results in increased expression of ARID5A mRNA CTD PMID:31378766 NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363 		JBrowse link
G Arih1 ariadne RBR E3 ubiquitin protein ligase 1 increases expression ISO methylmercuric chloride results in increased expression of ARIH1 mRNA CTD PMID:28001369 NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:68,673,200...68,775,572 		JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 increases expression ISO methylmercuric chloride results in increased expression of ARIH2 mRNA CTD PMID:20061341 NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284 		JBrowse link
G Ark2n arkadia (RNF111) N-terminal like PKA signaling regulator 2N increases expression ISO methylmercuric chloride results in increased expression of ARK2N mRNA CTD PMID:28001369 NCBI chr18:73,431,104...73,520,759
Ensembl chr18:73,431,104...73,518,144 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ARL5B mRNA
methylmercuric chloride results in decreased expression of ARL5B mRNA 		CTD PMID:28001369 NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646 		JBrowse link
G Arl6ip5 ARF like GTPase 6 interacting protein 5 decreases expression ISO methylmercuric chloride results in decreased expression of ARL6IP5 mRNA CTD PMID:23179753 NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130 		JBrowse link
G Arl8b ARF like GTPase 8B increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ARL8B mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL8B mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 4:143,304,597...143,348,580
Ensembl chr 4:143,304,621...143,349,068 		JBrowse link
G Arln allregulin decreases expression ISO methylmercuric chloride results in decreased expression of ARLN mRNA CTD PMID:28001369 NCBI chr 2:213,740,519...213,742,279
Ensembl chr 2:213,740,525...213,742,952 		JBrowse link
G Armc8 armadillo repeat containing 8 decreases expression ISO methylmercuric chloride results in decreased expression of ARMC8 mRNA CTD PMID:28001369 NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717 		JBrowse link
G Armh4 armadillo-like helical domain containing 4 decreases expression ISO methylmercuric chloride results in decreased expression of ARMH4 mRNA CTD PMID:28001369 NCBI chr15:25,455,478...25,556,569
Ensembl chr15:25,455,297...25,556,534 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B decreases expression ISO methylmercuric chloride results in decreased expression of ARPC1B mRNA CTD PMID:23179753 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504 		JBrowse link
G Arpin actin-related protein 2/3 complex inhibitor decreases expression ISO methylmercuric chloride results in decreased expression of ARPIN mRNA CTD PMID:28001369 NCBI chr 1:143,273,590...143,282,426
Ensembl chr 1:143,273,590...143,282,532 		JBrowse link
G Arrb2 arrestin, beta 2 increases expression EXP methylmercuric chloride results in increased expression of ARRB2 mRNA CTD PMID:20864626 NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487 		JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression ISO methylmercuric chloride results in decreased expression of ARRDC4 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565 		JBrowse link
G Arsb arylsulfatase B decreases expression ISO methylmercuric chloride results in decreased expression of ARSB mRNA CTD PMID:28001369 NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611 		JBrowse link
G Arsg arylsulfatase G decreases expression ISO methylmercuric chloride results in decreased expression of ARSG mRNA CTD PMID:28001369 NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447 		JBrowse link
G Arsj arylsulfatase family, member J increases expression ISO methylmercuric chloride results in increased expression of ARSJ mRNA CTD PMID:28001369 NCBI chr 2:217,449,147...217,529,142
Ensembl chr 2:217,449,147...217,529,142 		JBrowse link
G Arsl arylsulfatase L decreases expression ISO methylmercuric chloride results in decreased expression of ARSL mRNA CTD PMID:23179753 NCBI chr 2:120,966,992...120,975,015
Ensembl chr 2:120,966,950...120,975,011 		JBrowse link
G Arv1 ARV1 homolog, fatty acid homeostasis modulator decreases expression ISO methylmercuric chloride results in decreased expression of ARV1 mRNA CTD PMID:28001369 NCBI chr19:69,589,728...69,601,547
Ensembl chr19:69,589,328...69,601,537 		JBrowse link
G Arx aristaless related homeobox decreases expression ISO methylmercuric chloride results in decreased expression of ARX mRNA CTD PMID:28001369 NCBI chr  X:62,010,097...62,022,009
Ensembl chr  X:62,010,097...62,022,002 		JBrowse link
G Asb8 ankyrin repeat and SOCS box-containing 8 decreases expression ISO methylmercuric chloride results in decreased expression of ASB8 mRNA CTD PMID:28001369 NCBI chr 7:131,140,455...131,176,648
Ensembl chr 7:131,141,406...131,150,633 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 increases expression ISO methylmercuric chloride results in increased expression of ASCL1 mRNA CTD PMID:28001369 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone increases expression ISO methylmercuric chloride results in increased expression of ASF1A mRNA CTD PMID:28001369 NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639 		JBrowse link
G Ash2l ASH2 like histone lysine methyltransferase complex subunit decreases expression ISO methylmercuric chloride results in decreased expression of ASH2L mRNA CTD PMID:28001369 NCBI chr16:72,943,527...72,966,791
Ensembl chr16:72,944,949...72,967,839 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 decreases expression ISO methylmercuric chloride results in decreased expression of ASIC1 mRNA CTD PMID:28001369 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ASNS mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASNS mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspm assembly factor for spindle microtubules decreases expression
affects expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of ASPM mRNA
methylmercuric chloride affects the expression of ASPM mRNA 		CTD PMID:20061341 PMID:20864626 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Aspn asporin increases expression ISO methylmercuric chloride results in increased expression of ASPN mRNA CTD PMID:27188386 PMID:28001369 NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632 		JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ASS1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASS1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:34089799 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Astn1 astrotactin 1 decreases expression ISO methylmercuric chloride results in decreased expression of ASTN1 mRNA CTD PMID:28001369 NCBI chr13:73,070,754...73,388,902
Ensembl chr13:73,071,267...73,388,895 		JBrowse link
G Asxl1 ASXL transcriptional regulator 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ASXL1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:162,273,828...162,341,742 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of ATAD1 mRNA CTD PMID:28001369 NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO methylmercuric chloride results in increased expression of ATAD2 mRNA CTD PMID:28001369 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atf2 activating transcription factor 2 increases expression ISO methylmercuric chloride results in increased expression of ATF2 mRNA CTD PMID:20061341 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745 		JBrowse link
G Atf3 activating transcription factor 3 increases expression
decreases expression 		ISO
EXP 		methylmercuric chloride results in increased expression of ATF3 mRNA
methylmercuric chloride results in decreased expression of ATF3 mRNA 		CTD PMID:20061341 PMID:26272509 PMID:28001369 PMID:31378766 PMID:34089799 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ATF4 mRNA
methylmercuric chloride results in increased expression of ATF4 mRNA; methylmercuric chloride results in increased expression of ATF4 protein
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ATF4 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of ATF4 protein]; ATF4 protein promotes the reaction [methylmercuric chloride results in increased cleavage of CYCS protein]; ATF4 protein promotes the reaction [methylmercuric chloride results in increased expression of DDIT3 protein]; ATF4 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPA9 protein]; ATF4 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPD1 protein] 		CTD PMID:28001369 PMID:31330229 PMID:37967789 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf5 activating transcription factor 5 increases expression ISO methylmercuric chloride results in increased expression of ATF5 mRNA CTD PMID:28001369 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183 		JBrowse link
G Atf6 activating transcription factor 6 increases cleavage
multiple interactions 		ISO methylmercuric chloride results in increased cleavage of ATF6 protein
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein] 		CTD PMID:31330229 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atf7ip activating transcription factor 7 interacting protein decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of ATF7IP mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATF7IP mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 4:171,117,122...171,202,871
Ensembl chr 4:171,117,122...171,202,867 		JBrowse link
G Atg10 autophagy related 10 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ATG10 mRNA
methylmercuric chloride results in decreased expression of ATG10 mRNA 		CTD PMID:28001369 NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368 		JBrowse link
G Atg5 autophagy related 5 decreases expression
multiple interactions
affects response to substance 		ISO methylmercuric chloride results in decreased expression of ATG5 mRNA
ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein]; ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of MAP1LC3B protein]; ATG5 promotes the reaction [methylmercuric chloride results in increased expression of SQSTM1 protein]
ATG5 affects the susceptibility to methylmercuric chloride 		CTD PMID:23179753 PMID:27188386 PMID:27667695 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atp13a3 ATPase 13A3 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of ATP13A3 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of ATP13A3 mRNA 		CTD PMID:28001369 PMID:30744511 NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662 		JBrowse link
G Atp1a2 ATPase Na+/K+ transporting subunit alpha 2 decreases expression ISO methylmercuric chloride results in decreased expression of ATP1A2 mRNA CTD PMID:28001369 NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 increases expression ISO methylmercuric chloride results in increased expression of ATP1B1 mRNA CTD PMID:28001369 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 decreases expression ISO methylmercuric chloride results in decreased expression of ATP1B2 mRNA CTD PMID:28001369 NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708 		JBrowse link
G Atp1b4 ATPase Na+/K+ transporting family member beta 4 decreases expression ISO methylmercuric chloride results in decreased expression of ATP1B4 mRNA CTD PMID:28001369 NCBI chr  X:121,952,923...121,974,146
Ensembl chr  X:121,923,061...121,973,654 		JBrowse link
G Atp23 ATP23 metallopeptidase and ATP synthase assembly factor homolog decreases expression ISO methylmercuric chloride results in decreased expression of ATP23 mRNA CTD PMID:27188386 PMID:28001369 NCBI chr 7:64,600,100...64,615,240
Ensembl chr 7:64,600,100...64,615,392 		JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 decreases expression ISO methylmercuric chloride results in decreased expression of ATP2B1 mRNA CTD PMID:28001369 NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904 		JBrowse link
G Atp2b2 ATPase plasma membrane Ca2+ transporting 2 increases expression ISO methylmercuric chloride results in increased expression of ATP2B2 mRNA CTD PMID:34089799 NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239 		JBrowse link
G Atp2b3 ATPase plasma membrane Ca2+ transporting 3 decreases expression EXP methylmercuric chloride results in decreased expression of ATP2B3 mRNA CTD PMID:31378766 NCBI chr  X:156,367,582...156,464,085
Ensembl chr  X:156,367,852...156,438,153 		JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 decreases expression ISO methylmercuric chloride results in decreased expression of ATP5MC3 mRNA CTD PMID:28001369 NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:79,218,014...79,220,664 		JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO methylmercuric chloride results in increased expression of ATP5ME mRNA CTD PMID:34089799 NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988 		JBrowse link
G Atp5mg ATP synthase membrane subunit G decreases expression ISO methylmercuric chloride results in decreased expression of ATP5MG mRNA CTD PMID:28001369 NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831 		JBrowse link
G Atp6v0d2 ATPase H+ transporting V0 subunit D2 increases expression ISO methylmercuric chloride results in increased expression of ATP6V0D2 mRNA CTD PMID:28001369 NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245 		JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 decreases expression ISO methylmercuric chloride results in decreased expression of ATP6V0E2 mRNA CTD PMID:28001369 NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680 		JBrowse link
G Atp6v1c1 ATPase H+ transporting V1 subunit C1 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ATP6V1C1 mRNA
methylmercuric chloride results in decreased expression of ATP6V1C1 mRNA 		CTD PMID:28001369 NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184 		JBrowse link
G Atp6v1g2 ATPase H+ transporting V1 subunit G2 decreases expression ISO methylmercuric chloride results in decreased expression of ATP6V1G2 mRNA CTD PMID:28001369 NCBI chr20:3,592,374...3,595,986
Ensembl chr20:3,592,364...3,595,475 		JBrowse link
G Atp7a ATPase copper transporting alpha decreases expression ISO methylmercuric chloride results in decreased expression of ATP7A mRNA CTD PMID:28001369 NCBI chr  X:75,159,635...75,267,094
Ensembl chr  X:75,159,782...75,267,093 		JBrowse link
G Atp7b ATPase copper transporting beta decreases expression ISO methylmercuric chloride results in decreased expression of ATP7B mRNA CTD PMID:23179753 NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 decreases expression ISO methylmercuric chloride results in decreased expression of ATP8A1 mRNA CTD PMID:28001369 NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 increases expression ISO methylmercuric chloride results in increased expression of ATP8B1 mRNA CTD PMID:28001369 NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027 		JBrowse link
G Atp9a ATPase phospholipid transporting 9A (putative) decreases expression ISO methylmercuric chloride results in decreased expression of ATP9A mRNA CTD PMID:28001369 NCBI chr 3:177,779,203...177,886,431
Ensembl chr 3:177,779,203...178,023,661 		JBrowse link
G Atp9b ATPase phospholipid transporting 9B (putative) decreases expression ISO methylmercuric chloride results in decreased expression of ATP9B mRNA CTD PMID:28001369 NCBI chr18:76,451,821...76,643,931
Ensembl chr18:76,451,821...76,643,893 		JBrowse link
G Atpaf1 ATP synthase mitochondrial F1 complex assembly factor 1 decreases expression EXP
ISO 		methylmercuric chloride results in decreased expression of ATPAF1 mRNA CTD PMID:20864626 PMID:28001369 NCBI chr 5:134,503,164...134,530,323
Ensembl chr 5:134,499,687...134,530,321 		JBrowse link
G Atpsckmt ATP synthase c subunit lysine N-methyltransferase increases expression ISO methylmercuric chloride results in increased expression of ATPSCKMT mRNA CTD PMID:27188386 NCBI chr 2:84,313,991...84,329,195
Ensembl chr 2:84,313,921...84,329,194 		JBrowse link
G Atxn1 ataxin 1 decreases expression ISO methylmercuric chloride results in decreased expression of ATXN1 mRNA CTD PMID:28001369 NCBI chr17:18,943,397...19,354,751
Ensembl chr17:19,208,200...19,356,790 		JBrowse link
G Atxn10 ataxin 10 decreases expression ISO methylmercuric chloride results in decreased expression of ATXN10 mRNA CTD PMID:28001369 NCBI chr 7:118,321,516...118,444,967
Ensembl chr 7:118,319,490...118,445,636 		JBrowse link
G Atxn2l ataxin 2-like increases expression ISO methylmercuric chloride results in increased expression of ATXN2L mRNA CTD PMID:28001369 NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579 		JBrowse link
G Atxn3 ataxin 3 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of ATXN3 mRNA
methylmercuric chloride results in increased expression of ATXN3 mRNA 		CTD PMID:28001369 NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:126,839,327...126,872,781 		JBrowse link
G Aurkb aurora kinase B increases expression ISO methylmercuric chloride results in increased expression of AURKB mRNA CTD PMID:28001369 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Auts2 activator of transcription and developmental regulator AUTS2 increases expression ISO methylmercuric chloride results in increased expression of AUTS2 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr12:29,739,138...30,830,386
Ensembl chr12:29,740,523...30,830,386 		JBrowse link
G Azi2 5-azacytidine induced 2 decreases expression ISO methylmercuric chloride results in decreased expression of AZI2 mRNA CTD PMID:28001369 NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182 		JBrowse link
G B2m beta-2 microglobulin increases expression ISO methylmercuric chloride results in increased expression of B2M mRNA CTD PMID:28001369 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3galnt1 beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) decreases expression ISO methylmercuric chloride results in decreased expression of B3GALNT1 mRNA CTD PMID:28001369 NCBI chr 2:156,157,234...156,187,037
Ensembl chr 2:156,156,265...156,188,404 		JBrowse link
G B3galnt2 beta-1,3-N-acetylgalactosaminyltransferase 2 increases expression ISO methylmercuric chloride results in increased expression of B3GALNT2 mRNA CTD PMID:28001369 NCBI chr17:56,030,409...56,072,952
Ensembl chr17:56,030,409...56,072,952 		JBrowse link
G B3glct beta 3-glucosyltransferase decreases expression ISO methylmercuric chloride results in decreased expression of B3GLCT mRNA CTD PMID:28001369 NCBI chr12:10,291,910...10,383,190
Ensembl chr12:10,291,910...10,426,357 		JBrowse link
G B3gnt2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 decreases expression ISO methylmercuric chloride results in decreased expression of B3GNT2 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr14:101,009,682...101,034,507
Ensembl chr14:100,967,131...101,043,412 		JBrowse link
G B4galt4 beta-1,4-galactosyltransferase 4 decreases expression ISO methylmercuric chloride results in decreased expression of B4GALT4 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr11:75,501,358...75,527,291
Ensembl chr11:75,501,366...75,527,177 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 decreases expression ISO methylmercuric chloride results in decreased expression of B4GALT6 mRNA CTD PMID:28001369 NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204 		JBrowse link
G B9d1 B9 domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of B9D1 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr10:46,685,410...46,698,580
Ensembl chr10:46,686,133...46,695,428 		JBrowse link
G Baalc BAALC binder of MAP3K1 and KLF4 decreases expression ISO methylmercuric chloride results in decreased expression of BAALC mRNA CTD PMID:28001369 NCBI chr 7:71,803,640...71,877,608
Ensembl chr 7:71,774,898...71,879,261 		JBrowse link
G Bace1 beta-secretase 1 decreases expression ISO methylmercuric chloride results in decreased expression of BACE1 mRNA CTD PMID:24118919 PMID:28001369 NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918 		JBrowse link
G Bach2 BTB domain and CNC homolog 2 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of BACH2 mRNA
methylmercuric chloride results in decreased expression of BACH2 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234 		JBrowse link
G Bad BCL2-associated agonist of cell death increases expression ISO
EXP 		methylmercuric chloride results in increased expression of BAD mRNA
methylmercuric chloride results in increased expression of BAD protein 		CTD PMID:28001369 PMID:28821999 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag2 BAG cochaperone 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of BAG2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bag3 BAG cochaperone 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of BAG3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAG3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO methylmercuric chloride results in decreased expression of BAG5 mRNA CTD PMID:28001369 NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492 		JBrowse link
G Bahcc1 BAH domain and coiled-coil containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of BAHCC1 mRNA CTD PMID:28001369 NCBI chr10:106,020,534...106,081,698
Ensembl chr10:106,020,575...106,080,285 		JBrowse link
G Bahd1 bromo adjacent homology domain containing 1 increases expression ISO methylmercuric chloride results in increased expression of BAHD1 mRNA CTD PMID:28001369 NCBI chr 3:126,341,853...126,368,281
Ensembl chr 3:126,345,371...126,368,278 		JBrowse link
G Baiap2l1 BAR/IMD domain containing adaptor protein 2 like 1 decreases expression ISO methylmercuric chloride results in decreased expression of BAIAP2L1 mRNA CTD PMID:23179753 NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression ISO methylmercuric chloride results in increased expression of BAMBI mRNA CTD PMID:28001369 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO methylmercuric chloride results in decreased expression of BARD1 mRNA CTD PMID:28001369 NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873 		JBrowse link
G Batf3 basic leucine zipper ATF-like transcription factor 3 increases expression EXP methylmercuric chloride results in increased expression of BATF3 mRNA CTD PMID:31378766 NCBI chr13:105,220,782...105,232,365
Ensembl chr13:105,220,390...105,232,369 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of BAX mRNA
methylmercuric chloride results in increased expression of BAX protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [methylmercuric chloride results in increased expression of BAX protein]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of BAX mRNA]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of BAX protein]
methylmercuric chloride results in increased expression of BAX mRNA; methylmercuric chloride results in increased expression of BAX protein
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAX mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28821999 PMID:32061141 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A increases expression ISO methylmercuric chloride results in increased expression of BAZ1A mRNA CTD PMID:28001369 NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648 		JBrowse link
G Bbof1 basal body orientation factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of BBOF1 mRNA CTD PMID:28001369 NCBI chr 6:109,786,363...109,812,153
Ensembl chr 6:109,786,363...109,812,147 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 increases expression ISO methylmercuric chloride results in increased expression of BBOX1 mRNA CTD PMID:34089799 NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064 		JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 decreases expression ISO methylmercuric chloride results in decreased expression of BBS1 mRNA CTD PMID:28001369 NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:211,615,533...211,633,468 		JBrowse link
G Bbs12 Bardet-Biedl syndrome 12 decreases expression ISO methylmercuric chloride results in decreased expression of BBS12 mRNA CTD PMID:28001369 NCBI chr 2:122,131,550...122,149,152
Ensembl chr 2:122,137,856...122,149,153 		JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 increases expression ISO methylmercuric chloride results in increased expression of BBS9 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 8:29,288,846...29,713,889
Ensembl chr 8:29,289,997...29,713,880 		JBrowse link
G Bbx BBX high mobility group box domain containing decreases expression ISO methylmercuric chloride results in decreased expression of BBX mRNA CTD PMID:28001369 NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265 		JBrowse link
G Bcan brevican decreases expression ISO methylmercuric chloride results in decreased expression of BCAN mRNA CTD PMID:34089799 NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314 		JBrowse link
G Bcar1 BCAR1 scaffold protein, Cas family member increases expression ISO methylmercuric chloride results in increased expression of BCAR1 mRNA CTD PMID:28001369 NCBI chr19:56,588,500...56,623,190
Ensembl chr19:56,588,500...56,623,190 		JBrowse link
G Bcar3 BCAR3 adaptor protein, NSP family member decreases expression ISO methylmercuric chloride results in decreased expression of BCAR3 mRNA CTD PMID:28001369 NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302 		JBrowse link
G Bcdin3d BCDIN3 domain containing RNA methyltransferase decreases expression ISO methylmercuric chloride results in decreased expression of BCDIN3D mRNA CTD PMID:28001369 NCBI chr 7:132,484,404...132,488,998
Ensembl chr 7:132,484,431...132,488,998 		JBrowse link
G Bche butyrylcholinesterase decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of BCHE mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCHE mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bckdhb branched chain keto acid dehydrogenase E1 subunit beta decreases expression ISO methylmercuric chloride results in decreased expression of BCKDHB mRNA CTD PMID:28001369 NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor decreases expression ISO methylmercuric chloride results in decreased expression of BCL10 mRNA CTD PMID:28001369 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl11a BCL11 transcription factor A increases expression ISO methylmercuric chloride results in increased expression of BCL11A mRNA CTD PMID:28001369 NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of BCL2 mRNA; methylmercuric chloride results in decreased expression of BCL2 protein
LEP protein affects the reaction [methylmercuric chloride results in decreased expression of BCL2 protein]
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [methylmercuric chloride results in decreased expression of BCL2 protein]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of BCL2 mRNA]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of BCL2 protein]
methylmercuric chloride results in increased expression of BCL2 mRNA 		CTD PMID:23202902 PMID:28001369 PMID:28821999 PMID:32061141 PMID:33338554 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression EXP methylmercuric chloride results in decreased expression of BCL2L1 protein CTD PMID:28821999 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l10 Bcl2-like 10 increases expression ISO methylmercuric chloride results in increased expression of BCL2L10 mRNA CTD PMID:28001369 NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872 		JBrowse link
G Bcl2l11 Bcl2-like 11 increases expression ISO methylmercuric chloride results in increased expression of BCL2L11 mRNA CTD PMID:28001369 NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl3 BCL3, transcription coactivator increases expression EXP methylmercuric chloride results in increased expression of BCL3 mRNA CTD PMID:31378766 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO methylmercuric chloride results in increased expression of BCL6 mRNA CTD PMID:28001369 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bco1 beta-carotene oxygenase 1 decreases expression ISO methylmercuric chloride results in decreased expression of BCO1 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bco2 beta-carotene oxygenase 2 decreases expression ISO methylmercuric chloride results in decreased expression of BCO2 mRNA CTD PMID:23179753 NCBI chr 8:59,778,571...59,803,597
Ensembl chr 8:59,778,575...59,799,168 		JBrowse link
G Bcor BCL6 co-repressor decreases expression ISO methylmercuric chloride results in decreased expression of BCOR mRNA CTD PMID:28001369 NCBI chr  X:13,282,431...13,402,254
Ensembl chr  X:13,360,376...13,402,254 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 decreases expression ISO methylmercuric chloride results in decreased expression of BDH2 mRNA CTD PMID:28001369 NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions
affects response to substance
increases expression
decreases expression 		ISO
EXP 		diphenyldiselenide inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein]
BDNF protein affects the susceptibility to methylmercuric chloride
methylmercuric chloride results in increased expression of BDNF mRNA
[BDNF protein affects the susceptibility to methylmercuric chloride] which results in increased phosphorylation of MAPK1 protein; [BDNF protein affects the susceptibility to methylmercuric chloride] which results in increased phosphorylation of MAPK3 protein; fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein]; methylmercuric chloride promotes the reaction [HDAC4 protein binds to BDNF promoter]; MIR206 inhibits the reaction [methylmercuric chloride promotes the reaction [HDAC4 protein binds to BDNF promoter]]; MIR206 inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF mRNA]; MIR206 inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein]
methylmercuric chloride results in decreased expression of BDNF mRNA; methylmercuric chloride results in decreased expression of BDNF protein 		CTD PMID:23954720 PMID:28001369 PMID:29522201 PMID:30890323 PMID:31918252 More... NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bdp1 BDP1 general transcription factor IIIB subunit decreases expression ISO methylmercuric chloride results in decreased expression of BDP1 mRNA CTD PMID:28001369 NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241 		JBrowse link
G Bend6 BEN domain containing 6 increases expression ISO methylmercuric chloride results in increased expression of BEND6 mRNA CTD PMID:28001369 NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194 		JBrowse link
G Best4 bestrophin 4 decreases expression ISO methylmercuric chloride results in decreased expression of BEST4 mRNA CTD PMID:28001369 NCBI chr 5:135,858,774...135,865,624
Ensembl chr 5:135,860,018...135,863,707 		JBrowse link
G Bhlha15 basic helix-loop-helix family, member a15 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of BHLHA15 mRNA CTD PMID:30744511 NCBI chr12:15,534,123...15,538,299
Ensembl chr12:15,534,123...15,538,515 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of BHLHE40 mRNA
methylmercuric chloride results in increased expression of BHLHE40 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bhlhe41 basic helix-loop-helix family, member e41 increases expression ISO methylmercuric chloride results in increased expression of BHLHE41 mRNA CTD PMID:28001369 NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355 		JBrowse link
G Bicd1 BICD cargo adaptor 1 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of BICD1 mRNA
methylmercuric chloride results in decreased expression of BICD1 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:184,210,363...184,357,391 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO methylmercuric chloride results in decreased expression of BIRC5 mRNA CTD PMID:19465457 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Blcap BLCAP, apoptosis inducing factor decreases expression ISO methylmercuric chloride results in decreased expression of BLCAP mRNA CTD PMID:28001369 NCBI chr 3:166,642,676...166,656,924
Ensembl chr 3:166,642,677...166,652,829 		JBrowse link
G Bloc1s4 biogenesis of lysosomal organelles complex 1 subunit 4 decreases expression ISO methylmercuric chloride results in decreased expression of BLOC1S4 mRNA CTD PMID:28001369 NCBI chr14:78,267,735...78,269,035
Ensembl chr14:78,267,508...78,269,564 		JBrowse link
G Blvrb biliverdin reductase B increases expression ISO methylmercuric chloride results in increased expression of BLVRB mRNA CTD PMID:28001369 NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225 		JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of BMP2 mRNA
methylmercuric chloride results in increased expression of BMP2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp2k BMP-2 inducible kinase decreases expression ISO methylmercuric chloride results in decreased expression of BMP2K mRNA CTD PMID:28001369 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657 		JBrowse link
G Bmp4 bone morphogenetic protein 4 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of BMP4 mRNA
methylmercuric chloride results in increased expression of BMP4 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Bmp5 bone morphogenetic protein 5 increases expression ISO methylmercuric chloride results in increased expression of BMP5 mRNA CTD PMID:28001369 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Bmp7 bone morphogenetic protein 7 increases expression ISO methylmercuric chloride results in increased expression of BMP7 mRNA CTD PMID:28001369 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 decreases expression ISO methylmercuric chloride results in decreased expression of BMPR2 mRNA CTD PMID:28001369 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Bnc1 basonuclin zinc finger protein 1 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of BNC1 mRNA
methylmercuric chloride results in increased expression of BNC1 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr 1:145,326,881...145,352,534
Ensembl chr 1:145,326,892...145,353,510 		JBrowse link
G Bnc2 basonuclin zinc finger protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of BNC2 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428 		JBrowse link
G Bnip2 BCL2 interacting protein 2 increases expression ISO methylmercuric chloride results in increased expression of BNIP2 mRNA CTD PMID:28001369 NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368 		JBrowse link
G Bnip3 BCL2 interacting protein 3 decreases expression ISO methylmercuric chloride results in decreased expression of BNIP3 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Boc BOC cell adhesion associated, oncogene regulated affects expression
decreases expression
increases expression 		ISO methylmercuric chloride affects the expression of BOC mRNA
methylmercuric chloride results in decreased expression of BOC mRNA
methylmercuric chloride results in increased expression of BOC mRNA 		CTD PMID:21613230 PMID:28001369 NCBI chr11:69,628,703...69,704,009
Ensembl chr11:69,628,660...69,704,004 		JBrowse link
G Bphl biphenyl hydrolase like decreases expression ISO methylmercuric chloride results in decreased expression of BPHL mRNA CTD PMID:28001369 NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632 		JBrowse link
G Bpnt1 3'(2'), 5'-bisphosphate nucleotidase 1 decreases expression ISO methylmercuric chloride results in decreased expression of BPNT1 mRNA CTD PMID:28001369 NCBI chr13:99,397,127...99,425,056
Ensembl chr13:99,400,115...99,425,053 		JBrowse link
G Bptf bromodomain PHD finger transcription factor decreases expression ISO methylmercuric chloride results in decreased expression of BPTF mRNA CTD PMID:28001369 NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413 		JBrowse link
G Brca2 BRCA2, DNA repair associated decreases expression ISO methylmercuric chloride results in decreased expression of BRCA2 mRNA CTD PMID:28001369 NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194 		JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex subunit 3 decreases expression ISO methylmercuric chloride results in decreased expression of BRCC3 mRNA CTD PMID:28001369 NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185 		JBrowse link
G Brd10 bromodomain containing 10 decreases expression ISO methylmercuric chloride results in decreased expression of BRD10 mRNA CTD PMID:28001369 NCBI chr 1:236,904,520...236,984,414
Ensembl chr 1:236,904,520...236,983,923 		JBrowse link
G Brd2 bromodomain containing 2 increases expression ISO methylmercuric chloride results in increased expression of BRD2 mRNA CTD PMID:28001369 NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290 		JBrowse link
G Brd4 bromodomain containing 4 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of BRD4 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BRD4 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923 		JBrowse link
G Brd7 bromodomain containing 7 decreases expression ISO methylmercuric chloride results in decreased expression of BRD7 mRNA CTD PMID:28001369 NCBI chr19:34,882,238...34,910,944
Ensembl chr19:34,882,304...34,910,944 		JBrowse link
G Brf2 BRF2 general transcription factor 3B subunit increases expression ISO methylmercuric chloride results in increased expression of BRF2 mRNA CTD PMID:28001369 NCBI chr16:71,626,146...71,635,909
Ensembl chr16:71,623,238...71,635,903 		JBrowse link
G Bri3bp Bri3 binding protein decreases expression ISO methylmercuric chloride results in decreased expression of BRI3BP mRNA CTD PMID:28001369 NCBI chr12:36,838,098...36,849,919
Ensembl chr12:36,838,098...36,849,919 		JBrowse link
G Brinp1 BMP/retinoic acid inducible neural specific 1 increases expression ISO methylmercuric chloride results in increased expression of BRINP1 mRNA CTD PMID:23179753 NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256 		JBrowse link
G Brip1 BRCA1 interacting DNA helicase 1 decreases expression ISO methylmercuric chloride results in decreased expression of BRIP1 mRNA CTD PMID:28001369 NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206 		JBrowse link
G Brk1 BRICK1 subunit of SCAR/WAVE actin nucleating complex decreases expression ISO methylmercuric chloride results in decreased expression of BRK1 mRNA CTD PMID:28001369 NCBI chr 4:148,306,436...148,321,668
Ensembl chr 4:148,306,398...148,321,984 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of BRWD1 mRNA CTD PMID:28001369 NCBI chr11:48,756,174...48,853,692
Ensembl chr11:48,756,811...48,848,256 		JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin increases expression ISO methylmercuric chloride results in increased expression of BSCL2 mRNA CTD PMID:27188386 NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536 		JBrowse link
G Bst1 bone marrow stromal cell antigen 1 increases expression ISO methylmercuric chloride results in increased expression of BST1 mRNA CTD PMID:28001369 NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO methylmercuric chloride results in decreased expression of BST2 mRNA CTD PMID:23179753 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btbd8 BTB domain containing 8 decreases expression ISO methylmercuric chloride results in decreased expression of BTBD8 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr14:2,410,093...2,483,114
Ensembl chr14:2,410,093...2,479,202 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression ISO methylmercuric chloride results in increased expression of BTG3 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082 		JBrowse link
G Btrc beta-transducin repeat containing E3 ubiquitin protein ligase decreases expression ISO methylmercuric chloride results in decreased expression of BTRC mRNA CTD PMID:20061341 PMID:28001369 NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:254,159,124...254,328,357 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of BUB1 mRNA
methylmercuric chloride results in decreased expression of BUB1 mRNA 		CTD PMID:26272509 PMID:34089799 NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921 		JBrowse link
G C10h17orf99 similar to human chromosome 17 open reading frame 99 increases expression ISO methylmercuric chloride results in increased expression of C17ORF99 mRNA CTD PMID:28001369 NCBI chr10:103,514,067...103,526,132
Ensembl chr10:103,515,201...103,525,878 		JBrowse link
G C11h22orf39 similar to human chromosome 22 open reading frame 39 decreases expression ISO methylmercuric chloride results in decreased expression of C22ORF39 mRNA CTD PMID:28001369 NCBI chr11:95,660,135...95,665,750
Ensembl chr11:95,663,881...95,664,588 		JBrowse link
G C11h3orf38 similar to human chromosome 3 open reading frame 38 decreases expression ISO methylmercuric chloride results in decreased expression of C3ORF38 mRNA CTD PMID:28001369 NCBI chr11:15,930,504...15,935,152
Ensembl chr11:15,783,138...15,935,152 		JBrowse link
G C11h3orf70 similar to human chromosome 3 open reading frame 70 decreases expression ISO methylmercuric chloride results in decreased expression of C3ORF70 mRNA CTD PMID:28001369 NCBI chr11:92,850,327...92,900,608
Ensembl chr11:92,850,327...92,900,608 		JBrowse link
G C12h12orf76 similar to human chromosome 12 open reading frame 76 decreases expression ISO methylmercuric chloride results in decreased expression of C12ORF76 mRNA CTD PMID:28001369 NCBI chr12:47,452,148...47,456,832
Ensembl chr12:47,452,016...47,456,829 		JBrowse link
G C13h1orf21 similar to human chromosome 1 open reading frame 21 decreases expression ISO methylmercuric chloride results in decreased expression of C1ORF21 mRNA CTD PMID:28001369 NCBI chr13:66,540,245...66,749,631
Ensembl chr13:66,540,245...66,659,684 		JBrowse link
G C13h1orf53 similar to human chromosome 1 open reading frame 53 decreases expression ISO methylmercuric chloride results in decreased expression of C1ORF53 mRNA CTD PMID:28001369 NCBI chr13:52,965,244...52,970,432
Ensembl chr13:52,965,244...52,970,607 		JBrowse link
G C15h14orf93 similar to human chromosome 14 open reading frame 93 decreases expression ISO methylmercuric chloride results in decreased expression of C14ORF93 mRNA CTD PMID:28001369 NCBI chr15:32,007,591...32,034,337
Ensembl chr15:32,007,595...32,034,289 		JBrowse link
G C16h8orf48 similar to human chromosome 8 open reading frame 48 decreases expression ISO methylmercuric chloride results in decreased expression of C8ORF48 mRNA CTD PMID:28001369 NCBI chr16:61,948,170...61,950,066
Ensembl chr16:61,879,158...61,971,067 		JBrowse link
G C17h5orf24 similar to human chromosome 5 open reading frame 24 decreases expression ISO methylmercuric chloride results in decreased expression of C5ORF24 mRNA CTD PMID:28001369 NCBI chr17:8,928,209...8,938,126
Ensembl chr17:8,929,936...8,932,379 		JBrowse link
G C17h7orf25 similar to human chromosome 7 open reading frame 25 decreases expression ISO methylmercuric chloride results in decreased expression of C7ORF25 mRNA CTD PMID:28001369 NCBI chr17:55,238,751...55,245,399
Ensembl chr17:55,236,313...55,246,284 		JBrowse link
G C18h18orf54 similar to human chromosome 18 open reading frame 54 decreases expression ISO methylmercuric chloride results in decreased expression of C18ORF54 mRNA CTD PMID:28001369 NCBI chr18:66,340,567...66,364,831
Ensembl chr18:66,340,567...66,362,348 		JBrowse link
G C19h16orf87 similar to human chromosome 16 open reading frame 87 decreases expression ISO methylmercuric chloride results in decreased expression of C16ORF87 mRNA CTD PMID:28001369 NCBI chr19:37,800,187...37,827,091
Ensembl chr19:37,799,799...37,827,452 		JBrowse link
G C1galt1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 increases expression ISO methylmercuric chloride results in increased expression of C1GALT1 mRNA CTD PMID:28001369 NCBI chr 4:36,894,440...36,932,434
Ensembl chr 4:36,894,488...36,932,441 		JBrowse link
G C1h10orf143 similar to human chromosome 10 open reading frame 143 decreases expression ISO methylmercuric chloride results in decreased expression of C10ORF143 mRNA CTD PMID:28001369 NCBI chr 1:201,614,151...201,654,142
Ensembl chr 1:201,561,396...201,652,127 		JBrowse link
G C1h11orf98 similar to human chromosome 11 open reading frame 98 increases expression ISO methylmercuric chloride results in increased expression of C11ORF98 mRNA CTD PMID:34089799 NCBI chr 1:215,211,658...215,213,687
Ensembl chr 1:215,211,688...215,213,687 		JBrowse link
G C1h19orf18 similar to human chromosome 19 open reading frame 18 increases expression ISO methylmercuric chloride results in increased expression of C19ORF18 mRNA CTD PMID:28001369 NCBI chr 1:82,094,513...82,122,109
Ensembl chr 1:82,098,305...82,122,119 		JBrowse link
G C1h19orf33 similar to human chromosome 19 open reading frame 33 increases expression ISO methylmercuric chloride results in increased expression of C19ORF33 mRNA CTD PMID:28001369 NCBI chr 1:93,677,305...93,678,141
Ensembl chr 1:93,677,305...93,678,141 		JBrowse link
G C1h6orf118 similar to human chromosome 6 open reading frame 118 decreases expression ISO methylmercuric chloride results in decreased expression of C6ORF118 mRNA CTD PMID:28001369 NCBI chr 1:54,287,934...54,311,640
Ensembl chr 1:54,287,936...54,311,847 		JBrowse link
G C1h9orf40 similar to human chromosome 9 open reading frame 40 decreases expression ISO methylmercuric chloride results in decreased expression of C9ORF40 mRNA CTD PMID:28001369 NCBI chr 1:225,555,300...225,559,509
Ensembl chr 1:225,555,280...225,559,693 		JBrowse link
G C1rl complement C1r subcomponent like decreases expression ISO methylmercuric chloride results in decreased expression of C1RL mRNA CTD PMID:28001369 NCBI chr 4:159,080,495...159,097,066
Ensembl chr 4:159,080,495...159,097,066 		JBrowse link
G C1s complement C1s increases expression ISO methylmercuric chloride results in increased expression of C1S mRNA CTD PMID:28001369 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C20h6orf89 similar to human chromosome 6 open reading frame 89 decreases expression ISO methylmercuric chloride results in decreased expression of C6ORF89 mRNA CTD PMID:28001369 NCBI chr20:7,324,105...7,368,482
Ensembl chr20:7,324,129...7,363,666 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO methylmercuric chloride results in decreased expression of C2CD2 mRNA CTD PMID:28001369 NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016 		JBrowse link
G C2cd5 C2 calcium-dependent domain containing 5 increases expression EXP methylmercuric chloride results in increased expression of C2CD5 mRNA CTD PMID:20864626 NCBI chr 4:177,700,515...177,790,576
Ensembl chr 4:177,700,516...177,786,717 		JBrowse link
G C2h4orf33 similar to human chromosome 4 open reading frame 33 decreases expression ISO methylmercuric chloride results in decreased expression of C4ORF33 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 2:126,692,176...126,769,183
Ensembl chr 2:126,697,854...126,746,878 		JBrowse link
G C3 complement C3 increases expression EXP methylmercuric chloride results in increased expression of C3 mRNA CTD PMID:31378766 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C3ar1 complement C3a receptor 1 increases expression EXP methylmercuric chloride results in increased expression of C3AR1 mRNA CTD PMID:31378766 NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323 		JBrowse link
G C4a complement C4A (Rodgers blood group) increases expression EXP methylmercuric chloride results in increased expression of C4A mRNA CTD PMID:31378766 NCBI chr20:4,010,306...4,024,707 JBrowse link
G C4b complement C4B increases expression EXP methylmercuric chloride results in increased expression of C4B mRNA CTD PMID:31378766 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C4h12orf60 similar to human chromosome 12 open reading frame 60 decreases expression ISO methylmercuric chloride results in decreased expression of C12ORF60 mRNA CTD PMID:28001369 NCBI chr 4:171,450,603...171,462,735
Ensembl chr 4:171,425,040...171,484,498 		JBrowse link
G C4h2orf68 similar to human chromosome 2 open reading frame 68 decreases expression ISO methylmercuric chloride results in decreased expression of C2ORF68 mRNA CTD PMID:28001369 NCBI chr 4:105,960,543...105,966,509
Ensembl chr 4:105,960,751...105,966,508 		JBrowse link
G C5 complement C5 decreases expression ISO methylmercuric chloride results in decreased expression of C5 mRNA CTD PMID:28001369 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5h8orf88 similar to human chromosome 8 open reading frame 88 decreases expression ISO methylmercuric chloride results in decreased expression of C8ORF88 mRNA CTD PMID:27188386 NCBI chr 5:33,127,385...33,152,914
Ensembl chr 5:33,126,632...33,174,768 		JBrowse link
G C6 complement C6 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of C6 mRNA CTD PMID:30744511 NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120 		JBrowse link
G C8h11orf97 similar to human chromosome 11 open reading frame 97 increases expression ISO methylmercuric chloride results in increased expression of C11ORF97 mRNA CTD PMID:28001369 NCBI chr 8:19,884,682...19,901,931
Ensembl chr 8:19,883,390...19,902,044 		JBrowse link
G C9h2orf15 similar to human chromosome 2 open reading frame 15 decreases expression ISO methylmercuric chloride results in decreased expression of C2ORF15 mRNA CTD PMID:28001369 NCBI chr 9:47,596,762...47,601,833 JBrowse link
G C9h2orf49 similar to human chromosome 2 open reading frame 49 increases expression ISO methylmercuric chloride results in increased expression of C2ORF49 mRNA CTD PMID:28001369 NCBI chr 9:52,863,565...52,874,234
Ensembl chr 9:52,863,542...52,874,234 		JBrowse link
G Ca13 carbonic anhydrase 13 decreases expression ISO methylmercuric chloride results in decreased expression of CA13 mRNA CTD PMID:28001369 NCBI chr 2:88,649,643...88,680,763
Ensembl chr 2:88,649,625...88,680,763 		JBrowse link
G Ca4 carbonic anhydrase 4 decreases expression ISO methylmercuric chloride results in decreased expression of CA4 mRNA CTD PMID:28001369 NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916 		JBrowse link
G Ca5b carbonic anhydrase 5B decreases expression ISO methylmercuric chloride results in decreased expression of CA5B mRNA CTD PMID:28001369 NCBI chr  X:34,106,553...34,166,651
Ensembl chr  X:34,067,403...34,166,653 		JBrowse link
G Cab39l calcium binding protein 39-like increases expression ISO methylmercuric chloride results in increased expression of CAB39L mRNA CTD PMID:28001369 NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742 		JBrowse link
G Cables1 Cdk5 and Abl enzyme substrate 1 increases expression ISO methylmercuric chloride results in increased expression of CABLES1 mRNA CTD PMID:28001369 NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956 		JBrowse link
G Cabyr calcium binding tyrosine phosphorylation regulated increases expression ISO methylmercuric chloride results in increased expression of CABYR mRNA CTD PMID:28001369 NCBI chr18:4,166,790...4,178,570
Ensembl chr18:4,166,858...4,179,507 		JBrowse link
G Cachd1 cache domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of CACHD1 mRNA CTD PMID:28001369 NCBI chr 5:120,527,224...120,752,685
Ensembl chr 5:120,526,770...120,772,877 		JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G increases expression ISO methylmercuric chloride results in increased expression of CACNA1G mRNA CTD PMID:27188386 NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634 		JBrowse link
G Cacnb2 calcium voltage-gated channel auxiliary subunit beta 2 decreases expression ISO methylmercuric chloride results in decreased expression of CACNB2 mRNA CTD PMID:28001369 NCBI chr17:82,473,097...82,818,564
Ensembl chr17:82,473,129...82,818,564 		JBrowse link
G Cadm2 cell adhesion molecule 2 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CADM2 mRNA
methylmercuric chloride results in decreased expression of CADM2 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr11:17,994,856...18,971,895
Ensembl chr11:17,994,856...18,971,448 		JBrowse link
G Cadps calcium dependent secretion activator increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CADPS mRNA
methylmercuric chloride results in decreased expression of CADPS mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr15:14,719,078...15,173,218
Ensembl chr15:14,720,726...15,173,211 		JBrowse link
G Cadps2 calcium dependent secretion activator 2 decreases expression ISO methylmercuric chloride results in decreased expression of CADPS2 mRNA CTD PMID:28001369 NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004 		JBrowse link
G Calb2 calbindin 2 increases expression ISO methylmercuric chloride results in increased expression of CALB2 mRNA CTD PMID:28001369 PMID:34089799 NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression ISO methylmercuric chloride results in increased expression of CALCA mRNA CTD PMID:28001369 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calcb calcitonin-related polypeptide, beta increases expression ISO methylmercuric chloride results in increased expression of CALCB mRNA CTD PMID:28001369 NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654 		JBrowse link
G Cald1 caldesmon 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CALD1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALD1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085 		JBrowse link
G Calm1 calmodulin 1 increases expression ISO methylmercuric chloride results in increased expression of CALM1 mRNA CTD PMID:28001369 NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381 		JBrowse link
G Calml4 calmodulin-like 4 increases expression ISO methylmercuric chloride results in increased expression of CALML4 mRNA CTD PMID:28001369 NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650 		JBrowse link
G Calu calumenin increases expression ISO methylmercuric chloride results in increased expression of CALU mRNA CTD PMID:28001369 NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956 		JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID decreases expression ISO methylmercuric chloride results in decreased expression of CAMK1D mRNA CTD PMID:28001369 NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CAMK2D mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAMK2D mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 decreases expression ISO methylmercuric chloride results in decreased expression of CAMK2N1 mRNA CTD PMID:28001369 NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:155,957,878...155,961,058 		JBrowse link
G Camp cathelicidin antimicrobial peptide increases expression EXP methylmercuric chloride results in increased expression of CAMP mRNA CTD PMID:31378766 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Camsap1 calmodulin regulated spectrin-associated protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CAMSAP1 mRNA CTD PMID:28001369 NCBI chr 3:29,144,318...29,206,382
Ensembl chr 3:29,144,318...29,204,184 		JBrowse link
G Camta1 calmodulin binding transcription activator 1 increases expression ISO methylmercuric chloride results in increased expression of CAMTA1 mRNA CTD PMID:28001369 NCBI chr 5:166,791,639...167,639,502
Ensembl chr 5:166,793,101...167,639,733 		JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 decreases expression ISO methylmercuric chloride results in decreased expression of CAND1 mRNA CTD PMID:28001369 NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655 		JBrowse link
G Canx calnexin increases expression ISO methylmercuric chloride results in increased expression of CANX mRNA CTD PMID:26272509 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Capn2 calpain 2 increases expression ISO methylmercuric chloride results in increased expression of CAPN2 mRNA CTD PMID:28001369 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Capn6 calpain 6 decreases expression ISO methylmercuric chloride results in decreased expression of CAPN6 mRNA CTD PMID:28001369 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capn7 calpain 7 decreases expression ISO methylmercuric chloride results in decreased expression of CAPN7 mRNA CTD PMID:28001369 NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,552,049...6,588,316 		JBrowse link
G Caprin1 cell cycle associated protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CAPRIN1 mRNA CTD PMID:28001369 NCBI chr 3:110,606,489...110,685,408
Ensembl chr 3:110,606,489...110,685,562 		JBrowse link
G Caps calcyphosine increases expression ISO methylmercuric chloride results in increased expression of CAPS mRNA CTD PMID:34089799 NCBI chr 9:1,630,871...1,632,758 JBrowse link
G Caps2 calcyphosine 2 decreases expression ISO methylmercuric chloride results in decreased expression of CAPS2 mRNA CTD PMID:28001369 NCBI chr 7:49,467,320...49,525,465
Ensembl chr 7:49,464,885...49,525,465 		JBrowse link
G Car10 carbonic anhydrase 10 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CA10 mRNA
methylmercuric chloride results in decreased expression of CA10 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr10:78,551,067...79,053,421
Ensembl chr10:78,551,067...79,053,421 		JBrowse link
G Card19 caspase recruitment domain family, member 19 increases expression ISO methylmercuric chloride results in increased expression of CARD19 mRNA CTD PMID:28001369 NCBI chr17:15,638,973...15,651,720
Ensembl chr17:15,639,012...15,651,720 		JBrowse link
G Card6 caspase recruitment domain family, member 6 increases expression ISO methylmercuric chloride results in increased expression of CARD6 mRNA CTD PMID:28001369 NCBI chr 2:55,921,832...55,934,388
Ensembl chr 2:55,921,832...55,934,363 		JBrowse link
G Carf calcium responsive transcription factor decreases expression ISO methylmercuric chloride results in decreased expression of CARF mRNA CTD PMID:28001369 NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479 		JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CARHSP1 mRNA CTD PMID:28001369 NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770 		JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CARM1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARM1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:28,373,362...28,418,056 		JBrowse link
G Carmil1 capping protein regulator and myosin 1 linker 1 decreases expression ISO methylmercuric chloride results in decreased expression of CARMIL1 mRNA CTD PMID:28001369 NCBI chr17:41,235,819...41,516,204
Ensembl chr17:41,236,229...41,516,221 		JBrowse link
G Carnmt1 carnosine N-methyltransferase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CARNMT1 mRNA CTD PMID:23179753 NCBI chr 1:225,520,345...225,549,971
Ensembl chr 1:225,520,151...225,550,232 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression ISO methylmercuric chloride results in increased expression of CARS1 mRNA CTD PMID:28001369 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Cars2 cysteinyl-tRNA synthetase 2, mitochondrial increases expression ISO methylmercuric chloride results in increased expression of CARS2 mRNA CTD PMID:28001369 NCBI chr16:84,649,617...84,689,254
Ensembl chr16:84,645,627...84,690,192 		JBrowse link
G Cartpt CART prepropeptide increases expression ISO methylmercuric chloride results in increased expression of CARTPT mRNA CTD PMID:34089799 NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712 		JBrowse link
G Casp12 caspase 12 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of CASP12 protein
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CASP12 mRNA
Acetylcysteine inhibits the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; HSP90B1 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; HSPA5 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; XBP1 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein] 		CTD PMID:30744511 PMID:31330229 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 increases activity
increases cleavage
multiple interactions
increases expression
decreases activity 		EXP
ISO 		methylmercuric chloride results in increased activity of CASP3 protein
methylmercuric chloride results in increased cleavage of CASP3 protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein]; naringenin inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 mRNA]; Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein]
methylmercuric chloride results in increased expression of CASP3 mRNA; methylmercuric chloride results in increased expression of CASP3 protein; methylmercuric chloride results in increased expression of CASP3 protein modified form
[[lead chloride results in increased abundance of Lead] which co-treated with methylmercuric chloride] results in increased expression of CASP3 protein; [methylmercuric chloride co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of CASP3 protein; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [methylmercuric chloride results in increased activity of CASP3 protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; HSP90B1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; HSPA5 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; XBP1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]
methylmercuric chloride results in decreased activity of CASP3 protein
methylmercuric chloride results in increased expression of CASP3 mRNA; methylmercuric chloride results in increased expression of CASP3 protein modified form 		CTD PMID:17760861 PMID:23202902 PMID:26272509 PMID:27178136 PMID:27667695 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp7 caspase 7 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CASP7 mRNA; methylmercuric chloride results in increased expression of CASP7 protein modified form
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; HSP90B1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; HSPA5 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; XBP1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form] 		CTD PMID:23202902 PMID:31330229 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 increases expression ISO methylmercuric chloride results in increased expression of CASP8 mRNA CTD PMID:28001369 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp9 caspase 9 increases activity
multiple interactions
increases cleavage
increases expression 		ISO
EXP 		methylmercuric chloride results in increased activity of CASP9 protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [methylmercuric chloride results in increased cleavage of CASP9 protein]
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP9 protein modified form] 		CTD PMID:27178136 PMID:31330229 PMID:35678294 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cast calpastatin decreases expression ISO methylmercuric chloride results in decreased expression of CAST mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180 		JBrowse link
G Cat catalase increases expression
decreases expression
multiple interactions
decreases activity 		ISO
EXP 		methylmercuric chloride results in increased expression of CAT mRNA
methylmercuric chloride results in decreased expression of CAT protein
[[lead chloride results in increased abundance of Lead] which co-treated with methylmercuric chloride] results in increased expression of CAT protein; [methylmercuric chloride co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of CAT protein
methylmercuric chloride results in decreased activity of CAT protein
alpha-Linolenic Acid inhibits the reaction [methylmercuric chloride results in decreased activity of CAT protein]; Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of CAT protein]; Curcumin inhibits the reaction [methylmercuric chloride results in decreased activity of CAT protein]; eleostearic acid inhibits the reaction [methylmercuric chloride results in decreased activity of CAT protein] 		CTD PMID:19468715 PMID:20061341 PMID:22269903 PMID:29258870 PMID:31330227 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav1 caveolin 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CAV1 mRNA CTD PMID:30744511 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav2 caveolin 2 increases expression ISO methylmercuric chloride results in increased expression of CAV2 mRNA CTD PMID:28001369 NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Cavin1 caveolae associated protein 1 increases expression ISO methylmercuric chloride results in increased expression of CAVIN1 mRNA CTD PMID:28001369 NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383 		JBrowse link
G Cavin3 caveolae associated protein 3 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of CAVIN3 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of PRKCDBP mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of PRKCDBP mRNA 		CTD PMID:23179753 PMID:30744511 NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981 		JBrowse link
G Cbfa2t2 CBFA2/RUNX1 partner transcriptional co-repressor 2 increases expression ISO methylmercuric chloride results in increased expression of CBFA2T2 mRNA CTD PMID:28001369 NCBI chr 3:163,397,160...163,503,409
Ensembl chr 3:163,397,185...163,503,407 		JBrowse link
G Cbfb core-binding factor subunit beta increases expression ISO methylmercuric chloride results in increased expression of CBFB mRNA CTD PMID:28001369 NCBI chr19:49,955,133...50,002,661
Ensembl chr19:49,959,096...50,002,657 		JBrowse link
G Cbl Cbl proto-oncogene increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CBL mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBL mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067 		JBrowse link
G Cblc Cbl proto-oncogene C decreases expression ISO methylmercuric chloride results in decreased expression of CBLC mRNA CTD PMID:20061341 NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709 		JBrowse link
G Cbr1 carbonyl reductase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CBR1 mRNA CTD PMID:27188386 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Cbr4 carbonyl reductase 4 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CBR4 mRNA
methylmercuric chloride results in decreased expression of CBR4 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr16:33,625,734...33,695,067
Ensembl chr16:33,617,399...33,656,832 		JBrowse link
G Cbs cystathionine beta synthase increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CBS mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBS mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066 		JBrowse link
G Cbx4 chromobox 4 increases expression ISO methylmercuric chloride results in increased expression of CBX4 mRNA CTD PMID:28001369 NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727 		JBrowse link
G Cbx5 chromobox 5 decreases expression ISO methylmercuric chloride results in decreased expression of CBX5 mRNA CTD PMID:28001369 NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118 		JBrowse link
G Cbx6 chromobox 6 decreases expression ISO methylmercuric chloride results in decreased expression of CBX6 mRNA CTD PMID:28001369 NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413 		JBrowse link
G Cc2d2a coiled-coil and C2 domain containing 2A decreases expression ISO methylmercuric chloride results in decreased expression of CC2D2A mRNA CTD PMID:28001369 NCBI chr14:71,563,835...71,648,352
Ensembl chr14:71,563,835...71,648,331 		JBrowse link
G Ccar1 cell division cycle and apoptosis regulator 1 decreases expression ISO methylmercuric chloride results in decreased expression of CCAR1 mRNA CTD PMID:28001369 NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227 		JBrowse link
G Ccar2 cell cycle and apoptosis regulator 2 decreases expression ISO methylmercuric chloride results in decreased expression of CCAR2 mRNA CTD PMID:28001369 NCBI chr15:51,622,519...51,637,911
Ensembl chr15:51,622,464...51,637,774 		JBrowse link
G Ccdc110 coiled-coil domain containing 110 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC110 mRNA CTD PMID:28001369 NCBI chr16:53,048,305...53,069,606
Ensembl chr16:53,047,965...53,069,777 		JBrowse link
G Ccdc121 coiled-coil domain containing 121 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC121 mRNA CTD PMID:28001369 NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437 		JBrowse link
G Ccdc136 coiled-coil domain containing 136 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC136 mRNA CTD PMID:28001369 NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975 		JBrowse link
G Ccdc146 coiled-coil domain containing 146 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC146 mRNA CTD PMID:28001369 NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:14,554,966...14,703,799 		JBrowse link
G Ccdc148 coiled-coil domain containing 148 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC148 mRNA CTD PMID:28001369 NCBI chr 3:63,765,656...64,040,802
Ensembl chr 3:63,765,668...64,040,757 		JBrowse link
G Ccdc15 coiled-coil domain containing 15 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC15 mRNA CTD PMID:28001369 NCBI chr 8:45,165,297...45,257,641
Ensembl chr 8:45,134,596...45,277,989 		JBrowse link
G Ccdc152 coiled-coil domain containing 152 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC152 mRNA CTD PMID:28001369 NCBI chr 2:54,236,013...54,260,531
Ensembl chr 2:54,236,013...54,264,065 		JBrowse link
G Ccdc158 coiled-coil domain containing 158 increases expression ISO methylmercuric chloride results in increased expression of CCDC158 mRNA CTD PMID:28001369 NCBI chr14:15,695,456...15,752,896
Ensembl chr14:15,695,512...15,752,941 		JBrowse link
G Ccdc169 coiled-coil domain containing 169 decreases expression
multiple interactions
increases expression 		ISO methylmercuric chloride results in decreased expression of CCDC169 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCDC169 mRNA
methylmercuric chloride results in increased expression of CCDC169 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 2:141,471,762...141,501,325
Ensembl chr 2:141,471,810...141,501,325 		JBrowse link
G Ccdc171 coiled-coil domain containing 171 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC171 mRNA CTD PMID:28001369 NCBI chr 5:102,965,763...103,449,740
Ensembl chr 5:102,965,911...103,533,290 		JBrowse link
G Ccdc174 coiled-coil domain containing 174 decreases expression EXP methylmercuric chloride results in decreased expression of CCDC174 mRNA CTD PMID:20864626 NCBI chr 4:125,949,203...125,976,179
Ensembl chr 4:125,949,420...125,976,178 		JBrowse link
G Ccdc177 coiled-coil domain containing 177 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC177 mRNA CTD PMID:28001369 NCBI chr 6:106,135,827...106,142,413
Ensembl chr 6:106,134,333...106,144,441 		JBrowse link
G Ccdc18 coiled-coil domain containing 18 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC18 mRNA CTD PMID:28001369 NCBI chr14:1,646,725...1,752,581
Ensembl chr14:1,646,809...1,750,470 		JBrowse link
G Ccdc180 coiled-coil domain containing 180 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC180 mRNA CTD PMID:28001369 NCBI chr 5:64,950,522...65,019,127
Ensembl chr 5:64,950,515...65,019,127 		JBrowse link
G Ccdc183 coiled-coil domain containing 183 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC183 mRNA CTD PMID:28001369 NCBI chr 3:28,826,918...28,837,072
Ensembl chr 3:28,826,921...28,835,326 		JBrowse link
G Ccdc191 coiled-coil domain containing 191 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC191 mRNA CTD PMID:28001369 NCBI chr11:70,241,562...70,312,288
Ensembl chr11:70,241,562...70,312,431 		JBrowse link
G Ccdc50 coiled-coil domain containing 50 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC50 mRNA CTD PMID:28001369 NCBI chr11:86,837,624...86,900,164
Ensembl chr11:86,837,624...86,899,980 		JBrowse link
G Ccdc71l coiled-coil domain containing 71-like increases expression ISO methylmercuric chloride results in increased expression of CCDC71L mRNA CTD PMID:23179753 NCBI chr 6:54,687,474...54,691,566
Ensembl chr 6:54,617,540...55,014,344 		JBrowse link
G Ccdc74a coiled-coil domain containing 74A decreases expression ISO methylmercuric chloride results in decreased expression of CCDC74A mRNA CTD PMID:28001369 NCBI chr11:96,860,161...96,864,540
Ensembl chr11:96,860,161...96,864,540 		JBrowse link
G Ccdc91 coiled-coil domain containing 91 decreases expression ISO methylmercuric chloride results in decreased expression of CCDC91 mRNA CTD PMID:26272509 NCBI chr 4:182,132,931...182,304,948
Ensembl chr 4:182,132,942...182,304,948 		JBrowse link
G Ccdc93 coiled-coil domain containing 93 increases expression ISO methylmercuric chloride results in increased expression of CCDC93 mRNA CTD PMID:28001369 NCBI chr13:35,160,354...35,233,877
Ensembl chr13:35,160,363...35,233,875 		JBrowse link
G Cchcr1 coiled-coil alpha-helical rod protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CCHCR1 mRNA CTD PMID:28001369 NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,210,384...3,222,765 		JBrowse link
G Cck cholecystokinin increases expression ISO methylmercuric chloride results in increased expression of CCK mRNA CTD PMID:34089799 NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CCL11 mRNA CTD PMID:24213012 PMID:31378766 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of CCL12 mRNA
MT3 protein affects the reaction [methylmercuric chloride results in increased expression of CCL12 mRNA] 		CTD PMID:24213012 PMID:30103553 PMID:31378766 NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 increases expression ISO methylmercuric chloride results in increased expression of CCL17 mRNA CTD PMID:24213012 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
decreases expression
affects expression 		ISO methylmercuric chloride results in increased expression of CCL2 mRNA
methylmercuric chloride results in decreased expression of CCL2 mRNA
methylmercuric chloride affects the expression of CCL2 mRNA 		CTD PMID:24213012 PMID:34089799 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression EXP methylmercuric chloride results in increased expression of CCL20 protein CTD PMID:28526320 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CCL3 mRNA
[MT3 protein affects the susceptibility to methylmercuric chloride] which affects the expression of CCL3 mRNA 		CTD PMID:24213012 PMID:30103553 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO methylmercuric chloride results in increased expression of CCL4 mRNA CTD PMID:24213012 PMID:30103553 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of CCL5 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CCL5 mRNA
methylmercuric chloride results in increased expression of CCL5 protein 		CTD PMID:24213012 PMID:28526320 PMID:29581082 PMID:30744511 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CCL7 mRNA CTD PMID:24213012 PMID:30103553 PMID:31378766 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO methylmercuric chloride results in increased expression of CCN1 mRNA CTD PMID:28001369 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO methylmercuric chloride results in increased expression of CCN2 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn4 cellular communication network factor 4 decreases expression ISO methylmercuric chloride results in decreased expression of CCN4 mRNA CTD PMID:23179753 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccna1 cyclin A1 increases expression ISO methylmercuric chloride results in increased expression of CCNA1 mRNA CTD PMID:28001369 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccna2 cyclin A2 decreases expression ISO methylmercuric chloride results in decreased expression of CCNA2 mRNA CTD PMID:20061341 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO methylmercuric chloride results in decreased expression of CCNB1 mRNA CTD PMID:20061341 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb1ip1 cyclin B1 interacting protein 1 affects expression ISO methylmercuric chloride affects the expression of CCNB1IP1 mRNA CTD PMID:21613230 NCBI chr15:26,488,462...26,504,167
Ensembl chr15:26,488,465...26,502,028 		JBrowse link
G Ccnb2 cyclin B2 decreases expression ISO methylmercuric chloride results in decreased expression of CCNB2 mRNA CTD PMID:20061341 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnc cyclin C decreases expression ISO methylmercuric chloride results in decreased expression of CCNC mRNA CTD PMID:28001369 NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
affects expression
multiple interactions
increases expression 		EXP
ISO 		methylmercuric chloride results in decreased expression of CCND1 protein
methylmercuric chloride affects the expression of CCND1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCND1 mRNA
methylmercuric chloride results in increased expression of CCND1 mRNA; methylmercuric chloride results in increased expression of CCND1 protein 		CTD PMID:17760861 PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 increases expression ISO methylmercuric chloride results in increased expression of CCND2 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccnd3 cyclin D3 decreases expression
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of CCND3 mRNA
methylmercuric chloride results in increased expression of CCND3 mRNA
methylmercuric chloride results in decreased expression of CCND3 protein 		CTD PMID:17760861 PMID:20061341 PMID:28001369 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Ccne1 cyclin E1 increases cleavage
decreases expression 		EXP methylmercuric chloride results in increased cleavage of CCNE1 protein
methylmercuric chloride results in decreased expression of CCNE1 protein 		CTD PMID:17760861 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccne2 cyclin E2 decreases expression ISO methylmercuric chloride results in decreased expression of CCNE2 mRNA CTD PMID:20061341 NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882 		JBrowse link
G Ccng2 cyclin G2 decreases expression ISO methylmercuric chloride results in decreased expression of CCNG2 mRNA CTD PMID:28001369 NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206 		JBrowse link
G Ccnl1 cyclin L1 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of CCNL1 mRNA
methylmercuric chloride results in increased expression of CCNL1 mRNA 		CTD PMID:28001369 NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468 		JBrowse link
G Ccno cyclin O increases expression ISO methylmercuric chloride results in increased expression of CCNO mRNA CTD PMID:34089799 NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:46,350,717...46,367,113 		JBrowse link
G Ccnt1 cyclin T1 decreases expression ISO methylmercuric chloride results in decreased expression of CCNT1 mRNA CTD PMID:19465457 NCBI chr 7:131,566,176...131,596,988
Ensembl chr 7:131,566,176...131,596,938 		JBrowse link
G Ccnt2 cyclin T2 decreases expression ISO methylmercuric chloride results in decreased expression of CCNT2 mRNA CTD PMID:28001369 NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488 		JBrowse link
G Ccpg1 cell cycle progression 1 decreases expression ISO methylmercuric chloride results in decreased expression of CCPG1 mRNA CTD PMID:28001369 NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246 		JBrowse link
G Cct6b chaperonin containing TCP1 subunit 6B decreases expression ISO methylmercuric chloride results in decreased expression of CCT6B mRNA CTD PMID:28001369 NCBI chr10:68,150,111...68,198,932
Ensembl chr10:68,150,111...68,198,847 		JBrowse link
G Ccz1 CCZ1 homolog, vacuolar protein trafficking and biogenesis associated decreases expression EXP methylmercuric chloride results in decreased expression of CCZ1 mRNA CTD PMID:20864626 NCBI chr12:15,714,768...15,738,273
Ensembl chr12:15,714,748...15,738,268 		JBrowse link
G Cd14 CD14 molecule increases expression EXP methylmercuric chloride results in increased expression of CD14 mRNA CTD PMID:31378766 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd164 CD164 molecule increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CD164 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD164 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr20:46,606,439...46,618,015
Ensembl chr20:46,606,107...46,638,649 		JBrowse link
G Cd24 CD24 molecule increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CD24 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD24 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd2ap CD2-associated protein decreases expression ISO methylmercuric chloride results in decreased expression of CD2AP mRNA CTD PMID:23179753 NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968 		JBrowse link
G Cd36 CD36 molecule multiple interactions ISO [Cadmium Chloride co-treated with methylmercuric chloride] results in increased expression of CD36 mRNA CTD PMID:27814245 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd3g CD3 gamma subunit of T-cell receptor complex increases expression EXP methylmercuric chloride results in increased expression of CD3G mRNA CTD PMID:31378766 NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918 		JBrowse link
G Cd44 CD44 molecule increases expression ISO methylmercuric chloride results in increased expression of CD44 mRNA CTD PMID:28001369 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd47 Cd47 molecule decreases expression ISO methylmercuric chloride results in decreased expression of CD47 mRNA CTD PMID:28001369 NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272 		JBrowse link
G Cd52 CD52 molecule decreases expression ISO methylmercuric chloride results in decreased expression of CD52 mRNA CTD PMID:28001369 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) decreases expression ISO methylmercuric chloride results in decreased expression of CD55 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd68 Cd68 molecule increases expression EXP methylmercuric chloride results in increased expression of CD68 mRNA CTD PMID:31378766 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd82 Cd82 molecule decreases expression ISO methylmercuric chloride results in decreased expression of CD82 mRNA CTD PMID:28001369 NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744 		JBrowse link
G Cd86 CD86 molecule increases expression ISO methylmercuric chloride results in increased expression of CD86 protein CTD PMID:20417223 PMID:20457211 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cd9 CD9 molecule increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CD9 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD9 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cd99l2 CD99 molecule-like 2 decreases expression ISO methylmercuric chloride results in decreased expression of CD99L2 mRNA CTD PMID:28001369 NCBI chr15:6,861,242...6,906,838
Ensembl chr15:6,864,268...6,906,952 		JBrowse link
G Cdc14b cell division cycle 14B increases expression ISO methylmercuric chloride results in increased expression of CDC14B mRNA CTD PMID:28001369 NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression ISO methylmercuric chloride results in decreased expression of CDC20 mRNA CTD PMID:20061341 PMID:34089799 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdc20b cell division cycle 20B increases expression ISO methylmercuric chloride results in increased expression of CDC20B mRNA CTD PMID:34089799
G Cdc25b cell division cycle 25B increases expression
decreases expression 		EXP
ISO 		methylmercuric chloride results in increased expression of CDC25B mRNA
methylmercuric chloride results in decreased expression of CDC25B mRNA 		CTD PMID:20061341 PMID:20864626 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdc25c cell division cycle 25C decreases expression ISO methylmercuric chloride results in decreased expression of CDC25C mRNA CTD PMID:20061341 NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292 		JBrowse link
G Cdc34 cell division cycle 34, ubiquitin conjugating enzyme increases expression ISO methylmercuric chloride results in increased expression of CDC34 mRNA CTD PMID:28001369 NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526 		JBrowse link
G Cdc37l1 cell division cycle 37-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of CDC37L1 mRNA CTD PMID:28001369 NCBI chr 1:236,118,630...236,147,527
Ensembl chr 1:236,118,555...236,207,079 		JBrowse link
G Cdc42 cell division cycle 42 decreases expression EXP methylmercuric chloride results in decreased expression of CDC42 protein CTD PMID:22223485 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc42ep3 CDC42 effector protein 3 increases expression ISO methylmercuric chloride results in increased expression of CDC42EP3 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540 		JBrowse link
G Cdca3 cell division cycle associated 3 decreases expression ISO methylmercuric chloride results in decreased expression of CDCA3 mRNA CTD PMID:20061341 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca7l cell division cycle associated 7 like decreases expression ISO methylmercuric chloride results in decreased expression of CDCA7L mRNA CTD PMID:28001369 NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843 		JBrowse link
G Cdh1 cadherin 1 affects expression
multiple interactions
decreases expression
increases expression 		ISO
EXP 		methylmercuric chloride affects the expression of CDH1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH1 mRNA
methylmercuric chloride results in decreased expression of CDH1 mRNA
methylmercuric chloride results in increased expression of CDH1 mRNA
methylmercuric chloride results in increased expression of CDH1 mRNA; methylmercuric chloride results in increased expression of CDH1 protein 		CTD PMID:20864626 PMID:21613230 PMID:23179753 PMID:26272509 PMID:27188386 More... NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh10 cadherin 10 decreases expression ISO methylmercuric chloride results in decreased expression of CDH10 mRNA CTD PMID:28001369 NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:70,357,217...70,578,332 		JBrowse link
G Cdh11 cadherin 11 decreases expression ISO methylmercuric chloride results in decreased expression of CDH11 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140 		JBrowse link
G Cdh13 cadherin 13 increases expression ISO methylmercuric chloride results in increased expression of CDH13 mRNA CTD PMID:28001369 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh18 cadherin 18 increases expression ISO methylmercuric chloride results in increased expression of CDH18 mRNA CTD PMID:28001369 NCBI chr 2:74,548,681...75,550,720
Ensembl chr 2:75,075,595...75,550,720 		JBrowse link
G Cdh2 cadherin 2 decreases expression ISO methylmercuric chloride results in decreased expression of CDH2 mRNA CTD PMID:28001369 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh3 cadherin 3 decreases expression ISO methylmercuric chloride results in decreased expression of CDH3 mRNA CTD PMID:29581082 NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257 		JBrowse link
G Cdh6 cadherin 6 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CDH6 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH6 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 2:63,801,630...63,952,309
Ensembl chr 2:63,806,135...63,952,287 		JBrowse link
G Cdh7 cadherin 7 increases expression ISO methylmercuric chloride results in increased expression of CDH7 mRNA CTD PMID:28001369 NCBI chr13:27,186,223...27,336,076
Ensembl chr13:27,187,257...27,336,023 		JBrowse link
G Cdh8 cadherin 8 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CDH8 mRNA
methylmercuric chloride results in decreased expression of CDH8 mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627 		JBrowse link
G Cdh9 cadherin 9 decreases expression ISO methylmercuric chloride results in decreased expression of CDH9 mRNA CTD PMID:28001369 NCBI chr 2:67,954,708...68,094,371
Ensembl chr 2:67,955,166...68,094,365 		JBrowse link
G Cdiptos CDIP transferase, opposite strand increases expression ISO methylmercuric chloride results in increased expression of CDIPTOSP mRNA CTD PMID:28001369 NCBI chr 1:191,009,918...191,013,551
Ensembl chr 1:191,009,919...191,013,275 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CDK1 mRNA CTD PMID:20061341 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk12 cyclin-dependent kinase 12 decreases expression ISO methylmercuric chloride results in decreased expression of CDK12 mRNA CTD PMID:28001369 NCBI chr10:83,697,174...83,793,676
Ensembl chr10:83,767,206...83,777,183
Ensembl chr10:83,767,206...83,777,183 		JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CDK5R1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDK5R1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 increases expression ISO methylmercuric chloride results in increased expression of CDK6 mRNA CTD PMID:28001369 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdkl3 cyclin-dependent kinase-like 3 increases expression ISO methylmercuric chloride results in increased expression of CDKL3 mRNA CTD PMID:28001369 NCBI chr10:36,755,413...36,850,197
Ensembl chr10:36,764,377...36,878,660 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CDKN1A mRNA
methylmercuric chloride results in increased expression of CDKN1A protein
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1A mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 PMID:31706035 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of CDKN1C mRNA
methylmercuric chloride results in increased expression of CDKN1C mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A decreases expression
decreases methylation 		ISO
EXP 		methylmercuric chloride results in decreased expression of CDKN2A mRNA
methylmercuric chloride results in decreased methylation of CDKN2A promoter 		CTD PMID:19636072 PMID:20061341 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2aipnl CDKN2A interacting protein N-terminal like decreases expression ISO methylmercuric chloride results in decreased expression of CDKN2AIPNL mRNA CTD PMID:28001369 NCBI chr10:36,731,983...36,741,500
Ensembl chr10:36,732,013...36,741,495 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C decreases expression ISO methylmercuric chloride results in decreased expression of CDKN2C mRNA CTD PMID:20061341 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression ISO methylmercuric chloride results in decreased expression of CDKN3 mRNA CTD PMID:20061341 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdr2l cerebellar degeneration-related protein 2-like increases expression ISO methylmercuric chloride results in increased expression of CDR2L mRNA CTD PMID:28001369 NCBI chr10:101,123,777...101,137,634
Ensembl chr10:101,123,777...101,137,634 		JBrowse link
G Cdrt4 CMT1A duplicated region transcript 4 decreases expression ISO methylmercuric chloride results in decreased expression of CDRT4 mRNA CTD PMID:28001369 NCBI chr10:48,124,695...48,156,717
Ensembl chr10:48,124,695...48,156,717 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 decreases expression ISO methylmercuric chloride results in decreased expression of CDS2 mRNA CTD PMID:28001369 NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201 		JBrowse link
G Cdv3 carnitine deficiency-associated gene expressed in ventricle 3 increases expression ISO methylmercuric chloride results in increased expression of CDV3 mRNA CTD PMID:28001369 NCBI chr 8:112,812,898...112,826,073
Ensembl chr 8:112,813,952...112,826,056 		JBrowse link
G Cdx2 caudal type homeo box 2 affects expression EXP methylmercuric chloride affects the expression of CDX2 mRNA CTD PMID:20864626 NCBI chr12:12,762,769...12,769,246
Ensembl chr12:12,762,904...12,769,246 		JBrowse link
G Cdyl chromodomain Y-like increases expression ISO methylmercuric chloride results in increased expression of CDYL mRNA CTD PMID:28001369 NCBI chr17:29,188,697...29,409,805
Ensembl chr17:29,188,698...29,409,757 		JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CEACAM10 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CEACAM10 mRNA CTD PMID:30744511 NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CEBPB mRNA
methylmercuric chloride results in decreased expression of CEBPB mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 PMID:34089799 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CEBPD mRNA CTD PMID:28001369 PMID:31378766 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma increases expression ISO methylmercuric chloride results in increased expression of CEBPG mRNA CTD PMID:28001369 NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283 		JBrowse link
G Celf1 CUGBP, Elav-like family member 1 increases expression ISO methylmercuric chloride results in increased expression of CELF1 mRNA CTD PMID:28001369 NCBI chr 3:97,380,407...97,455,253
Ensembl chr 3:97,380,424...97,452,791 		JBrowse link
G Celf2 CUGBP, Elav-like family member 2 decreases expression ISO methylmercuric chloride results in decreased expression of CELF2 mRNA CTD PMID:28001369 NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362 		JBrowse link
G Celf4 CUGBP, Elav-like family member 4 increases expression ISO methylmercuric chloride results in increased expression of CELF4 mRNA CTD PMID:23179753 NCBI chr18:17,061,284...17,339,747
Ensembl chr18:17,061,293...17,339,571 		JBrowse link
G Celf5 CUGBP, Elav-like family member 5 decreases expression ISO methylmercuric chloride results in decreased expression of CELF5 mRNA CTD PMID:28001369 NCBI chr 7:8,876,551...8,901,078
Ensembl chr 7:8,876,564...8,901,069 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 affects expression
decreases expression 		EXP
ISO 		methylmercuric chloride affects the expression of CELSR1 mRNA
methylmercuric chloride results in decreased expression of CELSR1 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Celsr2 cadherin, EGF LAG seven-pass G-type receptor 2 decreases expression ISO methylmercuric chloride results in decreased expression of CELSR2 mRNA CTD PMID:28001369 NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 decreases expression ISO methylmercuric chloride results in decreased expression of CEMIP2 mRNA CTD PMID:28001369 NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906 		JBrowse link
G Cenpe centromere protein E decreases expression ISO methylmercuric chloride results in decreased expression of CENPE mRNA CTD PMID:34089799 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cenpf centromere protein F increases expression ISO methylmercuric chloride results in increased expression of CENPF mRNA CTD PMID:28001369 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cenpp centromere protein P decreases expression ISO methylmercuric chloride results in decreased expression of CENPP mRNA CTD PMID:20061341 NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739 		JBrowse link
G Cenpu centromere protein U decreases expression ISO methylmercuric chloride results in decreased expression of CENPU mRNA CTD PMID:28001369 NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662 		JBrowse link
G Cep128 centrosomal protein 128 decreases expression ISO methylmercuric chloride results in decreased expression of CEP128 mRNA CTD PMID:28001369 NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:115,681,712...116,057,167 		JBrowse link
G Cep162 centrosomal protein 162 decreases expression ISO methylmercuric chloride results in decreased expression of CEP162 mRNA CTD PMID:28001369 NCBI chr 8:97,029,677...97,088,243
Ensembl chr 8:97,029,677...97,088,207 		JBrowse link
G Cep164 centrosomal protein 164 increases expression ISO methylmercuric chloride results in increased expression of CEP164 mRNA CTD PMID:28001369 NCBI chr 8:54,967,621...55,031,264
Ensembl chr 8:54,967,621...55,031,206 		JBrowse link
G Cep19 centrosomal protein 19 decreases expression ISO methylmercuric chloride results in decreased expression of CEP19 mRNA CTD PMID:28001369 NCBI chr11:82,182,868...82,192,134
Ensembl chr11:82,182,868...82,192,032 		JBrowse link
G Cep350 centrosomal protein 350 decreases expression ISO methylmercuric chloride results in decreased expression of CEP350 mRNA CTD PMID:28001369 NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673 		JBrowse link
G Cep43 centrosomal protein 43 increases expression ISO methylmercuric chloride results in increased expression of CEP43 mRNA CTD PMID:28001369 NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:55,082,712...55,111,509 		JBrowse link
G Cep57l1 centrosomal protein 57-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of CEP57L1 mRNA CTD PMID:28001369 NCBI chr20:46,820,350...46,876,911
Ensembl chr20:46,820,353...46,876,926 		JBrowse link
G Cep68 centrosomal protein 68 decreases expression ISO methylmercuric chloride results in decreased expression of CEP68 mRNA CTD PMID:28001369 NCBI chr14:98,649,993...98,671,892
Ensembl chr14:98,649,993...98,671,868 		JBrowse link
G Cep78 centrosomal protein 78 decreases expression ISO methylmercuric chloride results in decreased expression of CEP78 mRNA CTD PMID:28001369 NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120 		JBrowse link
G Cep83 centrosomal protein 83 decreases expression ISO methylmercuric chloride results in decreased expression of CEP83 mRNA CTD PMID:28001369 NCBI chr 7:31,167,198...31,276,513
Ensembl chr 7:31,167,216...31,276,716 		JBrowse link
G Cep85l centrosomal protein 85-like increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CEP85L mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEP85L mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr20:33,111,114...33,282,182
Ensembl chr20:33,115,438...33,282,238 		JBrowse link
G Cep89 centrosomal protein 89 increases expression ISO methylmercuric chloride results in increased expression of CEP89 mRNA CTD PMID:28001369 NCBI chr 1:97,195,116...97,237,015
Ensembl chr 1:97,195,135...97,237,016 		JBrowse link
G Cep95 centrosomal protein 95 increases expression ISO methylmercuric chloride results in increased expression of CEP95 mRNA CTD PMID:28001369 NCBI chr10:92,231,829...92,259,813
Ensembl chr10:92,231,512...92,259,810 		JBrowse link
G Cept1 choline/ethanolamine phosphotransferase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CEPT1 mRNA CTD PMID:28001369 NCBI chr 2:196,682,455...196,724,430
Ensembl chr 2:196,681,681...196,723,812 		JBrowse link
G Cers1 ceramide synthase 1 increases expression ISO methylmercuric chloride results in increased expression of CERS1 mRNA CTD PMID:28001369 NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480 		JBrowse link
G Cers6 ceramide synthase 6 increases expression ISO methylmercuric chloride results in increased expression of CERS6 mRNA CTD PMID:28001369 NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544 		JBrowse link
G Ces1c carboxylesterase 1C multiple interactions
decreases expression 		EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CES1C mRNA
methylmercuric chloride results in decreased expression of ES2 mRNA 		CTD PMID:20864626 PMID:30744511 NCBI chr19:30,099,383...30,128,531
Ensembl chr19:30,099,323...30,128,528 		JBrowse link
G Ces1f carboxylesterase 1F multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CES1F mRNA CTD PMID:30744511 NCBI chr19:29,969,633...29,995,119
Ensembl chr19:29,968,473...29,995,117 		JBrowse link
G Ces2a carboxylesterase 2A multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of CES2A mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CES2A mRNA CTD PMID:30744511 NCBI chr19:135,885...142,935
Ensembl chr19:135,885...142,935 		JBrowse link
G Ces2h carboxylesterase 2H decreases expression ISO methylmercuric chloride results in decreased expression of CES2 mRNA CTD PMID:28001369 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Ces2j carboxylesterase 2J multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CES2J mRNA CTD PMID:30744511 NCBI chr19:286,461...312,887
Ensembl chr19:305,069...312,603 		JBrowse link
G Cesl1 carboxylesterase-like 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CESL1 mRNA CTD PMID:30744511 NCBI chr19:38,554,365...38,612,663 JBrowse link
G Cetn3 centrin 3 decreases expression ISO methylmercuric chloride results in decreased expression of CETN3 mRNA CTD PMID:19465457 NCBI chr 2:13,817,760...13,837,502
Ensembl chr 2:13,824,803...13,837,502 		JBrowse link
G Cfap20dc CFAP20 domain containing decreases expression ISO methylmercuric chloride results in decreased expression of CFAP20DC mRNA CTD PMID:28001369 NCBI chr15:18,661,562...18,907,226
Ensembl chr15:18,661,508...18,907,225 		JBrowse link
G Cfap210 cilia and flagella associated protein 210 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP210 mRNA CTD PMID:28001369 NCBI chr 3:74,928,368...74,962,508
Ensembl chr 3:74,927,880...74,962,497 		JBrowse link
G Cfap263 cilia and flagella associated protein 263 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP263 mRNA CTD PMID:27188386 NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,503,066...9,522,957 		JBrowse link
G Cfap300 cilia and flagella associated protein 300 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP300 mRNA CTD PMID:28001369 NCBI chr 8:13,465,016...13,483,679
Ensembl chr 8:13,464,984...13,483,839 		JBrowse link
G Cfap69 cilia and flagella associated protein 69 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP69 mRNA CTD PMID:28001369 NCBI chr 4:29,334,624...29,405,513
Ensembl chr 4:29,334,415...29,408,727 		JBrowse link
G Cfap70 cilia and flagella associated protein 70 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP70 mRNA CTD PMID:28001369 NCBI chr15:3,901,544...3,967,224
Ensembl chr15:3,901,610...3,967,220 		JBrowse link
G Cfap91 cilia and flagella associated protein 91 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP91 mRNA CTD PMID:28001369 NCBI chr11:75,919,129...75,962,786
Ensembl chr11:75,919,142...75,962,785 		JBrowse link
G Cfap95 cilia and flagella associated protein 95 decreases expression ISO methylmercuric chloride results in decreased expression of CFAP95 mRNA CTD PMID:27188386 NCBI chr 1:230,558,329...230,669,479
Ensembl chr 1:230,558,331...230,669,479 		JBrowse link
G Cfap96 cilia and flagella associated protein 96 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of CFAP96 mRNA
methylmercuric chloride results in increased expression of CFAP96 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr16:53,023,623...53,048,176
Ensembl chr16:53,023,878...53,048,965 		JBrowse link
G Cfdp1 craniofacial development protein 1 increases expression ISO methylmercuric chloride results in increased expression of CFDP1 mRNA CTD PMID:28001369 NCBI chr19:56,627,596...56,733,099
Ensembl chr19:56,626,963...56,733,098 		JBrowse link
G Cfhr4 complement factor H-related 4 decreases expression ISO methylmercuric chloride results in decreased expression of CFHR4 mRNA CTD PMID:28001369 NCBI chr13:53,973,301...54,042,179
Ensembl chr13:53,973,301...54,042,179 		JBrowse link
G Cfi complement factor I decreases expression ISO methylmercuric chloride results in decreased expression of CFI mRNA CTD PMID:34089799 NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786 		JBrowse link
G Cfl2 cofilin 2 decreases expression ISO methylmercuric chloride results in decreased expression of CFL2 mRNA CTD PMID:28001369 NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888 		JBrowse link
G Cgn cingulin increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CGN mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CGN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 2:184,997,425...185,024,785
Ensembl chr 2:184,997,425...185,023,635 		JBrowse link
G Cgnl1 cingulin-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of CGNL1 mRNA CTD PMID:23179753 NCBI chr 8:81,154,169...81,305,598
Ensembl chr 8:81,140,091...81,305,747 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression ISO methylmercuric chloride results in increased expression of CHAC1 mRNA CTD PMID:28001369 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chaf1a chromatin assembly factor 1 subunit A increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CHAF1A mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHAF1A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 increases expression ISO methylmercuric chloride results in increased expression of CHCHD10 mRNA CTD PMID:28001369 NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677 		JBrowse link
G Chchd2l3 coiled-coil-helix-coiled-coil-helix domain containing protein 2-like 3 decreases expression EXP methylmercuric chloride results in decreased expression of CHCHD2L3 mRNA CTD PMID:35527009 NCBI chr 9:101,947,769...101,948,440
Ensembl chr 9:101,947,746...101,948,461 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of CHD2 mRNA CTD PMID:28001369 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CHD4 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHD4 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:159,584,654...159,617,866 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 affects expression EXP methylmercuric chloride affects the expression of CHD7 mRNA CTD PMID:20864626 NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CHD9 mRNA
methylmercuric chloride results in decreased expression of CHD9 mRNA 		CTD PMID:23179753 PMID:28001369 NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042 		JBrowse link
G Chek1 checkpoint kinase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CHEK1 mRNA CTD PMID:20061341 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 affects expression EXP methylmercuric chloride affects the expression of CHEK2 mRNA CTD PMID:20864626 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Chgb chromogranin B increases expression ISO methylmercuric chloride results in increased expression of CHGB mRNA CTD PMID:28001369 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chi3l1 chitinase 3 like 1 decreases expression
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of CHI3L1 mRNA
methylmercuric chloride results in increased expression of CHI3L1 mRNA 		CTD PMID:28001369 PMID:31378766 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Chic1 cysteine-rich hydrophobic domain 1 decreases expression ISO methylmercuric chloride results in decreased expression of CHIC1 mRNA CTD PMID:28001369 NCBI chr  X:72,427,851...72,471,924
Ensembl chr  X:72,427,851...72,471,924 		JBrowse link
G Chka choline kinase alpha decreases expression
decreases response to substance 		ISO methylmercuric chloride results in decreased expression of CHKA mRNA
CHKA protein results in decreased susceptibility to methylmercuric chloride 		CTD PMID:24118919 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chkb choline kinase beta affects expression ISO methylmercuric chloride affects the expression of CHKB mRNA CTD PMID:24118919 NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949 		JBrowse link
G Chl1 cell adhesion molecule L1-like decreases expression ISO methylmercuric chloride results in decreased expression of CHL1 mRNA CTD PMID:28001369 NCBI chr 4:137,847,648...138,062,077
Ensembl chr 4:137,847,895...138,062,077 		JBrowse link
G Chmp1b charged multivesicular body protein 1B increases expression ISO methylmercuric chloride results in increased expression of CHMP1B mRNA CTD PMID:28001369 NCBI chr18:63,010,270...63,012,800
Ensembl chr18:63,010,251...63,011,415 		JBrowse link
G Chn2 chimerin 2 decreases expression ISO methylmercuric chloride results in decreased expression of CHN2 mRNA CTD PMID:28001369 NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068 		JBrowse link
G Chrdl1 chordin-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of CHRDL1 mRNA CTD PMID:28001369 PMID:29261810 NCBI chr  X:111,685,864...111,789,684
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3 decreases expression ISO methylmercuric chloride results in decreased expression of CHRM3 mRNA CTD PMID:28001369 NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit decreases expression ISO methylmercuric chloride results in decreased expression of CHRNA2 mRNA CTD PMID:21385734 NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144 		JBrowse link
G Chrna6 cholinergic receptor nicotinic alpha 6 subunit decreases expression ISO methylmercuric chloride results in decreased expression of CHRNA6 mRNA CTD PMID:21385734 NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit decreases expression ISO methylmercuric chloride results in decreased expression of CHRNA7 mRNA CTD PMID:37210002 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Chrnb3 cholinergic receptor nicotinic beta 3 subunit decreases expression ISO methylmercuric chloride results in decreased expression of CHRNB3 mRNA CTD PMID:21385734 NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225 		JBrowse link
G Chrne cholinergic receptor nicotinic epsilon subunit increases expression ISO methylmercuric chloride results in increased expression of CHRNE mRNA CTD PMID:21385734 NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154 		JBrowse link
G Chrng cholinergic receptor nicotinic gamma subunit decreases expression ISO methylmercuric chloride results in decreased expression of CHRNG mRNA CTD PMID:21385734 NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092 		JBrowse link
G Chst11 carbohydrate sulfotransferase 11 increases expression ISO methylmercuric chloride results in increased expression of CHST11 mRNA CTD PMID:28001369 NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441 		JBrowse link
G Chst2 carbohydrate sulfotransferase 2 decreases expression ISO methylmercuric chloride results in decreased expression of CHST2 mRNA CTD PMID:28001369 NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301 		JBrowse link
G Chst8 carbohydrate sulfotransferase 8 increases expression ISO methylmercuric chloride results in increased expression of CHST8 mRNA CTD PMID:28001369 NCBI chr 1:96,431,144...96,572,880
Ensembl chr 1:96,431,145...96,572,880 		JBrowse link
G Chst9 carbohydrate sulfotransferase 9 decreases expression ISO methylmercuric chloride results in decreased expression of CHST9 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr18:6,850,874...7,125,222
Ensembl chr18:6,851,831...7,125,161 		JBrowse link
G Churc1 churchill domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of CHURC1 mRNA CTD PMID:28001369 NCBI chr 6:101,203,778...101,218,364
Ensembl chr 6:101,203,841...101,237,748 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CIDEA mRNA CTD PMID:30744511 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cilp cartilage intermediate layer protein increases expression ISO methylmercuric chloride results in increased expression of CILP mRNA CTD PMID:28001369 NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409 		JBrowse link
G Cirbp cold inducible RNA binding protein increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CIRBP mRNA
methylmercuric chloride results in decreased expression of CIRBP mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 decreases expression ISO methylmercuric chloride results in decreased expression of CITED1 mRNA CTD PMID:28001369 NCBI chr  X:71,390,328...71,395,023
Ensembl chr  X:71,390,331...71,393,649 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CITED2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CITED2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of CKAP2 mRNA CTD PMID:28001369 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of CLASP2 mRNA CTD PMID:28001369 NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:122,555,524...122,737,587 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 increases expression EXP methylmercuric chloride results in increased expression of CLCF1 mRNA CTD PMID:31378766 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064 		JBrowse link
G Clcn4 chloride voltage-gated channel 4 decreases expression ISO methylmercuric chloride results in decreased expression of CLCN4 mRNA CTD PMID:28001369 NCBI chr  X:27,290,769...27,356,967
Ensembl chr  X:27,290,868...27,356,939 		JBrowse link
G Cldn1 claudin 1 decreases expression ISO methylmercuric chloride results in decreased expression of CLDN1 mRNA CTD PMID:28001369 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn10 claudin 10 decreases expression ISO methylmercuric chloride results in decreased expression of CLDN10 mRNA CTD PMID:23179753 NCBI chr15:102,269,858...102,361,589
Ensembl chr15:102,269,858...102,361,589 		JBrowse link
G Cldn11 claudin 11 increases expression ISO methylmercuric chloride results in increased expression of CLDN11 mRNA CTD PMID:28001369 NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539 		JBrowse link
G Cldn14 claudin 14 increases expression EXP methylmercuric chloride results in increased expression of CLDN14 mRNA CTD PMID:31378766 NCBI chr11:46,701,940...46,799,049
Ensembl chr11:46,701,940...46,799,096 		JBrowse link
G Cldn23 claudin 23 increases expression ISO methylmercuric chloride results in increased expression of CLDN23 mRNA CTD PMID:28001369 NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957 		JBrowse link
G Cldn5 claudin 5 decreases expression
multiple interactions 		EXP methylmercuric chloride results in decreased expression of CLDN5 mRNA
Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of CLDN5 mRNA] 		CTD PMID:34062221 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Cldn6 claudin 6 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CLDN6 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN6 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr10:13,213,837...13,218,578
Ensembl chr10:13,213,956...13,218,581 		JBrowse link
G Clec18a C-type lectin domain family 18, member A decreases expression ISO methylmercuric chloride results in decreased expression of CLEC18A mRNA CTD PMID:28001369 NCBI chr19:55,947,625...55,964,505
Ensembl chr19:55,947,223...55,965,323 		JBrowse link
G Clec3b C-type lectin domain family 3, member B increases expression EXP methylmercuric chloride results in increased expression of CLEC3B mRNA CTD PMID:35527009 NCBI chr 8:131,687,575...131,693,292 JBrowse link
G Clec4a3 C-type lectin domain family 4, member A3 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CLEC4A mRNA
methylmercuric chloride results in increased expression of CLEC4A3 mRNA 		CTD PMID:28001369 PMID:31378766 NCBI chr 4:157,885,899...157,896,728
Ensembl chr 4:157,885,895...157,896,727 		JBrowse link
G Clgn calmegin decreases expression ISO methylmercuric chloride results in decreased expression of CLGN mRNA CTD PMID:28001369 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Clic4 chloride intracellular channel 4 increases expression ISO methylmercuric chloride results in increased expression of CLIC4 mRNA CTD PMID:28001369 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118 		JBrowse link
G Clic6 chloride intracellular channel 6 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CLIC6 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLIC6 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr11:45,223,715...45,266,261
Ensembl chr11:45,223,669...45,267,344 		JBrowse link
G Clip1 CAP-GLY domain containing linker protein 1 increases expression ISO methylmercuric chloride results in increased expression of CLIP1 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr12:38,571,533...38,678,779
Ensembl chr12:38,571,834...38,678,779 		JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 decreases expression ISO methylmercuric chloride results in decreased expression of CLIP4 mRNA CTD PMID:28001369 NCBI chr 6:29,359,628...29,449,365
NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271 		JBrowse link
G Clk1 CDC-like kinase 1 increases expression ISO methylmercuric chloride results in increased expression of CLK1 mRNA CTD PMID:28001369 NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187 		JBrowse link
G Clk4 CDC-like kinase 4 decreases expression ISO methylmercuric chloride results in decreased expression of CLK4 mRNA CTD PMID:28001369 NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372 		JBrowse link
G Clmn calmin decreases expression ISO methylmercuric chloride results in decreased expression of CLMN mRNA CTD PMID:28001369 NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027 		JBrowse link
G Clock clock circadian regulator decreases expression ISO methylmercuric chloride results in decreased expression of CLOCK mRNA CTD PMID:28001369 NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872 		JBrowse link
G Clpb ClpB family mitochondrial disaggregase increases expression ISO methylmercuric chloride results in increased expression of CLPB mRNA CTD PMID:28001369 NCBI chr 1:165,440,705...165,563,514
Ensembl chr 1:165,440,861...165,583,815 		JBrowse link
G Clpp caseinolytic mitochondrial matrix peptidase proteolytic subunit increases expression ISO methylmercuric chloride results in increased expression of CLPP mRNA; methylmercuric chloride results in increased expression of CLPP protein CTD PMID:37967789 NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705 		JBrowse link
G Clstn2 calsyntenin 2 increases expression ISO methylmercuric chloride results in increased expression of CLSTN2 mRNA CTD PMID:28001369 NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053 		JBrowse link
G Cmtm5 CKLF-like MARVEL transmembrane domain containing 5 decreases expression ISO methylmercuric chloride results in decreased expression of CMTM5 mRNA CTD PMID:28001369 NCBI chr15:32,382,171...32,385,288
Ensembl chr15:32,382,608...32,385,271 		JBrowse link
G Cmtm8 CKLF-like MARVEL transmembrane domain containing 8 decreases expression ISO methylmercuric chloride results in decreased expression of CMTM8 mRNA CTD PMID:23179753 NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276 		JBrowse link
G Cnfn cornifelin decreases expression ISO methylmercuric chloride results in decreased expression of CNFN mRNA CTD PMID:28001369 NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556 		JBrowse link
G Cnksr2 connector enhancer of kinase suppressor of Ras 2 increases expression ISO methylmercuric chloride results in increased expression of CNKSR2 mRNA CTD PMID:23179753 NCBI chr  X:40,722,843...40,971,730
Ensembl chr  X:40,722,996...40,965,604 		JBrowse link
G Cnn1 calponin 1 increases expression ISO methylmercuric chloride results in increased expression of CNN1 mRNA CTD PMID:28001369 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnot3 CCR4-NOT transcription complex, subunit 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CNOT3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 1:74,471,284...74,487,527
Ensembl chr 1:74,470,566...74,487,527 		JBrowse link
G Cnot4 CCR4-NOT transcription complex, subunit 4 decreases expression ISO methylmercuric chloride results in decreased expression of CNOT4 mRNA CTD PMID:28001369 NCBI chr 4:64,679,903...64,781,432
Ensembl chr 4:64,679,904...64,738,083 		JBrowse link
G Cnot6l CCR4-NOT transcription complex, subunit 6-like decreases expression ISO methylmercuric chloride results in decreased expression of CNOT6L mRNA CTD PMID:28001369 NCBI chr14:13,714,475...13,806,481
Ensembl chr14:13,714,475...13,806,481 		JBrowse link
G Cnot7 CCR4-NOT transcription complex, subunit 7 decreases expression ISO methylmercuric chloride results in decreased expression of CNOT7 mRNA CTD PMID:28001369 NCBI chr16:58,478,882...58,498,046
Ensembl chr16:58,478,900...58,498,046 		JBrowse link
G Cnr1 cannabinoid receptor 1 decreases expression ISO methylmercuric chloride results in decreased expression of CNR1 mRNA CTD PMID:37210002 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cnrip1 cannabinoid receptor interacting protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CNRIP1 mRNA CTD PMID:28001369 NCBI chr14:95,664,435...95,707,062
Ensembl chr14:95,664,774...95,694,371 		JBrowse link
G Cntln centlein decreases expression ISO methylmercuric chloride results in decreased expression of CNTLN mRNA CTD PMID:28001369 NCBI chr 5:104,340,801...104,622,491
Ensembl chr 5:104,342,173...104,630,976 		JBrowse link
G Cntn2 contactin 2 decreases expression ISO methylmercuric chloride results in decreased expression of CNTN2 mRNA CTD PMID:28001369 NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027 		JBrowse link
G Cntn3 contactin 3 decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of CNTN3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTN3 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:136,397,575...136,770,765
Ensembl chr 4:136,398,572...136,770,717 		JBrowse link
G Cntn4 contactin 4 decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of CNTN4 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTN4 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:140,180,696...141,177,771
Ensembl chr 4:140,596,284...141,177,766 		JBrowse link
G Cntnap2 contactin associated protein 2 increases expression ISO methylmercuric chloride results in increased expression of CNTNAP2 mRNA CTD PMID:28001369 NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258 		JBrowse link
G Cntnap3 contactin associated protein family member 3 decreases expression ISO methylmercuric chloride results in decreased expression of CNTNAP3 mRNA CTD PMID:28001369 NCBI chr17:273,137...461,233
Ensembl chr17:273,137...461,233 		JBrowse link
G Coa5 cytochrome C oxidase assembly factor 5 decreases expression ISO methylmercuric chloride results in decreased expression of COA5 mRNA CTD PMID:28001369 NCBI chr 9:47,147,267...47,160,724
Ensembl chr 9:47,147,267...47,160,672 		JBrowse link
G Cobl cordon-bleu WH2 repeat protein increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of COBL mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr14:91,041,721...91,274,272
Ensembl chr14:91,041,721...91,274,257 		JBrowse link
G Cobll1 cordon-bleu WH2 repeat protein-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of COBLL1 mRNA CTD PMID:23179753 NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460 		JBrowse link
G Coch cochlin decreases expression EXP
ISO 		methylmercuric chloride results in decreased expression of COCH mRNA CTD PMID:20864626 PMID:28001369 NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502 		JBrowse link
G Cog5 component of oligomeric golgi complex 5 decreases expression ISO methylmercuric chloride results in decreased expression of COG5 mRNA CTD PMID:27188386 NCBI chr 6:53,969,967...54,267,869
Ensembl chr 6:53,969,979...54,278,973 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain increases expression ISO methylmercuric chloride results in increased expression of COL11A1 mRNA CTD PMID:28001369 NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain increases expression ISO methylmercuric chloride results in increased expression of COL12A1 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col13a1 collagen type XIII alpha 1 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL13A1 mRNA CTD PMID:23179753 NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800 		JBrowse link
G Col14a1 collagen type XIV alpha 1 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL14A1 mRNA CTD PMID:28001369 NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938 		JBrowse link
G Col16a1 collagen type XVI alpha 1 chain increases expression EXP methylmercuric chloride results in increased expression of COL16A1 mRNA CTD PMID:31378766 NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of COL1A1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of COL1A2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col22a1 collagen type XXII alpha 1 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL22A1 mRNA CTD PMID:28001369 NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960 		JBrowse link
G Col3a1 collagen type III alpha 1 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL3A1 mRNA CTD PMID:34089799 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL4A1 mRNA CTD PMID:34089799 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col5a1 collagen type V alpha 1 chain increases expression ISO methylmercuric chloride results in increased expression of COL5A1 mRNA CTD PMID:26272509 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a2 collagen type V alpha 2 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL5A2 mRNA CTD PMID:28001369 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain increases expression EXP methylmercuric chloride results in increased expression of COL7A1 mRNA CTD PMID:31378766 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col9a2 collagen type IX alpha 2 chain decreases expression ISO methylmercuric chloride results in decreased expression of COL9A2 mRNA CTD PMID:28001369 NCBI chr 5:139,892,798...139,910,131
Ensembl chr 5:139,892,798...139,909,855 		JBrowse link
G Col9a3 collagen type IX alpha 3 chain increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of COL9A3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL9A3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:34089799 NCBI chr 3:188,089,337...188,112,034
Ensembl chr 3:188,089,403...188,112,270 		JBrowse link
G Colec12 collectin sub-family member 12 decreases expression ISO methylmercuric chloride results in decreased expression of COLEC12 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297 		JBrowse link
G Commd2 COMM domain containing 2 decreases expression ISO methylmercuric chloride results in decreased expression of COMMD2 mRNA CTD PMID:28001369 NCBI chr 2:143,998,672...144,002,918
Ensembl chr 2:143,998,672...144,002,918 		JBrowse link
G Commd4 COMM domain containing 4 decreases expression ISO methylmercuric chloride results in decreased expression of COMMD4 mRNA CTD PMID:28001369 NCBI chr 8:66,462,188...66,465,700
Ensembl chr 8:66,462,188...66,465,756 		JBrowse link
G Copa COPI coat complex subunit alpha increases expression ISO methylmercuric chloride results in increased expression of COPA mRNA CTD PMID:28001369 NCBI chr13:87,078,853...87,119,256
Ensembl chr13:87,078,383...87,119,256 		JBrowse link
G Cops2 COP9 signalosome subunit 2 decreases expression ISO methylmercuric chloride results in decreased expression of COPS2 mRNA CTD PMID:28001369 NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369 		JBrowse link
G Cops6 COP9 signalosome subunit 6 decreases expression ISO methylmercuric chloride results in decreased expression of COPS6 mRNA CTD PMID:28001369 NCBI chr12:22,152,688...22,155,527
Ensembl chr12:22,147,482...22,161,106 		JBrowse link
G Cops8 COP9 signalosome subunit 8 decreases expression ISO methylmercuric chloride results in decreased expression of COPS8 mRNA CTD PMID:28001369 NCBI chr 9:98,655,031...98,664,861
Ensembl chr 9:98,654,870...98,665,381 		JBrowse link
G Coq10b coenzyme Q10B increases expression ISO methylmercuric chloride results in increased expression of COQ10B mRNA CTD PMID:28001369 NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of COTL1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox16 cytochrome c oxidase assembly factor COX16 increases expression ISO methylmercuric chloride results in increased expression of COX16 mRNA CTD PMID:34089799 NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484 		JBrowse link
G Cox19 cytochrome c oxidase assembly factor COX19 decreases expression ISO methylmercuric chloride results in decreased expression of COX19 mRNA CTD PMID:28001369 NCBI chr12:20,417,389...20,426,868
Ensembl chr12:20,417,341...20,426,868 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression ISO methylmercuric chloride results in decreased expression of COX5A mRNA CTD PMID:28001369 NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279 		JBrowse link
G Cox7b cytochrome c oxidase subunit 7B decreases expression ISO methylmercuric chloride results in decreased expression of COX7B mRNA CTD PMID:28001369 NCBI chr  X:75,149,036...75,155,285
Ensembl chr  X:75,148,996...75,155,284 		JBrowse link
G Cpb1 carboxypeptidase B1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CPB1 mRNA CTD PMID:30744511 NCBI chr 2:104,684,275...104,744,824
Ensembl chr 2:104,684,275...104,714,662 		JBrowse link
G Cpd carboxypeptidase D increases expression ISO methylmercuric chloride results in increased expression of CPD mRNA CTD PMID:23179753 NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638 		JBrowse link
G Cpe carboxypeptidase E increases expression ISO methylmercuric chloride results in increased expression of CPE mRNA CTD PMID:28001369 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb1 cytoplasmic polyadenylation element binding protein 1 increases expression ISO methylmercuric chloride results in increased expression of CPEB1 mRNA CTD PMID:28001369 NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:144,709,691...144,815,880 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CPEB2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPEB2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cpeb4 cytoplasmic polyadenylation element binding protein 4 decreases expression ISO methylmercuric chloride results in decreased expression of CPEB4 mRNA CTD PMID:28001369 NCBI chr10:16,222,271...16,284,248
Ensembl chr10:16,225,672...16,283,787 		JBrowse link
G Cplane1 ciliogenesis and planar polarity effector complex subunit 1 decreases expression ISO methylmercuric chloride results in decreased expression of CPLANE1 mRNA CTD PMID:28001369 NCBI chr 2:58,996,119...59,096,817
Ensembl chr 2:58,996,130...59,096,817 		JBrowse link
G Cplx2 complexin 2 multiple interactions
decreases expression 		EXP fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of CPLX2 mRNA] CTD PMID:30890323 NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467 		JBrowse link
G Cpne3 copine 3 decreases expression ISO methylmercuric chloride results in decreased expression of CPNE3 mRNA CTD PMID:28001369 NCBI chr 5:37,811,566...37,860,840
Ensembl chr 5:37,811,566...37,861,062 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CPS1 mRNA CTD PMID:23179753 NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734 		JBrowse link
G Cpvl carboxypeptidase, vitellogenic-like decreases expression ISO methylmercuric chloride results in decreased expression of CPVL mRNA CTD PMID:28001369 NCBI chr 4:84,311,853...84,422,098
Ensembl chr 4:84,311,854...84,416,033 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CRABP1 mRNA CTD PMID:28001369 NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470 		JBrowse link
G Crbn cereblon decreases expression ISO methylmercuric chloride results in decreased expression of CRBN mRNA CTD PMID:28001369 NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases expression
multiple interactions
decreases phosphorylation
increases phosphorylation 		ISO
EXP 		methylmercuric chloride results in decreased expression of CREB1 mRNA
methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the phosphorylation of CREB1 protein]; methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [CREB1 protein binds to NR4A1 promoter]]
methylmercuric chloride results in decreased phosphorylation of CREB1 protein
methylmercuric chloride results in increased phosphorylation of CREB1 protein
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of CREB1 protein]; methylmercuric chloride results in decreased expression of and results in increased phosphorylation of CREB1 protein; Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased phosphorylation of CREB1 protein] 		CTD PMID:28001369 PMID:32061141 PMID:33301842 PMID:36565944 PMID:36813253 More... NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 decreases expression ISO methylmercuric chloride results in decreased expression of CREB3L4 mRNA CTD PMID:28001369 NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 increases expression ISO methylmercuric chloride results in increased expression of CREB5 mRNA CTD PMID:28001369 NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793 		JBrowse link
G Crebbp CREB binding protein affects expression
multiple interactions 		EXP
ISO 		methylmercuric chloride affects the expression of CREBBP mRNA
methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [CREBBP protein binds to NR4A1 promoter]] 		CTD PMID:20864626 PMID:36565944 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crebl2 cAMP responsive element binding protein-like 2 decreases expression ISO methylmercuric chloride results in decreased expression of CREBL2 mRNA CTD PMID:28001369 NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611 		JBrowse link
G Crebrf CREB3 regulatory factor decreases expression ISO methylmercuric chloride results in decreased expression of CREBRF mRNA CTD PMID:28001369 NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430 		JBrowse link
G Crebzf CREB/ATF bZIP transcription factor decreases expression ISO methylmercuric chloride results in decreased expression of CREBZF mRNA CTD PMID:28001369 NCBI chr 1:153,829,544...153,836,073
Ensembl chr 1:153,829,448...153,845,122 		JBrowse link
G Creld1 cysteine-rich with EGF-like domains 1 decreases expression ISO methylmercuric chloride results in decreased expression of CRELD1 mRNA CTD PMID:28001369 NCBI chr 4:148,187,510...148,197,120
Ensembl chr 4:148,187,265...148,197,116 		JBrowse link
G Crh corticotropin releasing hormone decreases expression ISO methylmercuric chloride results in decreased expression of CRH mRNA CTD PMID:34089799 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 increases expression ISO methylmercuric chloride results in increased expression of CRIM1 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416 		JBrowse link
G Crip1 cysteine rich protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of CRIP1 mRNA CTD PMID:28001369 NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672 		JBrowse link
G Cripto cripto, EGF-CFC family member affects expression ISO methylmercuric chloride affects the expression of CRIPTO mRNA CTD PMID:21613230 NCBI chr 8:119,803,182...119,808,714
Ensembl chr 8:119,803,220...119,808,948 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 increases expression ISO methylmercuric chloride results in increased expression of CRISPLD2 mRNA CTD PMID:28001369 NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 increases expression EXP methylmercuric chloride results in increased expression of CRLF1 mRNA CTD PMID:31378766 NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970 		JBrowse link
G Crnkl1 crooked neck pre-mRNA splicing factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of CRNKL1 mRNA CTD PMID:28001369 NCBI chr 3:153,764,718...153,807,973
Ensembl chr 6:6,894,292...6,896,635
Ensembl chr 3:6,894,292...6,896,635 		JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression ISO methylmercuric chloride results in decreased expression of CROT mRNA CTD PMID:28001369 NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064 		JBrowse link
G Cryab crystallin, alpha B increases expression ISO methylmercuric chloride results in increased expression of CRYAB mRNA CTD PMID:28001369 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Cryba1 crystallin, beta A1 decreases expression ISO methylmercuric chloride results in decreased expression of CRYBA1 mRNA CTD PMID:28001369 NCBI chr10:63,106,465...63,113,020
Ensembl chr10:63,106,475...63,112,817 		JBrowse link
G Cryba2 crystallin, beta A2 increases expression ISO methylmercuric chloride results in increased expression of CRYBA2 mRNA CTD PMID:27188386 NCBI chr 9:83,895,921...83,906,651
Ensembl chr 9:83,895,922...83,899,131 		JBrowse link
G Cryba4 crystallin, beta A4 decreases expression ISO methylmercuric chloride results in decreased expression of CRYBA4 mRNA CTD PMID:28001369 NCBI chr12:50,039,148...50,053,636
Ensembl chr12:50,047,049...50,053,634 		JBrowse link
G Cryz crystallin zeta increases expression ISO methylmercuric chloride results in increased expression of CRYZ mRNA CTD PMID:28001369 NCBI chr 2:246,211,707...246,239,472
Ensembl chr 2:246,211,156...246,239,470 		JBrowse link
G Cryzl1 crystallin zeta like 1 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of CRYZL1 mRNA
methylmercuric chloride results in increased expression of CRYZL1 mRNA 		CTD PMID:28001369 NCBI chr11:44,419,099...44,464,366
Ensembl chr11:44,419,103...44,463,793 		JBrowse link
G Cs citrate synthase decreases expression ISO methylmercuric chloride results in decreased expression of CS mRNA CTD PMID:29104120 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Cse1l chromosome segregation 1 like increases expression ISO methylmercuric chloride results in increased expression of CSE1L mRNA CTD PMID:28001369 NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions ISO methylmercuric chloride affects the reaction [ITPR3 protein affects the expression of CSF2 mRNA]; methylmercuric chloride affects the reaction [ITPR3 protein affects the expression of CSF2 protein] CTD PMID:33166615 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of CSNK1A1 mRNA
methylmercuric chloride results in increased expression of CSNK1A1 mRNA 		CTD PMID:28001369 NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538 		JBrowse link
G Csnk1d casein kinase 1, delta increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CSNK1D mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1D mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953 		JBrowse link
G Csnk1g2 casein kinase 1, gamma 2 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CSNK1G2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1G2 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 7:9,727,430...9,746,341
Ensembl chr 7:9,727,431...9,745,741 		JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 decreases expression EXP methylmercuric chloride results in decreased expression of CSNK2A2 mRNA CTD PMID:20864626 NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136 		JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 increases expression ISO methylmercuric chloride results in increased expression of CSPG5 mRNA CTD PMID:28001369 NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907 		JBrowse link
G Cspp1 centrosome and spindle pole associated protein 1 increases expression ISO methylmercuric chloride results in increased expression of CSPP1 mRNA CTD PMID:28001369 NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:13,860,072...13,975,321 		JBrowse link
G Csrnp3 cysteine and serine rich nuclear protein 3 decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of CSRNP3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSRNP3 mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 3:70,906,587...71,102,596
Ensembl chr 3:70,906,380...71,094,009 		JBrowse link
G Cstf2t cleavage stimulation factor subunit 2, tau variant decreases expression ISO methylmercuric chloride results in decreased expression of CSTF2T mRNA CTD PMID:28001369 NCBI chr 1:238,366,042...238,369,608
Ensembl chr 1:238,365,912...238,369,749 		JBrowse link
G Ctbs chitobiase decreases expression ISO methylmercuric chloride results in decreased expression of CTBS mRNA CTD PMID:23179753 NCBI chr 2:238,000,800...238,015,368
Ensembl chr 2:238,000,842...238,015,475 		JBrowse link
G Ctdsp1 CTD small phosphatase 1 decreases expression ISO methylmercuric chloride results in decreased expression of CTDSP1 mRNA CTD PMID:28001369 NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412 		JBrowse link
G Ctdspl2 CTD small phosphatase like 2 decreases expression ISO methylmercuric chloride results in decreased expression of CTDSPL2 mRNA CTD PMID:28001369 NCBI chr 3:129,365,709...129,424,232
Ensembl chr 3:129,368,938...129,424,232 		JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO methylmercuric chloride results in increased expression of CTH mRNA CTD PMID:28001369 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnna2 catenin alpha 2 decreases expression ISO methylmercuric chloride results in decreased expression of CTNNA2 mRNA CTD PMID:28001369 NCBI chr 4:110,852,265...112,001,351
Ensembl chr 4:110,852,265...112,001,365 		JBrowse link
G Ctnnal1 catenin alpha-like 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CTNNAL1 mRNA CTD PMID:30744511 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases expression 		ISO
EXP 		methylmercuric chloride results in increased expression of CTNNB1 mRNA
methylmercuric chloride results in decreased expression of CTNNB1 mRNA
methylmercuric chloride results in decreased expression of CTNNB1 protein 		CTD PMID:23179753 PMID:28526320 PMID:29581082 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctnnd2 catenin delta 2 decreases expression ISO methylmercuric chloride results in decreased expression of CTNND2 mRNA CTD PMID:28001369 NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409 		JBrowse link
G Ctps2 CTP synthase 2 decreases expression ISO methylmercuric chloride results in decreased expression of CTPS2 mRNA CTD PMID:28001369 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505 		JBrowse link
G Ctrl chymotrypsin-like multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CTRB1 mRNA CTD PMID:30744511 NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979 		JBrowse link
G Ctsc cathepsin C increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CTSC mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSC mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Ctso cathepsin O decreases expression ISO methylmercuric chloride results in decreased expression of CTSO mRNA CTD PMID:28001369 NCBI chr 2:169,528,468...169,551,975
Ensembl chr 2:169,528,511...169,554,995 		JBrowse link
G Ctsz cathepsin Z decreases expression ISO methylmercuric chloride results in decreased expression of CTSZ mRNA CTD PMID:23179753 NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012 		JBrowse link
G Cttn cortactin increases expression ISO methylmercuric chloride results in increased expression of CTTN mRNA CTD PMID:28001369 NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211 		JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like decreases expression ISO methylmercuric chloride results in decreased expression of CTTNBP2NL mRNA CTD PMID:28001369 NCBI chr 2:195,196,318...195,244,792
Ensembl chr 2:195,196,318...195,243,181 		JBrowse link
G Cul2 cullin 2 decreases expression ISO methylmercuric chloride results in decreased expression of CUL2 mRNA CTD PMID:28001369 NCBI chr17:58,864,274...58,905,447
Ensembl chr17:58,864,274...58,905,132 		JBrowse link
G Cul3 cullin 3 decreases expression ISO methylmercuric chloride results in decreased expression of CUL3 mRNA CTD PMID:28001369 NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427 		JBrowse link
G Cul4a cullin 4A increases expression ISO methylmercuric chloride results in increased expression of CUL4A mRNA CTD PMID:28001369 NCBI chr16:83,086,688...83,124,503
Ensembl chr16:83,086,921...83,124,457 		JBrowse link
G Cul4b cullin 4B decreases expression ISO methylmercuric chloride results in decreased expression of CUL4B mRNA CTD PMID:28001369 NCBI chr  X:122,154,332...122,192,299
Ensembl chr  X:122,154,332...122,192,299 		JBrowse link
G Cux2 cut-like homeobox 2 decreases expression ISO methylmercuric chloride results in decreased expression of CUX2 mRNA CTD PMID:28001369 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of CUZD1 mRNA
methylmercuric chloride results in decreased expression of CUZD1 mRNA 		CTD PMID:28001369 NCBI chr 1:195,519,609...195,532,733
Ensembl chr 1:195,519,609...195,532,733 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 decreases expression ISO methylmercuric chloride results in decreased expression of CX3CL1 mRNA CTD PMID:29261810 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in increased expression of CXCL10 mRNA
[MT3 protein affects the susceptibility to methylmercuric chloride] which affects the expression of CXCL10 mRNA; MT3 protein affects the reaction [methylmercuric chloride results in increased expression of CXCL10 mRNA]
methylmercuric chloride results in increased expression of CXCL10 mRNA; methylmercuric chloride results in increased expression of CXCL10 protein 		CTD PMID:24213012 PMID:28526320 PMID:30103553 PMID:31378766 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 affects expression EXP methylmercuric chloride affects the expression of CXCL12 mRNA CTD PMID:20864626 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CXCL13 mRNA CTD PMID:28001369 PMID:31378766 NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 increases expression EXP methylmercuric chloride results in increased expression of CXCL14 mRNA CTD PMID:31378766 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 increases expression ISO methylmercuric chloride results in increased expression of CXCL17 mRNA CTD PMID:24213012 NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of CXCL2 mRNA
methylmercuric chloride results in increased expression of CXCL2 protein 		CTD PMID:24213012 PMID:28526320 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO methylmercuric chloride results in increased expression of CXCL1 mRNA; methylmercuric chloride results in increased expression of CXCL3 mRNA CTD PMID:24213012 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO methylmercuric chloride results in decreased expression of CXCR4 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cxxc4 CXXC finger protein 4 decreases expression ISO methylmercuric chloride results in decreased expression of CXXC4 mRNA CTD PMID:28001369 NCBI chr 2:225,329,044...225,363,347 JBrowse link
G Cxxc5 CXXC finger protein 5 increases expression ISO methylmercuric chloride results in increased expression of CXXC5 mRNA CTD PMID:23179753 PMID:26272509 NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635 		JBrowse link
G Cyb5a cytochrome b5 type A decreases expression ISO methylmercuric chloride results in decreased expression of CYB5A mRNA CTD PMID:23179753 PMID:27188386 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5b cytochrome b5 type B decreases expression ISO methylmercuric chloride results in decreased expression of CYB5B mRNA CTD PMID:28001369 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyb5d1 cytochrome b5 domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of CYB5D1 mRNA CTD PMID:23179753 NCBI chr10:54,612,230...54,616,375
Ensembl chr10:54,612,230...54,616,713 		JBrowse link
G Cyb5d2 cytochrome b5 domain containing 2 decreases expression ISO methylmercuric chloride results in decreased expression of CYB5D2 mRNA CTD PMID:28001369 NCBI chr10:57,892,799...57,911,831
Ensembl chr10:57,895,296...57,912,030 		JBrowse link
G Cyb5r2 cytochrome b5 reductase 2 decreases expression ISO methylmercuric chloride results in decreased expression of CYB5R2 mRNA CTD PMID:23179753 NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:171,067,614...171,075,904 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression ISO methylmercuric chloride results in decreased expression of CYB5R3 mRNA CTD PMID:19465457 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression ISO methylmercuric chloride results in increased expression of CYBA mRNA CTD PMID:29581082 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain increases expression EXP methylmercuric chloride results in increased expression of CYBB mRNA CTD PMID:31378766 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cycs cytochrome c, somatic increases expression
multiple interactions
increases cleavage 		ISO methylmercuric chloride results in increased expression of CYCS protein
ATF4 protein promotes the reaction [methylmercuric chloride results in increased cleavage of CYCS protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased cleavage of CYCS protein] 		CTD PMID:37967789 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of CYFIP2 mRNA CTD PMID:28001369 PMID:29261810 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cyld CYLD lysine 63 deubiquitinase decreases expression ISO methylmercuric chloride results in decreased expression of CYLD mRNA CTD PMID:28001369 NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions ISO [Tetrachlorodibenzodioxin co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with perfluorooctane sulfonic acid co-treated with hexabromocyclododecane co-treated with 2,2',4,4'-tetrabromodiphenyl ether co-treated with tributyltin co-treated with methylmercuric chloride] results in increased expression of CYP11B1 mRNA CTD PMID:25765474 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 multiple interactions ISO [Tetrachlorodibenzodioxin co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with perfluorooctane sulfonic acid co-treated with hexabromocyclododecane co-treated with 2,2',4,4'-tetrabromodiphenyl ether co-treated with tributyltin co-treated with methylmercuric chloride] results in increased expression of CYP11B2 mRNA CTD PMID:25765474 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CYP17A1 mRNA CTD PMID:30744511 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO [Tetrachlorodibenzodioxin co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with perfluorooctane sulfonic acid co-treated with hexabromocyclododecane co-treated with 2,2',4,4'-tetrabromodiphenyl ether co-treated with tributyltin co-treated with methylmercuric chloride] results in increased expression of CYP19A1 mRNA CTD PMID:25765474 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO
EXP 		[Tetrachlorodibenzodioxin co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with perfluorooctane sulfonic acid co-treated with hexabromocyclododecane co-treated with 2,2',4,4'-tetrabromodiphenyl ether co-treated with tributyltin co-treated with methylmercuric chloride] results in increased expression of CYP1A1 mRNA
[Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; mesoporphyrin IX inhibits the reaction [methylmercuric chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; methylmercuric chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; methylmercuric chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CYP1A1 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP1A1 mRNA 		CTD PMID:25765474 PMID:30744511 PMID:36245390 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions EXP
ISO 		[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP1A2 mRNA
[Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; methylmercuric chloride inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; methylmercuric chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; methylmercuric chloride promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] 		CTD PMID:30744511 PMID:36245390 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CYP1B1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP1B1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 affects expression
increases expression 		EXP
ISO 		methylmercuric chloride affects the expression of CYP26A1 mRNA
methylmercuric chloride results in increased expression of CYP26A1 mRNA 		CTD PMID:20864626 PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP2A1 mRNA CTD PMID:30744511 NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:91,359,272...91,389,730 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CYP2A3 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP2A3 mRNA CTD PMID:30744511 NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CYP2B2 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP2B2 mRNA CTD PMID:30744511 NCBI chr 1:90,722,243...90,736,272 JBrowse link
G Cyp2c12 cytochrome P450, family 2, subfamily c, polypeptide 12 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CYP2C12 mRNA CTD PMID:30744511 NCBI chr 1:248,619,887...248,681,945
Ensembl chr 1:248,619,882...248,677,042 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP2C6 mRNA CTD PMID:30744511 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2c7 cytochrome P450, family 2, subfamily c, polypeptide 7 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of CYP2C7 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP2C7 mRNA CTD PMID:30744511 NCBI chr 1:247,966,295...248,022,393
Ensembl chr 1:247,966,346...248,022,388 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 decreases expression ISO methylmercuric chloride results in decreased expression of CYP39A1 mRNA CTD PMID:28001369 NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:24,727,817...24,804,060 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP3A23-3A1 mRNA CTD PMID:30744511 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813 		JBrowse link
G Cyp4a2 cytochrome P450, family 4, subfamily a, polypeptide 2 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP4A2 mRNA CTD PMID:30744511 NCBI chr 5:134,160,356...134,170,908
Ensembl chr 5:134,160,358...134,176,156 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 decreases expression EXP methylmercuric chloride results in decreased expression of CYP7B1 mRNA CTD PMID:20864626 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cyren cell cycle regulator of NHEJ decreases expression ISO methylmercuric chloride results in decreased expression of CYREN mRNA CTD PMID:28001369 NCBI chr 4:64,514,477...64,519,896
Ensembl chr 4:64,514,477...64,518,742 		JBrowse link
G Cyrib CYFIP related Rac1 interactor B decreases expression ISO methylmercuric chloride results in decreased expression of CYRIB mRNA CTD PMID:28001369 NCBI chr 7:97,524,941...97,649,846
Ensembl chr 7:97,523,121...97,649,853 		JBrowse link
G Cystm1 cysteine-rich transmembrane module containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of CYSTM1 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr18:28,219,861...28,287,574
Ensembl chr18:28,220,004...28,287,574 		JBrowse link
G Cyth3 cytohesin 3 increases expression ISO methylmercuric chloride results in increased expression of CYTH3 mRNA CTD PMID:28001369 NCBI chr12:15,953,781...16,076,584
Ensembl chr12:15,953,791...16,047,506 		JBrowse link
G Cyth4 cytohesin 4 increases expression EXP methylmercuric chloride results in increased expression of CYTH4 mRNA CTD PMID:31378766 NCBI chr 7:112,032,711...112,057,204
Ensembl chr 7:112,032,775...112,057,204 		JBrowse link
G Cyyr1 cysteine and tyrosine rich 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of CYYR1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYYR1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473 		JBrowse link
G Daam1 dishevelled associated activator of morphogenesis 1 decreases expression ISO methylmercuric chloride results in decreased expression of DAAM1 mRNA CTD PMID:28001369 NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049 		JBrowse link
G Dach1 dachshund family transcription factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of DACH1 mRNA CTD PMID:28001369 NCBI chr15:80,936,063...81,317,746
Ensembl chr15:80,936,063...81,317,627 		JBrowse link
G Dand5 DAN domain BMP antagonist family member 5 increases expression ISO methylmercuric chloride results in increased expression of DAND5 mRNA CTD PMID:28001369 NCBI chr19:40,231,061...40,245,329 JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 decreases expression ISO methylmercuric chloride results in decreased expression of DARS1 mRNA CTD PMID:28001369 NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Dazap1 DAZ associated protein 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DAZAP1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 7:10,074,342...10,098,810
Ensembl chr 7:10,074,849...10,095,599 		JBrowse link
G Dazap2 DAZ associated protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of DAZAP2 mRNA CTD PMID:28001369 NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:133,593,512...133,599,047 		JBrowse link
G Dazl deleted in azoospermia-like decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of DAZL mRNA
methylmercuric chloride results in increased expression of DAZL mRNA 		CTD PMID:28001369 NCBI chr 9:18,193,363...18,210,100
Ensembl chr 9:18,193,363...18,210,100 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of DBP mRNA CTD PMID:30744511 NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression ISO methylmercuric chloride results in decreased expression of DBT mRNA CTD PMID:23179753 NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525 		JBrowse link
G Dcaf10 DDB1 and CUL4 associated factor 10 decreases expression ISO methylmercuric chloride results in decreased expression of DCAF10 mRNA CTD PMID:28001369 NCBI chr 5:64,402,307...64,442,839
Ensembl chr 5:64,403,451...64,440,614 		JBrowse link
G Dcaf11 DDB1 and CUL4 associated factor 11 decreases expression EXP methylmercuric chloride results in decreased expression of DCAF11 mRNA CTD PMID:20864626 NCBI chr15:33,015,370...33,027,407
Ensembl chr15:33,016,762...33,027,672 		JBrowse link
G Dcaf5 DDB1 and CUL4 associated factor 5 decreases expression ISO methylmercuric chloride results in decreased expression of DCAF5 mRNA CTD PMID:28001369 NCBI chr 6:104,904,423...104,993,150
Ensembl chr 6:104,904,423...104,993,103 		JBrowse link
G Dcaf7 DDB1 and CUL4 associated factor 7 increases expression ISO methylmercuric chloride results in increased expression of DCAF7 mRNA CTD PMID:23179753 NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080 		JBrowse link
G Dcbld1 discoidin, CUB and LCCL domain containing 1 increases expression ISO methylmercuric chloride results in increased expression of DCBLD1 mRNA CTD PMID:28001369 NCBI chr20:32,161,241...32,254,391
Ensembl chr20:32,161,254...32,281,176 		JBrowse link
G Dcdc1-ps1 doublecortin domain containing 1, pseudogene 1 decreases expression ISO methylmercuric chloride results in decreased expression of DCDC1 mRNA CTD PMID:28001369 NCBI chr 3:112,940,793...113,351,417
Ensembl chr 3:113,277,854...113,351,719 		JBrowse link
G Dclk1 doublecortin-like kinase 1 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DCLK1 mRNA
methylmercuric chloride results in decreased expression of DCLK1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCLK1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dclk2 doublecortin-like kinase 2 decreases expression ISO methylmercuric chloride results in decreased expression of DCLK2 mRNA CTD PMID:28001369 NCBI chr 2:174,506,660...174,636,353
Ensembl chr 2:174,506,660...174,636,192 		JBrowse link
G Dcn decorin multiple interactions
decreases expression 		EXP
ISO 		[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of DCN mRNA
methylmercuric chloride results in decreased expression of DCN mRNA 		CTD PMID:30744511 PMID:34089799 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Dct dopachrome tautomerase decreases expression ISO methylmercuric chloride results in decreased expression of DCT mRNA CTD PMID:34089799 NCBI chr15:101,469,159...101,508,029
Ensembl chr15:101,469,159...101,508,029 		JBrowse link
G Dctn3 dynactin subunit 3 decreases expression ISO methylmercuric chloride results in decreased expression of DCTN3 mRNA CTD PMID:28001369 NCBI chr 5:61,676,950...61,684,958
Ensembl chr 5:61,676,950...61,684,903 		JBrowse link
G Dcun1d4 defective in cullin neddylation 1 domain containing 4 decreases expression ISO methylmercuric chloride results in decreased expression of DCUN1D4 mRNA CTD PMID:28001369 NCBI chr14:35,006,792...35,087,285
Ensembl chr14:35,006,792...35,088,520 		JBrowse link
G Dcun1d5 defective in cullin neddylation 1 domain containing 5 decreases expression ISO methylmercuric chloride results in decreased expression of DCUN1D5 mRNA CTD PMID:28001369 NCBI chr 8:12,697,160...12,718,242
Ensembl chr 8:12,697,127...12,718,991 		JBrowse link
G Dcx doublecortin decreases expression ISO methylmercuric chloride results in decreased expression of DCX mRNA CTD PMID:28001369 PMID:33831500 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 increases expression ISO methylmercuric chloride results in increased expression of DDAH1 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626 		JBrowse link
G Ddhd1 DDHD domain containing 1 increases expression EXP methylmercuric chloride results in increased expression of DDHD1 mRNA CTD PMID:20864626 NCBI chr15:21,304,053...21,370,608
Ensembl chr15:21,303,826...21,370,608 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DDIT3 mRNA
[Eicosapentaenoic Acid co-treated with methylmercuric chloride] results in increased expression of DDIT3 mRNA; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of DDIT3 protein]; ATF4 protein promotes the reaction [methylmercuric chloride results in increased expression of DDIT3 protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in decreased expression of CASP12 protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased cleavage of CYCS protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP3 protein modified form]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPA9 protein]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPD1 protein]; Docosahexaenoic Acids promotes the reaction [methylmercuric chloride results in increased expression of DDIT3 mRNA]; Eicosapentaenoic Acid inhibits the reaction [Docosahexaenoic Acids promotes the reaction [methylmercuric chloride results in increased expression of DDIT3 mRNA]]
methylmercuric chloride results in increased expression of DDIT3 mRNA; methylmercuric chloride results in increased expression of DDIT3 protein 		CTD PMID:28001369 PMID:30769081 PMID:31330229 PMID:32870474 PMID:33454823 More... NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 decreases expression ISO methylmercuric chloride results in decreased expression of DDIT4 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like decreases expression ISO methylmercuric chloride results in decreased expression of DDIT4L mRNA CTD PMID:28001369 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225 		JBrowse link
G Ddn dendrin decreases expression
multiple interactions 		EXP methylmercuric chloride results in decreased expression of DDN mRNA
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of DDN mRNA] 		CTD PMID:30890323 NCBI chr 7:131,832,270...131,836,252
Ensembl chr 7:131,832,271...131,836,294 		JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 affects expression EXP methylmercuric chloride affects the expression of DDR1 mRNA CTD PMID:20864626 NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276 		JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 increases expression ISO methylmercuric chloride results in increased expression of DDR2 mRNA CTD PMID:28001369 NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288 		JBrowse link
G Ddx17 DEAD-box helicase 17 increases expression ISO methylmercuric chloride results in increased expression of DDX17 mRNA CTD PMID:26272509 NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747 		JBrowse link
G Ddx19b DEAD-box helicase 19B decreases expression ISO methylmercuric chloride results in decreased expression of DDX19B mRNA CTD PMID:28001369 NCBI chr19:55,877,567...55,910,134
Ensembl chr19:55,877,567...55,906,745 		JBrowse link
G Ddx24 DEAD-box helicase 24 increases expression ISO methylmercuric chloride results in increased expression of DDX24 mRNA CTD PMID:28001369 NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:128,329,554...128,349,625 		JBrowse link
G Ddx25 DEAD-box helicase 25 decreases expression ISO methylmercuric chloride results in decreased expression of DDX25 mRNA CTD PMID:28001369 NCBI chr 8:42,152,046...42,168,635
Ensembl chr 8:42,152,047...42,168,080 		JBrowse link
G Ddx31 DEAD-box helicase 31 decreases expression EXP methylmercuric chloride results in decreased expression of DDX31 mRNA CTD PMID:20864626 NCBI chr 3:32,570,725...32,635,446
Ensembl chr 3:32,571,020...32,636,954 		JBrowse link
G Ddx43 DEAD-box helicase 43 increases expression ISO methylmercuric chloride results in increased expression of DDX43 mRNA CTD PMID:28001369 NCBI chr 8:88,135,255...88,172,872
Ensembl chr 8:88,135,882...88,164,749 		JBrowse link
G Ddx5 DEAD-box helicase 5 decreases expression ISO methylmercuric chloride results in decreased expression of DDX5 mRNA CTD PMID:28001369 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300 		JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO methylmercuric chloride results in decreased expression of DDX6 mRNA CTD PMID:28001369 NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977 		JBrowse link
G Ddx60 DEXD/H-box helicase 60 decreases expression ISO methylmercuric chloride results in decreased expression of DDX60 mRNA CTD PMID:19465457 PMID:28001369 NCBI chr16:33,087,940...33,208,843
Ensembl chr16:33,087,988...33,208,839 		JBrowse link
G Defa31 defensin alpha 31 multiple interactions
increases expression 		EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of DEFA10 mRNA
methylmercuric chloride results in increased expression of DEFA10 mRNA 		CTD PMID:30744511 PMID:31378766 NCBI chr16:77,216,346...77,218,685
Ensembl chr16:77,216,346...77,217,475 		JBrowse link
G Defa5 defensin alpha 5 increases expression EXP methylmercuric chloride results in increased expression of DEFA5 mRNA CTD PMID:31378766 NCBI chr16:77,044,994...77,047,318
Ensembl chr16:77,044,994...77,047,318 		JBrowse link
G Dennd1a DENN domain containing 1A decreases expression ISO methylmercuric chloride results in decreased expression of DENND1A mRNA CTD PMID:28001369 NCBI chr 3:41,974,502...42,461,816
Ensembl chr 3:41,974,502...42,461,886 		JBrowse link
G Dennd1b DENN domain containing 1B decreases expression
multiple interactions 		ISO methylmercuric chloride results in decreased expression of DENND1B mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND1B mRNA 		CTD PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr13:53,096,717...53,324,372
Ensembl chr13:53,092,261...53,324,369 		JBrowse link
G Dennd4a DENN domain containing 4A decreases expression ISO methylmercuric chloride results in decreased expression of DENND4A mRNA CTD PMID:28001369 NCBI chr 8:74,218,131...74,331,543
Ensembl chr 8:74,218,191...74,331,542 		JBrowse link
G Denr density regulated reinitiation and release factor increases expression ISO methylmercuric chloride results in increased expression of DENR mRNA CTD PMID:28001369 NCBI chr12:38,323,433...38,346,207
Ensembl chr12:38,323,445...38,344,797 		JBrowse link
G Depdc7 DEP domain containing 7 increases expression ISO methylmercuric chloride results in increased expression of DEPDC7 mRNA CTD PMID:28001369 NCBI chr 3:111,554,701...111,575,979
Ensembl chr 3:111,554,706...111,575,979 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein decreases expression ISO methylmercuric chloride results in decreased expression of DEPTOR mRNA CTD PMID:28001369 NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041 		JBrowse link
G Derl1 derlin 1 increases expression ISO methylmercuric chloride results in increased expression of DERL1 mRNA CTD PMID:28001369 NCBI chr 7:91,293,963...91,316,639
Ensembl chr 7:91,258,382...91,316,678 		JBrowse link
G Det1 DET1 partner of COP1 E3 ubiquitin ligase decreases expression ISO methylmercuric chloride results in decreased expression of DET1 mRNA CTD PMID:28001369 NCBI chr 1:142,159,120...142,175,366
Ensembl chr 1:142,127,876...142,175,336 		JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 decreases expression ISO methylmercuric chloride results in decreased expression of DGAT2 mRNA CTD PMID:28001369 NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566 		JBrowse link
G Dhfr dihydrofolate reductase decreases expression ISO methylmercuric chloride results in decreased expression of DHFR mRNA CTD PMID:28001369 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Dhrs1 dehydrogenase/reductase 1 decreases expression ISO methylmercuric chloride results in decreased expression of DHRS1 mRNA CTD PMID:28001369 NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734 		JBrowse link
G Dhrs11 dehydrogenase/reductase 11 decreases expression ISO methylmercuric chloride results in decreased expression of DHRS11 mRNA CTD PMID:28001369 NCBI chr10:70,195,637...70,205,735
Ensembl chr10:70,195,637...70,205,893 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression ISO methylmercuric chloride results in decreased expression of DHRS3 mRNA CTD PMID:34089799 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Dhrsx dehydrogenase/reductase X-linked decreases expression ISO methylmercuric chloride results in decreased expression of DHRSX mRNA CTD PMID:28001369 NCBI chr12:21,413,563...21,418,319
Ensembl chr12:21,413,575...21,418,319 		JBrowse link
G Dhx57 DExH-box helicase 57 decreases expression ISO methylmercuric chloride results in decreased expression of DHX57 mRNA CTD PMID:28001369 NCBI chr 6:20,474,889...20,528,556
Ensembl chr 6:20,477,191...20,528,556 		JBrowse link
G Dhx8 DEAH-box helicase 8 increases expression ISO methylmercuric chloride results in increased expression of DHX8 mRNA CTD PMID:34089799 NCBI chr10:87,167,861...87,204,426
Ensembl chr10:87,168,062...87,205,875 		JBrowse link
G Dhx9 DExH-box helicase 9 increases expression ISO methylmercuric chloride results in increased expression of DHX9 mRNA CTD PMID:26272509 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546 		JBrowse link
G Diaph3 diaphanous-related formin 3 increases expression ISO methylmercuric chloride results in increased expression of DIAPH3 mRNA CTD PMID:28001369 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Dido1 death inducer-obliterator 1 increases expression ISO methylmercuric chloride results in increased expression of DIDO1 mRNA CTD PMID:23179753 PMID:26272509 NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823 		JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO methylmercuric chloride results in increased expression of DIO3 mRNA CTD PMID:28001369 NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985 		JBrowse link
G Dipk1a divergent protein kinase domain 1A decreases expression ISO methylmercuric chloride results in decreased expression of DIPK1A mRNA CTD PMID:28001369 NCBI chr14:1,917,353...1,988,188
Ensembl chr14:1,917,324...1,988,678 		JBrowse link
G Dipk1c divergent protein kinase domain 1C decreases expression ISO methylmercuric chloride results in decreased expression of DIPK1C mRNA CTD PMID:28001369 PMID:34089799 NCBI chr18:80,362,854...80,384,774
Ensembl chr18:80,362,982...80,386,551 		JBrowse link
G Dis3 DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease decreases expression ISO methylmercuric chloride results in decreased expression of DIS3 mRNA CTD PMID:28001369 NCBI chr15:82,231,922...82,258,299
Ensembl chr15:82,231,283...82,258,333 		JBrowse link
G Dis3l2 DIS3-like 3'-5' exoribonuclease 2 decreases expression ISO methylmercuric chloride results in decreased expression of DIS3L2 mRNA CTD PMID:28001369 NCBI chr 9:94,802,056...95,184,523
Ensembl chr 9:94,804,382...95,184,522 		JBrowse link
G Dkc1 dyskerin pseudouridine synthase 1 increases expression ISO methylmercuric chloride results in increased expression of DKC1 mRNA CTD PMID:28001369 NCBI chr  X:157,751,651...157,757,796
Ensembl chr  Y:380,743...385,405
Ensembl chr  X:380,743...385,405 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DKK1 mRNA
methylmercuric chloride results in decreased expression of DKK1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DKK1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DLAT mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLAT mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:59,868,214...59,900,818
Ensembl chr 1:59,868,214...59,900,818 		JBrowse link
G Dlc1 DLC1 Rho GTPase activating protein affects expression
decreases expression 		ISO methylmercuric chloride affects the expression of DLC1 mRNA
methylmercuric chloride results in decreased expression of DLC1 mRNA 		CTD PMID:21613230 PMID:28001369 NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819 		JBrowse link
G Dld dihydrolipoamide dehydrogenase decreases expression ISO methylmercuric chloride results in decreased expression of DLD mRNA CTD PMID:28001369 NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of DLG1 mRNA CTD PMID:26272509 NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 decreases expression ISO methylmercuric chloride results in decreased expression of DLG4 mRNA; methylmercuric chloride results in decreased expression of DLG4 protein CTD PMID:39187442 NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839 		JBrowse link
G Dlgap4 DLG associated protein 4 increases expression ISO methylmercuric chloride results in increased expression of DLGAP4 mRNA CTD PMID:28001369 NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 increases expression ISO methylmercuric chloride results in increased expression of DLK1 mRNA CTD PMID:34089799 NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529 		JBrowse link
G Dll1 delta like canonical Notch ligand 1 affects expression
decreases expression 		EXP
ISO 		methylmercuric chloride affects the expression of DLL1 mRNA
methylmercuric chloride results in decreased expression of DLL1 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276 		JBrowse link
G Dll3 delta like canonical Notch ligand 3 affects expression EXP methylmercuric chloride affects the expression of DLL3 mRNA CTD PMID:20864626 NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406 		JBrowse link
G Dlx1 distal-less homeobox 1 increases expression ISO methylmercuric chloride results in increased expression of DLX1 mRNA CTD PMID:34089799 NCBI chr 3:76,763,864...76,768,454
Ensembl chr 3:76,763,500...76,768,447 		JBrowse link
G Dlx2 distal-less homeobox 2 increases expression ISO methylmercuric chloride results in increased expression of DLX2 mRNA CTD PMID:28001369 NCBI chr 3:76,777,912...76,781,255
Ensembl chr 3:76,777,912...76,781,255 		JBrowse link
G Dlx5 distal-less homeobox 5 increases expression ISO methylmercuric chloride results in increased expression of DLX5 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 4:35,965,579...35,969,973
Ensembl chr 4:35,965,579...35,969,845 		JBrowse link
G Dlx6 distal-less homeobox 6 increases expression ISO methylmercuric chloride results in increased expression of DLX6 mRNA CTD PMID:26272509 NCBI chr 4:35,951,005...35,956,354
Ensembl chr 4:35,951,005...35,956,354 		JBrowse link
G Dmac1 distal membrane arm assembly component 1 decreases expression ISO methylmercuric chloride results in decreased expression of DMAC1 mRNA CTD PMID:28001369 NCBI chr 5:94,288,900...94,290,053
Ensembl chr 5:94,280,654...94,290,119 		JBrowse link
G Dmac2l distal membrane arm assembly component 2 like decreases expression ISO methylmercuric chloride results in decreased expression of DMAC2L mRNA CTD PMID:28001369 NCBI chr 6:93,941,605...93,959,932
Ensembl chr 6:93,941,690...93,960,662 		JBrowse link
G Dmap1 DNA methyltransferase 1-associated protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of DMAP1 mRNA CTD PMID:28001369 NCBI chr 5:136,380,211...136,388,229
Ensembl chr 5:136,380,216...136,388,219 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression EXP methylmercuric chloride results in increased expression of DMBT1 mRNA CTD PMID:31378766 NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704 		JBrowse link
G Dmpk DM1 protein kinase decreases response to substance ISO DMPK results in decreased susceptibility to methylmercuric chloride CTD PMID:9694217 NCBI chr 1:87,858,294...87,868,624
Ensembl chr 1:87,858,316...87,868,910 		JBrowse link
G Dmrt3 doublesex and mab-3 related transcription factor 3 decreases expression ISO methylmercuric chloride results in decreased expression of DMRT3 mRNA CTD PMID:28001369 NCBI chr 1:232,670,642...232,690,557
Ensembl chr 1:232,675,059...232,688,833 		JBrowse link
G Dnaaf10 dynein axonemal assembly factor 10 decreases expression ISO methylmercuric chloride results in decreased expression of DNAAF10 mRNA CTD PMID:28001369 NCBI chr14:95,820,272...95,841,449
Ensembl chr14:95,820,234...95,841,442 		JBrowse link
G Dnaaf4 dynein axonemal assembly factor 4 decreases expression ISO methylmercuric chloride results in decreased expression of DNAAF4 mRNA CTD PMID:28001369 NCBI chr 8:82,577,044...82,601,653
Ensembl chr 8:82,578,755...82,592,205 		JBrowse link
G Dnah14 dynein axonemal heavy chain 14 increases expression ISO methylmercuric chloride results in increased expression of DNAH14 mRNA CTD PMID:28001369 NCBI chr13:95,853,735...96,070,327
Ensembl chr13:95,854,534...96,070,330 		JBrowse link
G Dnaja4 DnaJ heat shock protein family (Hsp40) member A4 increases expression ISO methylmercuric chloride results in increased expression of DNAJA4 mRNA CTD PMID:28001369 NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression ISO methylmercuric chloride results in increased expression of DNAJB1 mRNA CTD PMID:24356939 PMID:28001369 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJB4 mRNA CTD PMID:28001369 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042 		JBrowse link
G Dnajb5 DnaJ heat shock protein family (Hsp40) member B5 increases expression ISO methylmercuric chloride results in increased expression of DNAJB5 mRNA CTD PMID:28001369 NCBI chr 5:61,972,637...61,981,887
Ensembl chr 5:61,972,706...61,981,860 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 decreases expression
multiple interactions
increases expression 		ISO methylmercuric chloride results in decreased expression of DNAJB9 mRNA
Docosahexaenoic Acids promotes the reaction [methylmercuric chloride results in increased expression of DNAJB9 mRNA]; Eicosapentaenoic Acid inhibits the reaction [Docosahexaenoic Acids promotes the reaction [methylmercuric chloride results in increased expression of DNAJB9 mRNA]]; Eicosapentaenoic Acid promotes the reaction [methylmercuric chloride results in increased expression of DNAJB9 mRNA] 		CTD PMID:28001369 PMID:30769081 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344 		JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC10 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368 		JBrowse link
G Dnajc12 DnaJ heat shock protein family (Hsp40) member C12 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC12 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251 		JBrowse link
G Dnajc15 DnaJ heat shock protein family (Hsp40) member C15 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC15 mRNA CTD PMID:28001369 NCBI chr15:59,594,314...59,658,862
Ensembl chr15:59,594,314...59,658,987 		JBrowse link
G Dnajc18 DnaJ heat shock protein family (Hsp40) member C18 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC18 mRNA CTD PMID:28001369 NCBI chr18:27,543,438...27,577,535
Ensembl chr18:27,543,438...27,577,535 		JBrowse link
G Dnajc19 DnaJ heat shock protein family (Hsp40) member C19 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC19 mRNA CTD PMID:28001369 NCBI chr 2:118,851,497...118,875,813
Ensembl chr 2:118,869,413...118,873,781 		JBrowse link
G Dnajc2 DnaJ heat shock protein family (Hsp40) member C2 increases expression ISO methylmercuric chloride results in increased expression of DNAJC2 mRNA CTD PMID:28001369 NCBI chr 4:14,162,490...14,189,662
Ensembl chr 4:14,163,838...14,192,846 		JBrowse link
G Dnajc24 DnaJ heat shock protein family (Hsp40) member C24 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC24 mRNA CTD PMID:28001369 NCBI chr 3:112,905,369...112,940,741
Ensembl chr 3:112,904,769...112,940,640 		JBrowse link
G Dnajc28 DnaJ heat shock protein family (Hsp40) member C28 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC28 mRNA CTD PMID:28001369 NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482 		JBrowse link
G Dnajc4 DnaJ heat shock protein family (Hsp40) member C4 decreases expression ISO methylmercuric chloride results in decreased expression of DNAJC4 mRNA CTD PMID:28001369 NCBI chr 1:213,607,397...213,611,614
Ensembl chr 1:213,607,399...213,611,729 		JBrowse link
G Dnmt1 DNA methyltransferase 1 decreases expression
increases expression 		EXP
ISO 		methylmercuric chloride results in decreased expression of DNMT1 mRNA
methylmercuric chloride results in increased expression of DNMT1 protein 		CTD PMID:19636072 PMID:33454822 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha increases expression ISO methylmercuric chloride results in increased expression of DNMT3A protein CTD PMID:33454822 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta decreases expression
increases expression 		EXP
ISO 		methylmercuric chloride results in decreased expression of DNMT3B mRNA
methylmercuric chloride results in increased expression of DNMT3B mRNA; methylmercuric chloride results in increased expression of DNMT3B protein 		CTD PMID:19636072 PMID:33454822 PMID:34328791 NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Dnmt3l DNA methyltransferase 3 like affects expression ISO methylmercuric chloride affects the expression of DNMT3L mRNA CTD PMID:21613230 NCBI chr20:10,614,591...10,628,989
Ensembl chr20:10,614,591...10,629,168 		JBrowse link
G Dock4 dedicator of cytokinesis 4 decreases expression ISO methylmercuric chloride results in decreased expression of DOCK4 mRNA CTD PMID:28001369 NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772 		JBrowse link
G Dock7 dedicator of cytokinesis 7 decreases expression ISO methylmercuric chloride results in decreased expression of DOCK7 mRNA CTD PMID:28001369 NCBI chr 5:118,714,863...118,898,362
Ensembl chr 5:118,714,863...118,898,335 		JBrowse link
G Dock8 dedicator of cytokinesis 8 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of DOCK8 mRNA
methylmercuric chloride results in decreased expression of DOCK8 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833 		JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression ISO methylmercuric chloride results in decreased expression of DOCK9 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr15:105,018,341...105,289,799
Ensembl chr15:105,024,912...105,289,799 		JBrowse link
G Dok4 docking protein 4 decreases expression ISO methylmercuric chloride results in decreased expression of DOK4 mRNA CTD PMID:23179753 NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190 		JBrowse link
G Dok5 docking protein 5 decreases expression ISO methylmercuric chloride results in decreased expression of DOK5 mRNA CTD PMID:28001369 NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333 		JBrowse link
G Dop1a DOP1 leucine zipper like protein A decreases expression ISO methylmercuric chloride results in decreased expression of DOP1A mRNA CTD PMID:28001369 NCBI chr 8:96,295,302...96,397,951
Ensembl chr 8:96,295,328...96,398,652 		JBrowse link
G Dpcd deleted in primary ciliary dyskinesia decreases expression ISO methylmercuric chloride results in decreased expression of DPCD mRNA CTD PMID:28001369 NCBI chr 1:254,357,755...254,375,918
Ensembl chr 1:254,357,778...254,375,918 		JBrowse link
G Dph5 diphthamide biosynthesis 5 decreases expression ISO methylmercuric chloride results in decreased expression of DPH5 mRNA CTD PMID:28001369 NCBI chr 2:206,489,556...206,540,590
Ensembl chr 2:206,489,556...206,523,556 		JBrowse link
G Dph6 diphthamine biosynthesis 6 decreases expression ISO methylmercuric chloride results in decreased expression of DPH6 mRNA CTD PMID:28001369 NCBI chr 3:121,761,495...121,891,727
Ensembl chr 3:121,676,141...121,891,658 		JBrowse link
G Dpm3 dolichyl-phosphate mannosyltransferase subunit 3, regulatory decreases expression ISO methylmercuric chloride results in decreased expression of DPM3 mRNA CTD PMID:28001369 NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696 		JBrowse link
G Dpp10 dipeptidyl peptidase like 10 decreases expression ISO methylmercuric chloride results in decreased expression of DPP10 mRNA CTD PMID:28001369 NCBI chr13:37,145,531...38,821,987
Ensembl chr13:37,145,531...38,822,801 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression ISO methylmercuric chloride results in decreased expression of DPP4 mRNA CTD PMID:23179753 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 decreases expression ISO methylmercuric chloride results in decreased expression of DPP6 mRNA CTD PMID:28001369 NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209 		JBrowse link
G Dpp7 dipeptidylpeptidase 7 decreases expression ISO methylmercuric chloride results in decreased expression of DPP7 mRNA CTD PMID:28001369 NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492 		JBrowse link
G Dpp8 dipeptidylpeptidase 8 increases expression ISO methylmercuric chloride results in increased expression of DPP8 mRNA CTD PMID:28001369 NCBI chr 8:74,445,815...74,501,017
Ensembl chr 8:74,445,835...74,501,017 		JBrowse link
G Dppa2 developmental pluripotency-associated 2 increases expression ISO methylmercuric chloride results in increased expression of DPPA2 mRNA CTD PMID:28001369 NCBI chr11:66,008,002...66,020,044
Ensembl chr11:66,011,628...66,020,994 		JBrowse link
G Dppa4 developmental pluripotency associated 4 decreases expression ISO methylmercuric chloride results in decreased expression of DPPA4 mRNA CTD PMID:23179753 NCBI chr11:66,033,256...66,041,754
Ensembl chr11:66,033,256...66,041,754 		JBrowse link
G Dpy19l2 dpy-19 like 2 decreases expression ISO methylmercuric chloride results in decreased expression of DPY19L2 mRNA CTD PMID:28001369 NCBI chr 8:31,338,450...31,457,682
Ensembl chr 8:31,338,488...31,457,725 		JBrowse link
G Dpy19l4 dpy-19 like 4 decreases expression ISO methylmercuric chloride results in decreased expression of DPY19L4 mRNA CTD PMID:23179753 NCBI chr 5:29,148,518...29,208,132
Ensembl chr 5:29,151,129...29,208,132 		JBrowse link
G Dpysl3 dihydropyrimidinase-like 3 decreases expression ISO methylmercuric chloride results in decreased expression of DPYSL3 mRNA CTD PMID:28001369 PMID:37210002 NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152 		JBrowse link
G Dpysl4 dihydropyrimidinase-like 4 affects expression
multiple interactions
increases expression 		EXP
ISO 		methylmercuric chloride affects the expression of DPYSL4 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPYSL4 mRNA
methylmercuric chloride results in increased expression of DPYSL4 mRNA 		CTD PMID:20864626 PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr 1:203,312,646...203,328,523
Ensembl chr 1:203,311,694...203,328,523 		JBrowse link
G Dram1 DNA-damage regulated autophagy modulator 1 increases expression ISO methylmercuric chloride results in increased expression of DRAM1 mRNA CTD PMID:28001369 NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354 		JBrowse link
G Dram2 DNA damage regulated autophagy modulator 2 decreases expression ISO methylmercuric chloride results in decreased expression of DRAM2 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 2:196,724,052...196,752,645
Ensembl chr 2:196,723,858...196,755,103 		JBrowse link
G Draxin dorsal inhibitory axon guidance protein increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of DRAXIN mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DRAXIN mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 5:163,813,308...163,846,609
Ensembl chr 5:163,816,502...163,855,174 		JBrowse link
G Drd1 dopamine receptor D1 decreases expression ISO methylmercuric chloride results in decreased expression of DRD1 mRNA CTD PMID:21385734 NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166 		JBrowse link
G Drd2 dopamine receptor D2 decreases expression ISO methylmercuric chloride results in decreased expression of DRD2 mRNA CTD PMID:21385734 NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339 		JBrowse link
G Drd3 dopamine receptor D3 decreases expression ISO methylmercuric chloride results in decreased expression of DRD3 mRNA CTD PMID:21385734 NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760 		JBrowse link
G Drd4 dopamine receptor D4 decreases expression ISO methylmercuric chloride results in decreased expression of DRD4 mRNA CTD PMID:28001369 NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458 		JBrowse link
G Dsc2 desmocollin 2 decreases expression ISO methylmercuric chloride results in decreased expression of DSC2 mRNA CTD PMID:27188386 NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466 		JBrowse link
G Dsc3 desmocollin 3 increases expression ISO methylmercuric chloride results in increased expression of DSC3 mRNA CTD PMID:28001369 NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,653,832...11,688,871 		JBrowse link
G Dsel dermatan sulfate epimerase-like increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of DSEL mRNA
methylmercuric chloride results in decreased expression of DSEL mRNA 		CTD PMID:28001369 NCBI chr13:194,738...200,959
Ensembl chr13:179,618...200,993 		JBrowse link
G Dsg1 desmoglein 1 decreases expression ISO methylmercuric chloride results in decreased expression of DSG1A mRNA CTD PMID:19465457 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Dsg2 desmoglein 2 decreases expression ISO methylmercuric chloride results in decreased expression of DSG2 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590 		JBrowse link
G Dsp desmoplakin decreases expression ISO methylmercuric chloride results in decreased expression of DSP mRNA CTD PMID:23179753 PMID:27188386 NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121 		JBrowse link
G Dst dystonin decreases expression ISO methylmercuric chloride results in decreased expression of DST mRNA CTD PMID:28001369 NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533 		JBrowse link
G Dstn destrin, actin depolymerizing factor decreases expression ISO methylmercuric chloride results in decreased expression of DSTN mRNA CTD PMID:28001369 NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769 		JBrowse link
G Dstyk dual serine/threonine and tyrosine protein kinase decreases expression ISO methylmercuric chloride results in decreased expression of DSTYK mRNA CTD PMID:28001369 NCBI chr13:46,409,412...46,457,426
Ensembl chr13:46,409,412...46,457,424 		JBrowse link
G Dtna dystrobrevin, alpha increases expression ISO methylmercuric chloride results in increased expression of DTNA mRNA CTD PMID:23179753 PMID:28001369 NCBI chr18:14,862,801...15,218,993
Ensembl chr18:14,862,818...15,218,993 		JBrowse link
G Dtx1 deltex E3 ubiquitin ligase 1 decreases expression ISO methylmercuric chloride results in decreased expression of DTX1 mRNA CTD PMID:28001369 NCBI chr12:41,510,252...41,541,433
Ensembl chr12:41,510,264...41,541,430 		JBrowse link
G Dtx4 deltex E3 ubiquitin ligase 4 decreases expression EXP methylmercuric chloride results in decreased expression of DTX4 mRNA CTD PMID:20864626 NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:218,832,284...218,917,130 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO methylmercuric chloride results in increased expression of DUSP1 mRNA CTD PMID:23179753 PMID:26272509 PMID:28001369 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dusp10 dual specificity phosphatase 10 increases expression ISO methylmercuric chloride results in increased expression of DUSP10 mRNA CTD PMID:28001369 NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304 		JBrowse link
G Dusp16 dual specificity phosphatase 16 increases expression ISO methylmercuric chloride results in increased expression of DUSP16 mRNA CTD PMID:28001369 NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508 		JBrowse link
G Dusp26 dual specificity phosphatase 26 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of DUSP26 mRNA CTD PMID:30744511 NCBI chr16:67,744,830...67,752,673
Ensembl chr16:67,744,842...67,752,101 		JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression ISO methylmercuric chloride results in increased expression of DUSP3 mRNA CTD PMID:28001369 NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063 		JBrowse link
G Dusp4 dual specificity phosphatase 4 increases expression ISO methylmercuric chloride results in increased expression of DUSP4 mRNA CTD PMID:28001369 NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700 		JBrowse link
G Dusp5 dual specificity phosphatase 5 increases expression ISO methylmercuric chloride results in increased expression of DUSP5 mRNA CTD PMID:28001369 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO methylmercuric chloride results in increased expression of DUSP6 mRNA CTD PMID:28001369 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dusp8 dual specificity phosphatase 8 increases expression ISO methylmercuric chloride results in increased expression of DUSP8 mRNA CTD PMID:28001369 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Dut deoxyuridine triphosphatase decreases expression ISO methylmercuric chloride results in decreased expression of DUT mRNA CTD PMID:28001369 NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 increases expression ISO methylmercuric chloride results in increased expression of DYNC1H1 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Dync1i2 dynein cytoplasmic 1 intermediate chain 2 decreases expression ISO methylmercuric chloride results in decreased expression of DYNC1I2 mRNA CTD PMID:28001369 NCBI chr 3:76,441,621...76,492,782
Ensembl chr 3:76,424,469...76,492,782 		JBrowse link
G Dync2h1 dynein cytoplasmic 2 heavy chain 1 affects expression
decreases expression 		EXP
ISO 		methylmercuric chloride affects the expression of DYNC2H1 mRNA
methylmercuric chloride results in decreased expression of DYNC2H1 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058 		JBrowse link
G Dynlt2 dynein light chain Tctex-type 2 decreases expression ISO methylmercuric chloride results in decreased expression of DYNLT2 mRNA CTD PMID:28001369 NCBI chr 1:64,644,404...64,656,368
Ensembl chr 1:64,644,404...64,656,368 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 decreases expression ISO methylmercuric chloride results in decreased expression of DYRK2 mRNA CTD PMID:28001369 NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942 		JBrowse link
G Dzank1 double zinc ribbon and ankyrin repeat domains 1 decreases expression ISO methylmercuric chloride results in decreased expression of DZANK1 mRNA CTD PMID:28001369 NCBI chr 3:152,309,228...152,361,548
Ensembl chr 3:152,309,228...152,361,548 		JBrowse link
G Dzip3 DAZ interacting zinc finger protein 3 decreases expression ISO methylmercuric chloride results in decreased expression of DZIP3 mRNA CTD PMID:28001369 NCBI chr11:65,286,190...65,356,314
Ensembl chr11:65,286,190...65,356,314 		JBrowse link
G E2f2 E2F transcription factor 2 decreases expression ISO methylmercuric chloride results in decreased expression of E2F2 mRNA CTD PMID:28001369 NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087 		JBrowse link
G E2f7 E2F transcription factor 7 increases expression ISO methylmercuric chloride results in increased expression of E2F7 mRNA CTD PMID:27188386 NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055 		JBrowse link
G E2f8 E2F transcription factor 8 decreases expression ISO methylmercuric chloride results in decreased expression of E2F8 mRNA CTD PMID:28001369 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G Eaf2 ELL associated factor 2 decreases expression ISO methylmercuric chloride results in decreased expression of EAF2 mRNA CTD PMID:28001369 NCBI chr11:77,465,585...77,509,993
Ensembl chr11:77,406,020...77,509,993 		JBrowse link
G Ebf1 EBF transcription factor 1 increases expression ISO methylmercuric chloride results in increased expression of EBF1 mRNA CTD PMID:23179753 NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702 		JBrowse link
G Ebpl EBP like decreases expression EXP methylmercuric chloride results in decreased expression of EBPL mRNA CTD PMID:20864626 NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537 		JBrowse link
G Eci1 enoyl-CoA delta isomerase 1 decreases expression EXP methylmercuric chloride results in decreased expression of ECI1 mRNA CTD PMID:20864626 NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773 		JBrowse link
G Ecpas Ecm29 proteasome adaptor and scaffold decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of ECPAS mRNA
methylmercuric chloride results in increased expression of ECPAS mRNA 		CTD PMID:28001369 NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908 		JBrowse link
G Ecrg4 ECRG4 augurin precursor increases expression ISO methylmercuric chloride results in increased expression of ECRG4 mRNA CTD PMID:34089799 NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703 		JBrowse link
G Ect2 epithelial cell transforming 2 decreases expression ISO methylmercuric chloride results in decreased expression of ECT2 mRNA CTD PMID:34089799 NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626 		JBrowse link
G Edn1 endothelin 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of EDN1 mRNA
HOXB13 protein affects the reaction [methylmercuric chloride results in increased expression of EDN1 mRNA] 		CTD PMID:28001369 PMID:31878059 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednra endothelin receptor type A decreases expression ISO methylmercuric chloride results in decreased expression of EDNRA mRNA CTD PMID:28001369 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Ednrb endothelin receptor type B increases expression ISO methylmercuric chloride results in increased expression of EDNRB mRNA CTD PMID:34089799 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Eed embryonic ectoderm development increases expression ISO methylmercuric chloride results in increased expression of EED mRNA CTD PMID:28001369 NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 decreases expression ISO methylmercuric chloride results in decreased expression of EEF1A1 mRNA CTD PMID:28001369 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eeig2 EEIG family member 2 increases expression ISO methylmercuric chloride results in increased expression of EEIG2 mRNA CTD PMID:28001369 NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449 		JBrowse link
G Efcab10 EF-hand calcium binding domain 10 decreases expression ISO methylmercuric chloride results in decreased expression of EFCAB10 mRNA CTD PMID:28001369 NCBI chr 6:55,731,902...55,738,821
Ensembl chr 6:55,731,902...55,738,821 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of EFEMP1 mRNA CTD PMID:30744511 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Efemp2 EGF containing fibulin extracellular matrix protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of EFEMP2 mRNA CTD PMID:28001369 NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739 		JBrowse link
G Efhb EF hand domain family, member B decreases expression ISO methylmercuric chloride results in decreased expression of EFHB mRNA CTD PMID:28001369 NCBI chr 9:6,608,791...6,680,104
Ensembl chr 9:6,608,794...6,678,827 		JBrowse link
G Efhc1 EF-hand domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of EFHC1 mRNA CTD PMID:28001369 NCBI chr 9:30,872,238...30,910,703
Ensembl chr 9:30,871,565...30,910,703 		JBrowse link
G Efhc2 EF-hand domain containing 2 decreases expression ISO methylmercuric chloride results in decreased expression of EFHC2 mRNA CTD PMID:28001369 NCBI chr  X:7,943,603...8,144,073
Ensembl chr  X:7,943,725...8,144,215 		JBrowse link
G Efhd1 EF-hand domain family, member D1 decreases expression ISO methylmercuric chloride results in decreased expression of EFHD1 mRNA CTD PMID:28001369 NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798 		JBrowse link
G Efna1 ephrin A1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of EFNA1 mRNA CTD PMID:30744511 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Efna5 ephrin A5 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of EFNA5 mRNA
methylmercuric chloride results in decreased expression of EFNA5 mRNA 		CTD PMID:27188386 PMID:34089799 NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348 		JBrowse link
G Efnb3 ephrin B3 affects expression ISO methylmercuric chloride affects the expression of EFNB3 mRNA CTD PMID:21613230 NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,773,282...54,797,651 		JBrowse link
G Efr3a EFR3 homolog A decreases expression ISO methylmercuric chloride results in decreased expression of EFR3A mRNA CTD PMID:28001369 NCBI chr 7:99,441,764...99,522,454
Ensembl chr 7:99,441,767...99,522,454 		JBrowse link
G Egf epidermal growth factor increases expression ISO methylmercuric chloride results in increased expression of EGF mRNA CTD PMID:28001369 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfl7 EGF-like-domain, multiple 7 decreases expression ISO methylmercuric chloride results in decreased expression of EGFL7 mRNA CTD PMID:28001369 NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:29,802,690...29,814,951 		JBrowse link
G Egfr epidermal growth factor receptor increases expression
increases phosphorylation 		ISO methylmercuric chloride results in increased expression of EGFR mRNA
methylmercuric chloride results in increased phosphorylation of EGFR protein 		CTD PMID:28001369 PMID:28958600 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 increases expression ISO methylmercuric chloride results in increased expression of EGLN1 mRNA CTD PMID:28001369 NCBI chr19:69,765,276...69,804,681 JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of EGLN3 mRNA
methylmercuric chloride results in decreased expression of EGLN3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGLN3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Egr1 early growth response 1 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of EGR1 mRNA
methylmercuric chloride results in decreased expression of EGR1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 PMID:29261810 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 increases expression ISO
EXP 		methylmercuric chloride results in increased expression of EGR2 mRNA CTD PMID:28001369 PMID:31378766 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Egr3 early growth response 3 increases expression ISO methylmercuric chloride results in increased expression of EGR3 mRNA CTD PMID:23179753 PMID:26272509 NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712 		JBrowse link
G Egr4 early growth response 4 increases expression ISO methylmercuric chloride results in increased expression of EGR4 mRNA CTD PMID:28001369 NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368 		JBrowse link
G Ehbp1 EH domain binding protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of EHBP1 mRNA CTD PMID:28001369 NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579 		JBrowse link
G Ehd4 EH-domain containing 4 decreases expression ISO methylmercuric chloride results in decreased expression of EHD4 mRNA CTD PMID:27188386 NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase decreases expression ISO methylmercuric chloride results in decreased expression of EHHADH mRNA CTD PMID:28001369 NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662 		JBrowse link
G Eid2b EP300 interacting inhibitor of differentiation 2B decreases expression ISO methylmercuric chloride results in decreased expression of EID2B mRNA CTD PMID:28001369 NCBI chr 1:92,673,119...92,674,899 JBrowse link
G Eif1 eukaryotic translation initiation factor 1 increases expression ISO methylmercuric chloride results in increased expression of EIF1 mRNA CTD PMID:28001369 NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654 		JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 decreases expression ISO methylmercuric chloride results in decreased expression of EIF2AK1 mRNA CTD PMID:28001369 NCBI chr12:15,824,431...15,858,266
Ensembl chr12:15,825,124...15,858,281 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
increases phosphorylation
multiple interactions 		ISO methylmercuric chloride results in increased expression of EIF2AK3 mRNA
methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2AK3 protein] 		CTD PMID:28001369 PMID:31330229 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2ak4 eukaryotic translation initiation factor 2 alpha kinase 4 increases expression ISO methylmercuric chloride results in increased expression of EIF2AK4 mRNA CTD PMID:28001369 NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574 		JBrowse link
G Eif2d eukaryotic translation initiation factor 2D decreases expression ISO methylmercuric chloride results in decreased expression of EIF2D mRNA CTD PMID:28001369 NCBI chr13:45,168,161...45,189,362
Ensembl chr13:45,139,967...45,191,974 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation
multiple interactions 		ISO methylmercuric chloride results in increased phosphorylation of EIF2S1 protein
Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2S1 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased phosphorylation of EIF2S1 protein] 		CTD PMID:31330229 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif3b eukaryotic translation initiation factor 3, subunit B increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of EIF3B mRNA
methylmercuric chloride results in decreased expression of EIF3B mRNA 		CTD PMID:28001369 NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939 		JBrowse link
G Eif3f eukaryotic translation initiation factor 3, subunit F decreases expression ISO methylmercuric chloride results in decreased expression of EIF3F mRNA CTD PMID:28001369 NCBI chr 1:172,369,062...172,378,043
Ensembl chr 1:172,369,062...172,378,041 		JBrowse link
G Eif3h eukaryotic translation initiation factor 3, subunit H decreases expression ISO methylmercuric chloride results in decreased expression of EIF3H mRNA CTD PMID:28001369 NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:84,980,891...85,071,546 		JBrowse link
G Eif3m eukaryotic translation initiation factor 3, subunit M decreases expression ISO methylmercuric chloride results in decreased expression of EIF3M mRNA CTD PMID:28001369 NCBI chr 3:111,879,589...111,897,193
Ensembl chr 3:111,870,925...111,897,193 		JBrowse link
G Eif4e3 eukaryotic translation initiation factor 4E family member 3 decreases expression ISO methylmercuric chloride results in decreased expression of EIF4E3 mRNA CTD PMID:28001369 NCBI chr 4:133,709,802...133,858,398
Ensembl chr 4:133,625,768...133,885,647 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases expression ISO methylmercuric chloride results in increased expression of EIF4EBP1 mRNA CTD PMID:28001369 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4ebp3 eukaryotic translation initiation factor 4E binding protein 3 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of EIF4EBP3 mRNA CTD PMID:30744511 NCBI chr18:28,540,324...28,542,070
Ensembl chr18:28,540,058...28,542,061 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 increases expression ISO methylmercuric chloride results in increased expression of EIF4G1 mRNA CTD PMID:23179753 PMID:26272509 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 increases expression ISO methylmercuric chloride results in increased expression of EIF4G3 mRNA CTD PMID:28001369 NCBI chr 5:155,481,378...155,702,194
Ensembl chr 5:155,481,378...155,702,194 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of EIF5 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EIF5 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Eif5a2 eukaryotic translation initiation factor 5A2 decreases expression ISO methylmercuric chloride results in decreased expression of EIF5A2 mRNA CTD PMID:28001369 NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:113,657,797...113,674,594 		JBrowse link
G Eif5b eukaryotic translation initiation factor 5B increases expression ISO methylmercuric chloride results in increased expression of EIF5B mRNA CTD PMID:28001369 NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583 		JBrowse link
G Elac1 elaC ribonuclease Z 1 decreases expression ISO methylmercuric chloride results in decreased expression of ELAC1 mRNA CTD PMID:28001369 NCBI chr18:69,596,475...69,617,206
Ensembl chr18:69,598,827...69,616,175 		JBrowse link
G Elavl3 ELAV like RNA binding protein 3 increases expression ISO methylmercuric chloride results in increased expression of ELAVL3 mRNA CTD PMID:28001369 NCBI chr 8:28,823,120...28,859,395
Ensembl chr 8:28,825,707...28,859,659 		JBrowse link
G Elf1 E74 like ETS transcription factor 1 increases expression ISO methylmercuric chloride results in increased expression of ELF1 mRNA CTD PMID:28001369 NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 increases expression ISO methylmercuric chloride results in increased expression of ELF3 mRNA CTD PMID:28001369 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ELK3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELK3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661 		JBrowse link
G Elk4 ETS transcription factor ELK4 decreases expression ISO methylmercuric chloride results in decreased expression of ELK4 mRNA CTD PMID:28001369 NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199 		JBrowse link
G Ell elongation factor for RNA polymerase II decreases expression EXP methylmercuric chloride results in decreased expression of ELL mRNA CTD PMID:20864626 NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076 		JBrowse link
G Ell2 elongation factor for RNA polymerase II 2 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ELL2 mRNA
methylmercuric chloride results in decreased expression of ELL2 mRNA 		CTD PMID:28001369 NCBI chr 2:6,910,446...6,990,654
Ensembl chr 2:6,921,771...7,016,199 		JBrowse link
G Elmod2 ELMO domain containing 2 increases expression ISO methylmercuric chloride results in increased expression of ELMOD2 mRNA CTD PMID:28001369 NCBI chr19:41,690,713...41,710,194
Ensembl chr19:41,690,762...41,710,194
Ensembl chr18:41,690,762...41,710,194 		JBrowse link
G Eloa elongin A increases expression ISO methylmercuric chloride results in increased expression of ELOA mRNA CTD PMID:28001369 NCBI chr 5:153,513,246...153,530,819
Ensembl chr 5:153,515,066...153,530,916 		JBrowse link
G Elovl2 ELOVL fatty acid elongase 2 decreases expression ISO methylmercuric chloride results in decreased expression of ELOVL2 mRNA CTD PMID:28001369 NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601 		JBrowse link
G Elovl3 ELOVL fatty acid elongase 3 decreases response to substance
increases expression 		ISO ELOVL3 protein results in decreased susceptibility to methylmercuric chloride
methylmercuric chloride results in increased expression of ELOVL3 mRNA 		CTD PMID:24118919 NCBI chr 1:254,938,731...254,942,559
Ensembl chr 1:254,938,731...254,942,559 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 increases expression ISO methylmercuric chloride results in increased expression of ELOVL5 mRNA CTD PMID:28001369 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 decreases expression ISO methylmercuric chloride results in decreased expression of ELOVL6 mRNA CTD PMID:24118919 NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549 		JBrowse link
G Elovl7 ELOVL fatty acid elongase 7 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of ELOVL7 mRNA
methylmercuric chloride results in decreased expression of ELOVL7 mRNA 		CTD PMID:28001369 NCBI chr 2:41,522,695...41,592,021
Ensembl chr 2:41,522,738...41,592,020 		JBrowse link
G Elp1 elongator acetyltransferase complex subunit 1 decreases expression ISO methylmercuric chloride results in decreased expression of ELP1 mRNA CTD PMID:28001369 NCBI chr 5:76,248,545...76,300,985
Ensembl chr 5:76,248,550...76,300,985 		JBrowse link
G Elp2 elongator acetyltransferase complex subunit 2 decreases expression ISO methylmercuric chloride results in decreased expression of ELP2 mRNA CTD PMID:28001369 NCBI chr18:16,160,686...16,196,307
Ensembl chr18:16,160,671...16,196,414 		JBrowse link
G Elp4 elongator acetyltransferase complex subunit 4 decreases expression ISO methylmercuric chloride results in decreased expression of ELP4 mRNA CTD PMID:28001369 NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963 		JBrowse link
G Emc6 ER membrane protein complex subunit 6 decreases expression EXP methylmercuric chloride results in decreased expression of EMC6 mRNA CTD PMID:20864626 NCBI chr10:58,292,584...58,293,850
Ensembl chr10:58,292,470...58,298,885 		JBrowse link
G Emid1 EMI domain containing 1 decreases expression ISO methylmercuric chloride results in decreased expression of EMID1 mRNA CTD PMID:28001369 NCBI chr14:84,214,530...84,257,628
Ensembl chr14:84,214,530...84,257,579 		JBrowse link
G Emilin2 elastin microfibril interfacer 2 increases expression ISO methylmercuric chloride results in increased expression of EMILIN2 mRNA CTD PMID:28001369 NCBI chr 9:118,607,312...118,667,087
Ensembl chr 9:118,606,891...118,666,957 		JBrowse link
G Eml1 EMAP like 1 increases expression ISO methylmercuric chloride results in increased expression of EML1 mRNA CTD PMID:23179753 NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:133,048,427...133,221,642 		JBrowse link
G Eml4 EMAP like 4 increases expression ISO methylmercuric chloride results in increased expression of EML4 mRNA CTD PMID:28001369 NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:16,972,075...17,087,439 		JBrowse link
G Eml5 EMAP like 5 increases expression ISO methylmercuric chloride results in increased expression of EML5 mRNA CTD PMID:28001369 NCBI chr 6:123,775,269...123,905,585
Ensembl chr 6:123,776,368...123,905,538 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression EXP methylmercuric chloride results in increased expression of EMP1 mRNA CTD PMID:31378766 NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365 		JBrowse link
G Emp2 epithelial membrane protein 2 decreases expression ISO methylmercuric chloride results in decreased expression of EMP2 mRNA CTD PMID:28001369 NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532 		JBrowse link
G Emsy EMSY transcriptional repressor, BRCA2 interacting decreases expression ISO methylmercuric chloride results in decreased expression of EMSY mRNA CTD PMID:28001369 NCBI chr 1:162,295,167...162,364,742
Ensembl chr 1:162,295,169...162,364,707 		JBrowse link
G Emx2 empty spiracles homeobox 2 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of EMX2 mRNA
methylmercuric chloride results in increased expression of EMX2 mRNA 		CTD PMID:22555245 PMID:28001369 PMID:34089799 NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671 		JBrowse link
G Emx2os Emx2 opposite strand/antisense RNA decreases expression ISO methylmercuric chloride results in decreased expression of EMX2OS mRNA CTD PMID:28001369 NCBI chr 1:268,555,719...268,612,889 JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression ISO methylmercuric chloride results in increased expression of ENC1 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Endod1 endonuclease domain containing 1 decreases expression EXP methylmercuric chloride results in decreased expression of ENDOD1 mRNA CTD PMID:20864626 NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007 		JBrowse link
G Engase endo-beta-N-acetylglucosaminidase decreases expression ISO methylmercuric chloride results in decreased expression of ENGASE mRNA CTD PMID:28001369 NCBI chr10:104,205,753...104,218,416
Ensembl chr10:104,205,752...104,218,411 		JBrowse link
G Enosf1 enolase superfamily member 1 decreases expression ISO methylmercuric chloride results in decreased expression of ENOSF1 mRNA CTD PMID:28001369
G Enox2 ecto-NOX disulfide-thiol exchanger 2 decreases expression ISO methylmercuric chloride results in decreased expression of ENOX2 mRNA CTD PMID:28001369 NCBI chr  X:133,148,813...133,470,914
Ensembl chr  X:133,148,813...133,470,891 		JBrowse link
G Enpep glutamyl aminopeptidase decreases expression ISO methylmercuric chloride results in decreased expression of ENPEP mRNA CTD PMID:28001369 NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 decreases expression ISO methylmercuric chloride results in decreased expression of ENPP1 mRNA CTD PMID:28001369 NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression ISO methylmercuric chloride results in decreased expression of ENPP2 mRNA CTD PMID:28001369 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Enpp4 ectonucleotide pyrophosphatase/phosphodiesterase 4 decreases expression ISO methylmercuric chloride results in decreased expression of ENPP4 mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr 9:24,386,351...24,396,248
Ensembl chr 9:24,360,272...24,396,152 		JBrowse link
G Enpp5 ectonucleotide pyrophosphatase/phosphodiesterase family member 5 decreases expression ISO methylmercuric chloride results in decreased expression of ENPP5 mRNA CTD PMID:28001369 NCBI chr 9:24,407,574...24,415,029
Ensembl chr 9:24,408,218...24,414,867 		JBrowse link
G Ensa endosulfine alpha increases expression ISO methylmercuric chloride results in increased expression of ENSA mRNA CTD PMID:28001369 NCBI chr 2:185,874,500...185,881,838
Ensembl chr 2:185,874,500...185,881,838 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of ENTPD5 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ENTPD5 mRNA 		CTD PMID:28001369 PMID:30744511 NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495 		JBrowse link
G Eny2 ENY2, transcription and export complex 2 subunit decreases expression ISO methylmercuric chloride results in decreased expression of ENY2 mRNA CTD PMID:28001369 NCBI chr 7:77,465,885...77,489,637
Ensembl chr 7:77,466,119...77,491,057 		JBrowse link
G Eogt EGF domain specific O-linked N-acetylglucosamine transferase increases expression ISO methylmercuric chloride results in increased expression of EOGT mRNA CTD PMID:28001369 NCBI chr 4:131,275,587...131,313,243
Ensembl chr 4:131,276,573...131,311,926 		JBrowse link
G Eomes eomesodermin increases expression ISO methylmercuric chloride results in increased expression of EOMES mRNA CTD PMID:23903816 PMID:28001369 NCBI chr 8:127,059,215...127,067,070
Ensembl chr 8:127,059,215...127,067,070 		JBrowse link
G Ep400 E1A binding protein p400 increases expression ISO methylmercuric chloride results in increased expression of EP400 mRNA CTD PMID:28001369 NCBI chr12:51,551,665...51,658,635
Ensembl chr12:51,551,695...51,658,634 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1-like 3 decreases expression ISO methylmercuric chloride results in decreased expression of EPB41L3 mRNA CTD PMID:28001369 NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274 		JBrowse link
G Epb41l4a erythrocyte membrane protein band 4.1 like 4A decreases expression ISO methylmercuric chloride results in decreased expression of EPB41L4A mRNA CTD PMID:28001369 NCBI chr18:25,680,169...25,890,998
Ensembl chr18:25,680,171...25,888,498 		JBrowse link
G Epcam epithelial cell adhesion molecule decreases expression
multiple interactions
increases expression 		ISO methylmercuric chloride results in decreased expression of EPCAM mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPCAM mRNA
methylmercuric chloride results in increased expression of EPCAM mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Epdr1 ependymin related 1 increases expression ISO methylmercuric chloride results in increased expression of EPDR1 mRNA CTD PMID:28001369 NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250 		JBrowse link
G Epha2 Eph receptor A2 affects expression
multiple interactions
increases expression 		ISO methylmercuric chloride affects the expression of EPHA2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA
methylmercuric chloride results in increased expression of EPHA2 mRNA 		CTD PMID:21613230 PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234 		JBrowse link
G Epha3 Eph receptor A3 decreases expression ISO methylmercuric chloride results in decreased expression of EPHA3 mRNA CTD PMID:28001369 NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425 		JBrowse link
G Epha4 Eph receptor A4 decreases expression ISO methylmercuric chloride results in decreased expression of EPHA4 mRNA CTD PMID:28001369 NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755 		JBrowse link
G Epha7 Eph receptor A7 decreases expression ISO methylmercuric chloride results in decreased expression of EPHA7 mRNA CTD PMID:28001369 NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:47,771,865...47,925,058 		JBrowse link
G Ephb1 Eph receptor B1 decreases expression ISO methylmercuric chloride results in decreased expression of EPHB1 mRNA CTD PMID:28001369 NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759 		JBrowse link
G Ephb2 Eph receptor B2 decreases expression ISO methylmercuric chloride results in decreased expression of EPHB2 mRNA CTD PMID:28001369 NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615 		JBrowse link
G Ephb4 EPH receptor B4 decreases expression ISO methylmercuric chloride results in decreased expression of EPHB4 mRNA CTD PMID:28001369 NCBI chr12:24,963,174...24,988,473
Ensembl chr12:24,963,174...24,988,388 		JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of EPHX1 mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of EPHX1 mRNA CTD PMID:30744511 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of EPHX2 mRNA
methylmercuric chloride results in increased expression of EPHX2 mRNA 		CTD PMID:28001369 PMID:29581082 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Epm2aip1 EPM2A interacting protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of EPM2AIP1 mRNA CTD PMID:28001369 NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458 		JBrowse link
G Epo erythropoietin multiple interactions
decreases expression 		EXP 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of EPO protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein]; cobaltous chloride inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein]; protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein] CTD PMID:31850806 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Epor erythropoietin receptor decreases expression ISO methylmercuric chloride results in decreased expression of EPOR mRNA CTD PMID:23179753 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322 		JBrowse link
G Eppk1 epiplakin 1 decreases expression ISO methylmercuric chloride results in decreased expression of EPPK1 mRNA CTD PMID:28001369 NCBI chr 7:109,697,607...109,718,468
Ensembl chr 7:109,697,607...109,718,468 		JBrowse link
G Epsti1 epithelial stromal interaction 1 decreases expression ISO methylmercuric chloride results in decreased expression of EPSTI1 mRNA CTD PMID:23179753 NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380 		JBrowse link
G Erap1 endoplasmic reticulum aminopeptidase 1 decreases expression ISO methylmercuric chloride results in decreased expression of ERAP1 mRNA CTD PMID:28001369 NCBI chr 2:5,666,337...5,705,256
Ensembl chr 2:5,666,436...5,740,056 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 decreases expression ISO methylmercuric chloride results in decreased expression of ERBB4 mRNA CTD PMID:28001369 NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit decreases expression ISO methylmercuric chloride results in decreased expression of ERCC4 mRNA CTD PMID:28001369 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Ercc6l2 ERCC excision repair 6 like 2 decreases expression ISO methylmercuric chloride results in decreased expression of ERCC6L2 mRNA CTD PMID:28001369 NCBI chr17:1,055,881...1,323,207
Ensembl chr17:1,222,139...1,316,056 		JBrowse link
G Ercc8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit decreases expression ISO methylmercuric chloride results in decreased expression of ERCC8 mRNA CTD PMID:28001369 NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294 		JBrowse link
G Ereg epiregulin increases expression ISO methylmercuric chloride results in increased expression of EREG mRNA CTD PMID:28001369 NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260 		JBrowse link
G Erich1 glutamate-rich 1 increases expression ISO methylmercuric chloride results in increased expression of ERICH1 mRNA CTD PMID:28001369 NCBI chr16:82,203,536...82,271,361
Ensembl chr16:82,203,610...82,272,989 		JBrowse link
G Erich5 glutamate-rich 5 decreases expression ISO methylmercuric chloride results in decreased expression of ERICH5 mRNA CTD PMID:34089799 NCBI chr 7:67,538,154...67,569,433
Ensembl chr 7:67,536,588...67,563,989 		JBrowse link
G Ermn ermin decreases expression ISO methylmercuric chloride results in decreased expression of ERMN mRNA CTD PMID:28001369 NCBI chr 3:63,037,001...63,042,657
Ensembl chr 3:63,035,150...63,042,585 		JBrowse link
G Ermp1 endoplasmic reticulum metallopeptidase 1 decreases expression ISO methylmercuric chloride results in decreased expression of ERMP1 mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of ERN1 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of ERN1 protein modified form] CTD PMID:31330229 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Erp44 endoplasmic reticulum protein 44 decreases expression ISO methylmercuric chloride results in decreased expression of ERP44 mRNA CTD PMID:28001369 NCBI chr 5:67,313,245...67,406,207
Ensembl chr 5:67,312,098...67,406,444 		JBrowse link
G Esco1 establishment of sister chromatid cohesion N-acetyltransferase 1 increases expression ISO methylmercuric chloride results in increased expression of ESCO1 mRNA CTD PMID:23179753 PMID:26272509 NCBI chr18:1,904,748...1,959,609
Ensembl chr18:1,904,762...1,959,805 		JBrowse link
G Esd esterase D decreases expression ISO methylmercuric chloride results in decreased expression of ESD mRNA CTD PMID:28001369 NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of ESM1 mRNA
[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ESM1 mRNA 		CTD PMID:23179753 PMID:30744511 NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:46,609,204...46,617,990 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of ESRP1 mRNA CTD PMID:23179753 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrrb estrogen-related receptor beta affects expression ISO methylmercuric chloride affects the expression of ESRRB mRNA CTD PMID:21613230 NCBI chr 6:111,738,662...111,894,087
Ensembl chr 6:111,738,662...111,894,087 		JBrowse link
G Esrrg estrogen-related receptor gamma decreases expression ISO methylmercuric chloride results in decreased expression of ESRRG mRNA CTD PMID:28001369 NCBI chr13:101,699,043...102,316,877
Ensembl chr13:101,889,706...102,316,877 		JBrowse link
G Esyt2 extended synaptotagmin 2 decreases expression
increases expression 		EXP
ISO 		methylmercuric chloride results in decreased expression of ESYT2 mRNA
methylmercuric chloride results in increased expression of ESYT2 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr 6:143,359,870...143,455,600
Ensembl chr 6:143,362,694...143,455,593 		JBrowse link
G Etaa1 ETAA1 activator of ATR kinase decreases expression ISO methylmercuric chloride results in decreased expression of ETAA1 mRNA CTD PMID:28001369 NCBI chr14:96,500,899...96,515,617
Ensembl chr14:96,500,899...96,517,796 		JBrowse link
G Etfrf1 electron transfer flavoprotein regulatory factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of ETFRF1 mRNA CTD PMID:28001369 NCBI chr 4:179,910,651...179,916,095
Ensembl chr 4:179,910,914...179,916,095 		JBrowse link
G Etnk1 ethanolamine kinase 1 increases expression
decreases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of ETNK1 mRNA
methylmercuric chloride results in decreased expression of ETNK1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETNK1 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor increases expression ISO methylmercuric chloride results in increased expression of ETS1 mRNA CTD PMID:26272509 PMID:28001369 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Ets2 ETS proto-oncogene 2, transcription factor increases expression ISO methylmercuric chloride results in increased expression of ETS2 mRNA CTD PMID:28001369 NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842 		JBrowse link
G Etv4 ETS variant transcription factor 4 affects expression
multiple interactions
increases expression 		EXP
ISO 		methylmercuric chloride affects the expression of ETV4 mRNA
methylmercuric chloride inhibits the reaction [ETV4 protein binds to MMP9 promoter]
methylmercuric chloride results in increased expression of ETV4 mRNA 		CTD PMID:20864626 PMID:28001369 PMID:28526320 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318 		JBrowse link
G Etv5 ETS variant transcription factor 5 increases expression ISO methylmercuric chloride results in increased expression of ETV5 mRNA CTD PMID:28001369 NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767 		JBrowse link
G Eva1b eva-1 homolog B increases expression ISO methylmercuric chloride results in increased expression of EVA1B mRNA CTD PMID:28001369 NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:143,711,395...143,717,551 		JBrowse link
G Evl Enah/Vasp-like decreases expression ISO methylmercuric chloride results in decreased expression of EVL mRNA CTD PMID:28001369 NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:133,238,547...133,358,729 		JBrowse link
G Exoc4 exocyst complex component 4 decreases expression ISO methylmercuric chloride results in decreased expression of EXOC4 mRNA CTD PMID:28001369 NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943 		JBrowse link
G Exoc5 exocyst complex component 5 decreases expression ISO methylmercuric chloride results in decreased expression of EXOC5 mRNA CTD PMID:28001369 NCBI chr15:24,788,738...24,834,941
Ensembl chr15:24,790,337...24,834,970 		JBrowse link
G Exoc6 exocyst complex component 6 decreases expression ISO methylmercuric chloride results in decreased expression of EXOC6 mRNA CTD PMID:28001369 NCBI chr 1:244,727,084...244,870,263
Ensembl chr 1:244,711,981...244,870,396 		JBrowse link
G Exoc7 exocyst complex component 7 decreases expression ISO methylmercuric chloride results in decreased expression of EXOC7 mRNA CTD PMID:28001369 NCBI chr10:102,019,805...102,039,333
Ensembl chr10:102,019,806...102,039,447 		JBrowse link
G Exoc8 exocyst complex component 8 decreases expression
multiple interactions 		ISO
EXP 		methylmercuric chloride results in decreased expression of EXOC8 mRNA
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of EXOC8 mRNA] 		CTD PMID:28001369 PMID:30890323 NCBI chr19:69,752,387...69,754,876
Ensembl chr19:69,727,231...69,804,820 		JBrowse link
G Exosc2 exosome component 2 decreases expression ISO methylmercuric chloride results in decreased expression of EXOSC2 mRNA CTD PMID:28001369 NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373 		JBrowse link
G Exosc6 exosome component 6 decreases expression ISO methylmercuric chloride results in decreased expression of EXOSC6 mRNA CTD PMID:28001369 NCBI chr19:55,931,523...55,932,937
Ensembl chr19:55,931,523...55,932,937 		JBrowse link
G Eya2 EYA transcriptional coactivator and phosphatase 2 decreases expression ISO methylmercuric chloride results in decreased expression of EYA2 mRNA CTD PMID:28001369 NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 decreases expression ISO methylmercuric chloride results in decreased expression of EYA4 mRNA CTD PMID:28001369 NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:23,991,431...24,235,131 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions ISO methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]] CTD PMID:36565944 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G Ezr ezrin increases expression ISO methylmercuric chloride results in increased expression of EZR mRNA CTD PMID:26272509 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F11r F11 receptor decreases expression ISO methylmercuric chloride results in decreased expression of F11R mRNA CTD PMID:23179753 PMID:27188386 NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 decreases expression ISO methylmercuric chloride results in decreased expression of F2RL1 mRNA CTD PMID:23179753 NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954 		JBrowse link
G F2rl2 coagulation factor II (thrombin) receptor-like 2 decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of F2RL2 mRNA
methylmercuric chloride results in increased expression of F2RL2 mRNA 		CTD PMID:28001369 NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression ISO methylmercuric chloride results in increased expression of F3 mRNA CTD PMID:28001369 NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F8 coagulation factor VIII decreases expression ISO methylmercuric chloride results in decreased expression of F8 mRNA CTD PMID:28001369 NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683 		JBrowse link
G F9 coagulation factor IX multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of F9 mRNA CTD PMID:30744511 NCBI chr  X:143,388,642...143,433,143
Ensembl chr  X:143,388,621...143,433,146 		JBrowse link
G Fabp1 fatty acid binding protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of FABP1 mRNA CTD PMID:23179753 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fabp3 fatty acid binding protein 3 increases expression ISO methylmercuric chloride results in increased expression of FABP3 mRNA CTD PMID:28001369 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of FABP4 mRNA CTD PMID:30744511 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fabp5 fatty acid binding protein 5 increases expression ISO methylmercuric chloride results in increased expression of FABP5 mRNA CTD PMID:28001369 NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127 		JBrowse link
G Fabp7 fatty acid binding protein 7 affects expression
multiple interactions
decreases expression 		EXP
ISO 		methylmercuric chloride affects the expression of FABP7 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FABP7 mRNA
methylmercuric chloride results in decreased expression of FABP7 mRNA 		CTD PMID:20864626 PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 More... NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907 		JBrowse link
G Fads1 fatty acid desaturase 1 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of FADS1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FADS1 mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615 		JBrowse link
G Faf1 Fas associated factor 1 decreases expression ISO methylmercuric chloride results in decreased expression of FAF1 mRNA CTD PMID:28001369 NCBI chr 5:129,654,677...130,018,604
Ensembl chr 5:129,654,445...130,020,516 		JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO methylmercuric chloride results in decreased expression of FAH mRNA CTD PMID:27188386 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046 		JBrowse link
G Fam107a family with sequence similarity 107, member A decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of FAM107A mRNA
methylmercuric chloride results in increased expression of FAM107A mRNA 		CTD PMID:28001369 PMID:34089799 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam111a FAM111 trypsin like peptidase A multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of FAM111A mRNA CTD PMID:30744511 NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211 		JBrowse link
G Fam114a2 family with sequence similarity 114, member A2 decreases expression ISO methylmercuric chloride results in decreased expression of FAM114A2 mRNA CTD PMID:28001369 NCBI chr10:42,162,295...42,197,307
Ensembl chr10:42,162,295...42,197,257 		JBrowse link
G Fam117b family with sequence similarity 117, member B increases expression ISO methylmercuric chloride results in increased expression of FAM117B mRNA CTD PMID:28001369 NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543 		JBrowse link
G Fam120a family with sequence similarity 120 member A increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of FAM120A mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM120A mRNA 		CTD PMID:26272509 PMID:27188386 NCBI chr17:15,890,151...15,981,337
Ensembl chr17:15,890,605...15,981,332 		JBrowse link
G Fam120b family with sequence similarity 120 member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM120B mRNA CTD PMID:28001369 NCBI chr 1:64,993,104...65,058,160
Ensembl chr 1:65,012,060...65,058,160 		JBrowse link
G Fam124a family with sequence similarity 124 member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM124A mRNA CTD PMID:28001369 NCBI chr15:40,975,789...41,031,069
Ensembl chr15:40,975,877...41,029,628 		JBrowse link
G Fam13b family with sequence similarity 13, member B increases expression ISO methylmercuric chloride results in increased expression of FAM13B mRNA CTD PMID:23179753 NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,314,440...26,380,732 		JBrowse link
G Fam149a family with sequence similarity 149, member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM149A mRNA CTD PMID:28001369 NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072 		JBrowse link
G Fam149b1 family with sequence similarity 149, member B1 decreases expression ISO methylmercuric chloride results in decreased expression of FAM149B1 mRNA CTD PMID:28001369 NCBI chr15:3,978,377...4,016,323
Ensembl chr15:3,978,377...4,016,317 		JBrowse link
G Fam161a FAM161 centrosomal protein A increases expression ISO methylmercuric chloride results in increased expression of FAM161A mRNA CTD PMID:28001369 NCBI chr14:101,210,694...101,256,020
Ensembl chr14:101,210,662...101,229,535 		JBrowse link
G Fam162a family with sequence similarity 162, member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM162A mRNA CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560 		JBrowse link
G Fam168b family with sequence similarity 168, member B increases expression ISO methylmercuric chloride results in increased expression of FAM168B mRNA CTD PMID:28001369 NCBI chr 9:44,501,466...44,534,571
Ensembl chr 9:44,502,584...44,534,974 		JBrowse link
G Fam174a family with sequence similarity 174, member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM174A mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 9:103,190,144...103,208,419
Ensembl chr 9:103,190,127...103,209,228 		JBrowse link
G Fam174b family with sequence similarity 174, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM174B mRNA CTD PMID:28001369 NCBI chr 1:136,925,162...137,006,082
Ensembl chr 1:136,925,151...137,035,589 		JBrowse link
G Fam184a family with sequence similarity 184, member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM184A mRNA CTD PMID:28001369 NCBI chr20:33,477,089...33,599,296
Ensembl chr20:33,477,089...33,599,293 		JBrowse link
G Fam193b family with sequence similarity 193, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM193B mRNA CTD PMID:28001369 NCBI chr17:9,071,974...9,104,659
Ensembl chr17:9,071,795...9,104,656 		JBrowse link
G Fam199x family with sequence similarity 199, X-linked decreases expression
increases expression 		ISO methylmercuric chloride results in decreased expression of FAM199X mRNA
methylmercuric chloride results in increased expression of FAM199X mRNA 		CTD PMID:28001369 NCBI chr  X:105,176,504...105,212,207
Ensembl chr  X:105,176,504...105,212,207 		JBrowse link
G Fam227b family with sequence similarity 227, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM227B mRNA CTD PMID:28001369 NCBI chr 3:133,686,602...133,845,793
Ensembl chr 3:133,686,605...133,845,717 		JBrowse link
G Fam228b family with sequence similarity 228, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM228B mRNA CTD PMID:28001369 NCBI chr 6:33,473,949...33,505,833
Ensembl chr 6:33,473,348...33,505,325 		JBrowse link
G Fam229b family with sequence similarity 229, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM229B mRNA CTD PMID:28001369 NCBI chr20:44,093,492...44,106,871
Ensembl chr20:44,093,493...44,106,871 		JBrowse link
G Fam234b family with sequence similarity 234, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM234B mRNA CTD PMID:28001369 NCBI chr 4:169,779,651...169,854,024
Ensembl chr 4:169,779,737...169,828,678 		JBrowse link
G Fam241a family with sequence similarity 241 member A decreases expression ISO methylmercuric chloride results in decreased expression of FAM241A mRNA CTD PMID:23179753 PMID:26272509 NCBI chr 2:219,019,025...219,049,648
Ensembl chr 2:219,018,241...219,049,770 		JBrowse link
G Fam241b family with sequence similarity 241 member B increases expression ISO methylmercuric chloride results in increased expression of FAM241B mRNA CTD PMID:28001369 NCBI chr20:30,595,082...30,598,007
Ensembl chr20:30,595,084...30,597,844
Ensembl chr 6:30,595,084...30,597,844 		JBrowse link
G Fam3c FAM3 metabolism regulating signaling molecule C decreases expression ISO methylmercuric chloride results in decreased expression of FAM3C mRNA CTD PMID:26272509 NCBI chr 4:51,805,686...51,853,030
Ensembl chr 4:51,805,703...51,853,030 		JBrowse link
G Fam83b family with sequence similarity 83, member B decreases expression ISO methylmercuric chloride results in decreased expression of FAM83B mRNA CTD PMID:28001369 NCBI chr 8:86,167,778...86,244,222
Ensembl chr 8:86,167,778...86,244,222 		JBrowse link
G Fancb FA complementation group B decreases expression ISO methylmercuric chloride results in decreased expression of FANCB mRNA CTD PMID:28001369 NCBI chr  X:33,035,387...33,051,993
Ensembl chr  X:33,035,387...33,051,808 		JBrowse link
G Fancg FA complementation group G decreases expression ISO methylmercuric chloride results in decreased expression of FANCG mRNA CTD PMID:28001369 NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787 		JBrowse link
G Fancm FA complementation group M decreases expression ISO methylmercuric chloride results in decreased expression of FANCM mRNA CTD PMID:28001369 NCBI chr 6:88,862,898...88,916,701
Ensembl chr 6:88,863,306...88,921,652 		JBrowse link
G Fank1 fibronectin type III and ankyrin repeat domains 1 decreases expression ISO methylmercuric chloride results in decreased expression of FANK1 mRNA CTD PMID:28001369 NCBI chr 1:198,007,496...198,114,790
Ensembl chr 1:198,007,547...198,115,561 		JBrowse link
G Far1 fatty acyl CoA reductase 1 decreases expression ISO methylmercuric chloride results in decreased expression of FAR1 mRNA CTD PMID:28001369 NCBI chr 1:177,078,973...177,140,363
Ensembl chr 1:177,079,150...177,161,696 		JBrowse link
G Far2 fatty acyl CoA reductase 2 decreases expression ISO methylmercuric chloride results in decreased expression of FAR2 mRNA CTD PMID:23179753 NCBI chr 4:182,705,499...182,819,290
Ensembl chr 4:182,705,381...182,825,279 		JBrowse link
G Farp1 FERM, ARH/RhoGEF and pleckstrin domain protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of FARP1 mRNA CTD PMID:28001369 NCBI chr15:104,531,196...104,770,148
Ensembl chr15:104,531,813...104,770,147 		JBrowse link
G Farsb phenylalanyl-tRNA synthetase subunit beta decreases expression ISO methylmercuric chloride results in decreased expression of FARSB mRNA CTD PMID:28001369 NCBI chr 9:87,336,321...87,395,546
Ensembl chr 9:87,336,326...87,395,505 		JBrowse link
G Fas Fas cell surface death receptor increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of FAS mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAS mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fasn fatty acid synthase multiple interactions ISO [Cadmium Chloride co-treated with methylmercuric chloride] results in decreased expression of FASN mRNA CTD PMID:27814245 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fastkd2 FAST kinase domains 2 decreases expression ISO methylmercuric chloride results in decreased expression of FASTKD2 mRNA CTD PMID:28001369 NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:72,661,764...72,721,338 		JBrowse link
G Fastkd3 FAST kinase domains 3 decreases expression EXP methylmercuric chloride results in decreased expression of FASTKD3 mRNA CTD PMID:20864626 NCBI chr 1:36,686,727...36,695,376
Ensembl chr 1:36,686,730...36,695,259 		JBrowse link
G Fat3 FAT atypical cadherin 3 decreases expression ISO methylmercuric chloride results in decreased expression of FAT3 mRNA CTD PMID:28001369 NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:20,972,840...21,555,240 		JBrowse link
G Fat4 FAT atypical cadherin 4 decreases expression ISO methylmercuric chloride results in decreased expression of FAT4 mRNA CTD PMID:28001369 NCBI chr 2:123,855,289...123,984,716
Ensembl chr 2:123,855,289...123,984,716 		JBrowse link
G Fblim1 filamin binding LIM protein 1 increases expression ISO methylmercuric chloride results in increased expression of FBLIM1 mRNA CTD PMID:28001369 NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853 		JBrowse link
G Fbll1 fibrillarin-like 1 increases expression ISO methylmercuric chloride results in increased expression of FBLL1 mRNA CTD PMID:28001369 NCBI chr10:20,762,716...20,764,359
Ensembl chr10:20,761,581...20,764,670 		JBrowse link
G Fbln1 fibulin 1 increases expression ISO methylmercuric chloride results in increased expression of FBLN1 mRNA CTD PMID:23179753 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbln2 fibulin 2 increases expression EXP methylmercuric chloride results in increased expression of FBLN2 mRNA CTD PMID:20864626 NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029 		JBrowse link
G Fbn1 fibrillin 1 decreases expression ISO methylmercuric chloride results in decreased expression of FBN1 mRNA CTD PMID:28001369 NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283 		JBrowse link
G Fbn2 fibrillin 2 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of FBN2 mRNA
methylmercuric chloride results in decreased expression of FBN2 mRNA 		CTD PMID:28001369 PMID:34089799 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191 		JBrowse link
G Fbrs fibrosin increases expression EXP methylmercuric chloride results in increased expression of FBRS mRNA CTD PMID:20864626 NCBI chr 1:191,520,148...191,534,510
Ensembl chr 1:191,522,036...191,534,500 		JBrowse link
G Fbxl14 F-box and leucine-rich repeat protein 14 decreases expression ISO methylmercuric chloride results in decreased expression of FBXL14 mRNA CTD PMID:28001369 NCBI chr 4:154,334,820...154,338,638
Ensembl chr 4:154,334,092...154,377,959 		JBrowse link
G Fbxl20 F-box and leucine-rich repeat protein 20 decreases expression ISO methylmercuric chloride results in decreased expression of FBXL20 mRNA CTD PMID:28001369 NCBI chr10:83,577,038...83,640,022
Ensembl chr10:83,577,038...83,639,977 		JBrowse link
G Fbxo15 F-box protein 15 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO15 mRNA CTD PMID:28001369 NCBI chr18:80,594,444...80,909,549
Ensembl chr 6:51,576,566...51,577,639
Ensembl chr18:51,576,566...51,577,639 		JBrowse link
G Fbxo16 F-box protein 16 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO16 mRNA CTD PMID:28001369 NCBI chr15:43,667,207...43,717,096
Ensembl chr15:43,667,855...43,734,346 		JBrowse link
G Fbxo22 F-box protein 22 increases expression ISO methylmercuric chloride results in increased expression of FBXO22 mRNA CTD PMID:28001369 NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062 		JBrowse link
G Fbxo28 F-box protein 28 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO28 mRNA CTD PMID:28001369 NCBI chr13:96,527,667...96,553,138
Ensembl chr13:96,527,670...96,553,138 		JBrowse link
G Fbxo3 F-box protein 3 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO3 mRNA CTD PMID:28001369 NCBI chr 3:110,872,185...110,904,479
Ensembl chr 3:110,872,220...110,904,479 		JBrowse link
G Fbxo32 F-box protein 32 increases expression ISO methylmercuric chloride results in increased expression of FBXO32 mRNA CTD PMID:28001369 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fbxo4 F-box protein 4 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO4 mRNA CTD PMID:28001369 NCBI chr 2:54,902,394...54,915,388
Ensembl chr 2:54,902,394...54,915,388 		JBrowse link
G Fbxo45 F-box protein 45 increases expression ISO methylmercuric chloride results in increased expression of FBXO45 mRNA CTD PMID:28001369 NCBI chr11:82,056,457...82,072,080
Ensembl chr11:82,056,457...82,072,080 		JBrowse link
G Fbxo7 F-box protein 7 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO7 mRNA CTD PMID:28001369 NCBI chr 7:19,696,951...19,725,180
Ensembl chr 7:19,696,961...19,725,180 		JBrowse link
G Fbxo9 f-box protein 9 decreases expression ISO methylmercuric chloride results in decreased expression of FBXO9 mRNA CTD PMID:28001369 NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504 		JBrowse link
G Fcer1g Fc epsilon receptor Ig increases expression EXP methylmercuric chloride results in increased expression of FCER1G mRNA CTD PMID:31378766 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fcgr2a Fc gamma receptor 2A increases expression ISO methylmercuric chloride results in increased expression of FCGR3 mRNA CTD PMID:31270303 NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394 		JBrowse link
G Fcgr2b Fc gamma receptor 2B increases expression EXP
ISO 		methylmercuric chloride results in increased expression of FCGR2B mRNA CTD PMID:31270303 PMID:31378766 NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517 		JBrowse link
G Fcgr3a Fc gamma receptor 3A increases expression EXP methylmercuric chloride results in increased expression of FCGR3A mRNA CTD PMID:31378766 NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651 		JBrowse link
G Fcnb ficolin B increases expression EXP methylmercuric chloride results in increased expression of FCNB mRNA CTD PMID:31378766 NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188 		JBrowse link
G Fcsk fucose kinase increases expression EXP methylmercuric chloride results in increased expression of FCSK mRNA CTD PMID:20864626 NCBI chr19:55,743,746...55,783,873
Ensembl chr19:55,739,842...55,800,496 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 increases expression ISO methylmercuric chloride results in increased expression of FDFT1 mRNA CTD PMID:28001369 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fdx1 ferredoxin 1 decreases expression EXP methylmercuric chloride results in decreased expression of FDX1 mRNA CTD PMID:20864626 NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583 		JBrowse link
G Fem1b fem-1 homolog B decreases expression ISO methylmercuric chloride results in decreased expression of FEM1B mRNA CTD PMID:28001369 NCBI chr 8:72,160,722...72,173,996
Ensembl chr 8:72,160,722...72,173,996 		JBrowse link
G Fer FER tyrosine kinase decreases expression ISO methylmercuric chloride results in decreased expression of FER mRNA CTD PMID:28001369 NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315 		JBrowse link
G Fermt1 FERM domain containing kindlin 1 increases expression ISO methylmercuric chloride results in increased expression of FERMT1 mRNA CTD PMID:28001369 NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 increases expression ISO methylmercuric chloride results in increased expression of FERMT2 mRNA CTD PMID:28001369 NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115 		JBrowse link
G Ferry3 FERRY endosomal RAB5 effector complex subunit 3 decreases expression ISO methylmercuric chloride results in decreased expression of FERRY3 mRNA CTD PMID:28001369 NCBI chr 4:161,458,942...161,494,213
Ensembl chr 4:161,458,931...161,493,075 		JBrowse link
G Fez1 fasciculation and elongation protein zeta 1 affects expression
decreases expression 		EXP
ISO 		methylmercuric chloride affects the expression of FEZ1 mRNA
methylmercuric chloride results in decreased expression of FEZ1 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097 		JBrowse link
G Fezf2 Fez family zinc finger 2 affects expression
decreases expression 		ISO methylmercuric chloride affects the expression of FEZF2 mRNA
methylmercuric chloride results in decreased expression of FEZF2 mRNA 		CTD PMID:21613230 PMID:28001369 NCBI chr15:15,199,045...15,207,982
Ensembl chr15:15,204,193...15,207,982 		JBrowse link
G Fga fibrinogen alpha chain decreases expression ISO methylmercuric chloride results in decreased expression of FGA mRNA CTD PMID:23179753 NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577 		JBrowse link
G Fgb fibrinogen beta chain decreases expression ISO methylmercuric chloride results in decreased expression of FGB mRNA CTD PMID:23179753 PMID:27188386 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgf12 fibroblast growth factor 12 decreases expression ISO methylmercuric chloride results in decreased expression of FGF12 mRNA CTD PMID:28001369 NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543 		JBrowse link
G Fgf18 fibroblast growth factor 18 affects expression
increases expression 		EXP
ISO 		methylmercuric chloride affects the expression of FGF18 mRNA
methylmercuric chloride results in increased expression of FGF18 mRNA 		CTD PMID:20864626 PMID:28001369 NCBI chr10:18,210,240...18,241,929
Ensembl chr10:18,210,512...18,240,933 		JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression
increases expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of FGF2 mRNA
methylmercuric chloride results in increased expression of FGF2 mRNA 		CTD PMID:23179753 PMID:28001369 PMID:31378766 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf21 fibroblast growth factor 21 multiple interactions EXP [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of FGF21 mRNA CTD PMID:30744511 NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056 		JBrowse link
G Fgf8 fibroblast growth factor 8 decreases expression
affects expression 		ISO
EXP 		methylmercuric chloride results in decreased expression of FGF8 mRNA
methylmercuric chloride affects the expression of FGF8 mRNA 		CTD PMID:20864626 PMID:21385734 NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:254,533,504...254,539,605 		JBrowse link
G Fgf9 fibroblast growth factor 9 increases expression
decreases expression 		ISO methylmercuric chloride results in increased expression of FGF9 mRNA
methylmercuric chloride results in decreased expression of FGF9 mRNA 		CTD PMID:23179753 PMID:27188386 PMID:28001369 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fgfbp3 fibroblast growth factor binding protein 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of FGFBP3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFBP3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 NCBI chr 1:244,056,569...244,058,574
Ensembl chr 1:244,056,307...244,065,654 		JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 affects expression
increases expression 		ISO methylmercuric chloride affects the expression of FGFR1 mRNA
methylmercuric chloride results in increased expression of FGFR1 mRNA 		CTD PMID:21613230 PMID:28001369 NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 decreases expression ISO methylmercuric chloride results in decreased expression of FGFR2 mRNA CTD PMID:28001369 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914 		JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 increases expression
multiple interactions 		ISO methylmercuric chloride results in increased expression of FGFR3 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR3 mRNA 		CTD PMID:23179753 PMID:26272509 PMID:27188386 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209 		JBrowse link
G Fgg fibrinogen gamma chain decreases expression ISO methylmercuric chloride results in decreased expression of FGG mRNA CTD PMID:23179753 NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170 		JBrowse link
G Fggy FGGY carbohydrate kinase domain containing decreases expression ISO methylmercuric chloride results in decreased expression of FGGY mRNA CTD PMID:28001369 NCBI chr 5:115,514,573...115,901,713
Ensembl chr 5:115,472,211...115,901,714 		JBrowse link
G Fh fumarate hydratase decreases expression ISO methylmercuric chloride results in decreased expression of FH mRNA CTD PMID:28001369 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627 		JBrowse link
G Fhl1 four and a half LIM domains 1 increases expression EXP methylmercuric chloride results in increased expression of FHL1 mRNA CTD PMID:20864626 NCBI chr  X:139,592,794...139,652,290
Ensembl chr  X:139,592,604...139,652,282 		JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression ISO methylmercuric chloride results in increased expression of FHL2 mRNA CTD PMID:28001369 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression ISO methylmercuric chloride results in decreased expression of FHOD3 mRNA CTD PMID:28001369 NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508 		JBrowse link
G Fibin fin bud initiation factor homolog increases expression ISO methylmercuric chloride results in increased expression of FIBIN mRNA CTD PMID:32870474 PMID:34089799 NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479 		JBrowse link
G Fign fidgetin, microtubule severing factor decreases expression ISO methylmercuric chloride results in decreased expression of FIGN mRNA CTD PMID:28001369 NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:69,045,050...69,169,988 		JBrowse link
G Fignl1 fidgetin-like 1 decreases expression ISO methylmercuric chloride results in decreased expression of FIGNL1 mRNA CTD PMID:28001369 NCBI chr14:90,573,090...90,595,342
Ensembl chr14:90,581,771...90,592,316 		JBrowse link
G Filip1 filamin A interacting protein 1 decreases expression ISO methylmercuric chloride results in decreased expression of FILIP1 mRNA CTD PMID:28001369 NCBI chr 8:89,641,509...89,836,772
Ensembl chr 8:89,644,579...89,802,771 		JBrowse link
G Filip1l filamin A interacting protein 1-like increases expression EXP
ISO 		methylmercuric chloride results in increased expression of FILIP1L mRNA CTD PMID:20864626 PMID:28001369 NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402 		JBrowse link
G Fkbp10 FKBP prolyl isomerase 10 decreases expression ISO methylmercuric chloride results in decreased expression of FKBP10 mRNA CTD PMID:23179753 PMID:28001369 NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 decreases expression ISO methylmercuric chloride results in decreased expression of FKBP11 mRNA CTD PMID:23179753 NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Fkbp14 FKBP prolyl isomerase 14 increases expression ISO methylmercuric chloride results in increased expression of FKBP14 mRNA CTD PMID:28001369 NCBI chr 4:85,035,840...85,051,917
Ensembl chr 4:85,037,145...85,051,808 		JBrowse link
G Fktn fukutin decreases expression ISO methylmercuric chloride results in decreased expression of FKTN mRNA CTD PMID:28001369 NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181 		JBrowse link
G Flcn folliculin increases expression ISO methylmercuric chloride results in increased expression of FLCN mRNA CTD PMID:28001369 NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309 		JBrowse link
G Flg2